1	The	DT	O	the	det	4	SENT_1	[p1l385t81r431b102],
2	NEW	NNP	O	NEW	nn	4	SENT_1	[p1l449t83r534b102],
3	ENGLAND	NNP	O	ENGLAND	nn	4	SENT_1	[p1l553t83r742b102],
4	JOURNAL	NNP	O	JOURNAL	_	0	SENT_1	[p1l761t83r940b109],
5	of	IN	O	of	_	0	SENT_1	[p1l960t81r988b108],
6	MEDICINE	NNP	O	MEDICINE	prep_of	4	SENT_1	[p1l1000t83r1199b102],

1	l	NN	O	l	_	0	SENT_2	[p1l92t184r95b303],
2	BRIEF	NNP	O	BRIEF	nn	3	SENT_2	[p1l634t234r763b260],
3	REPORT	NNP	O	REPORT	dep	1	SENT_2	[p1l780t234r954b260],
4	l	NN	O	l	tmod	3	SENT_2	[p1l1490t184r1493b303],

1	Acquired	VBN	O	acquire	_	0	SENT_3	[p1l270t378r544b448],
2	Resistance	NN	O	resistance	dobj	1	SENT_3	[p1l572t379r892b436],
3	to	TO	O	to	_	0	SENT_3	[p1l922t389r978b433],
4	Crizotinib	JJ	O	crizotinib	prep_to	1	SENT_3	[p1l1008t378r1311b433],
5	from	IN	O	from	_	0	SENT_3	[p1l309t460r456b515],
6	a	DT	O	a	det	7	SENT_3	[p1l485t479r516b515],
7	Mutation	NN	O	mutation	prep_from	1	SENT_3	[p1l542t461r819b516],
8	in	IN	O	in	_	0	SENT_3	[p1l847t461r905b514],
9	CD74	NN	O	cd74	prep_in	7	SENT_3	[p1l934t465r1274b516],
10	.	.	O	.	_	0	SENT_3	[p1l934t465r1274b516],

1	—	NN	O	—	_	0	SENT_4	[p1l934t465r1274b516],
2	.	.	O	.	_	0	SENT_4	[p1l934t465r1274b516],

1	ROS1	NN	O	ros1	_	0	SENT_5	[p1l934t465r1274b516],

1	Mark	NNP	PERSON	Mark	nn	3	SENT_6	[p1l123t583r207b614],
2	M.	NNP	PERSON	M.	nn	3	SENT_6	[p1l222t586r261b614],
3	Awad	NNP	PERSON	Awad	nsubj	47	SENT_6	[p1l274t583r376b620],
4	,	,	O	,	_	0	SENT_6	[p1l274t583r376b620],
5	M.D.	NNP	O	M.D.	appos	3	SENT_6	[p1l393t586r483b620],
6	,	,	O	,	_	0	SENT_6	[p1l393t586r483b620],
7	Ph.D.	NNP	O	Ph.D.	appos	5	SENT_6	[p1l501t583r600b620],
8	,	,	O	,	_	0	SENT_6	[p1l501t583r600b620],
9	Ryohei	NNP	PERSON	Ryohei	nn	10	SENT_6	[p1l617t583r725b624],
10	Katayama	NNP	PERSON	Katayama	appos	5	SENT_6	[p1l742t586r913b624],
11	,	,	O	,	_	0	SENT_6	[p1l742t586r913b624],
12	Ph.D.	NNP	O	Ph.D.	appos	5	SENT_6	[p1l931t583r1030b620],
13	,	,	O	,	_	0	SENT_6	[p1l931t583r1030b620],
14	Michele	NNP	PERSON	Michele	nn	15	SENT_6	[p1l1047t583r1178b614],
15	McTigue	NNP	PERSON	McTigue	appos	5	SENT_6	[p1l1193t586r1347b624],
16	,	,	O	,	_	0	SENT_6	[p1l1193t586r1347b624],
17	Ph.D.	NNP	O	Ph.D.	appos	5	SENT_6	[p1l1365t583r1463b620],
18	,	,	O	,	_	0	SENT_6	[p1l1365t583r1463b620],
19	Wei	NNP	PERSON	Wei	nn	20	SENT_6	[p1l155t635r217b663],
20	Liu	NNP	PERSON	Liu	appos	5	SENT_6	[p1l234t635r290b669],
21	,	,	O	,	_	0	SENT_6	[p1l234t635r290b669],
22	M.A.	NNP	O	M.A.	appos	5	SENT_6	[p1l308t634r393b669],
23	,	,	O	,	_	0	SENT_6	[p1l308t634r393b669],
24	Ya-Li	NNP	PERSON	Ya-Li	nn	25	SENT_6	[p1l406t635r488b663],
25	Deng	NNP	PERSON	Deng	appos	5	SENT_6	[p1l505t635r601b673],
26	,	,	O	,	_	0	SENT_6	[p1l505t635r601b673],
27	B.S.	NNP	O	B.S.	appos	5	SENT_6	[p1l618t635r689b669],
28	,	,	O	,	_	0	SENT_6	[p1l618t635r689b669],
29	Alexei	NNP	PERSON	Alexei	nn	30	SENT_6	[p1l702t632r800b663],
30	Brooun	NNP	PERSON	Brooun	appos	5	SENT_6	[p1l817t635r948b669],
31	,	,	O	,	_	0	SENT_6	[p1l817t635r948b669],
32	Ph.D.	NNP	O	Ph.D.	appos	5	SENT_6	[p1l965t632r1064b669],
33	,	,	O	,	_	0	SENT_6	[p1l965t632r1064b669],
34	Luc	NN	PERSON	luc	nn	35	SENT_6	[p1l1082t635r1138b663],
35	Friboulet	NNP	PERSON	Friboulet	appos	5	SENT_6	[p1l1153t632r1311b669],
36	,	,	O	,	_	0	SENT_6	[p1l1153t632r1311b669],
37	Ph.D.	NNP	O	Ph.D.	appos	5	SENT_6	[p1l1328t632r1427b669],
38	,	,	O	,	_	0	SENT_6	[p1l1328t632r1427b669],
39	Donghui	NNP	PERSON	Donghui	nn	40	SENT_6	[p1l169t682r312b723],
40	Huang	NNP	PERSON	Huang	appos	5	SENT_6	[p1l329t684r451b723],
41	,	,	O	,	_	0	SENT_6	[p1l329t684r451b723],
42	Ph.D.	NNP	O	Ph.D.	appos	5	SENT_6	[p1l468t682r567b719],
43	,	,	O	,	_	0	SENT_6	[p1l468t682r567b719],
44	Matthew	NNP	PERSON	Matthew	nn	46	SENT_6	[p1l584t682r731b713],
45	D.	NNP	PERSON	D.	nn	46	SENT_6	[p1l746t685r778b713],
46	Fa	NNP	PERSON	Fa	appos	5	SENT_6	[p1l795t682r869b719],
47	|	VBD	O	|	_	0	SENT_6	[p1l795t682r869b719],
48	|	CD	NUMBER	|	dobj	47	SENT_6	[p1l795t682r869b719],
49	<	JJR	O	<	amod	48	SENT_6	[p1l795t682r869b719],
50	,	,	O	,	_	0	SENT_6	[p1l795t682r869b719],
51	B.S.	NNP	O	B.S.	dep	49	SENT_6	[p1l886t684r957b719],
52	,	,	O	,	_	0	SENT_6	[p1l886t684r957b719],
53	Sergei	NNP	PERSON	Sergei	nn	54	SENT_6	[p1l972t684r1073b723],
54	Timofeevski	NNP	PERSON	Timofeevski	appos	51	SENT_6	[p1l1086t681r1301b719],
55	,	,	O	,	_	0	SENT_6	[p1l1086t681r1301b719],
56	Ph.D.	NNP	O	Ph.D.	appos	51	SENT_6	[p1l1318t682r1417b719],
57	,	,	O	,	_	0	SENT_6	[p1l1318t682r1417b719],
58	Keith	NNP	PERSON	Keith	nn	60	SENT_6	[p1l156t731r237b762],
59	D.	NNP	PERSON	D.	nn	60	SENT_6	[p1l255t734r288b762],
60	Wilner	NNP	PERSON	Wilner	appos	51	SENT_6	[p1l301t731r420b768],
61	,	,	O	,	_	0	SENT_6	[p1l301t731r420b768],
62	Ph.D.	NNP	O	Ph.D.	appos	51	SENT_6	[p1l437t731r536b768],
63	,	,	O	,	_	0	SENT_6	[p1l437t731r536b768],
64	Elizabeth	NNP	PERSON	Elizabeth	nn	66	SENT_6	[p1l554t731r704b762],
65	L.	NNP	PERSON	L.	nn	66	SENT_6	[p1l722t734r745b762],
66	Lockerman	NNP	PERSON	Lockerman	appos	51	SENT_6	[p1l763t731r957b768],
67	,	,	O	,	_	0	SENT_6	[p1l763t731r957b768],
68	B.A.	NNP	O	B.A.	appos	51	SENT_6	[p1l974t733r1048b768],
69	,	,	O	,	_	0	SENT_6	[p1l974t733r1048b768],
70	Tahsin	NNP	PERSON	Tahsin	nn	72	SENT_6	[p1l1061t731r1173b762],
71	M.	NNP	PERSON	M.	nn	72	SENT_6	[p1l1191t734r1230b762],
72	Khan	NNP	PERSON	Khan	appos	51	SENT_6	[p1l1248t731r1339b768],
73	,	,	O	,	_	0	SENT_6	[p1l1248t731r1339b768],
74	B.A.	NNP	O	B.A.	appos	51	SENT_6	[p1l1356t733r1430b768],
75	,	,	O	,	_	0	SENT_6	[p1l1356t733r1430b768],
76	Sidra	NNP	PERSON	Sidra	nn	77	SENT_6	[p1l158t781r243b812],
77	Mahmood	NNP	PERSON	Mahmood	appos	51	SENT_6	[p1l259t781r443b818],
78	,	,	O	,	_	0	SENT_6	[p1l259t781r443b818],
79	B.A.	NNP	O	B.A.	appos	51	SENT_6	[p1l460t783r642b821],
80	,	,	O	,	_	0	SENT_6	[p1l460t783r642b821],
81	Justin	NNP	PERSON	Justin	nn	83	SENT_6	[p1l460t783r642b821],
82	F.	NNP	PERSON	F.	nn	83	SENT_6	[p1l660t784r685b812],
83	Gainor	NNP	PERSON	Gainor	appos	51	SENT_6	[p1l699t784r823b818],
84	,	,	O	,	_	0	SENT_6	[p1l699t784r823b818],
85	M.D.	NNP	O	M.D.	appos	51	SENT_6	[p1l841t784r931b818],
86	,	,	O	,	_	0	SENT_6	[p1l841t784r931b818],
87	Subba	NNP	PERSON	Subba	nn	89	SENT_6	[p1l946t781r1050b812],
88	R.	NNP	PERSON	R.	nn	89	SENT_6	[p1l1066t784r1094b812],
89	Digumarthy	NNP	PERSON	Digumarthy	appos	51	SENT_6	[p1l1111t781r1318b822],
90	,	,	O	,	_	0	SENT_6	[p1l1111t781r1318b822],
91	M.D.	NNP	O	M.D.	appos	51	SENT_6	[p1l1336t784r1426b818],
92	,	,	O	,	_	0	SENT_6	[p1l1336t784r1426b818],

1	James	NNP	PERSON	James	nn	3	SENT_7	[p1l294t833r401b870],
2	R.	NNP	PERSON	R.	nn	3	SENT_7	[p1l418t833r445b861],
3	Stone	NNP	PERSON	Stone	_	0	SENT_7	[p1l460t833r565b867],
4	,	,	O	,	_	0	SENT_7	[p1l460t833r565b867],
5	M.D.	NNP	O	M.D.	appos	3	SENT_7	[p1l582t833r672b867],
6	,	,	O	,	_	0	SENT_7	[p1l582t833r672b867],
7	Ph.D.	NNP	O	Ph.D.	appos	3	SENT_7	[p1l689t830r788b867],
8	,	,	O	,	_	0	SENT_7	[p1l689t830r788b867],
9	Mari	NNP	PERSON	Mari	nn	10	SENT_7	[p1l805t833r879b861],
10	Mino-Kenudson	NNP	PERSON	Mino-Kenudson	appos	3	SENT_7	[p1l896t830r1177b867],
11	,	,	O	,	_	0	SENT_7	[p1l896t830r1177b867],
12	M.D.	NNP	O	M.D.	appos	3	SENT_7	[p1l1194t833r1284b867],
13	,	,	O	,	_	0	SENT_7	[p1l1194t833r1284b867],
14	James	NNP	PERSON	James	nn	16	SENT_7	[p1l295t883r402b920],
15	G.	NNP	PERSON	G.	nn	16	SENT_7	[p1l417t882r452b911],
16	Christensen	NNP	PERSON	Christensen	appos	3	SENT_7	[p1l466t880r678b917],
17	,	,	O	,	_	0	SENT_7	[p1l466t880r678b917],
18	Ph.D.	NNP	O	Ph.D.	appos	3	SENT_7	[p1l695t880r794b917],
19	,	,	O	,	_	0	SENT_7	[p1l695t880r794b917],
20	A.	NNP	PERSON	A.	nn	22	SENT_7	[p1l808t880r928b920],
21	John	NNP	PERSON	John	nn	22	SENT_7	[p1l808t880r928b920],
22	Iafrate	NNP	PERSON	Iafrate	appos	3	SENT_7	[p1l946t879r1059b917],
23	,	,	O	,	_	0	SENT_7	[p1l946t879r1059b917],
24	M.D.	NNP	O	M.D.	nn	26	SENT_7	[p1l1076t882r1166b917],
25	,	,	O	,	_	0	SENT_7	[p1l1076t882r1166b917],
26	Ph.D.	NNP	O	Ph.D.	appos	3	SENT_7	[p1l1184t880r1283b917],
27	,	,	O	,	_	0	SENT_7	[p1l1184t880r1283b917],

1	Jeffrey	NNP	PERSON	Jeffrey	nn	3	SENT_8	[p1l237t929r346b971],
2	A.	NNP	PERSON	A.	nn	3	SENT_8	[p1l357t932r389b961],
3	Engelman	NNP	PERSON	Engelman	_	0	SENT_8	[p1l406t930r582b971],
4	,	,	O	,	_	0	SENT_8	[p1l406t930r582b971],
5	M.D.	NNP	O	M.D.	conj_and	3	SENT_8	[p1l599t932r689b967],
6	,	,	O	,	_	0	SENT_8	[p1l599t932r689b967],
7	Ph.D.	NNP	O	Ph.D.	conj_and	3	SENT_8	[p1l707t930r806b967],
8	,	,	O	,	_	0	SENT_8	[p1l707t930r806b967],
9	and	CC	O	and	_	0	SENT_8	[p1l821t930r880b961],
10	Alice	NNP	PERSON	Alice	nn	12	SENT_8	[p1l894t930r975b961],
11	T.	NNP	PERSON	T.	nn	12	SENT_8	[p1l986t932r1016b961],
12	Shaw	NNP	PERSON	Shaw	conj_and	3	SENT_8	[p1l1031t930r1128b967],
13	,	,	O	,	_	0	SENT_8	[p1l1031t930r1128b967],
14	M.D.	NNP	O	M.D.	nn	16	SENT_8	[p1l1145t932r1235b967],
15	,	,	O	,	_	0	SENT_8	[p1l1145t932r1235b967],
16	Ph.D.	NNP	O	Ph.D.	appos	12	SENT_8	[p1l1253t930r1341b961],
17	.	.	O	.	_	0	SENT_8	[p1l1253t930r1341b961],

1	SUMMARY	NN	O	summary	_	0	SENT_9	[p1l687t1077r901b1100],

1	Crizotinib	NNP	PERSON	Crizotinib	nsubj	16	SENT_10	[p1l94t1177r272b1214],
2	,	,	O	,	_	0	SENT_10	[p1l94t1177r272b1214],
3	an	DT	O	a	det	4	SENT_10	[p1l293t1187r333b1208],
4	inhibitor	NN	O	inhibitor	appos	1	SENT_10	[p1l351t1177r499b1208],
5	of	IN	O	of	_	0	SENT_10	[p1l516t1177r555b1208],
6	anaplastic	JJ	O	anaplastic	amod	8	SENT_10	[p1l566t1177r735b1216],
7	lymphoma	NN	O	lymphoma	nn	8	SENT_10	[p1l753t1177r932b1216],
8	kinase	NN	O	kinase	prep_of	4	SENT_10	[p1l949t1177r1057b1208],
9	(	CD	NUMBER	(	num	11	SENT_10	[p1l1077t1180r1181b1214],
10	ALK	NN	O	alk	nn	11	SENT_10	[p1l1077t1180r1181b1214],
11	)	NN	O	)	dep	4	SENT_10	[p1l1077t1180r1181b1214],
12	,	,	O	,	_	0	SENT_10	[p1l1077t1180r1181b1214],
13	has	VBZ	O	have	aux	16	SENT_10	[p1l1201t1177r1257b1208],
14	also	RB	O	also	advmod	16	SENT_10	[p1l1276t1177r1343b1208],
15	recently	RB	DATE	recently	advmod	16	SENT_10	[p1l1361t1177r1493b1216],
16	shown	VBN	O	show	_	0	SENT_10	[p1l94t1226r203b1257],
17	efficacy	NN	O	efficacy	dobj	16	SENT_10	[p1l220t1226r351b1266],
18	in	IN	O	in	_	0	SENT_10	[p1l365t1227r397b1257],
19	the	DT	O	the	det	20	SENT_10	[p1l414t1226r465b1257],
20	treatment	NN	O	treatment	prep_in	16	SENT_10	[p1l482t1233r646b1257],
21	of	IN	O	of	_	0	SENT_10	[p1l661t1226r699b1257],
22	lung	NN	O	lung	nn	23	SENT_10	[p1l708t1226r783b1266],
23	cancers	NNS	O	cancer	prep_of	20	SENT_10	[p1l799t1236r923b1257],
24	with	IN	O	with	_	0	SENT_10	[p1l938t1226r1014b1257],
25	ROS1	NN	O	ros1	nn	26	SENT_10	[p1l1030t1229r1109b1258],
26	translocations	NNS	O	translocation	prep_with	16	SENT_10	[p1l1127t1226r1374b1257],
27	.	.	O	.	_	0	SENT_10	[p1l1127t1226r1374b1257],

1	Resistance	NN	O	resistance	nsubj	4	SENT_11	[p1l1392t1227r1491b1259, p1l94t1282r182b1306],
2	to	TO	O	to	_	0	SENT_11	[p1l201t1282r233b1306],
3	crizotinib	NN	O	crizotinib	prep_to	1	SENT_11	[p1l253t1276r416b1306],
4	developed	VBD	O	develop	_	0	SENT_11	[p1l435t1276r601b1315],
5	in	IN	O	in	_	0	SENT_11	[p1l619t1276r651b1306],
6	a	DT	O	a	det	7	SENT_11	[p1l670t1286r687b1306],
7	patient	NN	O	patient	prep_in	4	SENT_11	[p1l705t1276r822b1315],
8	with	IN	O	with	_	0	SENT_11	[p1l837t1276r913b1307],
9	metastatic	JJ	O	metastatic	amod	11	SENT_11	[p1l932t1276r1105b1306],
10	lung	NN	O	lung	nn	11	SENT_11	[p1l1123t1276r1198b1315],
11	adenocarcinoma	NN	O	adenocarcinoma	prep_with	7	SENT_11	[p1l1215t1276r1492b1306],
12	harboring	VBG	O	harbor	xcomp	4	SENT_11	[p1l94t1325r262b1364],
13	a	DT	O	a	det	14	SENT_11	[p1l281t1335r298b1355],
14	CD74	NN	O	cd74	dobj	12	SENT_11	[p1l318t1327r501b1356],
15	.	.	O	.	_	0	SENT_11	[p1l318t1327r501b1356],

1	—	NN	O	—	_	0	SENT_12	[p1l318t1327r501b1356],
2	.	.	O	.	_	0	SENT_12	[p1l318t1327r501b1356],

1	ROS1	NN	O	ros1	nn	2	SENT_13	[p1l318t1327r501b1356],
2	rearrangement	NN	O	rearrangement	_	0	SENT_13	[p1l523t1331r772b1364],
3	who	WP	O	who	nsubj	6	SENT_13	[p1l789t1325r860b1355],
4	had	VBD	O	have	aux	6	SENT_13	[p1l881t1325r942b1355],
5	initially	RB	O	initially	advmod	6	SENT_13	[p1l962t1325r1091b1364],
6	shown	VBN	O	show	rcmod	2	SENT_13	[p1l1111t1325r1220b1355],
7	a	DT	O	a	det	9	SENT_13	[p1l1240t1335r1258b1355],
8	dramatic	JJ	O	dramatic	amod	9	SENT_13	[p1l1278t1325r1427b1355],
9	response	NN	O	response	dobj	6	SENT_13	[p1l1447t1335r1491b1355, p1l94t1384r208b1413],
10	to	TO	O	to	_	0	SENT_13	[p1l222t1381r253b1405],
11	treatment	NN	O	treatment	prep_to	6	SENT_13	[p1l267t1381r439b1405],
12	.	.	O	.	_	0	SENT_13	[p1l267t1381r439b1405],

1	We	PRP	O	we	nsubj	10	SENT_14	[p1l453t1377r505b1405],
2	performed	VBD	O	perform	_	0	SENT_14	[p1l517t1374r695b1413],
3	a	DT	O	a	det	4	SENT_14	[p1l707t1384r725b1405],
4	biopsy	NN	O	biopsy	dobj	2	SENT_14	[p1l737t1374r845b1413],
5	of	IN	O	of	_	0	SENT_14	[p1l857t1374r896b1405],
6	a	DT	O	a	det	8	SENT_14	[p1l902t1384r919b1405],
7	resistant	JJ	O	resistant	amod	8	SENT_14	[p1l931t1375r1076b1405],
8	tumor	NN	O	tumor	prep_of	4	SENT_14	[p1l1087t1381r1191b1405],
9	and	CC	O	and	_	0	SENT_14	[p1l1203t1374r1264b1405],
10	identified	VBD	O	identify	conj_and	2	SENT_14	[p1l1277t1374r1439b1405],
11	an	DT	O	a	det	13	SENT_14	[p1l1451t1384r1492b1405],
12	acquired	VBN	O	acquire	amod	13	SENT_14	[p1l93t1424r237b1463],
13	mutation	NN	O	mutation	dobj	10	SENT_14	[p1l254t1424r406b1455],
14	leading	VBG	O	lead	partmod	13	SENT_14	[p1l423t1424r547b1463],
15	to	TO	O	to	_	0	SENT_14	[p1l563t1430r594b1454],
16	a	DT	O	a	det	20	SENT_14	[p1l612t1434r629b1454],
17	glycine	NN	O	glycine	nn	20	SENT_14	[p1l645t1424r965b1463],
18	—	CD	NUMBER	—	num	20	SENT_14	[p1l645t1424r965b1463],
19	to-arginine	NN	O	to-arginine	nn	20	SENT_14	[p1l645t1424r965b1463],
20	substitution	NN	O	substitution	prep_to	14	SENT_14	[p1l983t1424r1183b1454],
21	at	IN	O	at	_	0	SENT_14	[p1l1200t1430r1231b1454],
22	codon	NN	O	codon	prep_at	20	SENT_14	[p1l1246t1424r1348b1454],
23	2032	CD	DATE	2032	num	22	SENT_14	[p1l1365t1426r1442b1454],
24	in	IN	O	in	_	0	SENT_14	[p1l1460t1424r1492b1454],
25	the	DT	O	the	det	28	SENT_14	[p1l94t1473r145b1503],
26	ROS1	NN	O	ros1	nn	28	SENT_14	[p1l162t1475r253b1505],
27	kinase	NN	O	kinase	nn	28	SENT_14	[p1l270t1473r379b1504],
28	domain	NN	O	domain	prep_in	14	SENT_14	[p1l396t1473r533b1503],
29	.	.	O	.	_	0	SENT_14	[p1l396t1473r533b1503],

1	Although	IN	O	although	mark	6	SENT_15	[p1l551t1473r709b1512],
2	this	DT	O	this	det	3	SENT_15	[p1l727t1473r789b1503],
3	mutation	NN	O	mutation	nsubj	6	SENT_15	[p1l807t1473r959b1503],
4	does	VBZ	O	do	aux	6	SENT_15	[p1l977t1473r1052b1503],
5	not	RB	O	not	neg	6	SENT_15	[p1l1070t1479r1126b1503],
6	lie	VB	O	lie	advcl	13	SENT_15	[p1l1141t1473r1179b1503],
7	at	IN	O	at	_	0	SENT_15	[p1l1197t1479r1227b1503],
8	the	DT	O	the	det	10	SENT_15	[p1l1243t1473r1294b1503],
9	gatekeeper	NN	O	gatekeeper	nn	10	SENT_15	[p1l1312t1473r1493b1512],
10	residue	NN	O	residue	prep_at	6	SENT_15	[p1l94t1522r221b1560],
11	,	,	O	,	_	0	SENT_15	[p1l94t1522r221b1560],
12	it	PRP	O	it	nsubj	13	SENT_15	[p1l236t1523r259b1553],
13	confers	VBZ	O	confer	_	0	SENT_15	[p1l271t1522r393b1553],
14	resistance	NN	O	resistance	dobj	13	SENT_15	[p1l408t1523r574b1553],
15	to	TO	O	to	_	0	SENT_15	[p1l588t1529r620b1553],
16	ROS1	NN	O	ros1	nn	18	SENT_15	[p1l633t1525r724b1555],
17	kinase	NN	O	kinase	nn	18	SENT_15	[p1l738t1522r846b1554],
18	inhibition	NN	O	inhibition	prep_to	13	SENT_15	[p1l860t1522r1026b1553],
19	through	IN	O	through	_	0	SENT_15	[p1l1040t1522r1175b1562],
20	steric	JJ	O	steric	amod	21	SENT_15	[p1l1190t1523r1279b1553],
21	interference	NN	O	interference	prep_through	13	SENT_15	[p1l1292t1522r1491b1553],
22	with	IN	O	with	_	0	SENT_15	[p1l92t1572r167b1603],
23	drug	NN	O	drug	nn	24	SENT_15	[p1l186t1572r265b1611],
24	binding	NN	O	binding	prep_with	21	SENT_15	[p1l282t1572r420b1611],
25	.	.	O	.	_	0	SENT_15	[p1l282t1572r420b1611],

1	The	DT	O	the	det	4	SENT_16	[p1l439t1572r501b1602],
2	same	JJ	O	same	amod	4	SENT_16	[p1l519t1582r605b1602],
3	resistance	NN	O	resistance	nn	4	SENT_16	[p1l623t1572r789b1602],
4	mutation	NN	O	mutation	nsubjpass	6	SENT_16	[p1l807t1572r959b1602],
5	was	VBD	O	be	auxpass	6	SENT_16	[p1l976t1582r1039b1602],
6	observed	VBN	O	observe	_	0	SENT_16	[p1l1058t1572r1205b1602],
7	at	IN	O	at	_	0	SENT_16	[p1l1223t1578r1254b1602],
8	all	PDT	O	all	predet	11	SENT_16	[p1l1269t1572r1310b1602],
9	the	DT	O	the	det	11	SENT_16	[p1l1328t1572r1379b1602],
10	metastatic	JJ	O	metastatic	amod	11	SENT_16	[p1l1397t1578r1491b1602, p1l94t1621r183b1651],
11	sites	NNS	O	site	prep_at	6	SENT_16	[p1l200t1621r272b1651],
12	that	WDT	O	that	nsubjpass	14	SENT_16	[p1l290t1621r356b1651],
13	were	VBD	O	be	auxpass	14	SENT_16	[p1l370t1631r448b1652],
14	examined	VBN	O	examine	rcmod	11	SENT_16	[p1l465t1621r628b1651],
15	at	IN	O	at	_	0	SENT_16	[p1l645t1627r676b1651],
16	autopsy	NN	O	autopsy	prep_at	14	SENT_16	[p1l690t1627r824b1660],
17	,	,	O	,	_	0	SENT_16	[p1l690t1627r824b1660],
18	suggesting	VBG	O	suggest	xcomp	14	SENT_16	[p1l844t1621r1026b1660],
19	that	IN	O	that	complm	25	SENT_16	[p1l1042t1621r1109b1651],
20	this	DT	O	this	det	21	SENT_16	[p1l1124t1621r1186b1651],
21	mutation	NN	O	mutation	nsubj	25	SENT_16	[p1l1204t1621r1356b1651],
22	was	VBD	O	be	cop	25	SENT_16	[p1l1371t1631r1434b1652],
23	an	DT	O	a	det	25	SENT_16	[p1l1452t1631r1492b1651],
24	early	JJ	O	early	amod	25	SENT_16	[p1l94t1670r174b1709],
25	event	NN	O	event	ccomp	18	SENT_16	[p1l192t1677r279b1701],
26	in	IN	O	in	_	0	SENT_16	[p1l296t1671r329b1700],
27	the	DT	O	the	det	29	SENT_16	[p1l349t1670r401b1701],
28	clonal	JJ	O	clonal	amod	29	SENT_16	[p1l421t1670r522b1701],
29	evolution	NN	O	evolution	prep_in	25	SENT_16	[p1l542t1670r695b1701],
30	of	IN	O	of	_	0	SENT_16	[p1l715t1670r753b1701],
31	resistance	NN	O	resistance	prep_of	29	SENT_16	[p1l766t1671r941b1701],
32	.	.	O	.	_	0	SENT_16	[p1l766t1671r941b1701],

1	(	NN	O	(	nsubj	2	SENT_17	[p1l965t1670r1101b1705],
2	Funded	VBN	O	fund	_	0	SENT_17	[p1l965t1670r1101b1705],
3	by	IN	O	by	_	0	SENT_17	[p1l1121t1670r1159b1709],
4	Pﬁzer	NN	PERSON	pﬁzer	prep_by	2	SENT_17	[p1l1176t1670r1277b1701],
5	and	CC	O	and	_	0	SENT_17	[p1l1295t1670r1357b1701],
6	others	NNS	O	other	prep_by	2	SENT_17	[p1l1377t1670r1490b1707],
7	;	:	O	;	_	0	SENT_17	[p1l1377t1670r1490b1707],
8	ClinicalTrials	NNS	O	clinicaltrial	dep	4	SENT_17	[p1l94t1720r389b1759],
9	.	.	O	.	_	0	SENT_17	[p1l94t1720r389b1759],

1	gov	NN	O	gov	nn	2	SENT_18	[p1l94t1720r389b1759],
2	number	NN	O	number	_	0	SENT_18	[p1l401t1720r539b1757],
3	,	,	O	,	_	0	SENT_18	[p1l401t1720r539b1757],
4	NCT00585195	NN	O	nct00585195	appos	2	SENT_18	[p1l554t1722r809b1755],
5	.	.	O	.	_	0	SENT_18	[p1l554t1722r809b1755],
6	)	SYM	O	)	dep	2	SENT_18	[p1l554t1722r809b1755],

1	INCE	NNP	O	INCE	nsubj	53	SENT_19	[p1l191t1878r277b1900],
2	THE	DT	O	the	det	4	SENT_19	[p1l292t1878r365b1900],
3	PIVOTAL	JJ	MISC	pivotal	amod	4	SENT_19	[p1l383t1878r531b1900],
4	DISCOVERY	NN	MISC	discovery	nsubj	28	SENT_19	[p1l548t1878r745b1900],
5	OF	IN	MISC	of	_	0	SENT_19	[p1l760t1878r804b1900],
6	IMATINIB	NNP	MISC	IMATINIB	nn	9	SENT_19	[p1l822t1878r996b1900],
7	AS	NNP	O	AS	nn	9	SENT_19	[p1l1012t1878r1052b1900],
8	A	NNP	O	A	nn	9	SENT_19	[p1l1068t1878r1091b1900],
9	SAFE	NNPS	O	SAFE	prep_of	4	SENT_19	[p1l1107t1878r1189b1900],
10	AND	CC	O	and	_	0	SENT_19	[p1l1204t1878r1285b1900],
11	EFFECTIVE	NNP	O	EFFECTIVE	conj_and	9	SENT_19	[p1l1303t1878r1492b1900],
12	From	IN	O	from	_	0	SENT_19	[p1l1533t1878r1598b1899],
13	the	DT	O	the	det	14	SENT_19	[p1l1625t1875r1666b1899],
14	Departments	NNP	O	Departments	prep_from	28	SENT_19	[p1l1696t1878r1867b1906],
15	of	IN	O	of	_	0	SENT_19	[p1l1895t1875r1923b1899],
16	Medicine	NNP	O	Medicine	nn	17	SENT_19	[p1l1948t1875r2067b1899],
17	drug	NN	O	drug	prep_of	14	SENT_19	[p1l190t1920r271b1959],
18	for	IN	O	for	_	0	SENT_19	[p1l285t1919r333b1950],
19	the	DT	O	the	det	20	SENT_19	[p1l347t1920r398b1950],
20	treatment	NN	O	treatment	prep_for	17	SENT_19	[p1l414t1926r578b1950],
21	of	IN	O	of	_	0	SENT_19	[p1l591t1919r630b1950],
22	chronic	JJ	O	chronic	amod	27	SENT_19	[p1l638t1920r764b1950],
23	myeloid	JJ	O	myeloid	amod	27	SENT_19	[p1l779t1920r909b1959],
24	leukemia	NN	O	leukemia	nn	27	SENT_19	[p1l923t1920r1101b1957],
25	}	NN	O	}	nn	27	SENT_19	[p1l923t1920r1101b1957],
26	kinase	NN	O	kinase	nn	27	SENT_19	[p1l1115t1920r1224b1950],
27	inhibitors	NNS	O	inhibitor	prep_of	20	SENT_19	[p1l1238t1920r1402b1950],
28	have	VBP	O	have	rcmod	1	SENT_19	[p1l1418t1920r1492b1950],
29	lM	NN	O	lm	dobj	28	SENT_19	[p1l1534t1915r1648b1944],
30	~	CD	NUMBER	~	num	29	SENT_19	[p1l1534t1915r1648b1944],
31	M	NN	O	m	prep	29	SENT_19	[p1l1534t1915r1648b1944],
32	~	NN	O	~	nn	33	SENT_19	[p1l1534t1915r1648b1944],
33	A	NN	O	a	dep	31	SENT_19	[p1l1534t1915r1648b1944],
34	'	''	O	'	_	0	SENT_19	[p1l1534t1915r1648b1944],
35	i	FW	O	i	dep	29	SENT_19	[p1l1534t1915r1648b1944],
36	R	NN	O	r	nn	38	SENT_19	[p1l1665t1915r1722b1941],
37	~	NN	O	~	nn	38	SENT_19	[p1l1665t1915r1722b1941],
38	K	NN	O	k	dep	35	SENT_19	[p1l1665t1915r1722b1941],
39	~	CD	NUMBER	~	dep	35	SENT_19	[p1l1665t1915r1722b1941],
40	v	LS	O	v	dep	35	SENT_19	[p1l1665t1915r1722b1941],
41	LF	SYM	O	lf	dep	43	SENT_19	[p1l1738t1915r1787b1941],
42	"	``	O	"	punct	43	SENT_19	[p1l1738t1915r1787b1941],
43	E	NN	O	e	dep	35	SENT_19	[p1l1804t1915r1880b1956],
44	'	''	O	'	_	0	SENT_19	[p1l1804t1915r1880b1956],
45	l	NN	O	l	tmod	35	SENT_19	[p1l1804t1915r1880b1956],
46	"	''	O	"	punct	29	SENT_19	[p1l1804t1915r1880b1956],
47	L	NN	O	l	dep	29	SENT_19	[p1l1804t1915r1880b1956],
48	_	CD	NUMBER	_	num	47	SENT_19	[p1l1804t1915r1880b1956],
49	"	``	O	"	punct	47	SENT_19	[p1l1804t1915r1880b1956],
50	T	NN	O	t	dep	47	SENT_19	[p1l1894t1915r1986b1941],
51	'M	VBP	O	be	cop	53	SENT_19	[p1l1894t1915r1986b1941],
52	'	''	O	'	_	0	SENT_19	[p1l1894t1915r1986b1941],
53	K	NN	O	k	dep	70	SENT_19	[p1l1894t1915r1986b1941],
54	"	''	O	"	punct	53	SENT_19	[p1l1894t1915r1986b1941],
55	5-M	NN	O	5-m	nsubj	70	SENT_19	[p1l2001t1915r2066b1941],
56	"	''	O	"	punct	55	SENT_19	[p1l2001t1915r2066b1941],
57	. . .	FW	O	. . .	nn	58	SENT_19	[p1l1445t1970r1450b1975],[p1l679t1970r684b1975],
58	j.F.G.	FW	O	j.f.g.	amod	55	SENT_19	[p1l1527t1952r1606b1981],
59	,	,	O	,	_	0	SENT_19	[p1l1527t1952r1606b1981],
60	J.A.E.	NNP	O	J.A.E.	appos	55	SENT_19	[p1l1616t1952r1697b1981],
61	,	,	O	,	_	0	SENT_19	[p1l1616t1952r1697b1981],
62	A.T.S.	NNP	O	A.T.S.	nn	63	SENT_19	[p1l1711t1952r1801b1981],
63	)	NNP	O	)	appos	55	SENT_19	[p1l1711t1952r1801b1981],
64	,	,	O	,	_	0	SENT_19	[p1l1711t1952r1801b1981],
65	Radiology	NNP	O	Radiology	appos	55	SENT_19	[p1l1818t1950r1945b1982],
66	(	CD	NUMBER	(	num	65	SENT_19	[p1l1960t1952r2065b1982],
67	S.R.D.	NNP	O	S.R.D.	dep	65	SENT_19	[p1l1960t1952r2065b1982],
68	)	CD	NUMBER	)	num	67	SENT_19	[p1l1960t1952r2065b1982],
69	,	,	O	,	_	0	SENT_19	[p1l1960t1952r2065b1982],
70	emerged	VBD	O	emerge	_	0	SENT_19	[p1l190t1970r333b2009],
71	as	IN	O	as	_	0	SENT_19	[p1l346t1980r379b2000],
72	powerful	JJ	O	powerful	amod	73	SENT_19	[p1l392t1969r544b2009],
73	agents	NNS	O	agent	prep_as	70	SENT_19	[p1l556t1976r663b2009],
74	in	IN	O	in	_	0	SENT_19	[p1l677t1980r709b2000],
75	the	DT	O	the	det	76	SENT_19	[p1l722t1970r774b2000],
76	treatment	NN	O	treatment	prep_in	70	SENT_19	[p1l787t1976r951b2000],
77	of	IN	O	of	_	0	SENT_19	[p1l963t1969r1001b2000],
78	several	JJ	O	several	amod	79	SENT_19	[p1l1008t1970r1121b2000],
79	cancers	NNS	O	cancer	prep_of	76	SENT_19	[p1l1134t1980r1268b2000],
80	.	.	O	.	_	0	SENT_19	[p1l1134t1980r1268b2000],

1	The	DT	O	the	det	2	SENT_20	[p1l1282t1970r1344b2000],
2	identifi	NN	O	identifus	_	0	SENT_20	[p1l1357t1969r1491b2000],
3	-	:	O	-	_	0	SENT_20	[p1l1357t1969r1491b2000],
4	and	CC	O	and	_	0	SENT_20	[p1l1532t1988r1577b2012],
5	Pathology	NN	O	pathology	nn	6	SENT_20	[p1l1599t1988r1728b2019],
6	U_R	NN	O	u_r	conj_and	2	SENT_20	[p1l1748t1990r1828b2019],
7	.	.	O	.	_	0	SENT_20	[p1l1748t1990r1828b2019],

1	S	NN	O	s	nsubj	31	SENT_21	[p1l1748t1990r1828b2019],
2	_	CD	NUMBER	_	num	1	SENT_21	[p1l1748t1990r1828b2019],
3	M.M.	NNP	ORGANIZATION	M.M.	nn	8	SENT_21	[p1l1857t1990r1960b2012],
4	_	NNP	ORGANIZATION	_	nn	8	SENT_21	[p1l1857t1990r1960b2012],
5	K.	NNP	ORGANIZATION	K.	nn	8	SENT_21	[p1l1857t1990r1960b2012],
6	AM	NNP	ORGANIZATION	AM	nn	8	SENT_21	[p1l1987t1990r2057b2019],
7	)	JJ	O	)	amod	8	SENT_21	[p1l1987t1990r2057b2019],
8	cation	NN	O	cation	dep	1	SENT_21	[p1l94t2020r196b2050],
9	of	IN	O	of	_	0	SENT_21	[p1l211t2019r250b2050],
10	activating	VBG	O	activate	amod	11	SENT_21	[p1l257t2020r421b2059],
11	mutations	NNS	O	mutation	prep_of	1	SENT_21	[p1l434t2020r603b2051],
12	within	IN	O	within	prep	11	SENT_21	[p1l617t2020r727b2051],
13	the	DT	O	the	det	15	SENT_21	[p1l742t2020r793b2050],
14	kinase	NN	O	kinase	nn	15	SENT_21	[p1l808t2020r916b2051],
15	domain	NN	O	domain	dep	27	SENT_21	[p1l932t2020r1059b2050],
16	of	IN	O	of	_	0	SENT_21	[p1l1074t2019r1113b2050],
17	the	DT	O	the	det	19	SENT_21	[p1l1121t2020r1173b2050],
18	epidermal	JJ	O	epidermal	amod	19	SENT_21	[p1l1188t2020r1355b2059],
19	growth	NN	O	growth	prep_of	15	SENT_21	[p1l1370t2020r1492b2059],
20	Massachusetts	NNP	ORGANIZATION	Massachusetts	nn	25	SENT_21	[p1l1533t2026r1728b2049],
21	General	NNP	ORGANIZATION	General	nn	25	SENT_21	[p1l1740t2026r1841b2049],
22	Hospital	NNP	ORGANIZATION	Hospital	nn	25	SENT_21	[p1l1856t2026r1964b2056],
23	Cancer	NNP	ORGANIZATION	Cancer	nn	25	SENT_21	[p1l1977t2027r2068b2049],
24	factor	NN	O	factor	nn	25	SENT_21	[p1l94t2070r191b2100],
25	receptor	NN	O	receptor	dep	27	SENT_21	[p1l203t2076r341b2109],
26	(	CD	NUMBER	(	num	27	SENT_21	[p1l355t2072r512b2105],
27	EGFR	NN	ORGANIZATION	egfr	dep	12	SENT_21	[p1l355t2072r512b2105],
28	)	CD	NUMBER	)	num	29	SENT_21	[p1l355t2072r512b2105],
29	23	CD	NUMBER	23	dep	27	SENT_21	[p1l355t2072r512b2105],
30	has	VBZ	O	have	aux	31	SENT_21	[p1l526t2070r582b2100],
31	led	VBN	O	lead	_	0	SENT_21	[p1l596t2070r644b2100],
32	to	TO	O	to	_	0	SENT_21	[p1l658t2076r690b2101],
33	the	DT	O	the	det	35	SENT_21	[p1l704t2070r755b2100],
34	widespread	JJ	O	widespread	amod	35	SENT_21	[p1l767t2070r957b2109],
35	use	NN	O	use	prep_to	31	SENT_21	[p1l970t2080r1025b2101],
36	of	IN	O	of	_	0	SENT_21	[p1l1039t2070r1078b2100],
37	kinase	NN	O	kinase	nn	38	SENT_21	[p1l1084t2070r1192b2101],
38	inhibitors	NNS	O	inhibitor	prep_of	35	SENT_21	[p1l1205t2070r1369b2100],
39	in	IN	O	in	_	0	SENT_21	[p1l1383t2070r1415b2100],
40	this	DT	O	this	det	43	SENT_21	[p1l1429t2070r1491b2100],
41	Ceme	NN	O	ceme	nn	43	SENT_21	[p1l1532t2065r1622b2091],
42	“	NN	O	“	nn	43	SENT_21	[p1l1532t2065r1622b2091],
43	B	NN	O	b	prep_in	38	SENT_21	[p1l1634t2065r1731b2091],
44	°	CD	NUMBER	°	num	45	SENT_21	[p1l1634t2065r1731b2091],
45	5t	NN	O	5t	dep	43	SENT_21	[p1l1634t2065r1731b2091],
46	°	CD	NUMBER	°	rcmod	45	SENT_21	[p1l1634t2065r1731b2091],
47	"	``	O	"	punct	46	SENT_21	[p1l1634t2065r1731b2091],
48	i	FW	O	i	nn	53	SENT_21	[p1l1634t2065r1731b2091],
49	‘	FW	O	‘	nn	53	SENT_21	[p1l1740t2063r1786b2087],
50	*	FW	O	*	nn	53	SENT_21	[p1l1740t2063r1786b2087],
51	“	FW	O	“	nn	53	SENT_21	[p1l1740t2063r1786b2087],
52	d	NN	O	d	nn	53	SENT_21	[p1l1740t2063r1786b2087],
53	Pf	NN	O	pf	dep	46	SENT_21	[p1l1797t2063r2018b2087],
54	'	''	O	'	_	0	SENT_21	[p1l1797t2063r2018b2087],
55	Ze’W	NN	O	ze’w	dep	46	SENT_21	[p1l1797t2063r2018b2087],
56	°	NN	O	°	nn	58	SENT_21	[p1l1797t2063r2018b2087],
57	'	''	O	'	_	0	SENT_21	[p1l1797t2063r2018b2087],
58	l‘lW	NN	O	l‘lw	dep	55	SENT_21	[p1l1797t2063r2018b2087],
59	'	''	O	'	_	0	SENT_21	[p1l1797t2063r2018b2087],
60	de	IN	O	de	_	0	SENT_21	[p1l1797t2063r2018b2087],
61	Re	NNP	O	Re	prep_de	38	SENT_21	[p1l2028t2065r2067b2087],
62	‘	CD	NUMBER	‘	num	61	SENT_21	[p1l2028t2065r2067b2087],
63	.	.	O	.	_	0	SENT_21	[p1l189t2120r194b2126],

1	.	.	O	.	_	0	SENT_22	[p1l343t2120r347b2126],

1	4	CD	NUMBER	4	dep	4	SENT_23	[p1l807t2122r821b2138],
2	I	PRP	O	I	dep	3	SENT_23	[p1l1034t2120r1043b2150],
3	h	NN	O	h	dep	1	SENT_23	[p1l1098t2120r1119b2150],
4	I	PRP	O	I	dep	15	SENT_23	[p1l1303t2120r1313b2150],
5	I	PRP	O	I	nsubj	6	SENT_23	[p1l1412t2120r1421b2150],
6	search	VBP	O	search	parataxis	15	SENT_23	[p1l1532t2101r1614b2124],
7	and	CC	O	and	cc	8	SENT_23	[p1l1634t2101r1679b2124],
8	Development	NNP	O	Development	dobj	6	SENT_23	[p1l1700t2101r1883b2132],
9	,	,	O	,	_	0	SENT_23	[p1l1700t2101r1883b2132],
10	La	NNP	PERSON	La	nn	11	SENT_23	[p1l1904t2103r1930b2124],
11	Jolla	NNP	PERSON	Jolla	appos	8	SENT_23	[p1l1945t2101r2011b2131],
12	,	,	O	,	_	0	SENT_23	[p1l1945t2101r2011b2131],
13	CA	NNP	O	CA	nsubj	15	SENT_23	[p1l2030t2102r2068b2124],
14	genetically	RB	O	genetically	advmod	15	SENT_23	[p1l93t2120r274b2176],
15	defined	VBD	O	define	_	0	SENT_23	[p1l285t2120r412b2151],
16	subset	NN	O	subset	dobj	15	SENT_23	[p1l424t2120r530b2176],
17	of	IN	O	of	_	0	SENT_23	[p1l541t2120r580b2151],
18	lung	NN	O	lung	nn	19	SENT_23	[p1l584t2120r659b2176],
19	cancers	NNS	O	cancer	prep_of	16	SENT_23	[p1l670t2130r804b2176],
20	.	.	O	.	_	0	SENT_23	[p1l670t2130r804b2176],

1	More	RBR	O	more	advmod	2	SENT_24	[p1l832t2123r918b2151],
2	recent	JJ	O	recent	amod	3	SENT_24	[p1l930t2126r1033b2176],
3	y	NN	O	y	_	0	SENT_24	[p1l1044t2131r1067b2176],
4	,	,	O	,	_	0	SENT_24	[p1l1044t2131r1067b2176],
5	c	NN	O	c	nn	6	SENT_24	[p1l1081t2130r1097b2150],
6	romosorna	NN	O	romosorna	appos	3	SENT_24	[p1l1121t2130r1301b2176],
7	trans	JJ	O	trans	amod	8	SENT_24	[p1l1325t2126r1410b2150],
8	oca	NN	O	oca	dep	3	SENT_24	[p1l1423t2130r1491b2151],
9	—	CD	NUMBER	—	number	10	SENT_24	[p1l1423t2130r1491b2151],
10	(	CD	NUMBER	(	num	11	SENT_24	[p1l1534t2140r1619b2169],
11	MIMI	NNP	ORGANIZATION	MIMI	dep	8	SENT_24	[p1l1534t2140r1619b2169],
12	,	,	O	,	_	0	SENT_24	[p1l1534t2140r1619b2169],
13	W	NNP	O	W	nn	14	SENT_24	[p1l1633t2140r1697b2166],
14	_	NNP	O	_	appos	8	SENT_24	[p1l1633t2140r1697b2166],
15	,	,	O	,	_	0	SENT_24	[p1l1633t2140r1697b2166],
16	_	CD	NUMBER	_	appos	14	SENT_24	[p1l1633t2140r1697b2166],
17	.	.	O	.	_	0	SENT_24	[p1l1633t2140r1697b2166],

1	,	,	O	,	_	0	SENT_25	[p1l1633t2140r1697b2166],
2	Y	NN	O	y	_	0	SENT_25	[p1l1711t2140r1803b2166],
3	__	CD	NUMBER	__	dep	2	SENT_25	[p1l1711t2140r1803b2166],
4	,	,	O	,	_	0	SENT_25	[p1l1711t2140r1803b2166],
5	_	CD	NUMBER	_	dep	2	SENT_25	[p1l1711t2140r1803b2166],
6	.	.	O	.	_	0	SENT_25	[p1l1711t2140r1803b2166],

1	D.	NNP	O	D.	nn	7	SENT_26	[p1l1711t2140r1803b2166],
2	’	NNP	O	’	nn	7	SENT_26	[p1l1711t2140r1803b2166],
3	AB	NNP	O	AB	nn	7	SENT_26	[p1l1817t2140r1877b2166],
4	”	NNP	O	”	nn	7	SENT_26	[p1l1817t2140r1877b2166],
5	DH	NNP	O	DH	nn	7	SENT_26	[p1l1894t2140r1959b2166],
6	”	NNP	O	”	nn	7	SENT_26	[p1l1894t2140r1959b2166],
7	M_D_F.	NNP	O	M_D_F.	_	0	SENT_26	[p1l1975t2140r2066b2166],
8	,	,	O	,	_	0	SENT_26	[p1l1975t2140r2066b2166],
9	tions	NNS	O	tion	appos	7	SENT_26	[p1l94t2176r176b2201],
10	that	WDT	O	that	nsubj	11	SENT_26	[p1l190t2170r257b2200],
11	create	VBP	O	create	rcmod	9	SENT_26	[p1l269t2176r367b2200],
12	fusion	NN	O	fusion	nn	13	SENT_26	[p1l381t2170r486b2201],
13	proteins	NNS	O	protein	dobj	11	SENT_26	[p1l499t2176r636b2209],
14	involving	VBG	O	involve	_	0	SENT_26	[p1l650t2170r804b2209],
15	the	DT	O	the	det	18	SENT_26	[p1l817t2170r868b2200],
16	tyrosine	NN	O	tyrosine	nn	18	SENT_26	[p1l882t2177r1017b2209],
17	kinase	NN	O	kinase	nn	18	SENT_26	[p1l1030t2170r1139b2201],
18	domains	NNS	O	domain	prep_involving	13	SENT_26	[p1l1153t2170r1297b2201],
19	of	IN	O	of	_	0	SENT_26	[p1l1312t2170r1351b2201],
20	ALK5	NN	O	alk5	prep_of	18	SENT_26	[p1l1356t2172r1443b2201],
21	or	CC	O	or	_	0	SENT_26	[p1l1458t2180r1493b2201],
22	S.T.	NNP	O	S.T.	nn	26	SENT_26	[p1l1532t2178r1582b2204],
23	,	,	O	,	_	0	SENT_26	[p1l1532t2178r1582b2204],
24	K.D.W.	NNP	O	K.D.W.	appos	26	SENT_26	[p1l1600t2178r1692b2204],
25	,	,	O	,	_	0	SENT_26	[p1l1600t2178r1692b2204],
26	j.G.C.	NNP	O	j.G.C.	conj_or	20	SENT_26	[p1l1703t2178r1797b2207],
27	)	CD	NUMBER	)	num	26	SENT_26	[p1l1703t2178r1797b2207],
28	.	.	O	.	_	0	SENT_26	[p1l1703t2178r1797b2207],

1	Address	NN	O	address	nsubj	2	SENT_27	[p1l1811t2176r1917b2199],
2	reprint	VBP	O	reprint	_	0	SENT_27	[p1l1933t2178r2020b2207],
3	reROS1	NN	O	reros1	nsubj	8	SENT_27	[p1l2035t2184r2067b2199, p1l93t2221r198b2252],
4	°	CD	NUMBER	°	num	3	SENT_27	[p1l2035t2184r2067b2199, p1l93t2221r198b2252],
5	have	VBP	O	have	aux	8	SENT_27	[p1l214t2220r287b2251],
6	been	VBN	O	be	cop	8	SENT_27	[p1l304t2220r382b2250],
7	the	DT	O	the	det	8	SENT_27	[p1l398t2220r449b2250],
8	subject	NN	O	subject	ccomp	2	SENT_27	[p1l466t2220r582b2259],
9	of	IN	O	of	_	0	SENT_27	[p1l596t2219r635b2250],
10	intense	JJ	O	intense	amod	11	SENT_27	[p1l644t2220r764b2250],
11	investigation	NN	O	investigation	prep_of	8	SENT_27	[p1l779t2220r995b2259],
12	in	IN	O	in	_	0	SENT_27	[p1l1010t2220r1043b2250],
13	lung	NN	O	lung	nn	14	SENT_27	[p1l1058t2220r1133b2259],
14	adenocarcinoma	NN	O	adenocarcinoma	prep_in	11	SENT_27	[p1l1148t2220r1425b2250],
15	be	VB	O	be	cop	16	SENT_27	[p1l1440t2220r1491b2250],
16	—	JJ	O	—	dep	14	SENT_27	[p1l1440t2220r1491b2250],
17	q	NN	O	q	nsubj	34	SENT_27	[p1l1531t2217r1650b2244],
18	“	CD	NUMBER	“	num	17	SENT_27	[p1l1531t2217r1650b2244],
19	°	CD	NUMBER	°	num	21	SENT_27	[p1l1531t2217r1650b2244],
20	5t5t	NN	O	5t5t	nn	21	SENT_27	[p1l1531t2217r1650b2244],
21	°	NN	O	°	dep	17	SENT_27	[p1l1531t2217r1650b2244],
22	D	NN	O	d	poss	25	SENT_27	[p1l1662t2215r1713b2237],
23	's	POS	O	's	_	0	SENT_27	[p1l1662t2215r1713b2237],
24	’	NN	O	’	nn	25	SENT_27	[p1l1662t2215r1713b2237],
25	E	NN	O	e	dep	17	SENT_27	[p1l1725t2213r1851b2244],
26	"	''	O	"	punct	25	SENT_27	[p1l1725t2213r1851b2244],
27	3e	CD	NUMBER	3e	dep	25	SENT_27	[p1l1725t2213r1851b2244],
28	'm	VBP	O	be	cop	34	SENT_27	[p1l1725t2213r1851b2244],
29	‘‘	JJ	O	‘‘	amod	34	SENT_27	[p1l1725t2213r1851b2244],
30	”	NN	O	”	amod	34	SENT_27	[p1l1725t2213r1851b2244],
31	3	CD	NUMBER	3	number	30	SENT_27	[p1l1862t2213r1908b2237],
32	“	NN	O	“	nn	34	SENT_27	[p1l1862t2213r1908b2237],
33	§	NN	O	§	nn	34	SENT_27	[p1l1919t2213r1987b2256],
34	l	NN	O	l	ccomp	16	SENT_27	[p1l1919t2213r1987b2256],
35	‘	CD	NUMBER	‘	number	36	SENT_27	[p1l1919t2213r1987b2256],
36	3	CD	NUMBER	3	dep	37	SENT_27	[p1l1919t2213r1987b2256],
37	‘	NN	O	‘	dep	34	SENT_27	[p1l1919t2213r1987b2256],
38	"	''	O	"	punct	11	SENT_27	[p1l1919t2213r1987b2256],
39	“	IN	O	“	prep	8	SENT_27	[p1l1995t2213r2067b2237],
40	the	DT	O	the	det	41	SENT_27	[p1l1995t2213r2067b2237],
41	f	FW	O	f	dep	42	SENT_27	[p1l223t2269r241b2300],
42	h	NN	O	h	dep	45	SENT_27	[p1l265t2270r285b2300],
43	.1	CD	NUMBER	.1	num	42	SENT_27	[p1l377t2270r396b2300],
44	/	:	O	/	punct	45	SENT_27	[p1l417t2270r468b2301],
45	*	CD	NUMBER	*	dep	39	SENT_27	[p1l417t2270r468b2301],
46	f	LS	O	f	dep	45	SENT_27	[p1l539t2269r557b2300],
47	1	LS	NUMBER	1	dep	45	SENT_27	[p1l585t2270r604b2300],
48	.	.	O	.	_	0	SENT_27	[p1l585t2270r604b2300],

1	.	.	O	.	_	0	SENT_28	[p1l634t2270r639b2276],

1	11	CD	NUMBER	11	_	0	SENT_29	[p1l680t2270r701b2300],
2	.	.	O	.	_	0	SENT_29	[p1l787t2270r792b2275],

1	.	.	O	.	_	0	SENT_30	[p1l848t2270r853b2275],

1	/	:	O	/	punct	5	SENT_31	[p1l881t2270r943b2301],
2	*	FW	O	*	nn	3	SENT_31	[p1l881t2270r943b2301],
3	f	FW	O	f	dep	4	SENT_31	[p1l1048t2269r1067b2300],
4	h	NN	O	h	dep	5	SENT_31	[p1l1091t2270r1111b2300],
5	1	CD	NUMBER	1	_	0	SENT_31	[p1l1181t2270r1210b2300],
6	.	.	O	.	_	0	SENT_31	[p1l1181t2270r1210b2300],

1	1h	NN	O	1h	nn	6	SENT_32	[p1l1361t2270r1406b2300],
2	h	NN	O	h	nn	6	SENT_32	[p1l1471t2270r1492b2300],
3	Massachusetts	NNP	ORGANIZATION	Massachusetts	nn	6	SENT_32	[p1l1533t2251r1728b2274],
4	General	NNP	ORGANIZATION	General	nn	6	SENT_32	[p1l1740t2251r1841b2274],
5	Hospital	NNP	ORGANIZATION	Hospital	nn	6	SENT_32	[p1l1856t2251r1964b2282],
6	Cancer	NNP	ORGANIZATION	Cancer	nsubj	7	SENT_32	[p1l1977t2252r2068b2274],
7	cause	VB	O	cause	_	0	SENT_32	[p1l94t2280r184b2326],
8	o	NN	O	o	nn	9	SENT_32	[p1l202t2280r221b2326],
9	teavai	NNS	O	teavaus	nn	14	SENT_32	[p1l251t2276r384b2326],
10	a	DT	O	a	det	13	SENT_32	[p1l398t2280r415b2300],
11	i	FW	O	i	nn	13	SENT_32	[p1l437t2280r447b2300],
12	ityo	FW	O	ityo	nn	13	SENT_32	[p1l461t2276r539b2326],
13	cinica	FW	O	cinica	dep	9	SENT_32	[p1l568t2280r678b2300],
14	y'	NN	O	y'	dobj	7	SENT_32	[p1l702t2276r828b2326],
15	active	JJ	O	active	amod	14	SENT_32	[p1l702t2276r828b2326],
16	in	IN	O	in	_	0	SENT_32	[p1l846t2280r878b2300],
17	i	FW	O	i	nn	18	SENT_32	[p1l903t2280r913b2300],
18	ltOI‘S	FW	O	ltoi‘s	prep_in	15	SENT_32	[p1l935t2276r1046b2326],
19	.	.	O	.	_	0	SENT_32	[p1l935t2276r1046b2326],

1	O	NN	O	o	_	0	SENT_33	[p1l935t2276r1046b2326],
2	t	NN	O	t	dep	1	SENT_33	[p1l1077t2276r1089b2300],
3	.	.	O	.	_	0	SENT_33	[p1l1105t2280r1164b2326],

1	ese	FW	O	ese	_	0	SENT_34	[p1l1105t2280r1164b2326],
2	<	JJR	O	<	amod	3	SENT_34	[p1l1188t2280r1316b2326],
3	inases	NNS	O	inase	dep	1	SENT_34	[p1l1188t2280r1316b2326],
4	.	.	O	.	_	0	SENT_34	[p1l1188t2280r1316b2326],

1	At	IN	O	at	_	0	SENT_35	[p1l1334t2273r1384b2326],
2	oug	NN	O	oug	nn	4	SENT_35	[p1l1408t2280r1470b2309],
3	Centeryss	NNP	O	Centeryss	nn	4	SENT_35	[p1l1532t2290r1659b2316],
4	Fruits	NNP	O	Fruits	prep_at	18	SENT_35	[p1l1671t2290r2068b2316],
5	,	,	O	,	_	0	SENT_35	[p1l1671t2290r2068b2316],
6	”	CD	NUMBER	”	num	7	SENT_35	[p1l1671t2290r2068b2316],
7	BoSt0n	NN	O	bost0n	nsubj	18	SENT_35	[p1l1671t2290r2068b2316],
8	,	,	O	,	_	0	SENT_35	[p1l1671t2290r2068b2316],
9	MA02114	NN	O	ma02114	dep	18	SENT_35	[p1l1671t2290r2068b2316],
10	,	,	O	,	_	0	SENT_35	[p1l1671t2290r2068b2316],
11	°	NN	O	°	dep	9	SENT_35	[p1l1671t2290r2068b2316],
12	,	,	O	,	_	0	SENT_35	[p1l1671t2290r2068b2316],
13	kinase	NN	O	kinase	nn	14	SENT_35	[p1l93t2320r202b2351],
14	inhibitors	NNS	O	inhibitor	nsubj	18	SENT_35	[p1l213t2320r377b2351],
15	can	MD	O	can	aux	18	SENT_35	[p1l390t2330r448b2350],
16	be	VB	O	be	cop	18	SENT_35	[p1l460t2320r497b2351],
17	highly	RB	O	highly	advmod	18	SENT_35	[p1l509t2320r615b2359],
18	effective	JJ	O	effective	_	0	SENT_35	[p1l625t2320r773b2357],
19	,	,	O	,	_	0	SENT_35	[p1l625t2320r773b2357],
20	most	JJS	O	most	amod	21	SENT_35	[p1l787t2326r871b2351],
21	cancers	NNS	O	cancer	nsubj	23	SENT_35	[p1l881t2330r1005b2350],
22	invariably	RB	O	invariably	advmod	23	SENT_35	[p1l1018t2320r1182b2359],
23	acquire	VB	O	acquire	ccomp	18	SENT_35	[p1l1192t2330r1313b2359],
24	resistance	NN	O	resistance	dobj	23	SENT_35	[p1l1325t2326r1491b2350],
25	at	IN	O	at	_	0	SENT_35	[p1l1532t2330r1555b2349],
26	jengelman@partners.org	NN	O	jengelman@partners.org	amod	33	SENT_35	[p1l1563t2326r1896b2357],
27	or	CC	O	or	_	0	SENT_35	[p1l1906t2334r1933b2349],
28	ashaw1	NN	O	ashaw1	conj_or	26	SENT_35	[p1l1942t2326r2065b2354],
29	@	IN	O	@	amod	33	SENT_35	[p1l1942t2326r2065b2354],
30	to	TO	O	to	_	0	SENT_35	[p1l94t2375r125b2400],
31	these	DT	O	these	prep_to	29	SENT_35	[p1l144t2369r231b2399],
32	targeted	VBN	O	target	partmod	31	SENT_35	[p1l250t2369r387b2408],
33	therapies	NNS	O	therapy	prep_at	23	SENT_35	[p1l406t2369r566b2408],
34	,	,	O	,	_	0	SENT_35	[p1l406t2369r566b2408],
35	an	DT	O	a	det	36	SENT_35	[p1l587t2379r627b2399],
36	effect	NN	O	effect	appos	33	SENT_35	[p1l645t2369r739b2399],
37	that	WDT	O	that	nsubj	38	SENT_35	[p1l755t2369r822b2399],
38	represents	VBZ	O	represent	rcmod	36	SENT_35	[p1l839t2375r1010b2408],
39	a	DT	O	a	det	41	SENT_35	[p1l1029t2379r1046b2399],
40	major	JJ	O	major	amod	41	SENT_35	[p1l1064t2369r1161b2408],
41	limitation	NN	O	limitation	dobj	38	SENT_35	[p1l1178t2369r1345b2400],
42	to	TO	O	to	_	0	SENT_35	[p1l1363t2376r1395b2400],
43	their	PRP$	O	they	poss	44	SENT_35	[p1l1414t2369r1493b2399],
44	Pa	NNP	O	Pa	prep_to	41	SENT_35	[p1l1533t2367r1700b2393, p1l93t2419r259b2474],
45	”	CD	NUMBER	”	num	44	SENT_35	[p1l1533t2367r1700b2393, p1l93t2419r259b2474],
46	"	``	O	"	punct	44	SENT_35	[p1l1533t2367r1700b2393, p1l93t2419r259b2474],
47	e	SYM	O	e	dep	44	SENT_35	[p1l1533t2367r1700b2393, p1l93t2419r259b2474],
48	'	''	O	'	_	0	SENT_35	[p1l1533t2367r1700b2393, p1l93t2419r259b2474],
49	5	CD	NUMBER	5	dep	41	SENT_35	[p1l1533t2367r1700b2393, p1l93t2419r259b2474],
50	°	NN	O	°	dep	49	SENT_35	[p1l1533t2367r1700b2393, p1l93t2419r259b2474],
51	'	''	O	'	_	0	SENT_35	[p1l1533t2367r1700b2393, p1l93t2419r259b2474],
52	glong	JJ	O	glong	amod	54	SENT_35	[p1l1533t2367r1700b2393, p1l93t2419r259b2474],
53	—	NN	O	—	nn	54	SENT_35	[p1l1533t2367r1700b2393, p1l93t2419r259b2474],
54	term	NN	O	term	dep	41	SENT_35	[p1l1533t2367r1700b2393, p1l93t2419r259b2474],
55	clinical	JJ	O	clinical	amod	56	SENT_35	[p1l272t2419r393b2474],
56	benefit	NN	O	benefit	dep	54	SENT_35	[p1l406t2419r532b2450],
57	.	.	O	.	_	0	SENT_35	[p1l406t2419r532b2450],

1	By	IN	O	by	_	0	SENT_36	[p1l546t2422r587b2458],
2	identifying	VBG	O	identify	prepc_by	25	SENT_36	[p1l597t2419r781b2458],
3	the	DT	O	the	det	4	SENT_36	[p1l793t2419r844b2449],
4	ways	NNS	O	way	dobj	2	SENT_36	[p1l855t2429r935b2458],
5	in	IN	O	in	_	0	SENT_36	[p1l948t2419r981b2449],
6	which	WDT	O	which	rel	8	SENT_36	[p1l991t2419r1094b2450],
7	cancers	NNS	O	cancer	nsubj	8	SENT_36	[p1l1106t2429r1231b2449],
8	evolve	VBP	O	evolve	rcmod	4	SENT_36	[p1l1244t2419r1343b2474],
9	to	TO	O	to	aux	10	SENT_36	[p1l1356t2426r1388b2450],
10	evade	VB	O	evade	xcomp	8	SENT_36	[p1l1401t2419r1492b2474],
11	This	DT	O	this	det	12	SENT_36	[p1l1530t2437r1585b2461],
12	article	NN	O	article	nsubjpass	14	SENT_36	[p1l1605t2437r1685b2461],
13	was	VBD	O	be	auxpass	14	SENT_36	[p1l1703t2446r1751b2461],
14	published	VBN	O	publish	ccomp	10	SENT_36	[p1l1772t2437r1898b2468],
15	on	IN	O	on	_	0	SENT_36	[p1l1919t2446r1949b2461],
16	June	NNP	DATE	June	prep_on	14	SENT_36	[p1l1965t2440r2026b2468],
17	1	CD	DATE	1	num	16	SENT_36	[p1l2047t2440r2065b2465],
18	,	,	O	,	_	0	SENT_36	[p1l2047t2440r2065b2465],
19	kinase	NN	O	kinase	nn	20	SENT_36	[p1l93t2468r202b2499],
20	inhibitors	NNS	O	inhibitor	appos	16	SENT_36	[p1l215t2468r388b2505],
21	,	,	O	,	_	0	SENT_36	[p1l215t2468r388b2505],
22	researchers	NNS	O	researcher	nsubj	25	SENT_36	[p1l403t2468r592b2498],
23	have	VBP	O	have	aux	25	SENT_36	[p1l606t2468r680b2499],
24	been	VBN	O	be	cop	25	SENT_36	[p1l694t2468r772b2499],
25	able	JJ	O	able	_	0	SENT_36	[p1l785t2468r851b2499],
26	to	TO	O	to	aux	27	SENT_36	[p1l865t2474r896b2499],
27	develop	VB	O	develop	xcomp	25	SENT_36	[p1l910t2468r1036b2507],
28	new	JJ	O	new	amod	30	SENT_36	[p1l1049t2478r1118b2499],
29	therapeutic	JJ	O	therapeutic	amod	30	SENT_36	[p1l1130t2468r1318b2507],
30	strategies	NNS	O	strategy	iobj	27	SENT_36	[p1l1332t2474r1491b2507],
31	2013	CD	DATE	2013	dobj	27	SENT_36	[p1l1531t2475r1598b2502],
32	,	,	O	,	_	0	SENT_36	[p1l1531t2475r1598b2502],
33	at	IN	O	at	_	0	SENT_36	[p1l1609t2478r1632b2497],
34	NEjM.org	NN	O	nejm.org	prep_at	25	SENT_36	[p1l1643t2476r1774b2505],
35	.	.	O	.	_	0	SENT_36	[p1l1643t2476r1774b2505],

1	to	TO	O	to	aux	2	SENT_37	[p1l94t2524r125b2549],
2	overcome	VB	O	overcome	_	0	SENT_37	[p1l140t2528r298b2549],
3	‘	JJ	O	‘	amod	4	SENT_37	[p1l307t2518r477b2574],
4	resistance	NN	O	resistance	dobj	2	SENT_37	[p1l307t2518r477b2574],
5	in	IN	O	in	_	0	SENT_37	[p1l490t2518r523b2548],
6	several	JJ	O	several	prep_in	2	SENT_37	[p1l537t2518r832b2574],
7	.	.	O	.	_	0	SENT_37	[p1l537t2518r832b2574],

1	cance	NN	O	cance	_	0	SENT_38	[p1l537t2518r832b2574],
2	.	.	O	.	_	0	SENT_38	[p1l537t2518r832b2574],

1	rs	NNS	O	r	_	0	SENT_39	[p1l537t2518r832b2574],
2	.7	CD	NUMBER	.7	num	3	SENT_39	[p1l537t2518r832b2574],
3	»	CD	NUMBER	»	dep	1	SENT_39	[p1l537t2518r832b2574],
4	.3	NN	NUMBER	.3	prep	3	SENT_39	[p1l537t2518r832b2574],
5	‘	NN	O	‘	dep	4	SENT_39	[p1l847t2568r852b2574],
6	.	.	O	.	_	0	SENT_39	[p1l957t2568r962b2574],
7	'	''	O	'	_	0	SENT_39	[p1l1023t2568r1028b2574],
8	'	''	O	'	_	0	SENT_39	[p1l1058t2569r1062b2574],
9	'	''	O	'	_	0	SENT_39	[p1l1108t2568r1113b2574],

1	.	.	O	.	_	0	SENT_40	[p1l1177t2568r1182b2574],
2	'	''	O	'	_	0	SENT_40	[p1l1328t2569r1332b2574],
3	'	''	O	'	_	0	SENT_40	[p1l1391t2568r1396b2574],

1	N	NN	O	n	_	0	SENT_41	[p1l1533t2540r1550b2560],
2	Eng	NN	O	eng	nsubj	4	SENT_41	[p1l1560t2538r1622b2567],
3	”	CD	NUMBER	”	num	2	SENT_41	[p1l1560t2538r1622b2567],
4	Med	VBD	O	med	ccomp	1	SENT_41	[p1l1633t2538r1683b2560],
5	2o13	NN	O	2o13	dobj	4	SENT_41	[p1l1691t2540r1919b2565],
6	;	:	O	;	_	0	SENT_41	[p1l1691t2540r1919b2565],
7	36	CD	NUMBER	36	dep	5	SENT_41	[p1l1691t2540r1919b2565],
8	,	,	O	,	_	0	SENT_41	[p1l1691t2540r1919b2565],
9	,	,	O	,	_	0	SENT_41	[p1l1691t2540r1919b2565],
10	.	.	O	.	_	0	SENT_41	[p1l1691t2540r1919b2565],

1	m5_401	NN	O	m5_401	dep	109	SENT_42	[p1l1691t2540r1919b2565],
2	_	CD	NUMBER	_	dep	109	SENT_42	[p1l1691t2540r1919b2565],
3	The	DT	O	the	dep	109	SENT_42	[p1l142t2568r204b2598],
4	multitargeted	JJ	O	multitargeted	dep	109	SENT_42	[p1l224t2568r453b2607],
5	tyrosine	NN	O	tyrosine	dep	109	SENT_42	[p1l473t2574r607b2607],
6	kinase	NN	O	kinase	dep	109	SENT_42	[p1l627t2568r735b2599],
7	inhibitor	NN	O	inhibitor	dep	109	SENT_42	[p1l755t2568r903b2599],
8	crizotinib	NN	O	crizotinib	dep	109	SENT_42	[p1l922t2568r1085b2599],
9	1S	NN	O	1	dep	109	SENT_42	[p1l1105t2578r1131b2598],
10	highly	RB	O	highly	dep	109	SENT_42	[p1l1151t2568r1257b2607],
11	active	JJ	O	active	dep	109	SENT_42	[p1l1275t2574r1369b2599],
12	in	IN	O	in	dep	109	SENT_42	[p1l1388t2578r1421b2598],
13	pa	NN	O	pa	dep	109	SENT_42	[p1l1440t2578r1491b2607],
14	—	CD	NUMBER	—	dep	109	SENT_42	[p1l1440t2578r1491b2607],
15	DOI	NNP	O	DOI	dep	109	SENT_42	[p1l1533t2577r1891b2604],
16	:10.1056	CD	NUMBER	:10.1056	dep	109	SENT_42	[p1l1533t2577r1891b2604],
17	/	:	O	/	dep	109	SENT_42	[p1l1533t2577r1891b2604],
18	NEjMoa1215530	NN	O	nejmoa1215530	dep	109	SENT_42	[p1l1533t2577r1891b2604],
19	tients	NNS	O	tient	dep	109	SENT_42	[p1l94t2617r185b2647],
20	with	IN	O	with	dep	109	SENT_42	[p1l198t2617r274b2648],
21	lung	NN	O	lung	dep	109	SENT_42	[p1l286t2617r362b2656],
22	cancer	NN	O	cancer	dep	109	SENT_42	[p1l374t2627r483b2647],
23	who	WP	O	who	dep	109	SENT_42	[p1l493t2617r564b2648],
24	harbor	VBP	O	harbor	dep	109	SENT_42	[p1l578t2617r691b2648],
25	rearrangements	NNS	O	rearrangement	dep	109	SENT_42	[p1l703t2623r968b2656],
26	in	IN	O	in	dep	109	SENT_42	[p1l982t2617r1014b2647],
27	ALK9v1	NN	O	alk9v1	dep	109	SENT_42	[p1l1025t2619r1141b2647],
28	°	CD	NUMBER	°	dep	109	SENT_42	[p1l1025t2619r1141b2647],
29	or	CC	O	or	dep	109	SENT_42	[p1l1154t2627r1189b2648],
30	ROS1	NN	O	ros1	dep	109	SENT_42	[p1l1200t2619r1356b2648],
31	.11	CD	NUMBER	.11	dep	109	SENT_42	[p1l1200t2619r1356b2648],
32	‘	CD	NUMBER	‘	dep	109	SENT_42	[p1l1200t2619r1356b2648],
33	13	CD	NUMBER	13	dep	109	SENT_42	[p1l1200t2619r1356b2648],
34	Prompt	VB	O	prompt	dep	109	SENT_42	[p1l1369t2620r1494b2656],
35	C	NN	O	c	dep	109	SENT_42	[p1l1532t2615r1655b2640],
36	“	JJ	O	“	dep	109	SENT_42	[p1l1532t2615r1655b2640],
37	/	:	O	/	dep	109	SENT_42	[p1l1532t2615r1655b2640],
38	"	``	O	"	dep	109	SENT_42	[p1l1532t2615r1655b2640],
39	Y	NN	O	y	dep	109	SENT_42	[p1l1532t2615r1655b2640],
40	”	CD	NUMBER	”	dep	109	SENT_42	[p1l1532t2615r1655b2640],
41	1	CD	NUMBER	1	dep	109	SENT_42	[p1l1532t2615r1655b2640],
42	‘	NN	O	‘	dep	109	SENT_42	[p1l1532t2615r1655b2640],
43	=	JJ	O	=	dep	109	SENT_42	[p1l1532t2615r1655b2640],
44	”	CD	NUMBER	”	dep	109	SENT_42	[p1l1532t2615r1655b2640],
45	"	``	O	"	dep	109	SENT_42	[p1l1532t2615r1655b2640],
46	©	NN	O	©	dep	109	SENT_42	[p1l1532t2615r1655b2640],
47	2	CD	NUMBER	2	dep	109	SENT_42	[p1l1665t2616r1714b2634],
48	°	CD	NUMBER	°	dep	109	SENT_42	[p1l1665t2616r1714b2634],
49	13	CD	NUMBER	13	dep	109	SENT_42	[p1l1665t2616r1714b2634],
50	"	``	O	"	dep	109	SENT_42	[p1l1723t2615r1863b2634],
51	”“	CD	NUMBER	”“	dep	109	SENT_42	[p1l1723t2615r1863b2634],
52	““	CD	NUMBER	““	dep	109	SENT_42	[p1l1723t2615r1863b2634],
53	"	``	O	"	dep	109	SENT_42	[p1l1723t2615r1863b2634],
54	'	''	O	'	_	0	SENT_42	[p1l1723t2615r1863b2634],
55	“	CD	NUMBER	“	dep	109	SENT_42	[p1l1723t2615r1863b2634],
56	"	``	O	"	dep	109	SENT_42	[p1l1723t2615r1863b2634],
57	"	``	O	"	dep	109	SENT_42	[p1l1723t2615r1863b2634],
58	"	``	O	"	dep	109	SENT_42	[p1l1723t2615r1863b2634],
59	’	CD	NUMBER	’	dep	109	SENT_42	[p1l1872t2615r1949b2634],
60	V	NN	O	v	dep	109	SENT_42	[p1l1872t2615r1949b2634],
61	"	''	O	"	dep	109	SENT_42	[p1l1872t2615r1949b2634],
62	"	``	O	"	dep	109	SENT_42	[p1l1872t2615r1949b2634],
63	”‘	CD	NUMBER	”‘	dep	109	SENT_42	[p1l1872t2615r1949b2634],
64	”’	CD	NUMBER	”’	dep	109	SENT_42	[p1l1872t2615r1949b2634],
65	5	CD	NUMBER	5	dep	109	SENT_42	[p1l1957t2616r2029b2640],
66	"	``	O	"	dep	109	SENT_42	[p1l1957t2616r2029b2640],
67	"	``	O	"	dep	109	SENT_42	[p1l1957t2616r2029b2640],
68	'	''	O	'	_	0	SENT_42	[p1l1957t2616r2029b2640],
69	“	CD	NUMBER	“	dep	109	SENT_42	[p1l1957t2616r2029b2640],
70	V	NN	O	v	dep	109	SENT_42	[p1l1957t2616r2029b2640],
71	'	''	O	'	_	0	SENT_42	[p1l1957t2616r2029b2640],
72	identification	NN	O	identification	dep	109	SENT_42	[p1l93t2666r320b2697],
73	of	IN	O	of	dep	109	SENT_42	[p1l336t2666r374b2697],
74	secondary	JJ	O	secondary	dep	109	SENT_42	[p1l383t2666r553b2705],
75	ALK	NN	O	alk	dep	109	SENT_42	[p1l565t2668r632b2696],
76	mutations	NNS	O	mutation	dep	109	SENT_42	[p1l645t2666r813b2697],
77	that	WDT	O	that	dep	109	SENT_42	[p1l830t2666r897b2696],
78	confer	VBP	O	confer	dep	109	SENT_42	[p1l911t2666r1017b2697],
79	resistance	NN	O	resistance	dep	109	SENT_42	[p1l1032t2667r1198b2696],
80	to	TO	O	to	dep	109	SENT_42	[p1l1214t2672r1245b2697],
81	crizotinib14	NN	O	crizotinib14	dep	109	SENT_42	[p1l1262t2666r1492b2697],
82	‘	CD	NUMBER	‘	dep	109	SENT_42	[p1l1262t2666r1492b2697],
83	16	CD	NUMBER	16	dep	109	SENT_42	[p1l1262t2666r1492b2697],
84	has	VBZ	O	have	dep	109	SENT_42	[p1l93t2715r149b2745],
85	led	VBN	O	lead	dep	109	SENT_42	[p1l164t2715r213b2746],
86	to	TO	O	to	dep	109	SENT_42	[p1l227t2722r259b2746],
87	the	DT	O	the	dep	109	SENT_42	[p1l274t2715r325b2745],
88	clinical	JJ	O	clinical	dep	109	SENT_42	[p1l340t2715r462b2745],
89	investigation	NN	O	investigation	dep	109	SENT_42	[p1l475t2715r691b2754],
90	of	IN	O	of	dep	109	SENT_42	[p1l705t2715r744b2746],
91	novel	JJ	O	novel	dep	109	SENT_42	[p1l751t2715r838b2746],
92	compounds	NNS	O	compound	dep	109	SENT_42	[p1l852t2715r1047b2754],
93	that	WDT	O	that	dep	109	SENT_42	[p1l1062t2715r1129b2745],
94	are	VBP	O	be	dep	109	SENT_42	[p1l1141t2725r1191b2745],
95	able	JJ	O	able	dep	109	SENT_42	[p1l1206t2715r1272b2746],
96	to	TO	O	to	dep	109	SENT_42	[p1l1286t2721r1318b2746],
97	overcome	VB	O	overcome	dep	109	SENT_42	[p1l1333t2725r1491b2746],
98	crizotinib	JJ	O	crizotinib	dep	109	SENT_42	[p1l94t2764r257b2795],
99	resistance	NN	O	resistance	dep	109	SENT_42	[p1l270t2764r509b2795],
100	.17	CD	NUMBER	.17	dep	109	SENT_42	[p1l270t2764r509b2795],
101	i18	NN	O	i18	dep	109	SENT_42	[p1l270t2764r509b2795],
102	Similarly	RB	O	similarly	dep	109	SENT_42	[p1l523t2764r677b2803],
103	,	,	O	,	_	0	SENT_42	[p1l523t2764r677b2803],
104	elucidating	VBG	O	elucidate	dep	109	SENT_42	[p1l693t2764r878b2803],
105	the	DT	O	the	dep	109	SENT_42	[p1l890t2764r941b2794],
106	molecular	JJ	O	molecular	dep	109	SENT_42	[p1l954t2764r1122b2795],
107	mechanisms	NNS	O	mechanism	dep	109	SENT_42	[p1l1134t2764r1345b2794],
108	of	IN	O	of	dep	109	SENT_42	[p1l1359t2764r1397b2795],
109	resisN	NN	O	resisn	_	0	SENT_42	[p1l1403t2764r1491b2794, p1l478t2872r491b2887],

1	ENGLJ	NNP	O	ENGLJ	nn	2	SENT_43	[p1l506t2872r584b2894],
2	MED	NNP	O	MED	_	0	SENT_43	[p1l599t2872r651b2887],
3	368,25	CD	NUMBER	368,25	num	5	SENT_43	[p1l661t2866r740b2894],
4	NEJM.ORG	NNP	O	NEJM.ORG	nn	5	SENT_43	[p1l775t2872r899b2894],
5	JUNE	NNP	DATE	JUNE	dep	2	SENT_43	[p1l930t2872r994b2894],
6	20,2013	CD	NUMBER	20,2013	number	7	SENT_43	[p1l1005t2872r1109b2894],
7	23395	CD	NUMBER	23395	dep	5	SENT_43	[p1l1990t2862r2065b2885],

1	The	DT	O	the	det	4	SENT_44	[p1l752t2929r803b2953],
2	New	NNP	O	New	nn	4	SENT_44	[p1l812t2930r874b2953],
3	England	NNP	O	England	nn	4	SENT_44	[p1l883t2929r994b2960],
4	Journal	NNP	O	Journal	_	0	SENT_44	[p1l1003t2929r1100b2953],
5	of	IN	O	of	_	0	SENT_44	[p1l1110t2929r1139b2953],
6	Medicine	NNP	O	Medicine	prep_of	4	SENT_44	[p1l1145t2929r1270b2953],

1	The	DT	O	the	det	4	SENT_45	[p1l673t3117r718b3138],
2	NEW	NNP	O	NEW	nn	4	SENT_45	[p1l737t3119r822b3138],
3	ENGLAND	NNP	O	ENGLAND	nn	4	SENT_45	[p1l841t3119r1029b3138],
4	JOURNAL	NNP	O	JOURNAL	_	0	SENT_45	[p1l1048t3119r1227b3145],
5	of	IN	O	of	_	0	SENT_45	[p1l1247t3117r1275b3144],
6	MEDICINE	NNP	O	MEDICINE	prep_of	4	SENT_45	[p1l1287t3119r1486b3138],

1	tance	NN	O	tance	nsubj	9	SENT_46	[p1l8t3357r239b3420],
2	in	IN	O	in	_	0	SENT_46	[p1l281t3341r365b3419],
3	ROSl	NN	O	rosl	nn	4	SENT_46	[p1l406t3340r1124b3442],
4	—	NN	O	—	prep_in	1	SENT_46	[p1l406t3340r1124b3442],
5	rearranged	VBN	O	rearrange	partmod	4	SENT_46	[p1l406t3340r1124b3442],
6	cancers	NNS	O	cancer	dobj	5	SENT_46	[p1l1168t3366r1491b3420],
7	will	MD	O	will	aux	9	SENT_46	[p1l1531t3341r1697b3421],
8	be	VB	O	be	cop	9	SENT_46	[p1l1740t3341r1837b3420],
9	essential	JJ	O	essential	_	0	SENT_46	[p1l1881t3366r2148b3420, p1l8t3471r148b3550],
10	to	TO	O	to	_	0	SENT_46	[p1l203t3487r286b3550],
11	the	DT	O	the	det	13	SENT_46	[p1l343t3471r476b3550],
12	rapid	JJ	O	rapid	amod	13	SENT_46	[p1l531t3471r752b3572],
13	development	NN	O	development	prep_to	9	SENT_46	[p1l807t3470r1362b3572],
14	of	IN	O	of	_	0	SENT_46	[p1l1412t3470r1513b3550],
15	more	JJR	O	more	amod	17	SENT_46	[p1l1549t3496r1771b3550],
16	durable	JJ	O	durable	amod	17	SENT_46	[p1l1827t3471r2149b3551],
17	treatments	NNS	O	treatment	prep_of	13	SENT_46	[p1l8t3617r476b3680],
18	for	IN	O	for	_	0	SENT_46	[p1l517t3600r642b3680],
19	these	DT	O	these	det	20	SENT_46	[p1l680t3601r904b3680],
20	patients	NNS	O	patient	prep_for	17	SENT_46	[p1l943t3601r1312b3702],
21	.	.	O	.	_	0	SENT_46	[p1l943t3601r1312b3702],

1	A	DT	O	a	det	2	SENT_47	[p2l134t27r201b98],
2	Woman	NNP	O	Woman	nsubj	12	SENT_47	[p2l253t46r577b100],
3	with	IN	O	with	_	0	SENT_47	[p2l633t21r830b100],
4	metastatic	JJ	O	metastatic	amod	6	SENT_47	[p2l889t21r1340b99],
5	lung	NN	O	lung	nn	6	SENT_47	[p2l1398t21r1592b121],
6	adenocarcinoma	NN	O	adenocarcinoma	prep_with	2	SENT_47	[p2l1648t21r2148b99, p2l8t175r254b229],
7	harboring	VBG	O	harbor	partmod	6	SENT_47	[p2l300t150r739b251],
8	a	DT	O	a	det	10	SENT_47	[p2l782t176r827b229],
9	ROSI	NNP	O	ROSI	nn	10	SENT_47	[p2l870t156r1077b230],
10	rearrangement	NN	O	rearrangement	dobj	7	SENT_47	[p2l1127t166r1775b251],
11	initially	RB	O	initially	advmod	12	SENT_47	[p2l1817t150r2153b251],
12	showed	VBD	O	show	_	0	SENT_47	[p2l9t280r335b360],
13	a	DT	O	a	det	14	SENT_47	[p2l374t306r418b359],
14	response	NN	O	response	dobj	12	SENT_47	[p2l456t305r840b381],
15	to	TO	O	to	_	0	SENT_47	[p2l880t296r962b359],
16	treatment	NN	O	treatment	prep_to	12	SENT_47	[p2l1004t296r1431b359],
17	with	IN	O	with	_	0	SENT_47	[p2l1460t280r1657b360],
18	crizotinib	NN	O	crizotinib	prep_with	12	SENT_47	[p2l1697t280r2144b376],
19	,	,	O	,	_	0	SENT_47	[p2l1697t280r2144b376],
20	but	CC	O	but	_	0	SENT_47	[p2l8t410r148b490],
21	the	DT	O	the	det	22	SENT_47	[p2l187t410r318b489],
22	disease	NN	O	disease	nsubj	24	SENT_47	[p2l364t410r670b489],
23	ultimately	RB	O	ultimately	advmod	24	SENT_47	[p2l715t410r1146b511],
24	progressed	VBD	O	progress	conj_but	12	SENT_47	[p2l1184t410r1677b511],
25	.	.	O	.	_	0	SENT_47	[p2l1184t410r1677b511],

1	In	IN	O	in	_	0	SENT_48	[p2l1725t417r1813b488],
2	her	PRP$	O	she	poss	4	SENT_48	[p2l1857t410r1995b489],
3	resistant	JJ	O	resistant	amod	4	SENT_48	[p2l2036t436r2148b489, p2l9t540r286b619],
4	tumors	NNS	O	tumor	prep_in	7	SENT_48	[p2l313t556r634b636],
5	,	,	O	,	_	0	SENT_48	[p2l313t556r634b636],
6	We	PRP	O	we	nsubj	7	SENT_48	[p2l667t566r783b620],
7	identified	VBD	O	identify	_	0	SENT_48	[p2l815t539r1216b619],
8	an	DT	O	a	det	10	SENT_48	[p2l1247t565r1348b619],
9	acquired	VBN	O	acquire	amod	10	SENT_48	[p2l1379t539r1737b641],
10	mutation	NN	O	mutation	dobj	7	SENT_48	[p2l1769t540r2149b620],
11	affecting	VBG	O	affect	partmod	10	SENT_48	[p2l7t669r400b771],
12	the	DT	O	the	det	15	SENT_48	[p2l444t669r577b749],
13	R081	NN	O	r081	nn	15	SENT_48	[p2l623t675r859b754],
14	kinase	NN	O	kinase	nn	15	SENT_48	[p2l906t670r1187b750],
15	domain	NN	O	domain	dobj	11	SENT_48	[p2l1235t670r1568b749],
16	that	WDT	O	that	nsubj	17	SENT_48	[p2l1614t670r1789b749],
17	confers	VBZ	O	confer	rcmod	15	SENT_48	[p2l1831t669r2147b749],
18	resistance	NN	O	resistance	dobj	17	SENT_48	[p2l8t800r439b878],
19	to	TO	O	to	_	0	SENT_48	[p2l481t816r563b878],
20	crizotinib	NN	O	crizotinib	prep_to	17	SENT_48	[p2l605t800r1051b878],
21	.	.	O	.	_	0	SENT_48	[p2l605t800r1051b878],

1	CASE	NN	O	case	nn	2	SENT_49	[p2l696t1126r958b1184],
2	REPORT	NN	O	report	_	0	SENT_49	[p2l1014t1126r1453b1184],

1	A	DT	O	a	det	3	SENT_50	[p2l6t1362r72b1432],
2	48-year-old	JJ	DURATION	48-year-old	amod	3	SENT_50	[p2l118t1355r602b1455],
3	Woman	NNP	O	Woman	nsubj	11	SENT_50	[p2l648t1381r970b1434],
4	with	IN	O	with	_	0	SENT_50	[p2l1016t1355r1211b1434],
5	a	DT	O	a	det	7	SENT_50	[p2l1261t1381r1306b1433],
6	distant	JJ	O	distant	amod	7	SENT_50	[p2l1355t1355r1657b1433],
7	history	NN	O	history	prep_with	3	SENT_50	[p2l1702t1355r2007b1455],
8	of	IN	O	of	_	0	SENT_50	[p2l2053t1354r2153b1433],
9	light	JJ	O	light	amod	10	SENT_50	[p2l8t1483r201b1584],
10	smoking	NN	O	smoking	prep_of	7	SENT_50	[p2l231t1483r595b1584],
11	presented	VBN	O	present	_	0	SENT_50	[p2l623t1483r1025b1583],
12	with	IN	O	with	_	0	SENT_50	[p2l1054t1483r1243b1562],
13	progressive	JJ	O	progressive	amod	14	SENT_50	[p2l1274t1484r1742b1584],
14	dyspnea	NN	O	dyspnea	prep_with	11	SENT_50	[p2l1776t1483r2129b1583],
15	.	.	O	.	_	0	SENT_50	[p2l1776t1483r2129b1583],

1	Cytologic	JJ	MISC	cytologic	amod	2	SENT_51	[p2l10t1611r408b1712],
2	analysis	NN	O	analysis	nsubjpass	13	SENT_51	[p2l439t1611r772b1711],
3	of	IN	O	of	_	0	SENT_51	[p2l807t1610r906b1689],
4	a	DT	O	a	det	7	SENT_51	[p2l919t1637r963b1689],
5	malignant	JJ	O	malignant	amod	7	SENT_51	[p2l994t1611r1436b1712],
6	pleural	JJ	O	pleural	amod	7	SENT_51	[p2l1462t1611r1757b1711],
7	effusion	NN	O	effusion	prep_of	2	SENT_51	[p2l1789t1610r2135b1690],
8	in	IN	O	in	_	0	SENT_51	[p2l9t1740r93b1816],
9	the	DT	O	the	det	11	SENT_51	[p2l130t1739r263b1817],
10	right	JJ	O	right	amod	11	SENT_51	[p2l301t1739r511b1840],
11	lung	NN	O	lung	prep_in	7	SENT_51	[p2l542t1739r736b1840],
12	was	VBD	O	be	auxpass	13	SENT_51	[p2l765t1765r929b1818],
13	performed	VBN	O	perform	_	0	SENT_51	[p2l967t1738r1423b1839],
14	(	CD	NUMBER	(	num	15	SENT_51	[p2l1466t1740r1645b1840],
15	Fig	NN	O	fig	dobj	13	SENT_51	[p2l1466t1740r1645b1840],
16	.	.	O	.	_	0	SENT_51	[p2l1466t1740r1645b1840],

1	1A	NN	O	1a	nn	2	SENT_52	[p2l1692t1744r1855b1835],
2	)	NN	O	)	nsubjpass	12	SENT_52	[p2l1692t1744r1855b1835],
3	,	,	O	,	_	0	SENT_52	[p2l1692t1744r1855b1835],
4	and	CC	O	and	_	0	SENT_52	[p2l1897t1739r2055b1817],
5	a	DT	O	a	det	6	SENT_52	[p2l2092t1765r2136b1817],
6	diagnosis	NN	O	diagnosis	nsubjpass	12	SENT_52	[p2l10t1867r413b1968],
7	of	IN	O	of	_	0	SENT_52	[p2l448t1866r546b1945],
8	metastatic	JJ	O	metastatic	amod	10	SENT_52	[p2l559t1868r997b1945],
9	lung	NN	O	lung	nn	10	SENT_52	[p2l1027t1867r1218b1968],
10	adenocarcinoma	NN	O	adenocarcinoma	prep_of	6	SENT_52	[p2l1245t1867r1947b1945],
11	Was	VBD	O	be	auxpass	12	SENT_52	[p2l1972t1893r2134b1946],
12	made	VBN	O	make	_	0	SENT_52	[p2l10t1995r261b2073],
13	.	.	O	.	_	0	SENT_52	[p2l10t1995r261b2073],

1	Genetic	JJ	O	genetic	amod	2	SENT_53	[p2l298t1996r621b2073],
2	studies	NNS	O	study	nsubj	9	SENT_53	[p2l654t1995r948b2074],
3	of	IN	O	of	_	0	SENT_53	[p2l982t1994r1081b2073],
4	the	DT	O	the	det	5	SENT_53	[p2l1095t1995r1226b2073],
5	patient	NN	O	patient	poss	8	SENT_53	[p2l1256t1996r1611b2095],
6	’s	POS	O	’s	_	0	SENT_53	[p2l1256t1996r1611b2095],
7	cancer	NN	O	cancer	nn	8	SENT_53	[p2l1645t2021r1921b2073],
8	cells	NNS	O	cell	prep_of	2	SENT_53	[p2l1950t1995r2134b2073],
9	revealed	VBD	O	reveal	_	0	SENT_53	[p2l10t2124r354b2203],
10	no	DT	O	no	det	11	SENT_53	[p2l380t2149r484b2202],
11	mutations	NNS	O	mutation	dobj	9	SENT_53	[p2l512t2125r939b2203],
12	in	IN	O	in	_	0	SENT_53	[p2l967t2125r1049b2201],
13	KRAS	NNP	ORGANIZATION	KRAS	prep_in	9	SENT_53	[p2l1073t2129r1300b2203],
14	or	CC	O	or	_	0	SENT_53	[p2l1325t2149r1413b2202],
15	EGFR	NN	ORGANIZATION	egfr	conj_or	13	SENT_53	[p2l1434t2130r1644b2203],
16	and	CC	O	and	_	0	SENT_53	[p2l1663t2124r1819b2202],
17	no	DT	O	no	det	19	SENT_53	[p2l1845t2149r1949b2202],
18	ALK	NN	O	alk	nn	19	SENT_53	[p2l1971t2129r2143b2202],
19	translocation	NN	O	translocation	prep_in	9	SENT_53	[p2l10t2253r556b2331],
20	(	CD	NUMBER	(	npadvmod	21	SENT_53	[p2l590t2260r752b2344],
21	not	RB	O	not	neg	22	SENT_53	[p2l590t2260r752b2344],
22	shown	VBN	O	show	partmod	19	SENT_53	[p2l777t2253r1096b2344],
23	)	NN	O	)	dobj	22	SENT_53	[p2l777t2253r1096b2344],
24	.	.	O	.	_	0	SENT_53	[p2l777t2253r1096b2344],

1	She	PRP	O	she	nsubjpass	3	SENT_54	[p2l1132t2253r1275b2331],
2	was	VBD	O	be	auxpass	3	SENT_54	[p2l1299t2279r1457b2332],
3	started	VBN	O	start	_	0	SENT_54	[p2l1489t2253r1775b2331],
4	on	IN	O	on	_	0	SENT_54	[p2l1804t2279r1908b2331],
5	firstA	NN	O	firsta	prep_on	3	SENT_54	[p2l1936t2252r2134b2331, p3l437t44r457b67],

1	Cytologic	JJ	O	cytologic	amod	3	SENT_55	[p3l474t42r603b75],
2	Analysis	NN	O	analysis	nn	3	SENT_55	[p3l612t42r725b75],
3	ofa	NN	O	ofa	_	0	SENT_55	[p3l735t41r785b67],
4	Pleural	JJ	O	pleural	amod	5	SENT_55	[p3l797t42r890b67],
5	Effusion	NN	O	effusion	dep	3	SENT_55	[p3l902t41r1014b67],

1	TM	NN	MISC	tm	_	0	SENT_56	[p3l598t1002r642b1025],

1	ctccaccgaaagEATGATTTTTGGATACCAGA	NN	O	ctccaccgaaageatgatttttggataccaga	_	0	SENT_57	[p3l536t1051r1523b1101],

1	I	PRP	O	I	_	0	SENT_58	[p3l911t1107r915b1120],

1	ctcca	NN	O	ctcca	nn	2	SENT_59	[p3l536t1229r672b1251],
2	ccga	NN	O	ccga	_	0	SENT_59	[p3l691t1234r802b1260],
3	a	DT	O	a	predet	5	SENT_59	[p3l821t1234r835b1251],
4	a	DT	O	a	det	5	SENT_59	[p3l854t1234r868b1251],
5	glTCTGGCATAGAAGATTAAA	NN	O	gltctggcatagaagattaaa	dep	2	SENT_59	[p3l887t1220r1528b1270],

1	I	PRP	O	I	_	0	SENT_60	[p3l911t1276r915b1289],

1	Figure	NNP	O	Figure	_	0	SENT_61	[p3l409t1479r493b1511],
2	1	CD	NUMBER	1	dep	1	SENT_61	[p3l505t1481r527b1504],
3	.	.	O	.	_	0	SENT_61	[p3l505t1481r527b1504],

1	The	DT	O	the	det	2	SENT_62	[p3l537t1479r589b1504],
2	CD74	NN	O	cd74	_	0	SENT_62	[p3l600t1481r770b1504],
3	.	.	O	.	_	0	SENT_62	[p3l600t1481r770b1504],

1	—	NN	O	—	_	0	SENT_63	[p3l600t1481r770b1504],
2	.	.	O	.	_	0	SENT_63	[p3l600t1481r770b1504],

1	ROS1	NN	MISC	ros1	nn	2	SENT_64	[p3l600t1481r770b1504],
2	Translocation	NN	MISC	translocation	_	0	SENT_64	[p3l782t1479r969b1504],
3	in	IN	O	in	_	0	SENT_64	[p3l982t1479r1004b1503],
4	the	DT	O	the	det	5	SENT_64	[p3l1015t1479r1060b1504],
5	Patient	NN	O	patient	poss	8	SENT_64	[p3l1072t1479r1189b1504],
6	’s	POS	O	’s	_	0	SENT_64	[p3l1072t1479r1189b1504],
7	Lung	NN	O	lung	nn	8	SENT_64	[p3l1203t1481r1270b1512],
8	Cancer	NN	O	cancer	prep_in	2	SENT_64	[p3l1280t1481r1376b1504],
9	before	IN	O	before	_	0	SENT_64	[p3l1387t1478r1473b1504],
10	Treatment	NN	O	treatment	prep_before	2	SENT_64	[p3l1483t1481r1626b1504],
11	with	IN	O	with	_	0	SENT_64	[p3l1635t1479r1693b1504],
12	Crizotinib	NNP	O	Crizotinib	prep_with	2	SENT_64	[p3l1705t1479r1846b1504],
13	.	.	O	.	_	0	SENT_64	[p3l1705t1479r1846b1504],

1	In	IN	O	in	_	0	SENT_65	[p3l409t1531r431b1553],
2	Panel	NN	O	panel	nn	3	SENT_65	[p3l446t1529r518b1554],
3	A	NN	O	a	prep_in	14	SENT_65	[p3l530t1530r557b1558],
4	,	,	O	,	_	0	SENT_65	[p3l530t1530r557b1558],
5	a	DT	O	a	det	7	SENT_65	[p3l570t1537r583b1554],
6	cell	NN	O	cell	nn	7	SENT_65	[p3l595t1529r638b1554],
7	block	NN	O	block	nsubj	14	SENT_65	[p3l652t1529r724b1554],
8	prepared	VBN	O	prepare	partmod	7	SENT_65	[p3l737t1529r858b1561],
9	from	IN	O	from	_	0	SENT_65	[p3l870t1528r934b1554],
10	a	DT	O	a	det	13	SENT_65	[p3l948t1537r960b1554],
11	malignant	JJ	O	malignant	amod	13	SENT_65	[p3l974t1529r1112b1562],
12	pleural	JJ	O	pleural	amod	13	SENT_65	[p3l1124t1529r1216b1561],
13	effusion	NN	O	effusion	prep_from	8	SENT_65	[p3l1229t1528r1340b1554],
14	shows	VBZ	O	show	_	0	SENT_65	[p3l1353t1529r1438b1554],
15	clusters	NNS	O	cluster	nsubj	17	SENT_65	[p3l1451t1529r1558b1554],
16	oftumor	JJ	O	oftumor	amod	17	SENT_65	[p3l1570t1528r1692b1554],
17	cells	NNS	O	cell	xcomp	14	SENT_65	[p3l1702t1529r1761b1554],
18	in	IN	O	in	_	0	SENT_65	[p3l1775t1531r1796b1553],
19	a	DT	O	a	det	23	SENT_65	[p3l1809t1537r1822b1554],
20	micropapillary	JJ	O	micropapillary	amod	23	SENT_65	[p3l1835t1529r2034b1562],
21	pattern	NN	O	pattern	nn	23	SENT_65	[p3l408t1575r506b1603],
22	(	NN	O	(	nn	23	SENT_65	[p3l522t1570r698b1603],
23	hematoxylin	NN	O	hematoxylin	prep_in	17	SENT_65	[p3l522t1570r698b1603],
24	and	CC	O	and	_	0	SENT_65	[p3l712t1570r760b1596],
25	eosin	NN	O	eosin	nn	26	SENT_65	[p3l773t1572r864b1603],
26	)	NN	O	)	prep_in	17	SENT_65	[p3l773t1572r864b1603],
27	.	.	O	.	_	0	SENT_65	[p3l773t1572r864b1603],

1	In	IN	O	in	_	0	SENT_66	[p3l878t1573r901b1595],
2	Panel	NN	O	panel	nn	3	SENT_66	[p3l916t1570r987b1596],
3	B	NN	O	b	prep_in	34	SENT_66	[p3l1002t1573r1025b1600],
4	,	,	O	,	_	0	SENT_66	[p3l1002t1573r1025b1600],
5	a	DT	O	a	det	7	SENT_66	[p3l1038t1579r1051b1596],
6	break-apart	JJ	O	break-apart	amod	7	SENT_66	[p3l1064t1570r1221b1603],
7	fluorescence	NN	O	fluorescence	dep	14	SENT_66	[p3l1231t1570r1408b1596],
8	in	FW	O	in	prep	7	SENT_66	[p3l1421t1573r1442b1595],
9	situ	FW	O	situ	pobj	8	SENT_66	[p3l1456t1573r1504b1596],
10	hybridization	NN	O	hybridization	dep	14	SENT_66	[p3l1518t1570r1696b1603],
11	(	CD	NUMBER	(	num	10	SENT_66	[p3l1712t1572r1799b1603],
12	FISH	NN	O	fish	nn	14	SENT_66	[p3l1712t1572r1799b1603],
13	)	NN	O	)	nn	14	SENT_66	[p3l1712t1572r1799b1603],
14	assay	NN	O	assay	dep	24	SENT_66	[p3l1814t1570r1910b1603],
15	“	RB	O	“	advmod	14	SENT_66	[p3l1814t1570r1910b1603],
16	with	IN	O	with	_	0	SENT_66	[p3l1921t1570r1979b1596],
17	a	DT	O	a	det	21	SENT_66	[p3l1992t1579r2004b1596],
18	5	CD	NUMBER	5	num	21	SENT_66	[p3l407t1614r430b1637],
19	’	NN	O	’	nn	21	SENT_66	[p3l407t1614r430b1637],
20	R051	NN	O	r051	nn	21	SENT_66	[p3l443t1614r517b1637],
21	probe	NN	O	probe	prep_with	14	SENT_66	[p3l531t1612r610b1645],
22	(	CD	NUMBER	(	num	24	SENT_66	[p3l624t1614r719b1645],
23	green	JJ	O	green	amod	24	SENT_66	[p3l624t1614r719b1645],
24	)	NN	O	)	dep	34	SENT_66	[p3l624t1614r719b1645],
25	and	CC	O	and	_	0	SENT_66	[p3l734t1612r782b1637],
26	a	DT	O	a	det	30	SENT_66	[p3l795t1621r808b1637],
27	3	CD	NUMBER	3	num	30	SENT_66	[p3l820t1614r844b1637],
28	'	''	O	'	_	0	SENT_66	[p3l820t1614r844b1637],
29	ROS1	NN	O	ros1	nn	30	SENT_66	[p3l857t1614r931b1637],
30	probe	NN	O	probe	dep	34	SENT_66	[p3l945t1612r1023b1645],
31	(	CD	NUMBER	(	num	33	SENT_66	[p3l1038t1612r1099b1645],
32	red	JJ	O	red	amod	33	SENT_66	[p3l1038t1612r1099b1645],
33	)	NN	O	)	nsubj	34	SENT_66	[p3l1038t1612r1099b1645],
34	shows	VBZ	O	show	_	0	SENT_66	[p3l1114t1612r1200b1637],
35	the	DT	O	the	det	37	SENT_66	[p3l1211t1612r1254b1637],
36	ROS1	NN	O	ros1	nn	37	SENT_66	[p3l1267t1614r1340b1637],
37	rearrangement	NN	O	rearrangement	dobj	34	SENT_66	[p3l1355t1617r1567b1645],
38	,	,	O	,	_	0	SENT_66	[p3l1355t1617r1567b1645],
39	as	IN	O	as	dep	40	SENT_66	[p3l1580t1621r1608b1637],
40	indicated	VBN	O	indicate	dep	37	SENT_66	[p3l1621t1612r1746b1637],
41	by	IN	O	by	_	0	SENT_66	[p3l1760t1612r1789b1645],
42	the	DT	O	the	det	43	SENT_66	[p3l1799t1612r1842b1637],
43	presence	NN	O	presence	prep_by	40	SENT_66	[p3l1855t1621r1977b1645],
44	of	IN	O	of	_	0	SENT_66	[p3l1989t1612r2019b1637],
45	single	JJ	O	single	prep_of	43	SENT_66	[p3l408t1654r487b1687],
46	isolated	VBN	O	isolate	partmod	45	SENT_66	[p3l500t1654r606b1679],
47	red	JJ	O	red	amod	51	SENT_66	[p3l620t1654r660b1679],
48	3	CD	NUMBER	3	tmod	47	SENT_66	[p3l674t1656r697b1679],
49	’	NN	O	’	nn	51	SENT_66	[p3l674t1656r697b1679],
50	ROS1	NN	O	ros1	nn	51	SENT_66	[p3l711t1656r785b1679],
51	probes	NNS	O	probe	dobj	46	SENT_66	[p3l799t1654r891b1686],
52	(	VBP	O	(	dep	40	SENT_66	[p3l906t1654r1094b1687],
53	arrowheads	NNS	O	arrowhead	dobj	52	SENT_66	[p3l906t1654r1094b1687],
54	)	CD	NUMBER	)	nsubj	40	SENT_66	[p3l906t1654r1094b1687],
55	.	.	O	.	_	0	SENT_66	[p3l906t1654r1094b1687],

1	The	DT	O	the	det	4	SENT_67	[p3l1105t1654r1157b1679],
2	normal	JJ	O	normal	amod	4	SENT_67	[p3l1169t1654r1265b1679],
3	ROS1	NN	O	ros1	nn	4	SENT_67	[p3l1279t1656r1353b1679],
4	locus	NN	O	locus	nsubjpass	6	SENT_67	[p3l1367t1654r1438b1679],
5	is	VBZ	O	be	auxpass	6	SENT_67	[p3l1451t1656r1470b1679],
6	shown	VBN	O	show	_	0	SENT_67	[p3l1483t1654r1571b1679],
7	as	IN	O	as	_	0	SENT_67	[p3l1584t1662r1612b1679],
8	unsplit	JJ	O	unsplit	amod	12	SENT_67	[p3l1625t1654r1719b1686],
9	red	JJ	O	red	amod	12	SENT_67	[p3l1731t1654r1772b1679],
10	and	CC	O	and	_	0	SENT_67	[p3l1785t1654r1833b1679],
11	green	JJ	O	green	amod	12	SENT_67	[p3l1846t1662r1922b1687],
12	pairs	NNS	O	pair	prep_as	6	SENT_67	[p3l1936t1656r2001b1686],
13	of	IN	O	of	_	0	SENT_67	[p3l2013t1653r2043b1679],
14	probes	NNS	O	probe	prep_of	12	SENT_67	[p3l408t1695r501b1728],
15	(	CD	NUMBER	(	num	16	SENT_67	[p3l516t1697r635b1728],
16	arrows	NNS	O	arrow	tmod	6	SENT_67	[p3l516t1697r635b1728],
17	)	CD	NUMBER	)	dep	16	SENT_67	[p3l516t1697r635b1728],
18	.	.	O	.	_	0	SENT_67	[p3l516t1697r635b1728],

1	The	DT	O	the	det	2	SENT_68	[p3l646t1695r698b1721],
2	nuclei	NNS	O	nucleus	nsubjpass	4	SENT_68	[p3l710t1695r790b1721],
3	are	VBP	O	be	auxpass	4	SENT_68	[p3l803t1704r844b1721],
4	stained	VBN	O	stain	_	0	SENT_68	[p3l855t1695r955b1721],
5	with	IN	O	with	_	0	SENT_68	[p3l967t1695r1024b1721],
6	4	CD	NUMBER	4	num	7	SENT_68	[p3l1036t1695r1462b1728],
7	’	CD	NUMBER	’	prep_with	4	SENT_68	[p3l1036t1695r1462b1728],
8	,6	SYM	O	,6	dep	10	SENT_68	[p3l1036t1695r1462b1728],
9	-	:	O	-	_	0	SENT_68	[p3l1036t1695r1462b1728],
10	diamidino-2-phenylindole	NN	O	diamidino-2-phenylindole	dep	7	SENT_68	[p3l1036t1695r1462b1728],
11	.	.	O	.	_	0	SENT_68	[p3l1036t1695r1462b1728],

1	In	IN	O	in	_	0	SENT_69	[p3l1477t1698r1499b1720],
2	Panel	NN	O	panel	nn	3	SENT_69	[p3l1514t1695r1586b1721],
3	C	NN	O	c	prep_in	15	SENT_69	[p3l1599t1697r1624b1725],
4	,	,	O	,	_	0	SENT_69	[p3l1599t1697r1624b1725],
5	Sanger	NNP	PERSON	Sanger	nn	8	SENT_69	[p3l1638t1697r1733b1729],
6	sequencing	NN	O	sequencing	nn	8	SENT_69	[p3l1744t1698r1902b1729],
7	ofthe	NN	O	ofthe	nn	8	SENT_69	[p3l1913t1695r1992b1721],
8	product	NN	O	product	nsubj	15	SENT_69	[p3l408t1737r516b1770],
9	of	IN	O	of	_	0	SENT_69	[p3l527t1737r557b1762],
10	reverse-transcriptase	NN	O	reverse-transcriptase	nn	14	SENT_69	[p3l565t1737r1039b1770],
11	—	CD	NUMBER	—	num	14	SENT_69	[p3l565t1737r1039b1770],
12	polymerase	NN	O	polymerase	nn	14	SENT_69	[p3l565t1737r1039b1770],
13	chain	NN	O	chain	nn	14	SENT_69	[p3l1050t1737r1122b1762],
14	reaction	NN	O	reaction	prep_of	8	SENT_69	[p3l1136t1739r1246b1762],
15	shows	VBZ	O	show	_	0	SENT_69	[p3l1260t1737r1345b1762],
16	the	DT	O	the	det	17	SENT_69	[p3l1356t1737r1399b1762],
17	fusion	NN	O	fusion	npadvmod	38	SENT_69	[p3l1410t1737r1495b1762],
18	of	IN	O	of	_	0	SENT_69	[p3l1508t1737r1537b1762],
19	CD74	NN	O	cd74	nn	20	SENT_69	[p3l1545t1739r1617b1762],
20	exon	NN	O	exon	prep_of	17	SENT_69	[p3l1627t1746r1690b1762],
21	6	CD	NUMBER	6	num	22	SENT_69	[p3l1703t1739r1717b1762],
22	(	NN	O	(	dep	30	SENT_69	[p3l1731t1737r1793b1770],
23	red	JJ	O	red	amod	24	SENT_69	[p3l1731t1737r1793b1770],
24	)	NN	O	)	dep	22	SENT_69	[p3l1731t1737r1793b1770],
25	to	TO	O	to	dep	24	SENT_69	[p3l1806t1742r1833b1762],
26	either	CC	O	either	dep	27	SENT_69	[p3l1844t1737r1924b1762],
27	ROS1	NN	O	ros1	dep	24	SENT_69	[p3l1936t1739r2009b1762],
28	exon	NN	O	exon	dep	30	SENT_69	[p3l407t1787r469b1804],
29	34	CD	NUMBER	34	num	28	SENT_69	[p3l483t1781r513b1804],
30	(	NN	O	(	dep	17	SENT_69	[p3l528t1779r598b1812],
31	light	NN	O	light	prep	30	SENT_69	[p3l528t1779r598b1812],
32	blue	JJ	O	blue	amod	33	SENT_69	[p3l610t1779r676b1812],
33	)	NN	O	)	dep	31	SENT_69	[p3l610t1779r676b1812],
34	or	CC	O	or	_	0	SENT_69	[p3l690t1787r718b1804],
35	exon	NN	O	exon	conj_or	33	SENT_69	[p3l728t1787r791b1804],
36	35	CD	NUMBER	35	number	37	SENT_69	[p3l804t1781r833b1804],
37	(	CD	NUMBER	(	num	17	SENT_69	[p3l849t1779r917b1812],
38	dark	JJ	O	dark	amod	40	SENT_69	[p3l849t1779r917b1812],
39	blue	JJ	O	blue	amod	40	SENT_69	[p3l929t1779r1004b1812],
40	)	NN	O	)	dobj	15	SENT_69	[p3l929t1779r1004b1812],
41	.	.	O	.	_	0	SENT_69	[p3l929t1779r1004b1812],

1	The	DT	O	the	det	4	SENT_70	[p3l1015t1779r1066b1804],
2	predicted	VBN	O	predict	amod	4	SENT_70	[p3l1079t1779r1208b1811],
3	plasma-membrane	NN	O	plasma-membrane	nn	4	SENT_70	[p3l1222t1779r1484b1811],
4	orientations	NNS	O	orientation	nsubjpass	10	SENT_70	[p3l1495t1781r1663b1804],
5	for	IN	O	for	_	0	SENT_70	[p3l1674t1778r1713b1804],
6	each	DT	O	each	det	8	SENT_70	[p3l1723t1779r1785b1804],
7	splice	NN	O	splice	nn	8	SENT_70	[p3l1798t1779r1876b1811],
8	form	NN	O	form	prep_for	4	SENT_70	[p3l1886t1778r1951b1804],
9	are	VBP	O	be	auxpass	10	SENT_70	[p3l1964t1787r2005b1804],
10	shown	VBN	O	show	_	0	SENT_70	[p3l408t1820r495b1846],
11	at	IN	O	at	_	0	SENT_70	[p3l509t1825r533b1846],
12	right	NN	O	right	prep_at	10	SENT_70	[p3l545t1820r616b1854],
13	.	.	O	.	_	0	SENT_70	[p3l545t1820r616b1854],

1	The	DT	O	the	det	6	SENT_71	[p3l627t1820r678b1846],
2	N-terminal	JJ	O	n-terminal	amod	6	SENT_71	[p3l692t1820r839b1846],
3	(	NN	O	(	nn	6	SENT_71	[p3l855t1822r897b1853],
4	N	NN	O	n	nn	6	SENT_71	[p3l855t1822r897b1853],
5	)	CD	NUMBER	)	num	6	SENT_71	[p3l855t1822r897b1853],
6	ofCD74	NN	O	ofcd74	nsubj	10	SENT_71	[p3l911t1820r1020b1846],
7	is	VBZ	O	be	cop	8	SENT_71	[p3l1032t1823r1051b1846],
8	intracellular	JJ	O	intracellular	_	0	SENT_71	[p3l1064t1820r1228b1846],
9	and	CC	O	and	_	0	SENT_71	[p3l1239t1820r1287b1846],
10	contains	VBZ	O	contain	conj_and	8	SENT_71	[p3l1300t1823r1417b1846],
11	a	DT	O	a	det	16	SENT_71	[p3l1429t1829r1442b1846],
12	transmembrane	JJ	O	transmembrane	amod	16	SENT_71	[p3l1453t1820r1676b1846],
13	(	NN	O	(	nn	16	SENT_71	[p3l1690t1822r1756b1853],
14	TM	NN	MISC	tm	nn	16	SENT_71	[p3l1690t1822r1756b1853],
15	)	NN	O	)	nn	16	SENT_71	[p3l1690t1822r1756b1853],
16	domain	NN	O	domain	dobj	10	SENT_71	[p3l1770t1820r1882b1846],
17	.	.	O	.	_	0	SENT_71	[p3l1770t1820r1882b1846],

1	Only	RB	O	only	advmod	4	SENT_72	[p3l1895t1820r1959b1853],
2	the	DT	O	the	det	4	SENT_72	[p3l1969t1820r2013b1846],
3	major	JJ	O	major	amod	4	SENT_72	[p3l408t1864r488b1895],
4	splice	NN	O	splice	nsubj	5	SENT_72	[p3l499t1862r576b1895],
5	form	NN	O	form	_	0	SENT_72	[p3l587t1862r652b1887],
6	(	CD	NUMBER	(	num	7	SENT_72	[p3l668t1864r749b1895],
7	CD74	NN	O	cd74	dobj	5	SENT_72	[p3l668t1864r749b1895],
8	fused	VBN	O	fuse	partmod	7	SENT_72	[p3l759t1862r833b1887],
9	to	TO	O	to	_	0	SENT_72	[p3l845t1867r872b1887],
10	ROS1	NN	O	ros1	nn	11	SENT_72	[p3l885t1864r959b1887],
11	exon	NN	O	exon	prep_to	8	SENT_72	[p3l972t1871r1034b1887],
12	34	CD	NUMBER	34	num	13	SENT_72	[p3l1047t1864r1097b1895],
13	)	NN	O	)	nsubjpass	23	SENT_72	[p3l1047t1864r1097b1895],
14	,	,	O	,	_	0	SENT_72	[p3l1047t1864r1097b1895],
15	which	WDT	O	which	nsubj	16	SENT_72	[p3l1108t1862r1188b1887],
16	contains	VBZ	O	contain	rcmod	13	SENT_72	[p3l1201t1864r1317b1887],
17	a	DT	DURATION	a	det	20	SENT_72	[p3l1330t1871r1343b1887],
18	second	JJ	DURATION	second	amod	20	SENT_72	[p3l1355t1862r1452b1887],
19	transmembrane	NN	O	transmembrane	nn	20	SENT_72	[p3l1464t1862r1687b1887],
20	domain	NN	O	domain	dobj	16	SENT_72	[p3l1698t1862r1810b1892],
21	,	,	O	,	_	0	SENT_72	[p3l1698t1862r1810b1892],
22	is	VBZ	O	be	auxpass	23	SENT_72	[p3l1824t1864r1843b1887],
23	expected	VBN	O	expect	rcmod	11	SENT_72	[p3l1855t1862r1978b1895],
24	to	TO	O	to	aux	26	SENT_72	[p3l1990t1867r2016b1887],
25	be	VB	O	be	cop	26	SENT_72	[p3l408t1904r439b1929],
26	pathogenic	JJ	O	pathogenic	xcomp	23	SENT_72	[p3l451t1904r612b1937],
27	,	,	O	,	_	0	SENT_72	[p3l451t1904r612b1937],
28	as	IN	O	as	_	0	SENT_72	[p3l625t1912r653b1929],
29	a	DT	O	a	det	38	SENT_72	[p3l665t1912r678b1929],
30	result	NN	O	result	nn	38	SENT_72	[p3l691t1904r767b1929],
31	ofthe	NN	O	ofthe	nn	38	SENT_72	[p3l778t1903r857b1929],
32	placement	NN	O	placement	nn	38	SENT_72	[p3l870t1904r1014b1936],
33	ofthe	NN	O	ofthe	nn	38	SENT_72	[p3l1025t1903r1104b1929],
34	tyrosine	NN	O	tyrosine	nn	38	SENT_72	[p3l1114t1906r1225b1937],
35	kinase	NN	O	kinase	nn	38	SENT_72	[p3l1238t1904r1323b1929],
36	domain	NN	O	domain	nn	38	SENT_72	[p3l1335t1904r1438b1929],
37	ofthe	NN	O	ofthe	nn	38	SENT_72	[p3l1451t1903r1530b1929],
38	ROS1	NN	O	ros1	nn	42	SENT_72	[p3l1543t1906r1617b1929],
39	C-terminal	JJ	O	c-terminal	amod	42	SENT_72	[p3l1630t1904r1772b1929],
40	(	CD	NUMBER	(	tmod	39	SENT_72	[p3l1788t1906r1825b1937],
41	C	NN	O	c	nn	42	SENT_72	[p3l1788t1906r1825b1937],
42	)	NN	O	)	prep_as	7	SENT_72	[p3l1788t1906r1825b1937],
43	in	IN	O	in	_	0	SENT_72	[p3l1841t1906r1862b1928],
44	the	DT	O	the	det	46	SENT_72	[p3l1874t1904r1917b1929],
45	intracellular	JJ	O	intracellular	amod	46	SENT_72	[p3l1930t1906r2001b1929, p3l407t1945r507b1971],
46	compartment	NN	O	compartment	prep_in	7	SENT_72	[p3l517t1950r715b1978],
47	.	.	O	.	_	0	SENT_72	[p3l517t1950r715b1978],

1	2396	CD	DATE	2396	num	4	SENT_73	[p3l93t2084r170b2108],
2	N	NN	O	n	nn	4	SENT_73	[p3l908t2095r922b2110],
3	ENGLJ	NN	O	englj	nn	4	SENT_73	[p3l937t2095r1015b2117],
4	MED	NN	O	med	_	0	SENT_73	[p3l1029t2095r1081b2110],
5	368	CD	NUMBER	368	dep	4	SENT_73	[p3l1091t2089r1170b2117],
6	;	:	O	;	_	0	SENT_73	[p3l1091t2089r1170b2117],
7	25	CD	NUMBER	25	num	9	SENT_73	[p3l1091t2089r1170b2117],
8	NEjM.ORG	NN	O	nejm.org	nn	9	SENT_73	[p3l1206t2095r1330b2117],
9	JUNE20	NN	O	june20	dep	5	SENT_73	[p3l1361t2095r1539b2117],
10	,2013	CD	NUMBER	,2013	dep	9	SENT_73	[p3l1361t2095r1539b2117],

1	The	DT	O	the	det	4	SENT_74	[p3l880t2128r931b2152],
2	New	NNP	O	New	nn	4	SENT_74	[p3l940t2129r1002b2152],
3	England	NNP	O	England	nn	4	SENT_74	[p3l1011t2128r1122b2159],
4	Journal	NNP	O	Journal	_	0	SENT_74	[p3l1131t2128r1228b2152],
5	of	IN	O	of	_	0	SENT_74	[p3l1238t2128r1267b2152],
6	Medicine	NNP	O	Medicine	prep_of	4	SENT_74	[p3l1274t2128r1399b2152],

1	BRIEF	JJ	O	brief	amod	2	SENT_75	[p3l959t2316r1056b2335],
2	REPORT	NN	O	report	_	0	SENT_75	[p3l1070t2316r1200b2335],

1	line	NN	O	line	nn	2	SENT_76	[p3l10t2529r172b2606],
2	chemotherapy	NN	O	chemotherapy	nsubj	8	SENT_76	[p3l216t2529r838b2628],
3	with	IN	O	with	_	0	SENT_76	[p3l872t2529r1070b2608],
4	carboplatin	NN	O	carboplatin	nn	7	SENT_76	[p3l1114t2529r1618b2628],
5	and	CC	O	and	_	0	SENT_76	[p3l1660t2529r1821b2607],
6	peme	NN	O	peme	nn	7	SENT_76	[p3l1862t2555r2132b2628],
7	—	NN	O	—	prep_with	2	SENT_76	[p3l1862t2555r2132b2628],
8	trexed	VBD	O	trex	_	0	SENT_76	[p3l12t2656r292b2751],
9	,	,	O	,	_	0	SENT_76	[p3l12t2656r292b2751],
10	but	CC	O	but	_	0	SENT_76	[p3l324t2656r462b2735],
11	her	PRP$	O	she	poss	12	SENT_76	[p3l484t2656r620b2733],
12	condition	NN	O	condition	nsubj	28	SENT_76	[p3l644t2656r1046b2734],
13	deteriorated	VBN	O	deteriorate	partmod	12	SENT_76	[p3l1073t2656r1601b2751],
14	,	,	O	,	_	0	SENT_76	[p3l1073t2656r1601b2751],
15	as	IN	O	as	mark	16	SENT_76	[p3l1632t2682r1716b2733],
16	indicated	VBN	O	indicate	dep	12	SENT_76	[p3l1745t2656r2134b2734],
17	by	IN	O	by	_	0	SENT_76	[p3l12t2784r109b2884],
18	worsening	VBG	O	worsen	amod	19	SENT_76	[p3l137t2785r595b2885],
19	discomfort	NN	O	discomfort	prep_by	16	SENT_76	[p3l630t2783r1107b2863],
20	in	IN	O	in	_	0	SENT_76	[p3l1139t2785r1222b2862],
21	the	DT	O	the	det	23	SENT_76	[p3l1261t2784r1394b2862],
22	right	JJ	O	right	amod	23	SENT_76	[p3l1431t2784r1641b2885],
23	side	NN	O	side	prep_in	19	SENT_76	[p3l1676t2784r1840b2863],
24	of	IN	O	of	_	0	SENT_76	[p3l1878t2783r1978b2863],
25	her	PRP$	O	she	poss	26	SENT_76	[p3l1997t2784r2136b2862],
26	chest	NN	O	chest	prep_of	23	SENT_76	[p3l12t2912r255b3008],
27	,	,	O	,	_	0	SENT_76	[p3l12t2912r255b3008],
28	increased	VBD	O	increase	conj_but	8	SENT_76	[p3l292t2912r701b2991],
29	ﬂuid	JJ	O	ﬂuid	amod	30	SENT_76	[p3l733t2911r937b2991],
30	output	NN	O	output	nsubj	36	SENT_76	[p3l970t2929r1253b3012],
31	from	IN	O	from	_	0	SENT_76	[p3l1281t2911r1491b2991],
32	a	DT	O	a	det	35	SENT_76	[p3l1523t2938r1567b2990],
33	right	JJ	O	right	amod	35	SENT_76	[p3l1598t2912r1808b3013],
34	pleural	JJ	O	pleural	amod	35	SENT_76	[p3l1833t2912r2134b3012],
35	catheter	NN	O	catheter	prep_from	30	SENT_76	[p3l12t3040r359b3118],
36	(	VBD	O	(	ccomp	28	SENT_76	[p3l407t3047r535b3140],
37	up	RP	O	up	prt	36	SENT_76	[p3l407t3047r535b3140],
38	to	TO	O	to	_	0	SENT_76	[p3l582t3057r663b3119],
39	1	CD	NUMBER	1	num	40	SENT_76	[p3l714t3046r758b3117],
40	liter	NN	O	liter	prep_to	36	SENT_76	[p3l803t3040r976b3118],
41	per	IN	O	per	_	0	SENT_76	[p3l1017t3066r1156b3140],
42	day	NN	DURATION	day	prep_per	40	SENT_76	[p3l1199t3040r1392b3140],
43	)	CD	NUMBER	)	num	42	SENT_76	[p3l1199t3040r1392b3140],
44	,	,	O	,	_	0	SENT_76	[p3l1199t3040r1392b3140],
45	and	CC	O	and	_	0	SENT_76	[p3l1442t3040r1600b3119],
46	progressive	JJ	O	progressive	amod	47	SENT_76	[p3l1644t3041r2133b3141],
47	fatigue	NN	O	fatigue	prep_to	36	SENT_76	[p3l11t3167r331b3269],
48	,	,	O	,	_	0	SENT_76	[p3l11t3167r331b3269],
49	weight	NN	O	weight	nn	50	SENT_76	[p3l380t3168r673b3269],
50	loss	NN	O	loss	conj_and	40	SENT_76	[p3l715t3168r904b3264],
51	,	,	O	,	_	0	SENT_76	[p3l715t3168r904b3264],
52	intermittent	JJ	O	intermittent	amod	53	SENT_76	[p3l956t3169r1481b3246],
53	fevers	NNS	O	fever	conj_and	40	SENT_76	[p3l1524t3167r1794b3264],
54	,	,	O	,	_	0	SENT_76	[p3l1524t3167r1794b3264],
55	hypoxemia	NN	O	hypoxemia	conj_and	40	SENT_76	[p3l1847t3168r2132b3268, p3l12t3296r242b3391],
56	,	,	O	,	_	0	SENT_76	[p3l1847t3168r2132b3268, p3l12t3296r242b3391],
57	and	CC	O	and	_	0	SENT_76	[p3l299t3295r456b3374],
58	hypercalcemia	NN	O	hypercalcemia	conj_and	40	SENT_76	[p3l508t3295r1155b3395],
59	.	.	O	.	_	0	SENT_76	[p3l508t3295r1155b3395],

1	After	IN	O	after	_	0	SENT_77	[p3l1208t3294r1431b3373],
2	three	CD	NUMBER	three	num	3	SENT_77	[p3l1480t3295r1699b3373],
3	cycles	NNS	O	cycle	prep_after	12	SENT_77	[p3l1752t3295r1997b3395],
4	of	IN	O	of	_	0	SENT_77	[p3l2052t3294r2152b3374],
5	chemotherapy	NN	O	chemotherapy	prep_of	3	SENT_77	[p3l12t3424r635b3524],
6	,	,	O	,	_	0	SENT_77	[p3l12t3424r635b3524],
7	repeat	NN	O	repeat	nn	8	SENT_77	[p3l683t3441r950b3524],
8	imaging	NN	O	imaging	nsubj	12	SENT_77	[p3l987t3425r1349b3525],
9	of	IN	O	of	_	0	SENT_77	[p3l1388t3423r1488b3503],
10	the	DT	O	the	det	11	SENT_77	[p3l1512t3424r1645b3502],
11	chest	NN	O	chest	prep_of	8	SENT_77	[p3l1688t3424r1911b3502],
12	confirmed	VBD	O	confirm	_	0	SENT_77	[p3l1949t3450r2132b3503, p3l11t3551r306b3631],
13	marked	JJ	O	marked	amod	14	SENT_77	[p3l334t3552r661b3631],
14	progression	NN	O	progression	dobj	12	SENT_77	[p3l688t3553r1199b3653],
15	of	IN	O	of	_	0	SENT_77	[p3l1228t3551r1328b3631],
16	cancer	NN	O	cancer	prep_of	14	SENT_77	[p3l1339t3578r1620b3630],
17	throughout	IN	O	throughout	_	0	SENT_77	[p3l1646t3552r2138b3653],
18	the	DT	O	the	det	20	SENT_77	[p3l12t3680r144b3758],
19	right	JJ	O	right	amod	20	SENT_77	[p3l179t3680r389b3781],
20	lung	NN	O	lung	prep_throughout	12	SENT_77	[p3l417t3680r611b3781],
21	and	CC	O	and	_	0	SENT_77	[p3l641t3680r799b3759],
22	pleura	NN	O	pleuron	prep_throughout	12	SENT_77	[p3l832t3680r1124b3780],
23	.	.	O	.	_	0	SENT_77	[p3l832t3680r1124b3780],

1	Additional	JJ	O	additional	amod	3	SENT_78	[p4l136t21r593b100],
2	molecular	JJ	O	molecular	amod	3	SENT_78	[p4l636t21r1069b100],
3	testing	NN	O	testing	nsubjpass	5	SENT_78	[p4l1110t22r1407b122],
4	was	VBD	O	be	auxpass	5	SENT_78	[p4l1441t47r1604b100],
5	performed	VBN	O	perform	_	0	SENT_78	[p4l1648t20r2128b121],
6	.	.	O	.	_	0	SENT_78	[p4l1648t20r2128b121],

1	A	DT	O	a	det	3	SENT_79	[p4l7t157r73b226],
2	ROS1	NN	O	ros1	nn	3	SENT_79	[p4l122t155r327b228],
3	rearrangement	NN	O	rearrangement	nsubjpass	8	SENT_79	[p4l384t166r1026b250],
4	Within	IN	O	within	_	0	SENT_79	[p4l1071t149r1355b228],
5	tumor	NN	O	tumor	nn	6	SENT_79	[p4l1410t166r1678b228],
6	cells	NNS	O	cell	prep_within	8	SENT_79	[p4l1729t149r1916b227],
7	was	VBD	O	be	auxpass	8	SENT_79	[p4l1969t175r2130b228],
8	revealed	VBN	O	reveal	_	0	SENT_79	[p4l11t276r362b356],
9	on	IN	O	on	_	0	SENT_79	[p4l425t302r531b355],
10	ﬂuorescence	NN	O	ﬂuorescence	prep_on	8	SENT_79	[p4l592t275r1134b355],
11	in	FW	O	in	nn	12	SENT_79	[p4l1195t277r1279b354],
12	situ	FW	O	situ	advmod	13	SENT_79	[p4l1342t277r1496b356],
13	hybridization	NN	O	hybridization	rcmod	10	SENT_79	[p4l1557t276r2133b376],
14	(	CD	NUMBER	(	num	15	SENT_79	[p4l16t411r274b496],
15	FISH	NN	O	fish	dep	13	SENT_79	[p4l16t411r274b496],
16	)	CD	NUMBER	)	number	17	SENT_79	[p4l16t411r274b496],
17	(	CD	NUMBER	(	num	18	SENT_79	[p4l308t406r479b506],
18	Fig	NN	O	fig	dep	15	SENT_79	[p4l308t406r479b506],
19	.	.	O	.	_	0	SENT_79	[p4l308t406r479b506],

1	1B	NN	O	1b	_	0	SENT_80	[p4l511t411r661b496],
2	)	NN	O	)	dep	1	SENT_80	[p4l511t411r661b496],
3	.	.	O	.	_	0	SENT_80	[p4l511t411r661b496],

1	Reverse	JJ	O	reverse	amod	7	SENT_81	[p4l689t405r2132b505],
2	—	NN	O	—	nn	7	SENT_81	[p4l689t405r2132b505],
3	transcriptase	NN	O	transcriptase	nn	7	SENT_81	[p4l689t405r2132b505],
4	—	CD	NUMBER	—	num	7	SENT_81	[p4l689t405r2132b505],
5	polymerase	NN	O	polymerase	nn	7	SENT_81	[p4l689t405r2132b505],
6	—	NN	O	—	nn	7	SENT_81	[p4l689t405r2132b505],
7	chain	NN	O	chain	_	0	SENT_81	[p4l12t533r632b611],
8	—	CD	NUMBER	—	num	9	SENT_81	[p4l12t533r632b611],
9	reaction	NN	O	reaction	dep	7	SENT_81	[p4l12t533r632b611],
10	(	CD	NUMBER	(	num	11	SENT_81	[p4l697t539r1086b623],
11	RT	NN	O	rt	dep	9	SENT_81	[p4l697t539r1086b623],
12	.	.	O	.	_	0	SENT_81	[p4l697t539r1086b623],

1	—	NN	O	—	_	0	SENT_82	[p4l697t539r1086b623],
2	.	.	O	.	_	0	SENT_82	[p4l697t539r1086b623],

1	PCR	NN	O	pcr	nn	3	SENT_83	[p4l697t539r1086b623],
2	)	NN	O	)	nn	3	SENT_83	[p4l697t539r1086b623],
3	assays	NNS	O	assay	nsubj	14	SENT_83	[p4l1151t559r1416b632],
4	that	IN	O	that	nsubjpass	6	SENT_83	[p4l1480t533r1652b610],
5	Were	VBD	O	be	auxpass	6	SENT_83	[p4l1702t559r1904b612],
6	performed	VBN	O	perform	rcmod	3	SENT_83	[p4l1963t559r2132b632, p4l11t659r323b739],
7	on	IN	O	on	_	0	SENT_83	[p4l358t686r464b739],
8	total	JJ	O	total	amod	9	SENT_83	[p4l499t660r696b739],
9	RNA	NN	O	rna	prep_on	6	SENT_83	[p4l729t667r938b743],
10	extracted	VBN	O	extract	partmod	9	SENT_83	[p4l971t660r1364b739],
11	from	IN	O	from	_	0	SENT_83	[p4l1399t659r1609b739],
12	tumor	NN	O	tumor	nn	13	SENT_83	[p4l1644t677r1912b739],
13	cells	NNS	O	cell	prep_from	10	SENT_83	[p4l1944t660r2131b738],
14	showed	VBD	O	show	_	0	SENT_83	[p4l13t789r335b868],
15	that	IN	O	that	complm	18	SENT_83	[p4l373t789r545b867],
16	this	DT	O	this	det	17	SENT_83	[p4l578t789r737b867],
17	rearrangement	NN	O	rearrangement	nsubj	18	SENT_83	[p4l777t806r1418b890],
18	leads	VBZ	O	lead	ccomp	14	SENT_83	[p4l1449t789r1665b868],
19	to	TO	O	to	_	0	SENT_83	[p4l1704t806r1786b868],
20	expression	NN	O	expression	prep_to	18	SENT_83	[p4l1825t815r2132b889, p4l13t918r188b996],
21	of	IN	O	of	_	0	SENT_83	[p4l222t916r322b996],
22	a	DT	O	a	det	24	SENT_83	[p4l336t943r380b995],
23	fusion	NN	O	fusion	nn	24	SENT_83	[p4l412t916r682b996],
24	transcript	NN	O	transcript	prep_of	20	SENT_83	[p4l715t918r1139b1017],
25	joining	VBG	O	join	partmod	24	SENT_83	[p4l1153t918r1474b1018],
26	exon	NN	O	exon	dobj	25	SENT_83	[p4l1504t943r1704b996],
27	6	CD	NUMBER	6	num	26	SENT_83	[p4l1738t924r1785b996],
28	of	IN	O	of	_	0	SENT_83	[p4l1819t916r1919b996],
29	CD74	NN	O	cd74	prep_of	26	SENT_83	[p4l1934t924r2134b995],
30	to	TO	O	to	_	0	SENT_83	[p4l12t1061r92b1123],
31	either	CC	O	either	dep	32	SENT_83	[p4l128t1044r369b1122],
32	exon	NN	O	exon	prep_to	25	SENT_83	[p4l400t1070r597b1123],
33	34	CD	NUMBER	34	number	34	SENT_83	[p4l632t1051r731b1123],
34	(	CD	NUMBER	(	dep	32	SENT_83	[p4l769t1051r837b1135],
35	a	DT	O	a	det	38	SENT_83	[p4l769t1051r837b1135],
36	major	JJ	O	major	amod	38	SENT_83	[p4l870t1045r1115b1144],
37	splice	NN	O	splice	nn	38	SENT_83	[p4l1147t1044r1382b1144],
38	form	NN	O	form	dep	32	SENT_83	[p4l1417t1043r1647b1135],
39	)	CD	NUMBER	)	dep	38	SENT_83	[p4l1417t1043r1647b1135],
40	or	CC	O	or	_	0	SENT_83	[p4l1687t1070r1774b1123],
41	exon	NN	O	exon	prep_to	25	SENT_83	[p4l1806t1070r2003b1123],
42	35	CD	NUMBER	35	number	43	SENT_83	[p4l2038t1051r2130b1123],
43	(	CD	NUMBER	(	dep	41	SENT_83	[p4l15t1181r85b1265],
44	a	DT	O	a	det	48	SENT_83	[p4l15t1181r85b1265],
45	minor	JJ	O	minor	amod	48	SENT_83	[p4l135t1174r407b1252],
46	splice	NN	O	splice	nn	48	SENT_83	[p4l457t1174r704b1274],
47	form	NN	O	form	nn	48	SENT_83	[p4l756t1173r997b1265],
48	)	NN	O	)	dobj	18	SENT_83	[p4l756t1173r997b1265],
49	of	IN	O	of	_	0	SENT_83	[p4l1055t1173r1157b1252],
50	ROS1	NN	O	ros1	nn	52	SENT_83	[p4l1186t1180r1396b1254],
51	(	CD	NUMBER	(	num	52	SENT_83	[p4l1455t1174r1640b1274],
52	Fig	NN	O	fig	prep_of	48	SENT_83	[p4l1455t1174r1640b1274],
53	.	.	O	.	_	0	SENT_83	[p4l1455t1174r1640b1274],

1	1C	NN	O	1c	_	0	SENT_84	[p4l1700t1179r1862b1265],
2	)	NN	O	)	dep	1	SENT_84	[p4l1700t1179r1862b1265],
3	.	.	O	.	_	0	SENT_84	[p4l1700t1179r1862b1265],

1	Since	IN	O	since	mark	9	SENT_85	[p4l1921t1174r2149b1252],
2	CD74	NN	O	cd74	nsubj	9	SENT_85	[p4l10t1308r233b1381],
3	is	VBZ	O	be	cop	9	SENT_85	[p4l267t1303r333b1381],
4	a	DT	O	a	det	9	SENT_85	[p4l370t1329r415b1381],
5	type	NN	O	type	nn	9	SENT_85	[p4l449t1319r628b1403],
6	II	CD	NUMBER	ii	num	9	SENT_85	[p4l662t1309r727b1380],
7	integral	JJ	O	integral	amod	9	SENT_85	[p4l761t1303r1092b1403],
8	membrane	NN	O	membrane	nn	9	SENT_85	[p4l1127t1303r1583b1381],
9	protein	NN	O	protein	advcl	19	SENT_85	[p4l1618t1303r1925b1403],
10	with	IN	O	with	_	0	SENT_85	[p4l1956t1303r2149b1382],
11	a	DT	O	a	det	14	SENT_85	[p4l10t1458r54b1510],
12	cytoplasmic	JJ	O	cytoplasmic	amod	14	SENT_85	[p4l89t1432r597b1532],
13	N	NN	O	n	nn	14	SENT_85	[p4l630t1432r1199b1527],
14	—	NN	O	—	prep_with	9	SENT_85	[p4l630t1432r1199b1527],
15	terminal	JJ	O	terminal	amod	14	SENT_85	[p4l630t1432r1199b1527],
16	,19	CD	NUMBER	,19	tmod	15	SENT_85	[p4l630t1432r1199b1527],
17	We	PRP	O	we	nsubj	19	SENT_85	[p4l1231t1458r1348b1511],
18	would	MD	O	would	aux	19	SENT_85	[p4l1380t1432r1643b1511],
19	expect	VB	O	expect	_	0	SENT_85	[p4l1680t1448r1953b1532],
20	that	IN	O	that	complm	41	SENT_85	[p4l1984t1432r2154b1510],
21	only	RB	O	only	advmod	24	SENT_85	[p4l11t1561r193b1661],
22	the	DT	O	the	det	24	SENT_85	[p4l226t1561r357b1639],
23	major	JJ	O	major	amod	24	SENT_85	[p4l395t1561r642b1661],
24	splice	NN	O	splice	nsubj	41	SENT_85	[p4l678t1561r914b1661],
25	Variant	JJ	O	variant	tmod	24	SENT_85	[p4l947t1561r1247b1640],
26	that	IN	O	that	nsubj	27	SENT_85	[p4l1279t1561r1449b1639],
27	contains	VBZ	O	contain	rcmod	24	SENT_85	[p4l1482t1561r1842b1639],
28	an	DT	O	a	det	31	SENT_85	[p4l1881t1586r1984b1639],
29	additional	JJ	O	additional	amod	31	SENT_85	[p4l2020t1561r2148b1639, p4l11t1690r332b1768],
30	transmembrane	NN	O	transmembrane	nn	31	SENT_85	[p4l365t1690r1029b1768],
31	domain	NN	O	domain	dobj	27	SENT_85	[p4l1063t1690r1384b1768],
32	(	CD	NUMBER	(	tmod	27	SENT_85	[p4l1422t1690r1791b1781],
33	encoded	VBN	O	encode	partmod	32	SENT_85	[p4l1422t1690r1791b1781],
34	by	IN	O	by	_	0	SENT_85	[p4l1825t1690r1920b1790],
35	ROS1	NN	O	ros1	nn	36	SENT_85	[p4l1947t1696r2146b1769],
36	exon	NN	O	exon	agent	33	SENT_85	[p4l11t1843r209b1896],
37	34	CD	NUMBER	34	num	38	SENT_85	[p4l252t1823r377b1909],
38	)	NN	O	)	dep	32	SENT_85	[p4l252t1823r377b1909],
39	would	MD	O	would	aux	41	SENT_85	[p4l419t1818r682b1897],
40	be	VB	O	be	cop	41	SENT_85	[p4l725t1818r820b1896],
41	oncogenic	JJ	O	oncogenic	ccomp	19	SENT_85	[p4l863t1818r1297b1918],
42	because	IN	O	because	_	0	SENT_85	[p4l1338t1818r1670b1897],
43	of	IN	O	of	prepc_because_of	41	SENT_85	[p4l1713t1817r1812b1896],
44	the	DT	O	the	det	45	SENT_85	[p4l1835t1818r1967b1896],
45	positioning	NN	O	positioning	pobj	41	SENT_85	[p4l2007t1843r2148b1918, p4l12t1946r390b2046],
46	of	IN	O	of	_	0	SENT_85	[p4l423t1945r524b2024],
47	the	DT	O	the	det	51	SENT_85	[p4l543t1946r677b2024],
48	ROS1	NN	O	ros1	nn	51	SENT_85	[p4l714t1951r949b2029],
49	tyrosine	NN	O	tyrosine	nn	51	SENT_85	[p4l989t1946r1338b2046],
50	kinase	NN	O	kinase	nn	51	SENT_85	[p4l1375t1946r1656b2025],
51	domain	NN	O	domain	prep_of	45	SENT_85	[p4l1695t1946r2028b2024],
52	in	IN	O	in	_	0	SENT_85	[p4l2065t1946r2149b2023],
53	the	DT	O	the	det	57	SENT_85	[p4l11t2075r144b2153],
54	intracellular	JJ	O	intracellular	amod	57	SENT_85	[p4l184t2075r717b2154],
55	compartment	NN	O	compartment	nn	57	SENT_85	[p4l755t2090r1347b2175],
56	(	CD	NUMBER	(	num	57	SENT_85	[p4l1387t2075r1568b2175],
57	Fig	NN	O	fig	prep_in	41	SENT_85	[p4l1387t2075r1568b2175],
58	.	.	O	.	_	0	SENT_85	[p4l1387t2075r1568b2175],

1	1C	NN	O	1c	_	0	SENT_86	[p4l1617t2080r1775b2166],
2	)	NN	O	)	dep	1	SENT_86	[p4l1617t2080r1775b2166],
3	.	.	O	.	_	0	SENT_86	[p4l1617t2080r1775b2166],

1	The	DT	O	the	det	2	SENT_87	[p4l137t2204r299b2282],
2	patient	NN	O	patient	nsubjpass	4	SENT_87	[p4l357t2204r661b2304],
3	Was	VBD	O	be	auxpass	4	SENT_87	[p4l711t2230r875b2283],
4	enrolled	VBN	O	enrol	_	0	SENT_87	[p4l937t2204r1291b2282],
5	in	IN	O	in	_	0	SENT_87	[p4l1349t2204r1434b2281],
6	a	DT	O	a	det	8	SENT_87	[p4l1492t2230r1537b2282],
7	clinical	JJ	O	clinical	amod	8	SENT_87	[p4l1596t2204r1911b2282],
8	trial	NN	O	trial	prep_in	4	SENT_87	[p4l1971t2204r2150b2282],
9	investigating	VBG	O	investigate	partmod	8	SENT_87	[p4l10t2332r573b2432],
10	the	DT	O	the	det	11	SENT_87	[p4l603t2332r736b2410],
11	safety	NN	O	safety	dobj	9	SENT_87	[p4l770t2331r1024b2432],
12	and	CC	O	and	_	0	SENT_87	[p4l1051t2332r1210b2410],
13	efficacy	NN	O	efficacy	conj_and	11	SENT_87	[p4l1243t2331r1582b2432],
14	of	IN	O	of	_	0	SENT_87	[p4l1610t2331r1711b2410],
15	crizotinib	NN	O	crizotinib	prep_of	11	SENT_87	[p4l1725t2332r2148b2410],
16	in	IN	O	in	_	0	SENT_87	[p4l10t2461r91b2538],
17	cancers	NNS	O	cancer	prep_in	15	SENT_87	[p4l128t2486r438b2539],
18	with	IN	O	with	mark	21	SENT_87	[p4l473t2461r663b2540],
19	ROS1	NN	O	ros1	nn	20	SENT_87	[p4l696t2467r897b2540],
20	translocations	NNS	O	translocation	nsubj	21	SENT_87	[p4l937t2461r1526b2539],
21	(	VBP	O	(	advcl	9	SENT_87	[p4l1569t2461r2147b2552],
22	ClinicalTrials	NNS	O	clinicaltrial	dobj	21	SENT_87	[p4l1569t2461r2147b2552],
23	.	.	O	.	_	0	SENT_87	[p4l14t2615r189b2690],

1	goV	NN	O	gov	nn	2	SENT_88	[p4l14t2615r189b2690],
2	number	NN	O	number	_	0	SENT_88	[p4l232t2590r591b2685],
3	,	,	O	,	_	0	SENT_88	[p4l232t2590r591b2685],
4	NCTOO585195	NN	O	nctoo585195	nn	5	SENT_88	[p4l641t2595r1312b2681],
5	)	NN	O	)	appos	2	SENT_88	[p4l641t2595r1312b2681],
6	.	.	O	.	_	0	SENT_88	[p4l641t2595r1312b2681],

1	She	PRP	O	she	nsubj	2	SENT_89	[p4l1366t2590r1513b2668],
2	began	VBD	O	begin	_	0	SENT_89	[p4l1561t2590r1823b2690],
3	taking	VBG	O	take	xcomp	2	SENT_89	[p4l1870t2590r2153b2690],
4	250	CD	NUMBER	250	num	5	SENT_89	[p4l10t2723r158b2796],
5	mg	NN	O	mg	dobj	3	SENT_89	[p4l188t2744r325b2818],
6	of	IN	O	of	_	0	SENT_89	[p4l350t2717r449b2796],
7	crizotinib	NN	O	crizotinib	prep_of	5	SENT_89	[p4l460t2718r863b2796],
8	twice	RB	O	twice	advmod	9	SENT_89	[p4l893t2718r1113b2797],
9	daily	RB	SET	daily	advmod	3	SENT_89	[p4l1142t2718r1353b2818],
10	,	,	O	,	_	0	SENT_89	[p4l1142t2718r1353b2818],
11	and	CC	O	and	_	0	SENT_89	[p4l1387t2718r1542b2796],
12	Within	IN	O	within	_	0	SENT_89	[p4l1565t2718r1841b2797],
13	a	DT	DURATION	a	det	14	SENT_89	[p4l1868t2744r1913b2796],
14	Week	NN	DURATION	week	prep_within	16	SENT_89	[p4l1935t2718r2154b2797],
15	she	PRP	O	she	nsubj	16	SENT_89	[p4l12t2847r152b2925],
16	noted	VBD	O	note	conj_and	2	SENT_89	[p4l188t2847r431b2925],
17	a	DT	O	a	det	19	SENT_89	[p4l466t2873r511b2925],
18	substantial	JJ	O	substantial	amod	19	SENT_89	[p4l547t2847r1027b2926],
19	reduction	NN	O	reduction	dobj	16	SENT_89	[p4l1062t2847r1474b2926],
20	in	IN	O	in	_	0	SENT_89	[p4l1509t2847r1593b2924],
21	her	PRP$	O	she	poss	22	SENT_89	[p4l1629t2847r1768b2925],
22	dyspnea	NN	O	dyspnea	prep_in	16	SENT_89	[p4l1802t2847r2150b2947],
23	and	CC	O	and	_	0	SENT_89	[p4l10t2975r166b3053],
24	fatigue	NN	O	fatigue	prep_in	16	SENT_89	[p4l198t2974r491b3075],
25	and	CC	O	and	_	0	SENT_89	[p4l524t2975r681b3053],
26	a	DT	O	a	det	28	SENT_89	[p4l712t3001r757b3053],
27	substantial	JJ	O	substantial	amod	28	SENT_89	[p4l790t2975r1258b3054],
28	increase	NN	O	increase	prep_in	16	SENT_89	[p4l1289t2975r1637b3053],
29	in	IN	O	in	_	0	SENT_89	[p4l1669t2975r1752b3052],
30	appetite	NN	O	appetite	prep_in	16	SENT_89	[p4l1784t2975r2144b3075],
31	.	.	O	.	_	0	SENT_89	[p4l1784t2975r2144b3075],

1	As	IN	O	as	mark	10	SENT_90	[p4l6t3110r113b3182],
2	compared	VBN	O	compare	_	0	SENT_90	[p4l149t3104r578b3204],
3	with	IN	O	with	prepc_compared_with	10	SENT_90	[p4l605t3104r802b3183],
4	a	DT	O	a	det	8	SENT_90	[p4l834t3130r879b3182],
5	computed	JJ	O	computed	amod	8	SENT_90	[p4l910t3104r1339b3204],
6	tomographic	JJ	O	tomographic	amod	8	SENT_90	[p4l1372t3104r1929b3204],
7	(	NN	O	(	nn	8	SENT_90	[p4l1966t3109r2144b3195],
8	CT	NN	O	ct	pobj	10	SENT_90	[p4l1966t3109r2144b3195],
9	)	CD	NUMBER	)	nsubj	10	SENT_90	[p4l1966t3109r2144b3195],
10	scan	VBP	O	scan	_	0	SENT_90	[p4l12t3257r205b3310],
11	obtained	VBN	O	obtain	dep	10	SENT_90	[p4l252t3232r633b3310],
12	before	IN	O	before	mark	14	SENT_90	[p4l678t3231r949b3310],
13	she	PRP	O	she	nsubj	14	SENT_90	[p4l997t3232r1136b3310],
14	began	VBD	O	begin	advcl	11	SENT_90	[p4l1183t3232r1444b3332],
15	treatment	NN	O	treatment	dobj	14	SENT_90	[p4l1490t3248r1916b3310],
16	with	IN	O	with	_	0	SENT_90	[p4l1953t3232r2149b3311],
17	crizotinib	NN	O	crizotinib	prep_with	14	SENT_90	[p4l11t3360r446b3455],
18	,	,	O	,	_	0	SENT_90	[p4l11t3360r446b3455],
19	a	DT	O	a	det	21	SENT_90	[p4l486t3386r530b3438],
20	repeat	NN	O	repeat	nn	21	SENT_90	[p4l564t3376r828b3460],
21	CT	NN	O	ct	nsubj	22	SENT_90	[p4l859t3365r981b3438],
22	scan	VB	O	scan	dep	14	SENT_90	[p4l1015t3385r1205b3438],
23	of	IN	O	of	_	0	SENT_90	[p4l1241t3359r1340b3438],
24	the	DT	O	the	det	25	SENT_90	[p4l1357t3360r1488b3438],
25	chest	NN	O	chest	prep_of	22	SENT_90	[p4l1525t3360r1745b3438],
26	obtained	VBN	O	obtain	partmod	25	SENT_90	[p4l1776t3360r2149b3438],
27	after	IN	O	after	_	0	SENT_90	[p4l10t3488r213b3568],
28	2	CD	DURATION	2	num	29	SENT_90	[p4l256t3494r304b3567],
29	months	NNS	NUMBER	month	prep_after	26	SENT_90	[p4l350t3489r680b3568],
30	of	IN	O	of	_	0	SENT_90	[p4l729t3488r829b3568],
31	treatment	NN	O	treatment	prep_of	29	SENT_90	[p4l857t3505r1284b3568],
32	with	IN	O	with	_	0	SENT_90	[p4l1320t3489r1517b3569],
33	crizotinib	NN	O	crizotinib	nn	34	SENT_90	[p4l1564t3489r1988b3568],
34	reA	NN	O	rea	prep_with	26	SENT_90	[p4l2034t3515r2148b3568, p5l115t72r137b98],

1	CT	NNP	O	CT	nsubj	2	SENT_91	[p5l159t76r195b98],
2	Scans	VBZ	O	scan	_	0	SENT_91	[p5l203t76r278b98],
3	of	IN	O	of	_	0	SENT_91	[p5l287t74r317b98],
4	the	DT	O	the	det	6	SENT_91	[p5l319t74r361b98],
5	Chest	NN	O	chest	nn	6	SENT_91	[p5l369t74r443b98],
6	B	NN	O	b	prep_of	2	SENT_91	[p5l1546t72r1564b98],
7	Acquired	VBN	O	acquire	partmod	6	SENT_91	[p5l1587t74r1700b105],
8	G2032R	NN	O	g2032r	nn	9	SENT_91	[p5l1710t76r1812b98],
9	Mutation	NN	O	mutation	dobj	7	SENT_91	[p5l1823t75r1938b98],

1	Before	IN	O	before	mark	4	SENT_92	[p5l1589t128r1670b152],
2	G	NN	O	g	nn	3	SENT_92	[p5l1897t118r1992b147],
3	|	NNS	O	|	nsubj	4	SENT_92	[p5l1897t118r1992b147],
4	y2032	VBP	O	y2032	_	0	SENT_92	[p5l1897t118r1992b147],

1	V	NNP	O	V	poss	3	SENT_93	[p5l697t211r701b213],
2	'	POS	O	'	_	0	SENT_93	[p5l755t192r769b198],
3	_	NN	O	_	_	0	SENT_93	[p5l755t192r769b198],
4	ti	NN	O	ti	dep	3	SENT_93	[p5l1154t184r1234b209],
5	‘	NN	O	‘	dep	3	SENT_93	[p5l1154t184r1234b209],
6	,	,	O	,	_	0	SENT_93	[p5l1154t184r1234b209],
7	Crizotinib	NNP	O	Crizotinib	appos	5	SENT_93	[p5l1566t164r1690b188],

1	“‘	SYM	O	“‘	dep	3	SENT_94	[p5l267t220r332b242],
2	-	:	O	-	_	0	SENT_94	[p5l267t220r332b242],
3	\	NN	O	\	_	0	SENT_94	[p5l267t220r332b242],
4	'	''	O	'	_	0	SENT_94	[p5l361t230r363b233],
5	f	LS	O	f	dep	8	SENT_94	[p5l681t220r691b235],
6	v	LS	O	v	nsubj	8	SENT_94	[p5l681t220r691b235],
7	+	CC	O	+	cc	8	SENT_94	[p5l681t220r691b235],
8	I	PRP	O	I	csubj	9	SENT_94	[p5l745t218r749b224],
9	’	VBP	O	’	rcmod	3	SENT_94	[p5l1142t211r1152b230],
10	4	CD	NUMBER	4	dobj	9	SENT_94	[p5l1174t213r1222b242],
11	.	.	O	.	_	0	SENT_94	[p5l1174t213r1222b242],

1	‘	NN	O	‘	_	0	SENT_95	[p5l1174t213r1222b242],
2	J	NN	O	j	dobj	24	SENT_95	[p5l1835t222r1863b241],
3	"	''	O	"	punct	2	SENT_95	[p5l1835t222r1863b241],
4	"	``	O	"	punct	2	SENT_95	[p5l1990t219r1996b237],
5	I	PRP	O	I	dep	6	SENT_95	[p5l1990t219r1996b237],
6	I.	NN	O	i.	dep	2	SENT_95	[p5l2014t220r2022b242],
7	:	:	O	:	_	0	SENT_95	[p5l224t246r228b256],
8	"	``	O	"	punct	9	SENT_95	[p5l277t239r280b242],
9	I	PRP	O	I	dep	2	SENT_95	[p5l679t244r683b260],
10	v	LS	O	v	dep	9	SENT_95	[p5l731t245r769b288],
11	+	CC	O	+	_	0	SENT_95	[p5l731t245r769b288],
12	F	NN	O	f	nn	13	SENT_95	[p5l1124t231r1143b292],
13	Υ	NN	O	υ	dep	2	SENT_95	[p5l1160t236r1228b264],
14	v	LS	O	v	dep	9	SENT_95	[p5l1160t236r1228b264],
15	+	CC	O	+	_	0	SENT_95	[p5l1160t236r1228b264],
16	\	CD	NUMBER	\	dep	2	SENT_95	[p5l1622t204r1634b332],
17	,3	CD	NUMBER	,3	dep	9	SENT_95	[p5l1825t242r1835b260],
18	"	``	O	"	punct	17	SENT_95	[p5l1863t239r1869b252],
19	v	LS	O	v	dep	17	SENT_95	[p5l1863t239r1869b252],
20	,	,	O	,	_	0	SENT_95	[p5l1980t248r2000b273],
21	-	:	O	-	_	0	SENT_95	[p5l1980t248r2000b273],
22	I	PRP	O	I	dep	2	SENT_95	[p5l1980t248r2000b273],
23	'	''	O	'	_	0	SENT_95	[p5l2022t242r2030b256],
24	v	LS	O	v	dep	1	SENT_95	[p5l2022t242r2030b256],
25	_	SYM	O	_	dep	1	SENT_95	[p5l2022t242r2030b256],

1	i	LS	O	i	dep	3	SENT_96	[p5l589t318r635b410],
2	'	''	O	'	_	0	SENT_96	[p5l725t346r731b348],
3	‘	CD	NUMBER	‘	_	0	SENT_96	[p5l978t326r1030b410],
4	.	.	O	.	_	0	SENT_96	[p5l1046t344r1070b410],

1	‘	NN	O	‘	nn	2	SENT_97	[p5l1452t342r1487b410],
2	Crizotinib	NNP	O	Crizotinib	_	0	SENT_97	[p5l1566t347r1690b370],
3	,	,	O	,	_	0	SENT_97	[p5l381t402r392b403],
4	,	,	O	,	_	0	SENT_97	[p5l381t402r392b403],
5	Resistant	JJ	O	resistant	appos	2	SENT_97	[p5l1571t383r1688b406],

1	Pretreatment	NN	O	pretreatment	nn	2	SENT_98	[p5l270t427r437b448],
2	Response	NN	O	response	_	0	SENT_98	[p5l666t427r788b455],
3	to	TO	O	to	_	0	SENT_98	[p5l796t428r822b448],
4	Crizotinib	NNP	O	Crizotinib	nn	5	SENT_98	[p5l831t425r955b448],
5	Progression	NNP	O	Progression	prep_to	2	SENT_98	[p5l1104t425r1254b455],
6	on	IN	O	on	_	0	SENT_98	[p5l1264t432r1295b448],
7	Crizotinib	NNP	O	Crizotinib	prep_on	2	SENT_98	[p5l1305t425r1429b448],

1	C	NN	O	c	nn	2	SENT_99	[p5l116t513r137b539],
2	Detection	NN	O	detection	_	0	SENT_99	[p5l161t516r282b539],
3	of	IN	O	of	_	0	SENT_99	[p5l292t515r322b539],
4	the	DT	O	the	det	7	SENT_99	[p5l325t515r366b539],
5	G2032R	NN	O	g2032r	nn	7	SENT_99	[p5l375t517r476b539],
6	ROS1	NN	O	ros1	nn	7	SENT_99	[p5l486t517r557b539],
7	Mutation	NN	O	mutation	prep_of	2	SENT_99	[p5l570t516r685b539],
8	in	IN	O	in	_	0	SENT_99	[p5l696t516r717b539],
9	Autopsy	NNP	O	Autopsy	nn	13	SENT_99	[p5l727t518r833b546],
10	Specimens	NNP	O	Specimens	nn	13	SENT_99	[p5l841t516r981b546],
11	mm	NN	O	mm	nn	13	SENT_99	[p5l147t579r394b670],
12	)	NN	O	)	nn	13	SENT_99	[p5l694t667r695b671],
13	t	NN	O	t	prep_in	7	SENT_99	[p5l866t597r883b671],
14	v	LS	O	v	dep	13	SENT_99	[p5l866t597r883b671],
15	+	CC	O	+	_	0	SENT_99	[p5l866t597r883b671],
16	1	CD	NUMBER	1	num	18	SENT_99	[p5l898t598r913b657],
17	M1	NN	O	m1	nn	18	SENT_99	[p5l1205t625r1271b670],
18	Po	NNP	O	Po	prep_in	7	SENT_99	[p5l1301t623r1340b670],
19	v	LS	O	v	dep	13	SENT_99	[p5l1301t623r1340b670],
20	+	CC	O	+	_	0	SENT_99	[p5l1301t623r1340b670],
21	A	DT	O	a	det	24	SENT_99	[p5l1364t631r1386b670],
22	hest	NN	O	hest	nn	24	SENT_99	[p5l196t668r273b704],
23	WI	NN	O	wus	nn	24	SENT_99	[p5l280t667r336b704],
24	_	NN	O	_	conj_+	13	SENT_99	[p5l654t705r657b709],
25	'	''	O	'	_	0	SENT_99	[p5l672t685r675b691],
26	l	NN	O	l	tmod	24	SENT_99	[p5l696t677r701b695],
27	-	:	O	-	_	0	SENT_99	[p5l696t677r701b695],
28	5	CD	DATE	5	dep	2	SENT_99	[p5l718t681r732b707],
29	,	,	O	,	_	0	SENT_99	[p5l718t681r732b707],
30	_	CD	NUMBER	_	num	32	SENT_99	[p5l953t707r961b711],
31	Mediastinal	JJ	PERSON	mediastinal	amod	32	SENT_99	[p5l1190t681r1337b704],
32	Lymp	NN	PERSON	lymp	appos	28	SENT_99	[p5l1349t667r1434b712],

1	.	.	O	.	_	0	SENT_100	[p5l614t735r622b737],

1	~	NN	O	~	nn	2	SENT_101	[p5l654t729r656b733],
2	Node	NN	O	node	_	0	SENT_101	[p5l1278t716r1347b740],

1	Autopsy	NNP	O	Autopsy	nn	4	SENT_102	[p5l1505t853r1611b881],
2	Site	NN	O	site	nn	4	SENT_102	[p5l1619t851r1667b874],
3	G2032R	NN	O	g2032r	nn	4	SENT_102	[p5l1922t852r2024b874],
4	Liver	NN	O	liver	_	0	SENT_102	[p5l1508t897r1563b918],
5	(	NN	O	(	dep	4	SENT_102	[p5l1574t895r1675b924],
6	normal	JJ	O	normal	amod	5	SENT_102	[p5l1574t895r1675b924],
7	)	CD	NUMBER	)	tmod	6	SENT_102	[p5l1574t895r1675b924],
8	—	CD	NUMBER	—	number	9	SENT_102	[p5l1967t909r1979b911],
9	Chest	NN	O	chest	num	11	SENT_102	[p5l1506t937r1574b959],
10	wall	NN	O	wall	nn	11	SENT_102	[p5l1582t937r1627b959],
11	tumor	NN	O	tumor	npadvmod	12	SENT_102	[p5l1636t941r1711b959],
12	Right	RB	O	right	advmod	5	SENT_102	[p5l1508t979r1568b1008],
13	lung	NN	O	lung	nn	18	SENT_102	[p5l1578t979r1629b1008],
14	tumor	NN	O	tumor	nn	18	SENT_102	[p5l1637t983r1712b1001],
15	no.	NN	O	no.	nn	18	SENT_102	[p5l1721t987r1756b1001],
16	1	CD	NUMBER	1	num	18	SENT_102	[p5l1768t981r1778b1001],
17	Right	NNP	O	Right	nn	18	SENT_102	[p5l1508t1020r1568b1050],
18	lung	NN	O	lung	dep	5	SENT_102	[p5l1578t1020r1629b1050],
19	tumor	NN	O	tumor	nn	20	SENT_102	[p5l1637t1025r1712b1043],
20	no.	NN	O	no.	dep	18	SENT_102	[p5l1721t1022r1778b1043],
21	2	CD	NUMBER	2	num	24	SENT_102	[p5l1721t1022r1778b1043],
22	Malignant	JJ	O	malignant	amod	24	SENT_102	[p5l1508t1062r1628b1091],
23	pleural	JJ	O	pleural	amod	24	SENT_102	[p5l1638t1062r1716b1091],
24	effusion	NN	O	effusion	dep	4	SENT_102	[p5l1727t1062r1821b1084],

1	A	DT	O	a	amod	5	SENT_103	[p5l264t1093r280b1113],
2	,	,	O	,	_	0	SENT_103	[p5l1265t1123r1267b1133],
3	r	NN	O	r	dep	1	SENT_103	[p5l1299t1092r1308b1101],
4	,	,	O	,	_	0	SENT_103	[p5l1378t1126r1380b1134],
5	ll	NN	O	ll	_	0	SENT_103	[p5l1416t1095r1424b1110],
6	Mediastinal	JJ	MISC	mediastinal	dep	5	SENT_103	[p5l1508t1104r1645b1126],
7	lymph-node	JJ	O	lymph-node	amod	8	SENT_103	[p5l1657t1104r1798b1133],
8	tumor	NN	O	tumor	dep	5	SENT_103	[p5l1806t1108r1881b1126],
9	A	NN	O	a	rcmod	8	SENT_103	[p5l265t1130r278b1144],
10	H	NN	O	h	prep	9	SENT_103	[p5l1192t1133r1199b1140],
11	o	NN	O	o	dep	10	SENT_103	[p5l1281t1131r1289b1141],
12	"	''	O	"	punct	11	SENT_103	[p5l1394t1130r1404b1148],
13	,	,	O	,	_	0	SENT_103	[p5l1394t1130r1404b1148],

1	A	DT	O	a	det	2	SENT_104	[p5l163t1115r258b1183],
2	I	PRP	O	I	nsubj	3	SENT_104	[p5l284t1149r310b1183],
3	‘	VBP	O	‘	_	0	SENT_104	[p5l284t1149r310b1183],
4	A	DT	O	a	det	10	SENT_104	[p5l326t1152r356b1183],
5	A	DT	O	a	det	7	SENT_104	[p5l368t1138r394b1183],
6	,5	CD	NUMBER	,5	num	7	SENT_104	[p5l1186t1145r1191b1174],
7	K	NNP	O	K	nn	10	SENT_104	[p5l1200t1147r1205b1177],
8	‘	CD	NUMBER	‘	advmod	9	SENT_104	[p5l1200t1147r1205b1177],
9	I	PRP	O	I	dep	7	SENT_104	[p5l1275t1146r1281b1174],
10	V	NN	O	v	dobj	3	SENT_104	[p5l1289t1144r1295b1173],
11	,	,	O	,	_	0	SENT_104	[p5l1289t1144r1295b1173],
12	,9	CD	NUMBER	,9	num	13	SENT_104	[p5l1345t1144r1362b1174],
13	‘	NN	O	‘	appos	10	SENT_104	[p5l1345t1144r1362b1174],
14	;	:	O	;	_	0	SENT_104	[p5l1345t1144r1362b1174],
15	l	NN	O	l	dep	17	SENT_104	[p5l1391t1146r1394b1165],
16	v	LS	O	v	dep	17	SENT_104	[p5l1404t1154r1406b1162],
17	Left	VBN	O	leave	rcmod	10	SENT_104	[p5l1508t1145r1550b1168],
18	lung	NN	O	lung	nn	19	SENT_104	[p5l1560t1145r1611b1175],
19	(	NN	O	(	dobj	17	SENT_104	[p5l1622t1147r1777b1174],
20	microscopic	JJ	O	microscopic	amod	21	SENT_104	[p5l1622t1147r1777b1174],
21	disease	NN	O	disease	tmod	17	SENT_104	[p5l1785t1145r1882b1174],
22	)	CD	NUMBER	)	num	24	SENT_104	[p5l1785t1145r1882b1174],
23	Pleural	JJ	O	pleural	amod	24	SENT_104	[p5l189t1194r274b1217],
24	Fluid	NN	O	fluid	dep	21	SENT_104	[p5l286t1194r347b1217],

1	Figure	NN	O	figure	_	0	SENT_105	[p5l122t1282r206b1314],
2	2	CD	NUMBER	2	dep	1	SENT_105	[p5l217t1283r241b1306],
3	.	.	O	.	_	0	SENT_105	[p5l217t1283r241b1306],

1	Identification	NN	O	identification	nsubj	4	SENT_106	[p5l254t1281r437b1306],
2	of	IN	O	of	_	0	SENT_106	[p5l449t1281r480b1306],
3	an	DT	O	a	prep_of	1	SENT_106	[p5l485t1289r516b1306],
4	Acquired	VBN	O	acquire	_	0	SENT_106	[p5l528t1281r650b1314],
5	RO$	NN	O	ro$	nn	8	SENT_106	[p5l663t1283r738b1306],
6	1	CD	NUMBER	1	num	8	SENT_106	[p5l663t1283r738b1306],
7	G2032R	NN	O	g2032r	nn	8	SENT_106	[p5l750t1283r859b1306],
8	Mutation	NN	O	mutation	dobj	4	SENT_106	[p5l872t1282r996b1306],
9	at	IN	O	at	_	0	SENT_106	[p5l1008t1285r1033b1306],
10	the	DT	O	the	det	11	SENT_106	[p5l1042t1281r1086b1306],
11	Time	NN	O	time	prep_at	8	SENT_106	[p5l1096t1282r1166b1306],
12	of	IN	O	of	_	0	SENT_106	[p5l1176t1281r1207b1306],
13	Resistance	NN	O	resistance	prep_of	11	SENT_106	[p5l1214t1282r1362b1306],
14	to	TO	O	to	_	0	SENT_106	[p5l1371t1285r1398b1306],
15	Crizotinib	NNP	O	Crizotinib	prep_to	4	SENT_106	[p5l1408t1281r1549b1306],
16	.	.	O	.	_	0	SENT_106	[p5l1408t1281r1549b1306],

1	Axial	NNP	O	Axial	nn	2	SENT_107	[p5l119t1331r184b1356],
2	CT	NNP	O	CT	nsubj	3	SENT_107	[p5l197t1333r235b1356],
3	scans	VBZ	O	scan	_	0	SENT_107	[p5l246t1340r322b1356],
4	ofthe	NN	O	ofthe	nn	5	SENT_107	[p5l335t1331r414b1356],
5	chest	NN	O	chest	dobj	3	SENT_107	[p5l425t1331r499b1356],
6	(	CD	NUMBER	(	num	7	SENT_107	[p5l512t1331r595b1364],
7	Panel	NN	O	panel	tmod	3	SENT_107	[p5l512t1331r595b1364],
8	A	DT	O	a	det	9	SENT_107	[p5l608t1333r635b1364],
9	)	NN	O	)	nsubj	10	SENT_107	[p5l608t1333r635b1364],
10	show	VBP	O	show	rcmod	7	SENT_107	[p5l650t1331r722b1356],
11	the	DT	O	the	det	12	SENT_107	[p5l731t1331r775b1356],
12	patient	NN	O	patient	poss	15	SENT_107	[p5l787t1333r905b1364],
13	’s	POS	O	’s	_	0	SENT_107	[p5l787t1333r905b1364],
14	disease	NN	O	disease	nn	15	SENT_107	[p5l918t1331r1019b1356],
15	burden	NN	O	burden	dobj	10	SENT_107	[p5l1032t1331r1127b1356],
16	before	IN	O	before	_	0	SENT_107	[p5l1141t1331r1227b1356],
17	treatment	NN	O	treatment	prep_before	10	SENT_107	[p5l1238t1336r1383b1361],
18	,	,	O	,	_	0	SENT_107	[p5l1238t1336r1383b1361],
19	after	IN	O	after	_	0	SENT_107	[p5l1396t1331r1459b1356],
20	a	DT	O	a	det	21	SENT_107	[p5l1470t1340r1483b1356],
21	response	NN	O	response	conj_and	21	SENT_107	[p5l1496t1340r1621b1364],
22	to	TO	O	to	_	0	SENT_107	[p5l1631t1336r1658b1356],
23	crizotinib	NN	O	crizotinib	prep_to	21	SENT_107	[p5l1669t1331r1805b1361],
24	,	,	O	,	_	0	SENT_107	[p5l1669t1331r1805b1361],
25	and	CC	O	and	_	0	SENT_107	[p5l1818t1331r1867b1356],
26	at	IN	O	at	_	0	SENT_107	[p5l1880t1336r1904b1356],
27	the	DT	O	the	det	28	SENT_107	[p5l1914t1331r1958b1356],
28	time	NN	O	time	prep_at	21	SENT_107	[p5l1968t1333r2030b1356],
29	of	IN	O	of	_	0	SENT_107	[p5l120t1372r150b1398],
30	crizotinib	JJ	O	crizotinib	amod	31	SENT_107	[p5l157t1373r285b1398],
31	resistance	NN	O	resistance	prep_of	28	SENT_107	[p5l298t1375r444b1398],
32	.	.	O	.	_	0	SENT_107	[p5l298t1375r444b1398],

1	Sanger	NNP	PERSON	Sanger	nn	2	SENT_108	[p5l457t1375r553b1406],
2	sequencing	NN	O	sequencing	_	0	SENT_108	[p5l564t1375r722b1406],
3	of	IN	O	of	_	0	SENT_108	[p5l733t1372r763b1398],
4	RT-PCR	NN	O	rt-pcr	nn	5	SENT_108	[p5l772t1375r873b1398],
5	products	NNS	O	product	prep_of	2	SENT_108	[p5l886t1373r1008b1406],
6	(	CD	NUMBER	(	num	9	SENT_108	[p5l1023t1373r1106b1406],
7	Panel	NN	O	panel	nn	9	SENT_108	[p5l1023t1373r1106b1406],
8	B	NN	O	b	nn	9	SENT_108	[p5l1121t1375r1146b1406],
9	)	NN	O	)	dep	2	SENT_108	[p5l1121t1375r1146b1406],
10	before	IN	O	before	advmod	9	SENT_108	[p5l1161t1372r1247b1398],
11	and	CC	O	and	_	0	SENT_108	[p5l1259t1373r1308b1398],
12	after	IN	O	after	mark	16	SENT_108	[p5l1321t1372r1384b1398],
13	treatment	NN	O	treatment	nsubj	16	SENT_108	[p5l1393t1378r1531b1398],
14	with	IN	O	with	_	0	SENT_108	[p5l1541t1373r1598b1398],
15	crizotinib	NN	O	crizotinib	prep_with	13	SENT_108	[p5l1611t1373r1740b1398],
16	shows	VBZ	O	show	dep	2	SENT_108	[p5l1752t1373r1837b1398],
17	the	DT	O	the	det	20	SENT_108	[p5l1848t1373r1892b1398],
18	acquired	VBN	O	acquire	amod	20	SENT_108	[p5l1904t1373r2021b1406],
19	c.	NN	O	c.	nn	20	SENT_108	[p5l120t1416r279b1440],
20	6094G	NN	O	6094g	nsubj	22	SENT_108	[p5l120t1416r279b1440],
21	—	CD	NUMBER	—	npadvmod	22	SENT_108	[p5l120t1416r279b1440],
22	>	JJR	O	>	xcomp	16	SENT_108	[p5l120t1416r279b1440],
23	A	DT	O	a	det	24	SENT_108	[p5l120t1416r279b1440],
24	mutation	NN	O	mutation	dep	2	SENT_108	[p5l291t1417r424b1444],
25	,	,	O	,	_	0	SENT_108	[p5l291t1417r424b1444],
26	which	WDT	O	which	nsubj	27	SENT_108	[p5l436t1414r516b1440],
27	encodes	VBZ	O	encode	rcmod	24	SENT_108	[p5l528t1414r643b1440],
28	for	IN	O	for	_	0	SENT_108	[p5l654t1414r693b1440],
29	p.	NN	O	p.	nn	31	SENT_108	[p5l704t1414r896b1448],
30	G	NN	O	g	nn	31	SENT_108	[p5l704t1414r896b1448],
31	|	NNS	O	|	prep_for	27	SENT_108	[p5l704t1414r896b1448],
32	y2032Arg	NN	O	y2032arg	dep	31	SENT_108	[p5l704t1414r896b1448],
33	.	.	O	.	_	0	SENT_108	[p5l704t1414r896b1448],

1	(	NN	O	(	_	0	SENT_109	[p5l911t1414r1004b1447],
2	These	DT	O	these	nsubjpass	9	SENT_109	[p5l911t1414r1004b1447],
3	coding	VBG	O	code	amod	2	SENT_109	[p5l1015t1414r1108b1448],
4	and	CC	O	and	_	0	SENT_109	[p5l1119t1414r1168b1440],
5	amino	NN	O	amino	nn	7	SENT_109	[p5l1181t1417r1267b1440],
6	acid	NN	O	acid	nn	7	SENT_109	[p5l1279t1414r1333b1440],
7	sequences	NNS	O	sequence	conj_and	2	SENT_109	[p5l1346t1423r1491b1447],
8	are	VBP	O	be	auxpass	9	SENT_109	[p5l1503t1423r1544b1440],
9	numbered	VBN	O	number	rcmod	1	SENT_109	[p5l1557t1414r1697b1440],
10	in	IN	O	in	_	0	SENT_109	[p5l1710t1417r1732b1439],
11	accordance	NN	O	accordance	prep_in	12	SENT_109	[p5l1745t1414r1901b1440],
12	with	IN	O	with	dobj	9	SENT_109	[p5l1912t1414r1969b1440],
13	National	NNP	ORGANIZATION	National	nn	14	SENT_109	[p5l1984t1417r2031b1440, p5l119t1456r196b1481],
14	Center	NNP	ORGANIZATION	Center	dep	22	SENT_109	[p5l209t1458r300b1481],
15	for	IN	ORGANIZATION	for	_	0	SENT_109	[p5l310t1456r349b1481],
16	Biotechnology	NNP	ORGANIZATION	Biotechnology	nn	19	SENT_109	[p5l361t1456r559b1489],
17	Information	NNP	ORGANIZATION	Information	nn	19	SENT_109	[p5l572t1456r734b1481],
18	[	NNP	O	[	nn	19	SENT_109	[p5l747t1458r836b1489],
19	NCBI	NNP	O	NCBI	prep_for	14	SENT_109	[p5l747t1458r836b1489],
20	]	CD	NUMBER	]	num	22	SENT_109	[p5l747t1458r836b1489],
21	reference	NN	O	reference	nn	22	SENT_109	[p5l850t1456r977b1481],
22	sequences	NNS	O	sequence	dep	12	SENT_109	[p5l989t1465r1133b1489],
23	CCDS5116	NN	O	ccds5116	nn	26	SENT_109	[p5l1146t1458r1288b1481],
24	and	CC	O	and	_	0	SENT_109	[p5l1300t1456r1348b1481],
25	NP_O02935	NN	O	np_o02935	nn	26	SENT_109	[p5l1364t1458r1554b1486],
26	.2	NN	NUMBER	.2	dep	22	SENT_109	[p5l1364t1458r1554b1486],
27	,	,	O	,	_	0	SENT_109	[p5l1364t1458r1554b1486],
28	respectively	RB	O	respectively	advmod	26	SENT_109	[p5l1568t1456r1746b1489],
29	.	.	O	.	_	0	SENT_109	[p5l1568t1456r1746b1489],
30	)	SYM	O	)	dep	12	SENT_109	[p5l1568t1456r1746b1489],

1	In	IN	O	in	_	0	SENT_110	[p5l1763t1458r1785b1481],
2	all	DT	O	all	det	5	SENT_110	[p5l1798t1456r1826b1481],
3	six	CD	NUMBER	six	num	5	SENT_110	[p5l1840t1458r1874b1481],
4	malignant	JJ	O	malignant	amod	5	SENT_110	[p5l1886t1456r2025b1489],
5	sites	NNS	O	site	prep_in	23	SENT_110	[p5l121t1500r182b1523],
6	examined	VBN	O	examine	partmod	5	SENT_110	[p5l194t1498r326b1523],
7	at	IN	O	at	_	0	SENT_110	[p5l339t1503r363b1523],
8	autopsy	NN	O	autopsy	nn	12	SENT_110	[p5l375t1503r483b1531],
9	(	CD	NUMBER	(	num	12	SENT_110	[p5l496t1498r580b1531],
10	Panel	NN	O	panel	nn	12	SENT_110	[p5l496t1498r580b1531],
11	C	NN	O	c	nn	12	SENT_110	[p5l593t1500r630b1531],
12	)	NN	O	)	prep_at	6	SENT_110	[p5l593t1500r630b1531],
13	,	,	O	,	_	0	SENT_110	[p5l593t1500r630b1531],
14	the	DT	O	the	det	16	SENT_110	[p5l641t1498r685b1523],
15	c.	NN	O	c.	nn	16	SENT_110	[p5l696t1499r855b1523],
16	6094G	NN	O	6094g	nsubjpass	23	SENT_110	[p5l696t1499r855b1523],
17	—	CD	NUMBER	—	num	18	SENT_110	[p5l696t1499r855b1523],
18	>	JJR	O	>	dep	16	SENT_110	[p5l696t1499r855b1523],
19	A	DT	O	a	det	21	SENT_110	[p5l696t1499r855b1523],
20	R051	NN	O	r051	nn	21	SENT_110	[p5l867t1500r941b1523],
21	mutation	NN	O	mutation	dep	16	SENT_110	[p5l955t1500r1079b1523],
22	was	VBD	O	be	auxpass	23	SENT_110	[p5l1091t1507r1143b1523],
23	detected	VBN	O	detect	_	0	SENT_110	[p5l1155t1498r1274b1523],
24	by	IN	O	by	_	0	SENT_110	[p5l1288t1498r1317b1531],
25	means	NNS	O	means	_	0	SENT_110	[p5l1329t1507r1418b1523],
26	of	IN	O	of	_	0	SENT_110	[p5l1430t1497r1460b1523],
27	Sanger	NNP	PERSON	Sanger	nn	28	SENT_110	[p5l1467t1500r1562b1531],
28	sequencing	NN	O	sequencing	prep_by_means_of	23	SENT_110	[p5l1574t1500r1732b1531],
29	of	IN	O	of	_	0	SENT_110	[p5l1743t1497r1773b1523],
30	RT-PCR	NN	O	rt-pcr	nn	31	SENT_110	[p5l1782t1500r1883b1523],
31	products	NNS	O	product	prep_of	28	SENT_110	[p5l1896t1498r2026b1531],
32	.	.	O	.	_	0	SENT_110	[p5l1896t1498r2026b1531],

1	Genomic	JJ	O	genomic	amod	3	SENT_111	[p5l120t1541r247b1565],
2	DNA	NN	O	dna	nn	3	SENT_111	[p5l260t1541r325b1564],
3	sequencing	NN	O	sequencing	nsubj	18	SENT_111	[p5l337t1542r495b1573],
4	of	IN	O	of	_	0	SENT_111	[p5l506t1539r536b1565],
5	R051	NN	O	r051	nn	6	SENT_111	[p5l544t1541r617b1565],
6	exon	NN	O	exon	prep_of	3	SENT_111	[p5l630t1548r693b1565],
7	38	CD	NUMBER	38	num	6	SENT_111	[p5l706t1541r737b1565],
8	in	IN	O	in	_	0	SENT_111	[p5l749t1542r771b1564],
9	the	DT	O	the	det	10	SENT_111	[p5l783t1539r826b1565],
10	patient	NN	O	patient	poss	17	SENT_111	[p5l839t1541r957b1572],
11	’s	POS	O	’s	_	0	SENT_111	[p5l839t1541r957b1572],
12	grossly	RB	O	grossly	amod	17	SENT_111	[p5l970t1539r1066b1573],
13	and	CC	O	and	_	0	SENT_111	[p5l1077t1539r1125b1565],
14	microscopically	RB	O	microscopically	advmod	15	SENT_111	[p5l1140t1539r1354b1572],
15	normal	JJ	O	normal	conj_and	12	SENT_111	[p5l1366t1539r1462b1565],
16	liver	NN	O	liver	nn	17	SENT_111	[p5l1476t1539r1533b1565],
17	tissue	NN	O	tissue	prep_in	3	SENT_111	[p5l1542t1542r1623b1565],
18	shows	VBZ	O	show	_	0	SENT_111	[p5l1635t1539r1721b1565],
19	the	DT	O	the	det	21	SENT_111	[p5l1732t1539r1775b1565],
20	nonmutated	JJ	O	nonmutated	amod	21	SENT_111	[p5l1788t1539r1956b1565],
21	RO$	NN	O	ro$	dobj	18	SENT_111	[p5l122t1583r195b1606],
22	1	CD	NUMBER	1	num	23	SENT_111	[p5l122t1583r195b1606],
23	sequence	NN	O	sequence	dep	21	SENT_111	[p5l209t1590r346b1614],
24	;	:	O	;	_	0	SENT_111	[p5l209t1590r346b1614],
25	the	DT	O	the	det	26	SENT_111	[p5l357t1581r401b1606],
26	CD74	NN	O	cd74	dep	21	SENT_111	[p5l413t1583r581b1606],
27	.	.	O	.	_	0	SENT_111	[p5l413t1583r581b1606],

1	—	NN	O	—	_	0	SENT_112	[p5l413t1583r581b1606],
2	.	.	O	.	_	0	SENT_112	[p5l413t1583r581b1606],

1	ROS1	NN	O	ros1	nn	3	SENT_113	[p5l413t1583r581b1606],
2	fusion	NN	O	fusion	nn	3	SENT_113	[p5l594t1581r678b1606],
3	transcript	NN	O	transcript	nsubjpass	7	SENT_113	[p5l690t1583r825b1614],
4	could	MD	O	could	aux	7	SENT_113	[p5l836t1581r910b1606],
5	not	RB	O	not	neg	7	SENT_113	[p5l924t1586r968b1606],
6	be	VB	O	be	auxpass	7	SENT_113	[p5l980t1581r1010b1606],
7	detected	VBN	O	detect	_	0	SENT_113	[p5l1022t1581r1140b1606],
8	on	IN	O	on	_	0	SENT_113	[p5l1153t1590r1186b1606],
9	RT-PCR	NN	O	rt-pcr	prep_on	7	SENT_113	[p5l1201t1583r1302b1606],
10	in	IN	O	in	_	0	SENT_113	[p5l1315t1583r1336b1606],
11	the	DT	O	the	det	13	SENT_113	[p5l1348t1581r1392b1606],
12	normal	JJ	O	normal	amod	13	SENT_113	[p5l1404t1581r1500b1606],
13	liver	NN	O	liver	prep_in	9	SENT_113	[p5l1514t1581r1575b1606],
14	.	.	O	.	_	0	SENT_113	[p5l1514t1581r1575b1606],

1	In	IN	O	in	_	0	SENT_114	[p5l1590t1583r1612b1606],
2	the	DT	O	the	det	5	SENT_114	[p5l1624t1581r1668b1606],
3	summary	NN	O	summary	nn	5	SENT_114	[p5l1680t1590r1810b1614],
4	ofautopsy	NN	O	ofautopsy	nn	5	SENT_114	[p5l1820t1581r1965b1614],
5	findings	NNS	O	finding	prep_in	15	SENT_114	[p5l1975t1581r2040b1606, p5l121t1625r176b1656],
6	at	IN	O	at	_	0	SENT_114	[p5l188t1628r213b1648],
7	right	NN	O	right	prep_at	5	SENT_114	[p5l225t1623r295b1656],
8	,	,	O	,	_	0	SENT_114	[p5l225t1623r295b1656],
9	the	DT	O	the	det	13	SENT_114	[p5l307t1623r350b1648],
10	presence	NN	O	presence	nn	13	SENT_114	[p5l363t1632r486b1656],
11	ofthe	NN	O	ofthe	nn	13	SENT_114	[p5l497t1622r576b1648],
12	G2032R	NN	O	g2032r	nn	13	SENT_114	[p5l588t1624r695b1648],
13	mutation	NN	O	mutation	nsubjpass	15	SENT_114	[p5l708t1625r832b1648],
14	is	VBZ	O	be	auxpass	15	SENT_114	[p5l846t1625r865b1648],
15	indicated	VBN	O	indicate	_	0	SENT_114	[p5l878t1623r1003b1648],
16	by	IN	O	by	_	0	SENT_114	[p5l1017t1623r1046b1656],
17	a	DT	O	a	det	26	SENT_114	[p5l1057t1632r1069b1648],
18	plus	CC	O	plus	dep	26	SENT_114	[p5l1083t1623r1138b1656],
19	sign	NN	O	sign	dep	18	SENT_114	[p5l1151t1625r1214b1656],
20	,	,	O	,	_	0	SENT_114	[p5l1151t1625r1214b1656],
21	and	CC	O	and	_	0	SENT_114	[p5l1227t1623r1275b1648],
22	the	DT	O	the	det	24	SENT_114	[p5l1287t1623r1330b1648],
23	absence	NN	O	absence	nn	24	SENT_114	[p5l1342t1623r1454b1648],
24	ofthe	NN	O	ofthe	dep	26	SENT_114	[p5l1465t1622r1544b1648],
25	G2032R	NN	O	g2032r	nn	26	SENT_114	[p5l1555t1624r1662b1648],
26	mutation	NN	O	mutation	agent	15	SENT_114	[p5l1675t1625r1799b1648],
27	by	IN	O	by	_	0	SENT_114	[p5l1813t1623r1842b1656],
28	a	DT	O	a	det	30	SENT_114	[p5l1853t1632r1866b1648],
29	minus	NN	O	minus	nn	30	SENT_114	[p5l1879t1625r1963b1648],
30	sign	NN	O	sign	agent	15	SENT_114	[p5l1975t1625r2038b1656],
31	.	.	O	.	_	0	SENT_114	[p5l1975t1625r2038b1656],

1	N	NN	O	n	nn	3	SENT_115	[p5l622t1761r635b1777],
2	ENGLJ	NN	O	englj	nn	3	SENT_115	[p5l650t1761r728b1783],
3	MED	NN	O	med	dep	8	SENT_115	[p5l743t1761r794b1776],
4	368	CD	NUMBER	368	dep	3	SENT_115	[p5l805t1755r884b1783],
5	;	:	O	;	_	0	SENT_115	[p5l805t1755r884b1783],
6	25	CD	NUMBER	25	dep	3	SENT_115	[p5l805t1755r884b1783],
7	NE	NNS	O	ne	dep	6	SENT_115	[p5l919t1761r1043b1783],
8	)	VBP	O	)	_	0	SENT_115	[p5l919t1761r1043b1783],
9	M.oRG	NN	O	m.org	nn	10	SENT_115	[p5l919t1761r1043b1783],
10	jUNE20	NN	O	june20	dobj	8	SENT_115	[p5l1074t1761r1253b1783],
11	,2013	CD	NUMBER	,2013	num	10	SENT_115	[p5l1074t1761r1253b1783],
12	2397	CD	DATE	2397	nsubj	8	SENT_115	[p5l1990t1752r2066b1774],

1	The	DT	O	the	det	4	SENT_116	[p5l752t1794r803b1817],
2	New	NNP	O	New	nn	4	SENT_116	[p5l812t1794r874b1817],
3	England	NNP	O	England	nn	4	SENT_116	[p5l883t1794r994b1824],
4	Journal	NNP	O	Journal	_	0	SENT_116	[p5l1003t1794r1100b1817],
5	of	IN	O	of	_	0	SENT_116	[p5l1110t1794r1139b1817],
6	Medicine	NNP	O	Medicine	prep_of	4	SENT_116	[p5l1145t1794r1270b1817],

1	The	DT	O	the	det	4	SENT_117	[p5l673t1981r718b2002],
2	NEW	NNP	O	NEW	nn	4	SENT_117	[p5l737t1983r822b2002],
3	ENGLAND	NNP	O	ENGLAND	nn	4	SENT_117	[p5l841t1983r1029b2002],
4	JOURNAL	NNP	O	JOURNAL	_	0	SENT_117	[p5l1048t1983r1227b2009],
5	of	IN	O	of	_	0	SENT_117	[p5l1247t1981r1275b2008],
6	MEDICINE	NNP	O	MEDICINE	prep_of	4	SENT_117	[p5l1287t1983r1486b2002],

1	vealed	VBN	O	veal	_	0	SENT_118	[p5l7t2203r272b2282],
2	a	DT	O	a	det	4	SENT_118	[p5l302t2229r347b2281],
3	dramatic	JJ	O	dramatic	amod	4	SENT_118	[p5l378t2203r755b2282],
4	response	NN	O	response	dobj	1	SENT_118	[p5l786t2229r1159b2303],
5	to	TO	O	to	_	0	SENT_118	[p5l1192t2220r1272b2282],
6	treatment	NN	O	treatment	nn	8	SENT_118	[p5l1306t2220r1721b2282],
7	(	CD	NUMBER	(	num	8	SENT_118	[p5l1753t2204r1928b2304],
8	Fig	NN	O	fig	prep_to	1	SENT_118	[p5l1753t2204r1928b2304],
9	.	.	O	.	_	0	SENT_118	[p5l1753t2204r1928b2304],

1	2A	NN	O	2a	_	0	SENT_119	[p5l1965t2209r2129b2294],
2	)	NN	O	)	dep	1	SENT_119	[p5l1965t2209r2129b2294],
3	.	.	O	.	_	0	SENT_119	[p5l1965t2209r2129b2294],

1	However	RB	O	however	advmod	12	SENT_120	[p5l11t2338r406b2426],
2	,	,	O	,	_	0	SENT_120	[p5l11t2338r406b2426],
3	1	CD	DATE	1	num	4	SENT_120	[p5l450t2337r494b2408],
4	month	NN	DATE	month	npadvmod	5	SENT_120	[p5l530t2331r816b2409],
5	later	RB	DATE	later	advmod	12	SENT_120	[p5l849t2331r1060b2426],
6	,	,	O	,	_	0	SENT_120	[p5l849t2331r1060b2426],
7	the	DT	O	the	det	8	SENT_120	[p5l1101t2331r1234b2409],
8	patient	NN	O	patient	poss	11	SENT_120	[p5l1268t2332r1631b2430],
9	’s	POS	O	’s	_	0	SENT_120	[p5l1268t2332r1631b2430],
10	respiratory	JJ	O	respiratory	amod	11	SENT_120	[p5l1668t2332r2139b2430],
11	symptoms	NNS	O	symptom	nsubj	12	SENT_120	[p5l13t2476r456b2559],
12	worsened	VBD	O	worsen	_	0	SENT_120	[p5l503t2459r917b2538],
13	While	IN	O	while	mark	17	SENT_120	[p5l961t2459r1197b2538],
14	she	PRP	O	she	nsubj	17	SENT_120	[p5l1248t2459r1386b2537],
15	was	VBD	O	be	aux	17	SENT_120	[p5l1431t2485r1594b2538],
16	still	RB	O	still	advmod	17	SENT_120	[p5l1646t2459r1808b2537],
17	taking	VBG	O	take	csubj	25	SENT_120	[p5l1857t2459r2138b2560],
18	crizotinib	NN	O	crizotinib	dobj	17	SENT_120	[p5l12t2587r444b2683],
19	,	,	O	,	_	0	SENT_120	[p5l12t2587r444b2683],
20	and	CC	O	and	_	0	SENT_120	[p5l489t2587r644b2666],
21	imaging	NN	O	imaging	conj_and	18	SENT_120	[p5l684t2588r1039b2688],
22	of	IN	O	of	_	0	SENT_120	[p5l1076t2586r1175b2666],
23	the	DT	O	the	det	24	SENT_120	[p5l1197t2587r1327b2666],
24	chest	NN	O	chest	prep_of	21	SENT_120	[p5l1368t2587r1587b2665],
25	showed	VBD	O	show	ccomp	12	SENT_120	[p5l1623t2587r1940b2666],
26	disease	NN	O	disease	nn	27	SENT_120	[p5l1980t2587r2133b2666, p5l12t2741r190b2792],
27	progression	NN	O	progression	iobj	25	SENT_120	[p5l227t2716r738b2815],
28	(	CD	NUMBER	(	num	29	SENT_120	[p5l782t2716r962b2815],
29	Fig	NN	O	fig	dobj	25	SENT_120	[p5l782t2716r962b2815],
30	.	.	O	.	_	0	SENT_120	[p5l782t2716r962b2815],

1	2A	NN	O	2a	_	0	SENT_121	[p5l1007t2721r1173b2805],
2	)	NN	O	)	dep	1	SENT_121	[p5l1007t2721r1173b2805],
3	.	.	O	.	_	0	SENT_121	[p5l1007t2721r1173b2805],

1	METHODS	NNS	O	method	_	0	SENT_122	[p5l801t3010r1343b3071],

1	sruov	NN	O	sruov	nsubj	8	SENT_123	[p5l12t3246r268b3296],
2	OVERSIGHT	NNP	O	OVERSIGHT	dep	1	SENT_123	[p5l300t3246r761b3296],
3	The	DT	O	the	det	4	SENT_123	[p5l8t3344r169b3422],
4	patient	NN	O	patient	dep	1	SENT_123	[p5l212t3345r514b3444],
5	and	CC	O	and	_	0	SENT_123	[p5l552t3344r710b3423],
6	her	PRP$	O	she	poss	7	SENT_123	[p5l754t3344r892b3422],
7	family	NN	O	family	dep	1	SENT_123	[p5l933t3343r1209b3444],
8	provided	VBD	O	provide	_	0	SENT_123	[p5l1246t3344r1621b3444],
9	Written	VBN	O	write	dep	8	SENT_123	[p5l1660t3345r1974b3424],
10	informed	VBN	O	inform	amod	11	SENT_123	[p5l2018t3345r2133b3422, p5l12t3472r323b3552],
11	consent	NN	O	consent	dobj	9	SENT_123	[p5l362t3490r697b3552],
12	for	IN	O	for	_	0	SENT_123	[p5l729t3472r852b3552],
13	the	DT	O	the	det	16	SENT_123	[p5l888t3473r1020b3552],
14	genetic	JJ	O	genetic	amod	16	SENT_123	[p5l1058t3474r1367b3574],
15	research	NN	O	research	nn	16	SENT_123	[p5l1404t3473r1765b3551],
16	studies	NNS	O	study	prep_for	11	SENT_123	[p5l1805t3473r2129b3569],
17	,	,	O	,	_	0	SENT_123	[p5l1805t3473r2129b3569],
18	which	WDT	O	which	nsubjpass	20	SENT_123	[p5l7t3600r270b3680],
19	were	VBD	O	be	auxpass	20	SENT_123	[p5l297t3626r500b3680],
20	performed	VBN	O	perform	rcmod	16	SENT_123	[p5l530t3599r986b3700],
21	in	IN	O	in	_	0	SENT_123	[p5l1018t3601r1101b3678],
22	accordance	NN	O	accordance	prep_in	20	SENT_123	[p5l1133t3600r1613b3679],
23	with	IN	O	with	_	0	SENT_123	[p5l1641t3600r1836b3680],
24	protocols	NNS	O	protocol	prep_with	20	SENT_123	[p5l1867t3617r2133b3700, p6l12t21r176b99],

1	approved	VBN	O	approve	_	0	SENT_124	[p6l208t21r598b120],
2	by	IN	O	by	_	0	SENT_124	[p6l628t21r725b120],
3	the	DT	O	the	det	6	SENT_124	[p6l751t21r884b99],
4	institutional	JJ	O	institutional	amod	6	SENT_124	[p6l913t21r1447b100],
5	review	NN	O	review	nn	6	SENT_124	[p6l1476t22r1756b100],
6	board	NN	O	board	prep_by	1	SENT_124	[p6l1783t21r2031b99],
7	at	IN	O	at	_	0	SENT_124	[p6l2060t37r2139b99],
8	Massachusetts	NNP	ORGANIZATION	Massachusetts	nn	10	SENT_124	[p6l9t148r636b228],
9	General	NNP	ORGANIZATION	General	nn	10	SENT_124	[p6l668t148r1006b227],
10	Hospital	NNP	ORGANIZATION	Hospital	prep_at	6	SENT_124	[p6l1035t148r1423b248],
11	.	.	O	.	_	0	SENT_124	[p6l1035t148r1423b248],

1	The	DT	O	the	det	3	SENT_125	[p6l1455t148r1616b226],
2	first	JJ	ORDINAL	first	amod	3	SENT_125	[p6l1646t147r1830b226],
3	author	NN	O	author	nsubj	4	SENT_125	[p6l1854t148r2137b228],
4	Wrote	VBD	O	write	_	0	SENT_125	[p6l7t294r250b356],
5	the	DT	O	the	det	6	SENT_125	[p6l279t277r410b355],
6	manuscript	NN	O	manuscript	dobj	4	SENT_125	[p6l438t278r921b376],
7	in	IN	O	in	_	0	SENT_125	[p6l943t278r1025b354],
8	collaboration	NN	O	collaboration	prep_in	4	SENT_125	[p6l1054t277r1613b355],
9	with	IN	O	with	_	0	SENT_125	[p6l1637t277r1829b356],
10	the	DT	O	the	det	13	SENT_125	[p6l1858t277r1988b355],
11	senior	JJ	O	senior	amod	13	SENT_125	[p6l2018t303r2133b355, p6l12t405r185b482],
12	academic	JJ	O	academic	amod	13	SENT_125	[p6l213t404r613b482],
13	authors	NNS	O	author	prep_with	4	SENT_125	[p6l645t404r991b499],
14	;	:	O	;	_	0	SENT_125	[p6l645t404r991b499],
15	no	DT	O	no	det	16	SENT_125	[p6l1028t429r1133b482],
16	one	CD	NUMBER	one	nsubjpass	22	SENT_125	[p6l1168t429r1319b482],
17	other	JJ	O	other	advmod	22	SENT_125	[p6l1353t404r1581b482],
18	than	IN	O	than	_	0	SENT_125	[p6l1610t404r1807b481],
19	the	DT	O	the	det	20	SENT_125	[p6l1840t404r1973b481],
20	authors	NNS	O	author	prep_than	17	SENT_125	[p6l2005t430r2133b483, p6l12t532r233b611],
21	was	VBD	O	be	auxpass	22	SENT_125	[p6l271t558r433b611],
22	involved	VBN	O	involve	parataxis	4	SENT_125	[p6l475t532r827b611],
23	in	IN	O	in	_	0	SENT_125	[p6l866t533r950b610],
24	the	DT	O	the	det	25	SENT_125	[p6l990t532r1123b610],
25	writing	NN	O	writing	prep_in	22	SENT_125	[p6l1159t533r1480b633],
26	of	IN	O	of	_	0	SENT_125	[p6l1517t531r1618b611],
27	this	DT	O	this	det	28	SENT_125	[p6l1640t532r1799b610],
28	report	NN	O	report	prep_of	25	SENT_125	[p6l1841t549r2129b632],
29	.	.	O	.	_	0	SENT_125	[p6l1841t549r2129b632],

1	All	DT	O	all	det	2	SENT_126	[p6l8t659r133b737],
2	authors	NNS	O	author	nsubj	3	SENT_126	[p6l168t659r490b739],
3	vouch	VBP	O	vouch	_	0	SENT_126	[p6l523t659r776b739],
4	for	IN	O	for	_	0	SENT_126	[p6l812t658r935b738],
5	the	DT	O	the	det	6	SENT_126	[p6l968t659r1100b737],
6	accuracy	NN	O	accuracy	prep_for	3	SENT_126	[p6l1135t685r1502b759],
7	and	CC	O	and	_	0	SENT_126	[p6l1530t659r1685b738],
8	completeness	NN	O	completeness	prep_for	3	SENT_126	[p6l1719t659r2133b759, p6l12t813r193b865],
9	of	IN	O	of	_	0	SENT_126	[p6l239t786r339b866],
10	the	DT	O	the	det	11	SENT_126	[p6l364t787r495b865],
11	report	NN	O	report	prep_of	6	SENT_126	[p6l539t804r820b887],
12	.	.	O	.	_	0	SENT_126	[p6l539t804r820b887],

1	The	DT	O	the	det	2	SENT_127	[p6l866t787r1024b865],
2	patient	NN	O	patient	nsubj	3	SENT_127	[p6l1066t788r1362b887],
3	participated	VBD	O	participate	_	0	SENT_127	[p6l1400t787r1918b887],
4	in	IN	O	in	_	0	SENT_127	[p6l1963t788r2046b865],
5	a	DT	O	a	det	7	SENT_127	[p6l2091t813r2136b865],
6	clinical	JJ	O	clinical	amod	7	SENT_127	[p6l12t915r326b993],
7	trial	NN	O	trial	prep_in	3	SENT_127	[p6l360t915r538b993],
8	funded	VBN	O	fund	partmod	7	SENT_127	[p6l572t914r875b994],
9	by	IN	O	by	_	0	SENT_127	[p6l911t915r1008b1015],
10	Pﬁzer	NN	PERSON	pﬁzer	agent	8	SENT_127	[p6l1037t914r1314b994],
11	.	.	O	.	_	0	SENT_127	[p6l1037t914r1314b994],

1	GENETIC	JJ	O	genetic	amod	2	SENT_128	[p6l15t1190r358b1240],
2	sruonas	NNS	O	sruona	nsubjpass	10	SENT_128	[p6l390t1190r724b1240],
3	A	DT	O	a	det	8	SENT_128	[p6l8t1296r74b1366],
4	break-apart	JJ	O	break-apart	amod	8	SENT_128	[p6l102t1289r586b1388],
5	ROS1	NN	O	ros1	nn	8	SENT_128	[p6l609t1295r811b1368],
6	FISH	NN	O	fish	nn	8	SENT_128	[p6l843t1295r1049b1367],
7	assay	NN	O	assay	nn	8	SENT_128	[p6l1079t1294r1369b1388],
8	“	NN	O	“	dep	2	SENT_128	[p6l1079t1294r1369b1388],
9	was	VBD	O	be	auxpass	10	SENT_128	[p6l1396t1315r1556b1368],
10	used	VBN	O	use	_	0	SENT_128	[p6l1588t1289r1782b1368],
11	to	TO	O	to	aux	12	SENT_128	[p6l1813t1306r1893b1367],
12	identify	VB	O	identify	xcomp	10	SENT_128	[p6l1924t1289r2133b1367, p6l12t1416r156b1517],
13	ROS1	NN	O	ros1	nn	14	SENT_128	[p6l182t1424r387b1497],
14	rearrangements	NNS	O	rearrangement	dobj	12	SENT_128	[p6l425t1434r1106b1518],
15	and	CC	O	and	_	0	SENT_128	[p6l1143t1417r1301b1496],
16	gene	NN	O	gene	nn	18	SENT_128	[p6l1336t1443r1535b1518],
17	copy	NN	O	copy	nn	18	SENT_128	[p6l1571t1443r1769b1517],
18	number	NN	O	number	dobj	12	SENT_128	[p6l1800t1417r2137b1496],
19	in	IN	O	in	_	0	SENT_128	[p6l11t1546r94b1623],
20	specimens	NNS	O	specimen	prep_in	12	SENT_128	[p6l122t1546r561b1645],
21	of	IN	O	of	_	0	SENT_128	[p6l591t1544r690b1624],
22	malignant	JJ	O	malignant	amod	23	SENT_128	[p6l699t1545r1140b1646],
23	tissue	NN	O	tissue	prep_of	20	SENT_128	[p6l1163t1546r1426b1624],
24	.	.	O	.	_	0	SENT_128	[p6l1163t1546r1426b1624],

1	Complementary	JJ	O	complementary	amod	2	SENT_129	[p6l1458t1545r2139b1645],
2	DNA	NN	O	dna	nsubj	4	SENT_129	[p6l11t1680r216b1752],
3	was	VBD	O	be	cop	4	SENT_129	[p6l240t1699r401b1752],
4	reverse-transcribed	JJ	O	reverse-transcribed	_	0	SENT_129	[p6l434t1673r1243b1752],
5	from	IN	O	from	_	0	SENT_129	[p6l1274t1672r1481b1752],
6	total	JJ	O	total	amod	7	SENT_129	[p6l1512t1673r1706b1752],
7	RNA	NN	O	rna	prep_from	4	SENT_129	[p6l1735t1680r1942b1756],
8	that	WDT	O	that	nsubjpass	10	SENT_129	[p6l1970t1673r2139b1751],
9	was	VBD	O	be	auxpass	10	SENT_129	[p6l7t1826r170b1880],
10	extracted	VBN	O	extract	rcmod	7	SENT_129	[p6l221t1800r613b1879],
11	from	IN	O	from	_	0	SENT_129	[p6l661t1799r871b1879],
12	samples	NNS	O	sample	prep_from	10	SENT_129	[p6l921t1800r1266b1900],
13	obtained	VBN	O	obtain	dep	12	SENT_129	[p6l1316t1800r1694b1879],
14	from	IN	O	from	_	0	SENT_129	[p6l1743t1799r1952b1879],
15	the	DT	O	the	det	16	SENT_129	[p6l2001t1800r2134b1878],
16	patient	NN	O	patient	prep_from	13	SENT_129	[p6l11t1929r313b2028],
17	and	CC	O	and	_	0	SENT_129	[p6l336t1928r494b2007],
18	then	RB	O	then	advmod	19	SENT_129	[p6l524t1928r714b2006],
19	amplified	VBN	O	amplify	dep	12	SENT_129	[p6l743t1927r1160b2028],
20	by	IN	O	by	_	0	SENT_129	[p6l1191t1928r1288b2028],
21	means	NNS	O	means	_	0	SENT_129	[p6l1312t1954r1591b2006],
22	of	IN	O	of	_	0	SENT_129	[p6l1623t1927r1724b2007],
23	PCR	NN	O	pcr	prep_by_means_of	19	SENT_129	[p6l1733t1934r1925b2012],
24	with	IN	O	with	_	0	SENT_129	[p6l1939t1928r2134b2008],
25	primers	NNS	O	primer	prep_with	19	SENT_129	[p6l11t2058r339b2157],
26	to	TO	O	to	_	0	SENT_129	[p6l372t2074r452b2136],
27	CD74	NN	O	cd74	prep_to	25	SENT_129	[p6l484t2063r681b2135],
28	and	CC	O	and	_	0	SENT_129	[p6l710t2057r865b2136],
29	ROS1	NN	O	ros1	prep_to	25	SENT_129	[p6l894t2063r1118b2137],
30	.	.	O	.	_	0	SENT_129	[p6l894t2063r1118b2137],

1	Sanger	NNP	PERSON	Sanger	nn	2	SENT_130	[p6l1157t2063r1444b2158],
2	sequencing	NN	O	sequencing	nsubjpass	4	SENT_130	[p6l1473t2058r1949b2158],
3	was	VBD	O	be	auxpass	4	SENT_130	[p6l1972t2083r2132b2136],
4	performed	VBN	O	perform	_	0	SENT_130	[p6l11t2183r467b2284],
5	on	IN	O	on	_	0	SENT_130	[p6l515t2210r621b2263],
6	RT-PCR	NN	O	rt-pcr	nn	7	SENT_130	[p6l667t2190r1004b2268],
7	products	NNS	O	product	prep_on	4	SENT_130	[p6l1039t2184r1439b2284],
8	.	.	O	.	_	0	SENT_130	[p6l1039t2184r1439b2284],

1	Genomic	JJ	O	genomic	amod	2	SENT_131	[p6l1493t2185r1884b2263],
2	DNA	NN	O	dna	nsubjpass	8	SENT_131	[p6l1929t2191r2138b2263],
3	extracted	VBN	O	extract	partmod	2	SENT_131	[p6l12t2312r406b2391],
4	from	IN	O	from	_	0	SENT_131	[p6l434t2311r644b2391],
5	patient	NN	O	patient	nn	6	SENT_131	[p6l671t2313r973b2412],
6	samples	NNS	O	sample	prep_from	3	SENT_131	[p6l999t2312r1342b2412],
7	was	VBD	O	be	auxpass	8	SENT_131	[p6l1369t2338r1532b2392],
8	used	VBN	O	use	_	0	SENT_131	[p6l1562t2312r1759b2392],
9	both	DT	O	both	preconj	8	SENT_131	[p6l1788t2312r1986b2391],
10	for	IN	O	for	_	0	SENT_131	[p6l2014t2311r2137b2391],
11	deep	JJ	O	deep	amod	12	SENT_131	[p6l12t2441r210b2541],
12	sequencing	NN	O	sequencing	prep_for	8	SENT_131	[p6l248t2442r734b2542],
13	of	IN	O	of	_	0	SENT_131	[p6l767t2440r867b2520],
14	ROS1	NN	O	ros1	nn	15	SENT_131	[p6l883t2447r1116b2524],
15	exons	NNS	O	exon	prep_of	12	SENT_131	[p6l1153t2467r1395b2520],
16	34	CD	NUMBER	34	number	18	SENT_131	[p6l1434t2447r1534b2520],
17	to	TO	O	to	dep	18	SENT_131	[p6l1570t2458r1651b2520],
18	42	CD	NUMBER	42	num	15	SENT_131	[p6l1686t2447r1785b2520],
19	and	CC	O	and	_	0	SENT_131	[p6l1821t2441r1979b2520],
20	for	IN	O	for	_	0	SENT_131	[p6l2014t2440r2137b2520],
21	exon	NN	O	exon	nn	22	SENT_131	[p6l12t2595r212b2648],
22	sequencing	NN	O	sequencing	conj_and	12	SENT_131	[p6l248t2570r733b2670],
23	of	IN	O	of	_	0	SENT_131	[p6l765t2568r865b2648],
24	a	DT	O	a	det	25	SENT_131	[p6l880t2595r924b2647],
25	panel	NN	O	panel	prep_of	22	SENT_131	[p6l955t2569r1190b2669],
26	of	IN	O	of	_	0	SENT_131	[p6l1224t2568r1324b2648],
27	409	CD	NUMBER	409	num	29	SENT_131	[p6l1338t2575r1493b2648],
28	cancer-related	JJ	O	cancer-related	amod	29	SENT_131	[p6l1529t2569r2134b2648],
29	genes	NNS	O	gene	prep_of	25	SENT_131	[p6l12t2723r278b2798],
30	.	.	O	.	_	0	SENT_131	[p6l12t2723r278b2798],

1	Detailed	JJ	O	detailed	amod	2	SENT_132	[p6l315t2697r677b2776],
2	information	NN	O	information	nsubjpass	18	SENT_132	[p6l710t2696r1233b2776],
3	on	IN	O	on	_	0	SENT_132	[p6l1267t2723r1372b2776],
4	the	DT	O	the	det	5	SENT_132	[p6l1406t2697r1538b2775],
5	isolation	NN	O	isolation	prep_on	2	SENT_132	[p6l1571t2697r1945b2776],
6	and	CC	O	and	_	0	SENT_132	[p6l1977t2697r2135b2776],
7	sequencing	NN	O	sequencing	prep_on	2	SENT_132	[p6l13t2826r499b2926],
8	of	IN	O	of	_	0	SENT_132	[p6l550t2824r650b2904],
9	nucleic	JJ	O	nucleic	amod	10	SENT_132	[p6l685t2825r984b2904],
10	acid	NN	O	acid	prep_of	5	SENT_132	[p6l1036t2825r1207b2904],
11	and	CC	O	and	_	0	SENT_132	[p6l1260t2825r1418b2904],
12	descriptions	NNS	O	description	conj_and	5	SENT_132	[p6l1472t2825r1996b2925],
13	of	IN	O	of	_	0	SENT_132	[p6l2053t2824r2152b2904],
14	other	JJ	O	other	amod	16	SENT_132	[p6l12t2953r240b3031],
15	laboratory	NN	O	laboratory	nn	16	SENT_132	[p6l282t2953r728b3052],
16	techniques	NNS	O	technique	prep_of	12	SENT_132	[p6l769t2953r1233b3052],
17	are	VBP	O	be	auxpass	18	SENT_132	[p6l1280t2979r1409b3031],
18	provided	VBN	O	provide	_	0	SENT_132	[p6l1453t2953r1827b3052],
19	in	IN	O	in	_	0	SENT_132	[p6l1872t2954r1956b3030],
20	the	DT	O	the	det	22	SENT_132	[p6l2001t2953r2134b3031],
21	Supplementary	NNP	O	Supplementary	nn	22	SENT_132	[p6l14t3080r661b3180],
22	Appendix	NNP	O	Appendix	prep_in	18	SENT_132	[p6l692t3080r1129b3180],
23	,	,	O	,	_	0	SENT_132	[p6l692t3080r1129b3180],
24	available	JJ	O	available	acomp	18	SENT_132	[p6l1174t3080r1545b3159],
25	with	IN	O	with	_	0	SENT_132	[p6l1580t3080r1775b3160],
26	the	DT	O	the	det	28	SENT_132	[p6l1815t3080r1947b3158],
27	full	JJ	O	full	amod	28	SENT_132	[p6l1987t3079r2135b3159],
28	text	NN	O	text	prep_with	24	SENT_132	[p6l12t3226r173b3287],
29	of	IN	O	of	_	0	SENT_132	[p6l203t3208r303b3288],
30	this	DT	O	this	det	31	SENT_132	[p6l320t3209r479b3287],
31	article	NN	O	article	prep_of	28	SENT_132	[p6l515t3209r783b3288],
32	at	IN	O	at	_	0	SENT_132	[p6l817t3226r896b3287],
33	N	NN	O	n	nn	34	SENT_132	[p6l924t3217r998b3288],
34	EJM.org	NN	O	ejm.org	prep_at	31	SENT_132	[p6l1001t3217r1367b3310],
35	.	.	O	.	_	0	SENT_132	[p6l1001t3217r1367b3310],

1	ANALYSIS	NN	O	analysis	nsubjpass	10	SENT_133	[p6l10t3484r385b3535],
2	or	CC	O	or	_	0	SENT_133	[p6l420t3484r522b3535],
3	THE	DT	O	the	det	5	SENT_133	[p6l552t3485r705b3534],
4	ROS1	NN	O	ros1	nn	5	SENT_133	[p6l744t3484r941b3535],
5	G2032R	NN	O	g2032r	conj_or	1	SENT_133	[p6l979t3484r1288b3536],
6	MUTANT	JJ	O	mutant	amod	8	SENT_133	[p6l1329t3485r1656b3535],
7	Expression	NN	O	expression	nn	8	SENT_133	[p6l11t3585r479b3684],
8	plasmids	NNS	O	plasmid	dep	5	SENT_133	[p6l525t3584r912b3684],
9	were	VBD	O	be	auxpass	10	SENT_133	[p6l957t3610r1159b3663],
10	made	VBN	O	make	_	0	SENT_133	[p6l1206t3584r1438b3663],
11	containing	VBG	O	contain	xcomp	10	SENT_133	[p6l1486t3585r1956b3685],
12	the	DT	O	the	det	16	SENT_133	[p6l2001t3584r2134b3662],
13	nonmutated	JJ	O	nonmutated	amod	16	SENT_133	[p6l12t3712r536b3791],
14	or	CC	O	or	_	0	SENT_133	[p6l592t3738r681b3791],
15	mutated	VBN	O	mutate	conj_or	13	SENT_133	[p6l733t3712r1087b3791],
16	CD74	NN	O	cd74	dobj	11	SENT_133	[p6l1142t3718r1605b3792],
17	.	.	O	.	_	0	SENT_133	[p6l1142t3718r1605b3792],

1	—	NN	O	—	_	0	SENT_134	[p6l1142t3718r1605b3792],
2	.	.	O	.	_	0	SENT_134	[p6l1142t3718r1605b3792],

1	ROS1	NN	O	ros1	_	0	SENT_135	[p6l1142t3718r1605b3792],
2	coding	NN	O	coding	nn	3	SENT_135	[p6l1665t3712r1962b3813],
3	sequence	NN	O	sequence	dep	1	SENT_135	[p6l2016t3738r2133b3790, p7l13t48r311b122],

1	and	CC	O	and	cc	3	SENT_136	[p7l352t22r510b101],
2	were	VBD	O	be	auxpass	3	SENT_136	[p7l547t48r749b102],
3	used	VBN	O	use	_	0	SENT_136	[p7l791t22r987b101],
4	for	IN	O	for	_	0	SENT_136	[p7l1029t21r1152b101],
5	transient	JJ	O	transient	amod	7	SENT_136	[p7l1191t23r1577b100],
6	transfection	NN	O	transfection	nn	7	SENT_136	[p7l1614t21r2134b101],
7	assays	NNS	O	assay	prep_for	3	SENT_136	[p7l12t177r271b251],
8	in	IN	O	in	_	0	SENT_136	[p7l300t152r382b229],
9	293T	NN	O	293t	nn	10	SENT_136	[p7l409t157r619b230],
10	cells	NNS	O	cell	prep_in	7	SENT_136	[p7l644t151r851b230],
11	.	.	O	.	_	0	SENT_136	[p7l644t151r851b230],

1	For	IN	O	for	_	0	SENT_137	[p7l883t159r1022b230],
2	soft	JJ	O	soft	amod	5	SENT_137	[p7l1049t150r1422b252],
3	—	NN	O	—	nn	5	SENT_137	[p7l1049t150r1422b252],
4	agar	NN	O	agar	nn	5	SENT_137	[p7l1049t150r1422b252],
5	assays	NNS	O	assay	prep_for	13	SENT_137	[p7l1445t177r1729b251],
6	,	,	O	,	_	0	SENT_137	[p7l1445t177r1729b251],
7	N	NN	O	n	nn	11	SENT_137	[p7l1760t159r1835b230],
8	IH	NN	O	ih	nn	11	SENT_137	[p7l1837t157r2130b230],
9	—	NN	O	—	nn	11	SENT_137	[p7l1837t157r2130b230],
10	3T3	NN	O	3t3	nn	11	SENT_137	[p7l1837t157r2130b230],
11	cells	NNS	O	cell	nsubjpass	13	SENT_137	[p7l13t279r199b357],
12	were	VBD	O	be	auxpass	13	SENT_137	[p7l241t305r443b358],
13	infected	VBN	O	infect	_	0	SENT_137	[p7l486t278r834b358],
14	with	IN	O	with	_	0	SENT_137	[p7l872t279r1068b358],
15	lentivirus	NN	O	lentivirus	prep_with	13	SENT_137	[p7l1111t279r1514b358],
16	encoding	VBG	O	encode	xcomp	13	SENT_137	[p7l1560t279r1960b380],
17	the	DT	O	the	det	21	SENT_137	[p7l2001t279r2134b357],
18	nonmutated	JJ	O	nonmutated	amod	21	SENT_137	[p7l12t407r526b486],
19	or	CC	O	or	_	0	SENT_137	[p7l560t433r647b486],
20	mutated	VBN	O	mutate	conj_or	18	SENT_137	[p7l677t407r1025b486],
21	CD74	NN	O	cd74	dobj	16	SENT_137	[p7l1057t413r1534b487],
22	.	.	O	.	_	0	SENT_137	[p7l1057t413r1534b487],

1	—	NN	O	—	_	0	SENT_138	[p7l1057t413r1534b487],
2	.	.	O	.	_	0	SENT_138	[p7l1057t413r1534b487],

1	ROS1	NN	O	ros1	_	0	SENT_139	[p7l1057t413r1534b487],
2	.	.	O	.	_	0	SENT_139	[p7l1057t413r1534b487],

1	The	DT	O	the	det	6	SENT_140	[p7l1570t407r1728b485],
2	ROS1	NN	O	ros1	nn	6	SENT_140	[p7l1760t413r1991b490],
3	kinase	NN	O	kinase	nn	6	SENT_140	[p7l2024t407r2133b486, p7l12t561r198b613],
4	domain	NN	O	domain	nn	6	SENT_140	[p7l225t535r545b613],
5	(	NN	O	(	nn	6	SENT_140	[p7l576t535r932b625],
6	residues	NNS	O	residue	nsubjpass	12	SENT_140	[p7l576t535r932b625],
7	1934	CD	DATE	1934	advmod	6	SENT_140	[p7l964t541r1158b614],
8	to	TO	DATE	to	_	0	SENT_140	[p7l1185t552r1264b613],
9	2232	CD	DATE	2232	number	10	SENT_140	[p7l1293t541r1515b625],
10	)	CD	NUMBER	)	prep_to	7	SENT_140	[p7l1293t541r1515b625],
11	was	VBD	O	be	auxpass	12	SENT_140	[p7l1543t561r1701b614],
12	expressed	VBN	O	express	_	0	SENT_140	[p7l1730t535r2134b634],
13	in	IN	O	in	_	0	SENT_140	[p7l12t663r95b740],
14	Sf21	NN	O	sf21	nn	15	SENT_140	[p7l137t661r324b741],
15	cells	NNS	O	cell	prep_in	12	SENT_140	[p7l365t662r553b740],
16	and	CC	O	and	_	0	SENT_140	[p7l594t662r752b741],
17	purified	VBN	O	purify	conj_and	12	SENT_140	[p7l790t661r1140b762],
18	for	IN	O	for	_	0	SENT_140	[p7l1179t661r1302b741],
19	use	NN	O	use	prep_for	17	SENT_140	[p7l1340t688r1480b742],
20	in	IN	O	in	_	0	SENT_140	[p7l1520t663r1603b740],
21	the	DT	O	the	det	54	SENT_140	[p7l1644t662r1777b740],
22	in	IN	O	in	dep	54	SENT_140	[p7l1816t663r1899b740],
23	Vitro	NNP	O	Vitro	nn	25	SENT_140	[p7l1935t663r2133b742],
24	enzymatic	JJ	O	enzymatic	amod	25	SENT_140	[p7l13t791r455b890],
25	assays	NNS	O	assay	pobj	22	SENT_140	[p7l500t816r765b890],
26	and	CC	O	and	_	0	SENT_140	[p7l813t790r971b869],
27	for	IN	O	for	mark	44	SENT_140	[p7l1017t789r1140b869],
28	the	DT	O	the	det	29	SENT_140	[p7l1184t790r1316b868],
29	purpose	NN	O	purpose	nsubj	44	SENT_140	[p7l1362t816r1712b890],
30	of	IN	O	of	_	0	SENT_140	[p7l1760t789r1860b869],
31	determining	VBG	O	determine	prepc_of	29	SENT_140	[p7l1889t790r2133b869, p7l12t920r330b1020],
32	the	DT	O	the	det	34	SENT_140	[p7l378t919r510b997],
33	crystal	NN	O	crystal	nn	34	SENT_140	[p7l563t919r847b1019],
34	structure	NN	O	structure	dobj	31	SENT_140	[p7l898t936r1287b998],
35	of	IN	O	of	_	0	SENT_140	[p7l1339t918r1439b998],
36	the	DT	O	the	det	43	SENT_140	[p7l1472t919r1604b997],
37	nonmutant	JJ	O	nonmutant	amod	43	SENT_140	[p7l1655t936r2139b998],
38	ROS1	NN	O	ros1	nn	43	SENT_140	[p7l11t1047r722b1130],
39	—	NN	O	—	nn	43	SENT_140	[p7l11t1047r722b1130],
40	crizotinib	NN	O	crizotinib	nn	43	SENT_140	[p7l11t1047r722b1130],
41	complex	NN	O	complex	nn	43	SENT_140	[p7l758t1047r1118b1146],
42	(	CD	NUMBER	(	num	43	SENT_140	[p7l1154t1053r1569b1137],
43	structure	NN	O	structure	prep_of	34	SENT_140	[p7l1154t1053r1569b1137],
44	deposited	VBN	O	deposit	conj_and	22	SENT_140	[p7l1604t1047r2017b1146],
45	in	IN	O	in	_	0	SENT_140	[p7l2050t1048r2134b1124],
46	the	DT	O	the	det	50	SENT_140	[p7l12t1174r145b1252],
47	Worldwide	NNP	ORGANIZATION	Worldwide	nn	50	SENT_140	[p7l176t1174r642b1254],
48	Protein	NN	ORGANIZATION	protein	nn	50	SENT_140	[p7l675t1175r986b1253],
49	Data	NNP	ORGANIZATION	Data	nn	50	SENT_140	[p7l1019t1181r1220b1252],
50	Bank	NNP	ORGANIZATION	Bank	prep_in	44	SENT_140	[p7l1252t1174r1496b1270],
51	,	,	O	,	_	0	SENT_140	[p7l1252t1174r1496b1270],
52	entry	NN	O	entry	appos	50	SENT_140	[p7l1537t1191r1759b1274],
53	3zbf	CD	NUMBER	3zbf	num	52	SENT_140	[p7l1790t1173r2035b1265],
54	)	NN	O	)	prep_in	19	SENT_140	[p7l1790t1173r2035b1265],
55	.	.	O	.	_	0	SENT_140	[p7l1790t1173r2035b1265],

1	RESULTS	NNS	O	result	_	0	SENT_141	[p7l842t1521r1315b1579],

1	GENETIC	JJ	O	genetic	amod	2	SENT_142	[p7l23t1766r366b1816],
2	ANALYSIS	NNS	O	analysis	nsubj	7	SENT_142	[p7l395t1766r769b1816],
3	OF	IN	O	of	_	0	SENT_142	[p7l803t1766r905b1816],
4	RESISTANT	JJ	O	resistant	amod	5	SENT_142	[p7l942t1766r1364b1816],
5	TUMORS	NNS	O	tumor	prep_of	2	SENT_142	[p7l1392t1766r1729b1816],
6	To	TO	O	to	aux	7	SENT_142	[p7l17t1870r121b1943],
7	identify	VB	O	identify	purpcl	16	SENT_142	[p7l151t1864r475b1964],
8	the	DT	O	the	det	9	SENT_142	[p7l501t1865r631b1942],
9	mechanisms	NNS	O	mechanism	dobj	7	SENT_142	[p7l661t1865r1192b1942],
10	of	IN	O	of	_	0	SENT_142	[p7l1224t1864r1323b1943],
11	resistance	NN	O	resistance	prep_of	9	SENT_142	[p7l1333t1866r1751b1942],
12	to	TO	O	to	_	0	SENT_142	[p7l1781t1881r1861b1943],
13	crizotinib	NN	O	crizotinib	prep_to	7	SENT_142	[p7l1892t1866r2134b1943, p7l21t1992r239b2087],
14	,	,	O	,	_	0	SENT_142	[p7l1892t1866r2134b1943, p7l21t1992r239b2087],
15	We	PRP	O	we	nsubj	16	SENT_142	[p7l278t2018r395b2071],
16	obtained	VBD	O	obtain	_	0	SENT_142	[p7l434t1992r811b2070],
17	a	DT	O	a	det	19	SENT_142	[p7l848t2018r893b2069],
18	biopsy	NN	O	biopsy	nn	19	SENT_142	[p7l930t1992r1207b2091],
19	specimen	NN	O	specimen	nsubj	47	SENT_142	[p7l1243t1993r1647b2091],
20	of	IN	O	of	_	0	SENT_142	[p7l1685t1991r1786b2070],
21	a	DT	O	a	det	22	SENT_142	[p7l1805t2018r1849b2069],
22	lesion	NN	O	lesion	prep_of	19	SENT_142	[p7l1884t1992r2135b2070],
23	in	IN	O	in	_	0	SENT_142	[p7l20t2121r102b2196],
24	the	DT	O	the	det	26	SENT_142	[p7l137t2120r267b2197],
25	right	JJ	O	right	amod	26	SENT_142	[p7l300t2120r505b2220],
26	lung	NN	O	lung	prep_in	22	SENT_142	[p7l533t2120r723b2220],
27	that	WDT	O	that	nsubj	28	SENT_142	[p7l753t2120r922b2197],
28	was	VBD	O	be	rcmod	26	SENT_142	[p7l946t2145r1106b2198],
29	enlarging	VBG	O	enlarge	dep	28	SENT_142	[p7l1143t2120r1551b2220],
30	while	IN	O	while	mark	34	SENT_142	[p7l1577t2120r1808b2198],
31	the	DT	O	the	det	32	SENT_142	[p7l1842t2120r1972b2197],
32	patient	NN	O	patient	nsubj	34	SENT_142	[p7l2005t2145r2134b2219, p7l21t2248r213b2324],
33	was	VBD	O	be	aux	34	SENT_142	[p7l238t2272r400b2325],
34	receiving	VBG	O	receive	advcl	29	SENT_142	[p7l439t2247r828b2347],
35	crizotinib	NN	O	crizotinib	dobj	34	SENT_142	[p7l862t2247r1281b2324],
36	and	CC	O	and	_	0	SENT_142	[p7l1318t2247r1475b2324],
37	compared	VBN	O	compare	dep	28	SENT_142	[p7l1513t2247r1937b2346],
38	this	DT	O	this	det	39	SENT_142	[p7l1974t2247r2133b2324],
39	specimen	NN	O	specimen	dep	37	SENT_142	[p7l22t2374r426b2472],
40	With	IN	O	with	_	0	SENT_142	[p7l483t2373r678b2452],
41	one	CD	NUMBER	one	prep_with	39	SENT_142	[p7l739t2398r889b2451],
42	obtained	VBN	O	obtain	partmod	39	SENT_142	[p7l951t2373r1328b2451],
43	before	IN	O	before	_	0	SENT_142	[p7l1389t2372r1657b2451],
44	treatment	NN	O	treatment	prep_before	42	SENT_142	[p7l1718t2389r2140b2450],
45	with	IN	O	with	_	0	SENT_142	[p7l16t2501r208b2580],
46	crizotinib	NN	O	crizotinib	prep_with	42	SENT_142	[p7l237t2501r646b2579],
47	began	VBD	O	begin	ccomp	16	SENT_142	[p7l676t2501r953b2602],
48	.	.	O	.	_	0	SENT_142	[p7l676t2501r953b2602],

1	The	DT	O	the	det	2	SENT_143	[p7l983t2501r1141b2579],
2	persistence	NN	O	persistence	nsubjpass	12	SENT_143	[p7l1168t2502r1637b2601],
3	of	IN	O	of	_	0	SENT_143	[p7l1666t2500r1765b2579],
4	the	DT	O	the	det	6	SENT_143	[p7l1775t2501r1905b2579],
5	R081	NN	O	r081	nn	6	SENT_143	[p7l1932t2507r2133b2580],
6	rearrangement	NN	O	rearrangement	prep_of	2	SENT_143	[p7l21t2645r660b2729],
7	in	IN	O	in	_	0	SENT_143	[p7l705t2630r788b2705],
8	the	DT	O	the	det	10	SENT_143	[p7l840t2629r972b2706],
9	resistant	JJ	O	resistant	amod	10	SENT_143	[p7l1022t2630r1394b2706],
10	lesion	NN	O	lesion	prep_in	6	SENT_143	[p7l1438t2629r1689b2706],
11	was	VBD	O	be	auxpass	12	SENT_143	[p7l1736t2654r1898b2707],
12	confirmed	VBN	O	confirm	_	0	SENT_143	[p7l1951t2654r2134b2706, p7l21t2754r321b2832],
13	by	IN	O	by	_	0	SENT_143	[p7l371t2755r469b2854],
14	means	NNS	O	means	_	0	SENT_143	[p7l513t2780r796b2832],
15	of	IN	O	of	_	0	SENT_143	[p7l848t2754r949b2833],
16	FISH	NN	O	fish	prep_by_means_of	12	SENT_143	[p7l978t2760r1215b2849],
17	,	,	O	,	_	0	SENT_143	[p7l978t2760r1215b2849],
18	which	WDT	O	which	nsubj	20	SENT_143	[p7l1265t2755r1532b2834],
19	also	RB	O	also	advmod	20	SENT_143	[p7l1581t2755r1755b2832],
20	showed	VBD	O	show	rcmod	16	SENT_143	[p7l1807t2755r2135b2834],
21	no	DT	O	no	det	24	SENT_143	[p7l21t2909r127b2961],
22	ROS1	NN	O	ros1	nn	24	SENT_143	[p7l162t2890r371b2962],
23	gene	NN	O	gene	nn	24	SENT_143	[p7l410t2909r612b2984],
24	amplification	NN	O	amplification	iobj	20	SENT_143	[p7l648t2882r1246b2983],
25	(	CD	NUMBER	(	num	26	SENT_143	[p7l1287t2884r1471b2984],
26	Fig	NN	O	fig	dobj	20	SENT_143	[p7l1287t2884r1471b2984],
27	.	.	O	.	_	0	SENT_143	[p7l1287t2884r1471b2984],

1	S1	NN	O	s1	_	0	SENT_144	[p7l1515t2888r1611b2961],
2	in	IN	O	in	_	0	SENT_144	[p7l1648t2884r1732b2960],
3	the	DT	O	the	det	6	SENT_144	[p7l1769t2883r1904b2961],
4	Supplementary	NNP	O	Supplementary	nn	6	SENT_144	[p7l1943t2888r2134b2983, p7l20t3011r520b3110],
5	Appendix	NNP	O	Appendix	nn	6	SENT_144	[p7l557t3011r1032b3110],
6	)	NN	O	)	prep_in	1	SENT_144	[p7l557t3011r1032b3110],
7	.	.	O	.	_	0	SENT_144	[p7l557t3011r1032b3110],

1	Total	JJ	O	total	amod	2	SENT_145	[p7l1080t3011r1304b3088],
2	RNA	NN	O	rna	nsubjpass	4	SENT_145	[p7l1347t3017r1558b3093],
3	was	VBD	O	be	auxpass	4	SENT_145	[p7l1596t3037r1761b3090],
4	extracted	VBN	O	extract	_	0	SENT_145	[p7l1809t3027r2134b3088, p7l22t3139r119b3217],
5	from	IN	O	from	_	0	SENT_145	[p7l160t3138r373b3217],
6	tumor	NN	O	tumor	nn	7	SENT_145	[p7l414t3156r681b3218],
7	tissue	NN	O	tissue	prep_from	4	SENT_145	[p7l716t3140r985b3234],
8	,	,	O	,	_	0	SENT_145	[p7l716t3140r985b3234],
9	and	CC	O	and	_	0	SENT_145	[p7l1027t3139r1184b3217],
10	the	DT	O	the	det	11	SENT_145	[p7l1223t3139r1355b3217],
11	sequencing	NN	O	sequencing	prep_from	4	SENT_145	[p7l1395t3140r1878b3240],
12	of	IN	O	of	_	0	SENT_145	[p7l1914t3138r2014b3217],
13	an	DT	O	a	det	14	SENT_145	[p7l2033t3165r2135b3217],
14	RT	NN	O	rt	prep_of	11	SENT_145	[p7l20t3272r355b3350],
15	.	.	O	.	_	0	SENT_145	[p7l20t3272r355b3350],

1	—	NN	O	—	_	0	SENT_146	[p7l20t3272r355b3350],
2	.	.	O	.	_	0	SENT_146	[p7l20t3272r355b3350],

1	PCR	NN	O	pcr	nn	2	SENT_147	[p7l20t3272r355b3350],
2	product	NN	O	product	nsubj	8	SENT_147	[p7l381t3267r715b3367],
3	spanning	VBG	O	span	partmod	2	SENT_147	[p7l749t3268r1152b3368],
4	the	DT	O	the	det	7	SENT_147	[p7l1188t3267r1319b3345],
5	CD74-ROS1	NN	O	cd74-ros1	nn	7	SENT_147	[p7l1357t3273r1827b3346],
6	fusion	NN	O	fusion	nn	7	SENT_147	[p7l1866t3266r2135b3346],
7	junction	NN	O	junction	dobj	3	SENT_147	[p7l7t3396r380b3494],
8	revealed	VBD	O	reveal	_	0	SENT_147	[p7l439t3395r796b3473],
9	a	DT	O	a	det	11	SENT_147	[p7l853t3420r898b3472],
10	c.	NN	O	c.	nn	11	SENT_147	[p7l955t3400r1478b3489],
11	6094G	NN	O	6094g	dobj	8	SENT_147	[p7l955t3400r1478b3489],
12	—	CD	NUMBER	—	npadvmod	13	SENT_147	[p7l955t3400r1478b3489],
13	>	JJR	O	>	dep	11	SENT_147	[p7l955t3400r1478b3489],
14	A	DT	O	a	dep	13	SENT_147	[p7l955t3400r1478b3489],
15	,	,	O	,	_	0	SENT_147	[p7l955t3400r1478b3489],
16	p.	NN	O	p.	nn	17	SENT_147	[p7l1541t3395r2139b3495],
17	Gly2032Arg	NN	O	gly2032arg	appos	11	SENT_147	[p7l1541t3395r2139b3495],
18	(	CD	NUMBER	(	num	20	SENT_147	[p7l26t3527r435b3616],
19	G2032R	NN	O	g2032r	nn	20	SENT_147	[p7l26t3527r435b3616],
20	)	NN	O	)	dep	17	SENT_147	[p7l26t3527r435b3616],
21	,	,	O	,	_	0	SENT_147	[p7l26t3527r435b3616],
22	mutation	NN	O	mutation	appos	11	SENT_147	[p7l468t3522r859b3600],
23	that	WDT	O	that	nsubjpass	27	SENT_147	[p7l889t3522r1061b3599],
24	had	VBD	O	have	aux	27	SENT_147	[p7l1085t3522r1241b3599],
25	not	RB	O	not	neg	27	SENT_147	[p7l1270t3538r1412b3599],
26	been	VBN	O	be	auxpass	27	SENT_147	[p7l1437t3522r1637b3599],
27	detected	VBN	O	detect	rcmod	22	SENT_147	[p7l1667t3522r2023b3599],
28	in	IN	O	in	_	0	SENT_147	[p7l2053t3523r2135b3598],
29	the	DT	O	the	det	33	SENT_147	[p7l21t3649r156b3726],
30	pretreatment	NN	O	pretreatment	nn	33	SENT_147	[p7l190t3665r765b3748],
31	specimen	NN	O	specimen	nn	33	SENT_147	[p7l797t3650r1209b3748],
32	(	CD	NUMBER	(	num	33	SENT_147	[p7l1249t3650r1432b3749],
33	Fig	NN	O	fig	prep_in	27	SENT_147	[p7l1249t3650r1432b3749],
34	.	.	O	.	_	0	SENT_147	[p7l1249t3650r1432b3749],

1	2B	NN	O	2b	_	0	SENT_148	[p7l1473t3654r1608b3743],
2	,	,	O	,	_	0	SENT_148	[p7l1473t3654r1608b3743],
3	and	CC	O	and	_	0	SENT_148	[p7l1649t3649r1808b3726],
4	Fig	NN	O	fig	conj_and	1	SENT_148	[p7l1842t3650r1995b3749],
5	.	.	O	.	_	0	SENT_148	[p7l1842t3650r1995b3749],

1	S2	NN	O	s2	_	0	SENT_149	[p7l2039t3654r2134b3726],

1	in	IN	O	in	_	0	SENT_150	[p8l20t21r103b96],
2	the	DT	O	the	det	5	SENT_150	[p8l138t20r270b97],
3	Supplementary	NNP	O	Supplementary	nn	5	SENT_150	[p8l307t20r952b119],
4	Appendix	NNP	O	Appendix	nn	5	SENT_150	[p8l978t20r1442b119],
5	)	NN	O	)	pobj	1	SENT_150	[p8l978t20r1442b119],
6	.	.	O	.	_	0	SENT_150	[p8l978t20r1442b119],

1	After	IN	O	after	mark	4	SENT_151	[p8l146t146r372b224],
2	the	DT	O	the	det	3	SENT_151	[p8l419t147r553b224],
3	patient	NN	O	patient	nsubj	4	SENT_151	[p8l602t148r909b246],
4	died	VBD	O	die	advcl	9	SENT_151	[p8l955t147r1163b242],
5	,	,	O	,	_	0	SENT_151	[p8l955t147r1163b242],
6	an	DT	O	a	det	7	SENT_151	[p8l1218t172r1322b224],
7	autopsy	NN	O	autopsy	nsubjpass	9	SENT_151	[p8l1370t163r1707b246],
8	was	VBD	O	be	auxpass	9	SENT_151	[p8l1748t173r1913b226],
9	performed	VBN	O	perform	_	0	SENT_151	[p8l1963t173r2134b246, p8l21t274r354b353],
10	.	.	O	.	_	0	SENT_151	[p8l1963t173r2134b246, p8l21t274r354b353],

1	All	PDT	O	all	predet	3	SENT_152	[p8l396t275r521b352],
2	the	DT	O	the	det	3	SENT_152	[p8l561t275r692b353],
3	sites	NNS	O	site	nsubj	9	SENT_152	[p8l734t276r918b353],
4	of	IN	O	of	_	0	SENT_152	[p8l961t274r1061b353],
5	disease	NN	O	disease	prep_of	3	SENT_152	[p8l1082t275r1391b353],
6	that	WDT	O	that	nsubjpass	8	SENT_152	[p8l1432t275r1603b353],
7	were	VBD	O	be	auxpass	8	SENT_152	[p8l1634t301r1834b354],
8	examined	VBN	O	examine	rcmod	5	SENT_152	[p8l1875t301r2134b353, p8l20t403r205b480],
9	had	VBD	O	have	_	0	SENT_152	[p8l258t403r413b480],
10	the	DT	O	the	det	14	SENT_152	[p8l468t403r600b480],
11	G2032R	NN	O	g2032r	nn	14	SENT_152	[p8l653t408r1003b485],
12	mutation	NN	O	mutation	nn	14	SENT_152	[p8l1046t404r1437b481],
13	(	CD	NUMBER	(	num	14	SENT_152	[p8l1495t404r1674b503],
14	Fig	NN	O	fig	dobj	9	SENT_152	[p8l1495t404r1674b503],
15	.	.	O	.	_	0	SENT_152	[p8l1495t404r1674b503],

1	2C	NN	O	2c	nsubj	4	SENT_153	[p8l1733t408r1896b497],
2	)	NN	O	)	dep	1	SENT_153	[p8l1733t408r1896b497],
3	,	,	O	,	_	0	SENT_153	[p8l1733t408r1896b497],
4	suggesting	VBG	O	suggest	_	0	SENT_153	[p8l1957t428r2134b503, p8l21t531r339b630],
5	that	IN	O	that	complm	11	SENT_153	[p8l373t530r544b607],
6	its	PRP$	O	its	poss	7	SENT_153	[p8l576t531r674b607],
7	occurrence	NN	O	occurrence	nsubj	11	SENT_153	[p8l715t555r1184b608],
8	was	VBD	O	be	cop	11	SENT_153	[p8l1217t555r1379b608],
9	an	DT	O	a	det	11	SENT_153	[p8l1418t555r1521b607],
10	early	JJ	O	early	amod	11	SENT_153	[p8l1559t530r1764b629],
11	event	NN	O	event	ccomp	4	SENT_153	[p8l1797t546r2020b608],
12	in	IN	O	in	_	0	SENT_153	[p8l2052t531r2135b606],
13	the	DT	O	the	det	15	SENT_153	[p8l21t656r154b733],
14	clonal	JJ	O	clonal	amod	15	SENT_153	[p8l207t656r466b734],
15	expansion	NN	O	expansion	prep_in	11	SENT_153	[p8l518t657r953b755],
16	of	IN	O	of	_	0	SENT_153	[p8l1007t655r1106b734],
17	crizotinib-resistant	JJ	O	crizotinib-resistant	amod	19	SENT_153	[p8l1141t656r1970b734],
18	tumor	NN	O	tumor	nn	19	SENT_153	[p8l2018t672r2134b735, p8l21t810r196b862],
19	cells	NNS	O	cell	prep_of	15	SENT_153	[p8l249t784r460b862],
20	.	.	O	.	_	0	SENT_153	[p8l249t784r460b862],

1	Deep	JJ	O	deep	amod	2	SENT_154	[p8l519t791r736b884],
2	sequencing	NN	O	sequencing	nsubjpass	28	SENT_154	[p8l794t785r1278b885],
3	(	CD	NUMBER	(	num	4	SENT_154	[p8l1334t789r1687b880],
4	>	JJR	O	>	nsubj	6	SENT_154	[p8l1334t789r1687b880],
5	10,000	CD	NUMBER	10,000	dep	4	SENT_154	[p8l1334t789r1687b880],
6	reads	VBZ	O	read	rcmod	2	SENT_154	[p8l1743t784r1993b875],
7	)	NN	O	)	nsubj	17	SENT_154	[p8l1743t784r1993b875],
8	of	IN	O	of	_	0	SENT_154	[p8l2054t783r2153b862],
9	the	DT	O	the	det	12	SENT_154	[p8l21t912r154b990],
10	3	CD	NUMBER	3	num	12	SENT_154	[p8l199t910r274b991],
11	’	NN	O	’	nn	12	SENT_154	[p8l199t910r274b991],
12	portion	NN	O	portion	prep_of	7	SENT_154	[p8l319t913r641b1012],
13	of	IN	O	of	_	0	SENT_154	[p8l686t911r786b990],
14	the	DT	O	the	det	16	SENT_154	[p8l812t912r944b990],
15	R081	NN	O	r081	nn	16	SENT_154	[p8l986t919r1191b991],
16	gene	NN	O	gene	prep_of	12	SENT_154	[p8l1238t938r1436b1013],
17	involved	VBN	O	involve	dep	6	SENT_154	[p8l1481t912r1831b991],
18	in	IN	O	in	_	0	SENT_154	[p8l1875t913r1958b989],
19	the	DT	O	the	det	22	SENT_154	[p8l2003t912r2135b990],
20	rearrangement	NN	O	rearrangement	nn	22	SENT_154	[p8l21t1056r660b1141],
21	(	NN	O	(	nn	22	SENT_154	[p8l707t1047r972b1131],
22	exons	NNS	O	exon	prep_in	17	SENT_154	[p8l707t1047r972b1131],
23	34	CD	NUMBER	34	number	25	SENT_154	[p8l1023t1045r1123b1119],
24	to	TO	O	to	dep	25	SENT_154	[p8l1170t1056r1251b1118],
25	42	CD	NUMBER	42	num	26	SENT_154	[p8l1298t1045r1423b1131],
26	)	NN	O	)	dobj	17	SENT_154	[p8l1298t1045r1423b1131],
27	was	VBD	O	be	auxpass	28	SENT_154	[p8l1472t1066r1633b1119],
28	performed	VBN	O	perform	_	0	SENT_154	[p8l1681t1039r2135b1140],
29	on	IN	O	on	_	0	SENT_154	[p8l21t1194r127b1246],
30	all	DT	O	all	det	32	SENT_154	[p8l164t1169r268b1246],
31	autopsy	NN	O	autopsy	nn	32	SENT_154	[p8l305t1185r636b1268],
32	specimens	NNS	O	specimen	prep_on	28	SENT_154	[p8l670t1170r1141b1268],
33	;	:	O	;	_	0	SENT_154	[p8l670t1170r1141b1268],
34	no	DT	O	no	det	36	SENT_154	[p8l1183t1194r1288b1246],
35	somatic	JJ	O	somatic	amod	36	SENT_154	[p8l1328t1169r1663b1246],
36	mutations	NNS	O	mutation	nsubjpass	41	SENT_154	[p8l1700t1170r2133b1248],
37	other	JJ	O	other	amod	36	SENT_154	[p8l21t1297r248b1375],
38	than	IN	O	than	_	0	SENT_154	[p8l296t1297r492b1374],
39	G2032R	NN	O	g2032r	prep_than	36	SENT_154	[p8l541t1302r890b1380],
40	were	VBD	O	be	auxpass	41	SENT_154	[p8l926t1323r1126b1376],
41	revealed	VBN	O	reveal	parataxis	28	SENT_154	[p8l1176t1297r1526b1376],
42	within	IN	O	within	_	0	SENT_154	[p8l1572t1297r1855b1376],
43	ROSI	NNP	O	ROSI	prep_within	41	SENT_154	[p8l1903t1303r2130b1391],
44	,	,	O	,	_	0	SENT_154	[p8l1903t1303r2130b1391],
45	and	CC	O	and	_	0	SENT_154	[p8l20t1425r175b1502],
46	the	DT	O	the	det	48	SENT_154	[p8l208t1425r338b1502],
47	G2032R	NN	O	g2032r	nn	48	SENT_154	[p8l371t1430r714b1507],
48	mutation	NN	O	mutation	nsubjpass	51	SENT_154	[p8l737t1426r1120b1503],
49	was	VBD	O	be	auxpass	51	SENT_154	[p8l1148t1450r1308b1503],
50	not	RB	O	not	neg	51	SENT_154	[p8l1342t1441r1482b1502],
51	detected	VBN	O	detect	conj_and	41	SENT_154	[p8l1510t1425r1859b1502],
52	in	IN	O	in	_	0	SENT_154	[p8l1891t1426r1972b1501],
53	the	DT	O	the	det	54	SENT_154	[p8l2005t1425r2135b1502],
54	sample	NN	O	sample	prep_in	51	SENT_154	[p8l22t1552r323b1652],
55	of	IN	O	of	_	0	SENT_154	[p8l364t1551r463b1630],
56	malignant	JJ	O	malignant	amod	57	SENT_154	[p8l485t1552r933b1653],
57	cells	NNS	O	cell	prep_of	54	SENT_154	[p8l968t1552r1155b1630],
58	assessed	VBN	O	assess	partmod	57	SENT_154	[p8l1197t1552r1563b1630],
59	before	IN	O	before	_	0	SENT_154	[p8l1604t1551r1872b1630],
60	treatment	NN	O	treatment	prep_before	58	SENT_154	[p8l1912t1568r2134b1630, p8l21t1696r241b1757],
61	with	IN	O	with	_	0	SENT_154	[p8l272t1680r466b1758],
62	crizotinib	NN	O	crizotinib	nn	64	SENT_154	[p8l507t1680r926b1757],
63	(	CD	NUMBER	(	num	64	SENT_154	[p8l972t1681r1151b1780],
64	Fig	NN	O	fig	prep_with	58	SENT_154	[p8l972t1681r1151b1780],
65	.	.	O	.	_	0	SENT_154	[p8l972t1681r1151b1780],

1	S2	NN	O	s2	_	0	SENT_155	[p8l1198t1685r1293b1757],
2	in	IN	O	in	_	0	SENT_155	[p8l1334t1680r1417b1756],
3	the	DT	O	the	det	6	SENT_155	[p8l1457t1680r1589b1757],
4	Supplementary	NNP	O	Supplementary	nn	6	SENT_155	[p8l1632t1680r2134b1779, p8l21t1823r191b1907],
5	Appendix	NNP	O	Appendix	nn	6	SENT_155	[p8l233t1807r697b1907],
6	)	NN	O	)	prep_in	1	SENT_155	[p8l233t1807r697b1907],
7	.	.	O	.	_	0	SENT_155	[p8l233t1807r697b1907],

1	Exon	NN	O	exon	nn	2	SENT_156	[p8l752t1814r963b1885],
2	sequencing	NN	O	sequencing	nsubj	13	SENT_156	[p8l1016t1808r1499b1908],
3	of	IN	O	of	_	0	SENT_156	[p8l1547t1806r1647b1885],
4	a	DT	O	a	det	5	SENT_156	[p8l1678t1833r1722b1885],
5	panel	NN	O	panel	prep_of	2	SENT_156	[p8l1770t1807r2004b1907],
6	of	IN	O	of	_	0	SENT_156	[p8l2054t1806r2153b1885],
7	409	CD	NUMBER	409	num	8	SENT_156	[p8l19t1940r174b2012],
8	genes	NNS	O	gene	prep_of	5	SENT_156	[p8l210t1960r450b2035],
9	implicated	VBN	O	implicate	partmod	8	SENT_156	[p8l486t1935r939b2034],
10	in	IN	O	in	_	0	SENT_156	[p8l973t1936r1056b2011],
11	carcinogenesis	NN	O	carcinogenesis	prep_in	9	SENT_156	[p8l1091t1935r1723b2035],
12	independently	RB	O	independently	advmod	13	SENT_156	[p8l1758t1935r2134b2034, p8l21t2061r284b2160],
13	confirmed	VBD	O	confirm	_	0	SENT_156	[p8l338t2060r790b2139],
14	the	DT	O	the	det	15	SENT_156	[p8l847t2061r980b2138],
15	presence	NN	O	presence	nsubj	35	SENT_156	[p8l1036t2087r1409b2160],
16	of	IN	O	of	_	0	SENT_156	[p8l1468t2060r1567b2139],
17	the	DT	O	the	det	19	SENT_156	[p8l1607t2061r1739b2138],
18	G2032R	NN	O	g2032r	nn	19	SENT_156	[p8l1797t2066r2146b2144],
19	mutation	NN	O	mutation	prep_of	15	SENT_156	[p8l21t2189r412b2267],
20	in	IN	O	in	_	0	SENT_156	[p8l453t2189r537b2265],
21	tumors	NNS	O	tumor	prep_in	19	SENT_156	[p8l579t2205r885b2267],
22	that	WDT	O	that	nsubj	24	SENT_156	[p8l931t2189r1102b2266],
23	were	VBD	O	be	cop	24	SENT_156	[p8l1135t2214r1336b2267],
24	resistant	JJ	O	resistant	rcmod	21	SENT_156	[p8l1378t2190r1749b2266],
25	to	TO	O	to	_	0	SENT_156	[p8l1787t2205r1868b2266],
26	treatment	NN	O	treatment	prep_to	24	SENT_156	[p8l1912t2204r2134b2266, p8l21t2332r237b2394],
27	and	CC	O	and	_	0	SENT_156	[p8l265t2316r420b2394],
28	also	RB	O	also	advmod	29	SENT_156	[p8l453t2316r620b2394],
29	identified	VBD	O	identify	rcmod	21	SENT_156	[p8l654t2315r1060b2394],
30	mutations	NNS	O	mutation	dobj	29	SENT_156	[p8l1093t2317r1517b2395],
31	in	IN	O	in	_	0	SENT_156	[p8l1552t2317r1634b2393],
32	three	CD	NUMBER	three	num	34	SENT_156	[p8l1667t2316r1882b2394],
33	other	JJ	O	other	amod	34	SENT_156	[p8l1916t2316r2139b2394],
34	genes	NNS	O	gene	prep_in	29	SENT_156	[p8l21t2469r253b2544],
35	—	VBP	O	—	ccomp	13	SENT_156	[p8l343t2489r451b2496],
36	TP53	NN	O	tp53	nn	40	SENT_156	[p8l538t2450r746b2538],
37	,	,	O	,	_	0	SENT_156	[p8l538t2450r746b2538],
38	ataxia	NN	O	ataxia	dep	40	SENT_156	[p8l843t2444r1705b2544],
39	—	NN	O	—	nn	40	SENT_156	[p8l843t2444r1705b2544],
40	telangiectasia	NN	O	telangiectasium	dobj	35	SENT_156	[p8l843t2444r1705b2544],
41	mutated	VBN	O	mutate	partmod	40	SENT_156	[p8l1796t2444r2135b2522],
42	(	CD	NUMBER	(	num	43	SENT_156	[p8l26t2576r284b2666],
43	ATM	NNP	O	ATM	dobj	41	SENT_156	[p8l26t2576r284b2666],
44	)	CD	NUMBER	)	num	43	SENT_156	[p8l26t2576r284b2666],
45	,	,	O	,	_	0	SENT_156	[p8l26t2576r284b2666],
46	and	CC	O	and	_	0	SENT_156	[p8l328t2571r485b2648],
47	NOTCH2	NN	O	notch2	nn	48	SENT_156	[p8l523t2577r872b2648],
48	—	NN	O	—	conj_and	43	SENT_156	[p8l899t2616r1006b2623],
49	in	IN	O	in	_	0	SENT_156	[p8l1043t2572r1126b2647],
50	both	CC	O	both	preconj	52	SENT_156	[p8l1167t2571r1364b2648],
51	the	DT	O	the	det	52	SENT_156	[p8l1405t2571r1538b2648],
52	pretreatment	NN	O	pretreatment	prep_in	41	SENT_156	[p8l1577t2587r2140b2670],
53	and	CC	O	and	_	0	SENT_156	[p8l20t2699r177b2776],
54	the	DT	O	the	det	57	SENT_156	[p8l250t2699r381b2776],
55	crizotinib-resistant	JJ	O	crizotinib-resistant	amod	57	SENT_156	[p8l454t2699r1283b2776],
56	tumor	NN	O	tumor	nn	57	SENT_156	[p8l1350t2715r1617b2777],
57	specimens	NNS	O	specimen	conj_and	52	SENT_156	[p8l1688t2700r2133b2798],
58	but	CC	O	but	_	0	SENT_156	[p8l21t2827r160b2905],
59	not	RB	O	not	_	0	SENT_156	[p8l198t2843r340b2904],
60	in	IN	O	in	_	0	SENT_156	[p8l377t2828r460b2903],
61	normal	JJ	O	normal	amod	64	SENT_156	[p8l503t2827r815b2904],
62	tissue	NN	O	tissue	nn	64	SENT_156	[p8l858t2827r1102b2905],
63	(	CD	NUMBER	(	num	64	SENT_156	[p8l1150t2828r1328b2927],
64	Fig	NN	O	fig	prep_in	41	SENT_156	[p8l1150t2828r1328b2927],
65	.	.	O	.	_	0	SENT_156	[p8l1150t2828r1328b2927],

1	S2	NN	O	s2	_	0	SENT_157	[p8l1379t2832r1473b2904],
2	in	IN	O	in	_	0	SENT_157	[p8l1517t2828r1599b2903],
3	the	DT	O	the	det	6	SENT_157	[p8l1643t2827r1774b2904],
4	Supplementary	NNP	O	Supplementary	nn	6	SENT_157	[p8l1820t2827r2134b2926, p8l21t2970r380b3053],
5	Appendix	NNP	O	Appendix	nn	6	SENT_157	[p8l437t2954r894b3053],
6	)	NN	O	)	prep_in	1	SENT_157	[p8l437t2954r894b3053],
7	.	.	O	.	_	0	SENT_157	[p8l437t2954r894b3053],

1	No	DT	O	no	det	2	SENT_158	[p8l962t2961r1085b3032],
2	mutations	NNS	O	mutation	nsubjpass	8	SENT_158	[p8l1150t2955r1575b3032],
3	in	IN	O	in	_	0	SENT_158	[p8l1640t2955r1722b3030],
4	EGFR	NN	ORGANIZATION	egfr	prep_in	2	SENT_158	[p8l1784t2960r1993b3033],
5	or	CC	O	or	_	0	SENT_158	[p8l2051t2979r2138b3031],
6	KRAS	NNS	ORGANIZATION	kra	prep_in	2	SENT_158	[p8l19t3087r245b3160],
7	were	VBD	O	be	auxpass	8	SENT_158	[p8l275t3107r472b3160],
8	detected	VBN	O	detect	_	0	SENT_158	[p8l511t3082r860b3159],
9	on	IN	O	on	_	0	SENT_158	[p8l899t3107r1004b3159],
10	exon	NN	O	exon	nn	11	SENT_158	[p8l1044t3107r1243b3159],
11	sequencing	NN	O	sequencing	prep_on	8	SENT_158	[p8l1284t3083r1787b3182],
12	.	.	O	.	_	0	SENT_158	[p8l1284t3083r1787b3182],

1	MOLECULAR	JJ	O	molecular	amod	2	SENT_159	[p8l28t3355r505b3405],
2	BASIS	NN	O	basis	_	0	SENT_159	[p8l543t3355r759b3405],
3	or	CC	O	or	_	0	SENT_159	[p8l793t3355r895b3405],
4	cnnzonma	NN	O	cnnzonma	nn	5	SENT_159	[p8l929t3355r1391b3405],
5	RESISTANCE	NN	O	resistance	conj_or	2	SENT_159	[p8l1428t3355r1901b3405],
6	The	DT	O	the	det	7	SENT_159	[p8l17t3455r175b3532],
7	glycine	NN	O	glycine	nsubjpass	12	SENT_159	[p8l224t3455r516b3555],
8	at	IN	O	at	_	0	SENT_159	[p8l565t3471r642b3532],
9	position	NN	O	position	prep_at	7	SENT_159	[p8l684t3456r1029b3554],
10	2032	CD	DATE	2032	num	9	SENT_159	[p8l1077t3460r1272b3533],
11	is	VBZ	O	be	auxpass	12	SENT_159	[p8l1321t3456r1386b3532],
12	conserved	VBN	O	conserve	rcmod	2	SENT_159	[p8l1437t3455r1856b3533],
13	in	IN	O	in	_	0	SENT_159	[p8l1904t3456r1986b3531],
14	all	DT	O	all	det	17	SENT_159	[p8l2034t3455r2136b3532],
15	human	JJ	O	human	amod	17	SENT_159	[p8l21t3582r320b3660],
16	ROS1	NN	O	ros1	nn	17	SENT_159	[p8l353t3587r583b3664],
17	paralogs	NNS	O	paralog	prep_in	12	SENT_159	[p8l616t3582r978b3682],
18	and	CC	O	and	_	0	SENT_159	[p8l1014t3582r1170b3659],
19	in	IN	O	in	_	0	SENT_159	[p8l1203t3583r1286b3658],
20	several	JJ	O	several	amod	21	SENT_159	[p8l1321t3582r1606b3660],
21	other	JJ	O	other	conj_and	17	SENT_159	[p8l1640t3582r1879b3677],
22	,	,	O	,	_	0	SENT_159	[p8l1640t3582r1879b3677],
23	more	RBR	O	more	advmod	21	SENT_159	[p8l1920t3607r2135b3659],
24	distantly	RB	O	distantly	advmod	25	SENT_159	[p8l21t3709r380b3808],
25	related	JJ	O	related	amod	26	SENT_159	[p8l413t3709r691b3786],
26	tyrosine	NN	O	tyrosine	dep	21	SENT_159	[p8l729t3710r1058b3808],
27	and	CC	O	and	_	0	SENT_159	[p8l1096t3709r1249b3786],
28	serine	NN	O	serine	nn	31	SENT_159	[p8l1288t3709r1990b3786],
29	—	NN	O	—	nn	31	SENT_159	[p8l1288t3709r1990b3786],
30	threonine	NN	O	threonine	nn	31	SENT_159	[p8l1288t3709r1990b3786],
31	kinases	NNS	O	kinase	dep	21	SENT_159	[p8l2027t3709r2134b3788, p9l21t48r250b100],

1	(	NN	O	(	_	0	SENT_160	[p9l287t24r462b123],
2	Fig	NN	O	fig	dep	1	SENT_160	[p9l287t24r462b123],
3	.	.	O	.	_	0	SENT_160	[p9l287t24r462b123],

1	3A	NN	O	3a	_	0	SENT_161	[p9l498t28r656b113],
2	)	NN	O	)	dep	1	SENT_161	[p9l498t28r656b113],
3	.	.	O	.	_	0	SENT_161	[p9l498t28r656b113],

1	To	TO	O	to	aux	2	SENT_162	[p9l688t28r791b100],
2	determine	VB	O	determine	_	0	SENT_162	[p9l824t23r1251b100],
3	Whether	IN	O	whether	complm	12	SENT_162	[p9l1276t23r1624b101],
4	an	DT	O	a	det	6	SENT_162	[p9l1650t48r1752b100],
5	arginine	NN	O	arginine	nn	6	SENT_162	[p9l1781t24r2135b123],
6	substitution	NN	O	substitution	nsubj	12	SENT_162	[p9l22t150r525b228],
7	at	IN	O	at	_	0	SENT_162	[p9l562t166r639b227],
8	this	DT	O	this	det	11	SENT_162	[p9l671t150r827b227],
9	highly	RB	O	highly	amod	11	SENT_162	[p9l865t150r1132b250],
10	conserved	VBN	O	conserve	dep	9	SENT_162	[p9l1165t150r1584b228],
11	residue	NN	O	residue	prep_at	6	SENT_162	[p9l1620t150r1917b228],
12	conferred	VBD	O	confer	ccomp	19	SENT_162	[p9l1955t175r2134b227, p9l21t275r264b353],
13	resistance	NN	O	resistance	dobj	12	SENT_162	[p9l291t277r698b353],
14	to	TO	O	to	_	0	SENT_162	[p9l725t292r804b353],
15	ROS1	NN	O	ros1	nn	16	SENT_162	[p9l831t281r1057b358],
16	inhibitors	NNS	O	inhibitor	prep_to	12	SENT_162	[p9l1084t276r1507b371],
17	,	,	O	,	_	0	SENT_162	[p9l1084t276r1507b371],
18	We	PRP	O	we	nsubj	19	SENT_162	[p9l1535t302r1650b355],
19	transfected	VBD	O	transfect	ccomp	2	SENT_162	[p9l1677t275r2135b353],

1	293T	NN	O	293t	nn	2	SENT_163	[p9l21t409r227b482],
2	cells	NNS	O	cell	_	0	SENT_163	[p9l252t404r430b481],
3	with	IN	O	with	dep	2	SENT_163	[p9l456t404r644b482],
4	an	DT	O	a	det	8	SENT_163	[p9l671t429r772b481],
5	expression	NN	O	expression	nn	8	SENT_163	[p9l801t404r1236b503],
6	plasmid	NN	O	plasmid	nn	8	SENT_163	[p9l1263t404r1593b503],
7	encoding	VBG	O	encode	amod	8	SENT_163	[p9l1622t404r2006b504],
8	ei2393	NN	O	ei2393	pobj	3	SENT_163	[p9l2033t405r2134b481, p9l149t579r226b602],

1	NENGLJ	NN	O	nenglj	nn	2	SENT_164	[p9l964t589r1071b611],
2	MED368	NN	O	med368	_	0	SENT_164	[p9l1085t583r1226b611],
3	;	:	O	;	_	0	SENT_164	[p9l1085t583r1226b611],
4	25	CD	NUMBER	25	num	6	SENT_164	[p9l1085t583r1226b611],
5	NEjM.ORG	NN	O	nejm.org	nn	6	SENT_164	[p9l1262t589r1386b611],
6	JUNE20	NN	O	june20	dep	2	SENT_164	[p9l1417t589r1595b611],
7	,2013	CD	NUMBER	,2013	dep	6	SENT_164	[p9l1417t589r1595b611],

1	The	DT	O	the	det	4	SENT_165	[p9l936t622r987b646],
2	New	NNP	O	New	nn	4	SENT_165	[p9l996t623r1058b646],
3	England	NNP	O	England	nn	4	SENT_165	[p9l1067t622r1178b653],
4	Joumal	NNP	O	Joumal	_	0	SENT_165	[p9l1187t622r1284b646],
5	of	IN	O	of	_	0	SENT_165	[p9l1294t622r1323b646],
6	Medicine	NNP	O	Medicine	prep_of	4	SENT_165	[p9l1330t622r1455b646],

1	BRIEF	JJ	O	brief	amod	2	SENT_166	[p9l817t747r914b766],
2	REPORT	NN	O	report	_	0	SENT_166	[p9l928t747r1058b766],

1	B	NN	O	b	nn	2	SENT_167	[p9l1037t875r1056b900],
2	Resistance	NN	O	resistance	_	0	SENT_167	[p9l1081t878r1216b901],
3	to	TO	O	to	dep	2	SENT_167	[p9l1224t881r1250b901],
4	ROS1	NN	O	ros1	nn	5	SENT_167	[p9l1261t879r1331b901],
5	Inhibitors	NNS	O	inhibitor	pobj	3	SENT_167	[p9l1343t877r1465b901],
6	Conferred	VBN	O	confer	partmod	5	SENT_167	[p9l1474t877r1600b901],
7	by	IN	O	by	_	0	SENT_167	[p9l1611t877r1639b908],
8	G2032R	NN	O	g2032r	agent	6	SENT_167	[p9l1648t879r1749b901],

1	A	DT	O	a	det	2	SENT_168	[p9l116t875r139b900],
2	Conservation	NNP	O	Conservation	_	0	SENT_168	[p9l161t878r329b901],
3	of	IN	O	of	_	0	SENT_168	[p9l340t877r369b901],
4	G2032	NN	O	g2032	prep_of	2	SENT_168	[p9l373t879r456b901],
5	among	IN	O	among	_	0	SENT_168	[p9l465t885r554b908],
6	ROS1	NN	O	ros1	nn	7	SENT_168	[p9l565t879r635b901],
7	Paralogs	NNS	O	paralog	prep_among	2	SENT_168	[p9l647t877r754b908],

1	CD74-ROS1	NN	O	cd74-ros1	_	0	SENT_169	[p9l1460t962r1613b984],
2	Nonmutant	JJ	O	nonmutant	amod	4	SENT_169	[p9l1465t998r1613b1020],
3	CD74-ROS1	NN	O	cd74-ros1	nn	4	SENT_169	[p9l1792t962r1945b984],
4	G2032R	NN	O	g2032r	dep	1	SENT_169	[p9l1819t998r1920b1020],

1	o	NN	O	o	nn	3	SENT_170	[p9l1678t1050r1696b1068],
2	o	NN	O	o	nn	3	SENT_170	[p9l2007t1050r2025b1068],
3	HM	NNS	O	hm	_	0	SENT_170	[p9l1224t1075r1268b1095],
4	:	:	O	:	_	0	SENT_170	[p9l1224t1075r1268b1095],
5	o	NN	O	o	dep	3	SENT_170	[p9l1384t1081r1402b1099],
6	3	CD	NUMBER	3	num	7	SENT_170	[p9l1447t1071r1475b1100],
7	°	NN	O	°	dep	5	SENT_170	[p9l1447t1071r1475b1100],
8	9	CD	NUMBER	9	num	9	SENT_170	[p9l1509t1060r1549b1100],
9	°	NN	O	°	dep	17	SENT_170	[p9l1509t1060r1549b1100],
10	'90	CD	NUMBER	'90	num	11	SENT_170	[p9l1583t1060r1622b1100],
11	GD	NN	MISC	gd	dep	9	SENT_170	[p9l1646t1060r1686b1100],
12	Q	NNP	O	Q	dep	11	SENT_170	[p9l1711t1081r1729b1099],
13	'	POS	O	'	_	0	SENT_170	[p9l1774t1071r1803b1100],
14	5	CD	NUMBER	5	number	15	SENT_170	[p9l1774t1071r1803b1100],
15	“	CD	NUMBER	“	num	12	SENT_170	[p9l1774t1071r1803b1100],
16	9	CD	NUMBER	9	dep	17	SENT_170	[p9l1837t1060r1877b1100],
17	°	NN	O	°	dep	3	SENT_170	[p9l1837t1060r1877b1100],
18	"	''	O	"	punct	17	SENT_170	[p9l1912t1060r1951b1101],
19	-90	CD	NUMBER	-90	num	21	SENT_170	[p9l1912t1060r1951b1101],
20	9	CD	NUMBER	9	num	21	SENT_170	[p9l1975t1060r2014b1100],
21	°	NN	O	°	dep	17	SENT_170	[p9l1975t1060r2014b1100],
22	pROS1	NN	O	pros1	dep	21	SENT_170	[p9l1187t1126r1268b1153],
23	1	CD	NUMBER	1	num	22	SENT_170	[p9l1353t1120r1475b1151],
24	:	:	O	:	_	0	SENT_170	[p9l1353t1120r1475b1151],
25	3	CD	NUMBER	3	num	26	SENT_170	[p9l1487t1130r1540b1151],
26	cu	NN	O	cu	dep	21	SENT_170	[p9l1556t1132r1605b1149],
27	--	:	O	--	_	0	SENT_170	[p9l1625t1134r1666b1143],
28	‘	CD	NUMBER	‘	num	30	SENT_170	[p9l1680t1118r1806b1155],
29	M	NN	O	m	nn	30	SENT_170	[p9l1680t1118r1806b1155],
30	‘	NN	O	‘	dep	34	SENT_170	[p9l1814t1126r2018b1159],
31	i	FW	O	i	nn	33	SENT_170	[p9l1814t1126r2018b1159],
32	R051	FW	O	r051	nn	33	SENT_170	[p9l1204t1201r1268b1222],
33	GAPDH	NN	O	gapdh	dep	30	SENT_170	[p9l1174t1277r1267b1297],
34	+	CC	O	+	dep	26	SENT_170	[p9l1281t1259r2033b1318],

1	64	CD	NUMBER	64	_	0	SENT_171	[p9l1349t1358r1393b1396],
2	¢	NN	O	¢	dep	1	SENT_171	[p9l1349t1358r1393b1396],
3	.	.	O	.	_	0	SENT_171	[p9l1349t1358r1393b1396],

1	we	PRP	O	we	nsubj	2	SENT_172	[p9l1322t1391r1360b1428],
2	CD74-ROS1	VBP	O	cd74-ros1	_	0	SENT_172	[p9l1460t1388r1613b1410],
3	9	CD	NUMBER	9	number	4	SENT_172	[p9l1300t1418r1327b1445],
4	Nonmutant	JJ	O	nonmutant	acomp	2	SENT_172	[p9l1465t1424r1613b1446],

1	Crizotinib	NNP	O	Crizotinib	_	0	SENT_173	[p9l1050t1073r1174b1097],

1	ROS1	NN	O	ros1	nn	2	SENT_174	[p9l155t1150r225b1171],
2	Paralogs	NNS	O	paralog	_	0	SENT_174	[p9l238t1148r345b1179],

1	CD74-ROS1	NN	O	cd74-ros1	nn	2	SENT_175	[p9l1792t1388r1945b1410],
2	G2032R	NN	O	g2032r	_	0	SENT_175	[p9l1819t1424r1920b1446],

1	TAE684	NN	O	tae684	nn	3	SENT_176	[p9l1049t1501r1149b1523],
2	n	NN	O	n	nn	3	SENT_176	[p9l1224t1507r1235b1521],
3	M	NN	O	m	_	0	SENT_176	[p9l1240t1501r1268b1521],
4	:	:	O	:	_	0	SENT_176	[p9l1240t1501r1268b1521],
5	pROS1	NN	O	pros1	dep	3	SENT_176	[p9l1187t1552r1268b1579],

1	ooo	NN	O	ooo	nn	4	SENT_177	[p9l1531t1476r1696b1504],
2	°	CD	NUMBER	°	num	4	SENT_177	[p9l1531t1476r1696b1504],
3	QBQP	NN	O	qbqp	nn	4	SENT_177	[p9l1859t1476r2025b1504],
4	o	NN	O	o	nn	5	SENT_177	[p9l1384t1497r2004b1527],
5	~	NN	O	~	_	0	SENT_177	[p9l1384t1497r2004b1527],
6	>	JJR	O	>	dep	5	SENT_177	[p9l1384t1497r2004b1527],
7	°	CD	NUMBER	°	num	8	SENT_177	[p9l1384t1497r2004b1527],
8	\	NN	O	\	dep	5	SENT_177	[p9l1384t1497r2004b1527],
9	,	,	O	,	_	0	SENT_177	[p9l1384t1497r2004b1527],
10	°	CD	NUMBER	°	num	11	SENT_177	[p9l1384t1497r2004b1527],
11	~	NN	O	~	appos	8	SENT_177	[p9l1384t1497r2004b1527],
12	;	:	O	;	_	0	SENT_177	[p9l1384t1497r2004b1527],
13	°	CD	NUMBER	°	number	14	SENT_177	[p9l1384t1497r2004b1527],
14	\	CD	NUMBER	\	dep	11	SENT_177	[p9l1384t1497r2004b1527],
15	,	,	O	,	_	0	SENT_177	[p9l1384t1497r2004b1527],
16	°	CD	NUMBER	°	num	19	SENT_177	[p9l1384t1497r2004b1527],
17	o	NN	O	o	nn	19	SENT_177	[p9l1384t1497r2004b1527],
18	~	NN	O	~	nn	19	SENT_177	[p9l1384t1497r2004b1527],
19	Px	NN	O	px	appos	8	SENT_177	[p9l1384t1497r2004b1527],
20	°	CD	NUMBER	°	number	21	SENT_177	[p9l1384t1497r2004b1527],
21	*	CD	NUMBER	*	dep	19	SENT_177	[p9l1384t1497r2004b1527],
22	-9	CD	NUMBER	-9	num	25	SENT_177	[p9l1384t1497r2004b1527],
23	x9	NN	O	x9	nn	25	SENT_177	[p9l1384t1497r2004b1527],
24	T11Other	NN	O	t11other	nn	25	SENT_177	[p9l1690t1539r2020b1582, p9l163t1563r239b1586],
25	Kinases	NNS	O	kinase	dep	21	SENT_177	[p9l248t1563r345b1586],

1	ROS1	NN	O	ros1	_	0	SENT_178	[p9l1204t1627r1268b1648],

1	GAPDH	NN	O	gapdh	_	0	SENT_179	[p9l1174t1703r1267b1723],

1	C	NN	O	c	nn	2	SENT_180	[p9l117t1800r138b1826],
2	ROS1	NN	O	ros1	_	0	SENT_180	[p9l162t1804r232b1826],
3	In	IN	O	in	dep	2	SENT_180	[p9l245t1805r267b1826],
4	Vitro	NNP	O	Vitro	nn	6	SENT_180	[p9l276t1803r338b1826],
5	Kinase	NN	O	kinase	nn	6	SENT_180	[p9l349t1803r432b1826],
6	Assay	NN	O	assay	pobj	3	SENT_180	[p9l440t1805r515b1833],

1	0-8	CD	NUMBER	0-8	num	2	SENT_181	[p9l198t1913r232b1934],
2	G2032R	NN	O	g2032r	_	0	SENT_181	[p9l623t1919r717b1940],

1	0,2	CD	NUMBER	0,2	_	0	SENT_182	[p9l198t2098r232b2119],
2	Nonmutant	JJ	O	nonmutant	dep	1	SENT_182	[p9l308t2093r447b2113],

1	0.0001	CD	NUMBER	0.0001	number	2	SENT_183	[p9l260t2193r337b2214],
2	0.001	CD	NUMBER	0.001	_	0	SENT_183	[p9l360t2193r423b2214],
3	0.01	CD	NUMBER	0.01	num	4	SENT_183	[p9l460t2193r508b2214],
4	0.1	CD	NUMBER	0.1	dep	2	SENT_183	[p9l560t2193r594b2214],
5	1	CD	NUMBER	1	num	7	SENT_183	[p9l666t2193r676b2213],
6	Crizotinib	NNP	O	Crizotinib	nn	7	SENT_183	[p9l311t2244r435b2267],
7	Concentration	NN	O	concentration	dep	2	SENT_183	[p9l444t2244r624b2267],
8	(	CD	NUMBER	(	num	10	SENT_183	[p9l636t2246r695b2275],
9	yM	NN	O	ym	nn	10	SENT_183	[p9l636t2246r695b2275],
10	)	NN	O	)	dep	7	SENT_183	[p9l636t2246r695b2275],

1	Figure	NNP	O	Figure	_	0	SENT_184	[p9l122t2331r206b2363],
2	3	CD	NUMBER	3	dep	1	SENT_184	[p9l217t2333r239b2355],
3	.	.	O	.	_	0	SENT_184	[p9l217t2333r239b2355],

1	Mutation	NN	O	mutation	nsubj	4	SENT_185	[p9l253t2331r377b2356],
2	of	IN	O	of	prep	1	SENT_185	[p9l388t2330r420b2356],
3	Highly	RB	O	highly	pobj	2	SENT_185	[p9l427t2330r516b2363],
4	Conserved	VBN	O	conserve	_	0	SENT_185	[p9l526t2330r672b2356],
5	Glycine	NN	O	glycine	dobj	4	SENT_185	[p9l684t2330r786b2363],
6	at	IN	O	at	_	0	SENT_185	[p9l796t2334r822b2356],
7	Residue	NNP	O	Residue	prep_at	4	SENT_185	[p9l834t2330r942b2356],
8	2032	CD	DATE	2032	num	7	SENT_185	[p9l952t2332r1017b2356],
9	to	TO	O	to	_	0	SENT_185	[p9l1027t2334r1054b2356],
10	Arginine	NNP	O	Arginine	prep_to	4	SENT_185	[p9l1064t2331r1181b2363],
11	and	CC	O	and	_	0	SENT_185	[p9l1191t2330r1241b2356],
12	Resistance	NNP	O	Resistance	conj_and	10	SENT_185	[p9l1254t2331r1402b2356],
13	to	TO	O	to	_	0	SENT_185	[p9l1411t2334r1438b2356],
14	Crizotinib	NNP	O	Crizotinib	nn	17	SENT_185	[p9l1449t2330r1581b2356],
15	through	IN	O	through	amod	17	SENT_185	[p9l1591t2330r1700b2363],
16	Steric	NNP	O	Steric	nn	17	SENT_185	[p9l1712t2331r1791b2356],
17	Interference	NN	O	interference	prep_to	4	SENT_185	[p9l1803t2330r1970b2356],
18	with	IN	O	with	_	0	SENT_185	[p9l119t2372r177b2397],
19	Drug	NN	O	drug	nn	20	SENT_185	[p9l191t2374r260b2405],
20	Binding	NN	O	binding	prep_with	4	SENT_185	[p9l271t2372r384b2405],
21	.	.	O	.	_	0	SENT_185	[p9l271t2372r384b2405],

1	In	IN	O	in	_	0	SENT_186	[p9l122t2424r144b2447],
2	Panel	NN	O	panel	nn	3	SENT_186	[p9l159t2422r231b2447],
3	A	NN	O	a	prep_in	11	SENT_186	[p9l243t2424r270b2452],
4	,	,	O	,	_	0	SENT_186	[p9l243t2424r270b2452],
5	the	DT	O	the	det	6	SENT_186	[p9l282t2422r325b2447],
6	alignments	NNS	O	alignment	nsubj	11	SENT_186	[p9l337t2422r491b2455],
7	of	IN	O	of	_	0	SENT_186	[p9l503t2422r533b2447],
8	amino	NN	O	amino	nn	10	SENT_186	[p9l540t2424r626b2447],
9	acid	NN	O	acid	nn	10	SENT_186	[p9l638t2422r691b2447],
10	sequences	NNS	O	sequence	prep_of	6	SENT_186	[p9l705t2431r849b2455],
11	show	VBP	O	show	_	0	SENT_186	[p9l862t2422r934b2447],
12	that	IN	O	that	complm	20	SENT_186	[p9l943t2422r998b2447],
13	G2032	NN	O	g2032	nsubjpass	20	SENT_186	[p9l1009t2424r1096b2447],
14	(	CD	NUMBER	(	num	17	SENT_186	[p9l1111t2422r1162b2455],
15	red	JJ	O	red	amod	17	SENT_186	[p9l1111t2422r1162b2455],
16	asterisk	NN	O	asterisk	nn	17	SENT_186	[p9l1175t2422r1290b2455],
17	)	NN	O	)	dep	13	SENT_186	[p9l1175t2422r1290b2455],
18	is	VBZ	O	be	auxpass	20	SENT_186	[p9l1305t2424r1324b2447],
19	highly	RB	O	highly	advmod	20	SENT_186	[p9l1337t2422r1418b2455],
20	conserved	VBN	O	conserve	ccomp	11	SENT_186	[p9l1429t2422r1570b2447],
21	among	IN	O	among	_	0	SENT_186	[p9l1583t2431r1679b2455],
22	all	DT	O	all	det	25	SENT_186	[p9l1690t2422r1718b2447],
23	13	CD	NUMBER	13	num	25	SENT_186	[p9l1733t2424r1760b2447],
24	ROS1	NN	O	ros1	nn	25	SENT_186	[p9l1776t2424r1849b2447],
25	paralogs	NNS	O	paralog	prep_among	20	SENT_186	[p9l1863t2422r1980b2455],
26	and	CC	O	and	_	0	SENT_186	[p9l120t2464r169b2489],
27	among	IN	O	among	_	0	SENT_186	[p9l182t2473r278b2497],
28	many	JJ	O	many	amod	32	SENT_186	[p9l290t2473r364b2497],
29	other	JJ	O	other	amod	32	SENT_186	[p9l374t2464r447b2489],
30	clinically	RB	O	clinically	advmod	31	SENT_186	[p9l458t2464r576b2497],
31	important	JJ	O	important	amod	32	SENT_186	[p9l588t2466r727b2497],
32	tyrosine	NN	O	tyrosine	conj_and	25	SENT_186	[p9l737t2466r848b2497],
33	and	CC	O	and	_	0	SENT_186	[p9l859t2464r908b2489],
34	serine	NN	O	serine	nn	37	SENT_186	[p9l921t2464r1159b2489],
35	—	NN	O	—	nn	37	SENT_186	[p9l921t2464r1159b2489],
36	threonine	NN	O	threonine	nn	37	SENT_186	[p9l921t2464r1159b2489],
37	kinases	NNS	O	kinase	conj_and	32	SENT_186	[p9l1171t2464r1280b2489],
38	.	.	O	.	_	0	SENT_186	[p9l1171t2464r1280b2489],

1	Identical	JJ	O	identical	amod	2	SENT_187	[p9l1294t2464r1410b2489],
2	residues	NNS	O	residue	nsubjpass	9	SENT_187	[p9l1425t2464r1539b2489],
3	are	VBP	O	be	auxpass	4	SENT_187	[p9l1551t2473r1592b2489],
4	highlighted	VBN	O	highlight	_	0	SENT_187	[p9l1604t2464r1758b2497],
5	in	IN	O	in	_	0	SENT_187	[p9l1772t2466r1793b2489],
6	black	JJ	O	black	prep_in	4	SENT_187	[p9l1807t2464r1884b2493],
7	,	,	O	,	_	0	SENT_187	[p9l1807t2464r1884b2493],
8	and	CC	O	and	_	0	SENT_187	[p9l1897t2464r1946b2489],
9	conserved	VBN	O	conserve	conj_and	4	SENT_187	[p9l1958t2473r2017b2489, p9l121t2505r210b2531],
10	substitutions	NNS	O	substitution	nsubjpass	12	SENT_187	[p9l223t2505r404b2531],
11	are	VBP	O	be	auxpass	12	SENT_187	[p9l417t2514r457b2531],
12	highlighted	VBN	O	highlight	ccomp	9	SENT_187	[p9l470t2505r623b2539],
13	in	IN	O	in	_	0	SENT_187	[p9l637t2508r659b2530],
14	gray	JJ	O	gray	prep_in	12	SENT_187	[p9l672t2514r734b2539],
15	.	.	O	.	_	0	SENT_187	[p9l672t2514r734b2539],

1	Panel	NN	O	panel	nn	2	SENT_188	[p9l748t2505r820b2531],
2	B	NN	O	b	nsubj	3	SENT_188	[p9l835t2508r850b2530],
3	shows	VBZ	O	show	_	0	SENT_188	[p9l862t2505r948b2531],
4	the	DT	O	the	det	5	SENT_188	[p9l959t2505r1002b2531],
5	results	NNS	O	result	nsubj	6	SENT_188	[p9l1015t2505r1106b2531],
6	ofthe	VBP	O	ofthe	ccomp	3	SENT_188	[p9l1118t2505r1197b2531],
7	transient	JJ	O	transient	amod	10	SENT_188	[p9l1207t2508r1331b2531],
8	transfection	NN	O	transfection	nn	10	SENT_188	[p9l1341t2505r1508b2531],
9	of293T	NN	O	of293t	nn	10	SENT_188	[p9l1520t2505r1624b2531],
10	cells	NNS	O	cell	dobj	6	SENT_188	[p9l1634t2505r1693b2531],
11	with	IN	O	with	_	0	SENT_188	[p9l1704t2505r1762b2531],
12	expression	NN	O	expression	nn	13	SENT_188	[p9l1774t2508r1921b2538],
13	plasmids	NNS	O	plasmid	prep_with	6	SENT_188	[p9l1935t2505r1999b2538, p9l121t2547r187b2572],
14	containing	VBG	O	contain	partmod	13	SENT_188	[p9l199t2549r346b2580],
15	either	CC	O	either	prep	14	SENT_188	[p9l356t2547r436b2572],
16	nonmutated	JJ	O	nonmutated	amod	17	SENT_188	[p9l448t2547r616b2572],
17	CD74-ROS1	NN	O	cd74-ros1	dep	15	SENT_188	[p9l630t2549r799b2572],
18	or	CC	O	or	_	0	SENT_188	[p9l812t2556r840b2572],
19	G2032R	NN	O	g2032r	nn	20	SENT_188	[p9l850t2549r958b2572],
20	CD74-ROS1	NN	O	cd74-ros1	dep	15	SENT_188	[p9l970t2549r1147b2572],
21	.	.	O	.	_	0	SENT_188	[p9l970t2549r1147b2572],

1	The	DT	O	the	_	0	SENT_189	[p9l1158t2547r1210b2572],
2	transfected	VBN	O	transfect	partmod	1	SENT_189	[p9l1220t2547r1377b2572],
3	cells	NNS	O	cell	nsubjpass	5	SENT_189	[p9l1389t2547r1449b2572],
4	were	VBD	O	be	auxpass	5	SENT_189	[p9l1460t2556r1524b2572],
5	treated	VBN	O	treat	ccomp	2	SENT_189	[p9l1535t2547r1631b2572],
6	with	IN	O	with	_	0	SENT_189	[p9l1643t2547r1700b2572],
7	increasing	VBG	O	increase	amod	8	SENT_189	[p9l1714t2549r1855b2580],
8	concentrations	NNS	O	concentration	prep_with	5	SENT_189	[p9l1866t2552r2013b2572, p9l119t2591r187b2614],
9	ofcrizotinib	NN	O	ofcrizotinib	dep	17	SENT_189	[p9l199t2588r365b2614],
10	(	CD	NUMBER	(	num	9	SENT_189	[p9l379t2591r441b2622],
11	top	JJ	O	top	amod	12	SENT_189	[p9l379t2591r441b2622],
12	)	NN	O	)	dep	9	SENT_189	[p9l379t2591r441b2622],
13	or	CC	O	or	_	0	SENT_189	[p9l456t2598r484b2614],
14	TAE684	NN	O	tae684	dep	9	SENT_189	[p9l493t2590r598b2614],
15	(	CD	NUMBER	(	num	17	SENT_189	[p9l612t2589r733b2622],
16	bottom	JJ	O	bottom	amod	17	SENT_189	[p9l612t2589r733b2622],
17	)	NN	O	)	dep	1	SENT_189	[p9l612t2589r733b2622],
18	for	IN	O	for	_	0	SENT_189	[p9l746t2588r785b2614],
19	6	CD	DURATION	6	num	20	SENT_189	[p9l796t2591r810b2614],
20	hours	NNS	NUMBER	hour	prep_for	17	SENT_189	[p9l822t2589r908b2614],
21	.	.	O	.	_	0	SENT_189	[p9l822t2589r908b2614],

1	Lysates	NNS	O	lysate	nsubj	3	SENT_190	[p9l922t2591r1019b2622],
2	were	VBD	O	be	cop	3	SENT_190	[p9l1030t2598r1095b2614],
3	prepared	JJ	O	prepared	_	0	SENT_190	[p9l1108t2589r1229b2622],
4	and	CC	O	and	_	0	SENT_190	[p9l1242t2589r1291b2614],
5	Western	JJ	MISC	western	amod	7	SENT_190	[p9l1303t2591r1417b2614],
6	blot	NN	O	blot	nn	7	SENT_190	[p9l1431t2589r1482b2614],
7	analyses	NNS	O	analysis	nsubjpass	9	SENT_190	[p9l1494t2589r1609b2622],
8	were	VBD	O	be	auxpass	9	SENT_190	[p9l1620t2598r1685b2614],
9	performed	VBN	O	perform	conj_and	3	SENT_190	[p9l1697t2588r1843b2622],
10	with	IN	O	with	_	0	SENT_190	[p9l1855t2589r1912b2614],
11	the	DT	O	the	det	13	SENT_190	[p9l1924t2589r1967b2614],
12	use	NN	O	use	nn	13	SENT_190	[p9l1980t2598r2025b2614],
13	ofthe	NN	O	ofthe	prep_with	9	SENT_190	[p9l120t2630r199b2656],
14	indicated	VBD	O	indicate	partmod	13	SENT_190	[p9l211t2630r337b2656],
15	antibodies	NNS	O	antibody	dobj	14	SENT_190	[p9l350t2630r502b2656],
16	.	.	O	.	_	0	SENT_190	[p9l350t2630r502b2656],

1	The	DT	O	the	det	3	SENT_191	[p9l513t2630r565b2656],
2	293T	NN	O	293t	nn	3	SENT_191	[p9l576t2633r643b2656],
3	cells	NNS	O	cell	nsubjpass	6	SENT_191	[p9l653t2630r713b2656],
4	were	VBD	O	be	auxpass	6	SENT_191	[p9l724t2639r789b2656],
5	also	RB	O	also	advmod	6	SENT_191	[p9l800t2630r854b2656],
6	transfected	VBN	O	transfect	_	0	SENT_191	[p9l865t2630r1021b2656],
7	with	IN	O	with	_	0	SENT_191	[p9l1033t2630r1090b2656],
8	a	DT	O	a	det	12	SENT_191	[p9l1103t2639r1116b2656],
9	plasmid-expressing	JJ	O	plasmid-expressing	amod	12	SENT_191	[p9l1129t2630r1399b2664],
10	green	JJ	O	green	amod	12	SENT_191	[p9l1410t2639r1486b2664],
11	fluorescence	NN	O	fluorescence	nn	12	SENT_191	[p9l1498t2630r1676b2656],
12	protein	NN	O	protein	prep_with	6	SENT_191	[p9l1688t2633r1784b2663],
13	as	IN	O	as	_	0	SENT_191	[p9l1797t2639r1825b2656],
14	a	DT	O	a	det	16	SENT_191	[p9l1837t2639r1850b2656],
15	negative	JJ	O	negative	amod	16	SENT_191	[p9l1863t2633r1978b2664],
16	control	NN	O	control	prep_as	12	SENT_191	[p9l120t2672r225b2697],
17	.	.	O	.	_	0	SENT_191	[p9l120t2672r225b2697],

1	GAPDH	NN	O	gapdh	nsubj	2	SENT_192	[p9l237t2674r345b2697],
2	denotes	VBZ	O	denote	_	0	SENT_192	[p9l359t2672r468b2697],
3	glyceraldehyde-3-phosphate-dehydrogenase	NN	O	glyceraldehyde-3-phosphate-dehydrogenase	dobj	2	SENT_192	[p9l481t2672r1103b2705],
4	.	.	O	.	_	0	SENT_192	[p9l481t2672r1103b2705],

1	In	IN	O	in	dep	8	SENT_193	[p9l1118t2674r1140b2697],
2	Panel	NN	O	panel	nn	3	SENT_193	[p9l1155t2672r1227b2697],
3	C	NN	O	c	pobj	1	SENT_193	[p9l1240t2674r1266b2702],
4	,	,	O	,	_	0	SENT_193	[p9l1240t2674r1266b2702],
5	in	FW	O	in	nn	6	SENT_193	[p9l1279t2675r1301b2697],
6	vitro	FW	O	vitro	dep	1	SENT_193	[p9l1313t2675r1375b2698],
7	enzymatic	JJ	O	enzymatic	amod	8	SENT_193	[p9l1386t2675r1528b2705],
8	assays	NNS	O	assay	nsubj	9	SENT_193	[p9l1539t2681r1626b2705],
9	show	VBP	O	show	_	0	SENT_193	[p9l1639t2672r1711b2698],
10	a	DT	O	a	det	12	SENT_193	[p9l1721t2681r1734b2697],
11	marked	JJ	O	marked	amod	12	SENT_193	[p9l1748t2672r1848b2697],
12	decrease	NN	O	decrease	nsubj	18	SENT_193	[p9l1861t2672r1983b2697],
13	in	IN	O	in	_	0	SENT_193	[p9l1995t2675r2017b2697],
14	the	DT	O	the	det	16	SENT_193	[p9l119t2714r162b2739],
15	ability	NN	O	ability	nn	16	SENT_193	[p9l174t2714r256b2747],
16	ofcrizotinib	NN	O	ofcrizotinib	prep_in	12	SENT_193	[p9l267t2714r432b2739],
17	to	TO	O	to	aux	18	SENT_193	[p9l443t2719r470b2739],
18	inhibit	VB	O	inhibit	xcomp	9	SENT_193	[p9l482t2714r569b2739],
19	kinase	NN	O	kinase	nn	20	SENT_193	[p9l581t2714r667b2739],
20	activity	NN	O	activity	dobj	18	SENT_193	[p9l678t2716r777b2747],
21	for	IN	O	for	_	0	SENT_193	[p9l787t2714r825b2739],
22	the	DT	O	the	det	25	SENT_193	[p9l835t2714r878b2739],
23	G2032R	NN	O	g2032r	nn	25	SENT_193	[p9l890t2715r997b2739],
24	ROS1	NN	O	ros1	nn	25	SENT_193	[p9l1010t2716r1084b2739],
25	mutant	NN	O	mutant	prep_for	20	SENT_193	[p9l1098t2719r1197b2739],
26	as	IN	O	as	_	0	SENT_193	[p9l1209t2723r1236b2739],
27	compared	VBN	O	compare	prepc_as	18	SENT_193	[p9l1248t2714r1386b2747],
28	with	IN	O	with	pcomp	27	SENT_193	[p9l1398t2714r1455b2739],
29	the	DT	O	the	det	30	SENT_193	[p9l1467t2714r1510b2739],
30	nonmutant	JJ	O	nonmutant	pobj	28	SENT_193	[p9l1523t2719r1685b2739],
31	.	.	O	.	_	0	SENT_193	[p9l1523t2719r1685b2739],

1	V	NN	O	v	nsubj	9	SENT_194	[p9l1696t2716r1720b2745],
2	,	,	O	,	_	0	SENT_194	[p9l1696t2716r1720b2745],
3	and	CC	O	and	_	0	SENT_194	[p9l1733t2714r1781b2739],
4	Vo	NNP	O	Vo	nsubj	9	SENT_194	[p9l1793t2716r1824b2745],
5	are	VBP	O	be	cop	9	SENT_194	[p9l1835t2723r1876b2739],
6	the	DT	O	the	det	9	SENT_194	[p9l1886t2714r1930b2739],
7	initial	JJ	O	initial	amod	9	SENT_194	[p9l1942t2714r2015b2739],
8	reaction	NN	O	reaction	nn	9	SENT_194	[p9l121t2758r231b2781],
9	rates	NNS	O	rate	_	0	SENT_194	[p9l246t2760r310b2781],
10	in	IN	O	in	_	0	SENT_194	[p9l324t2758r345b2780],
11	the	DT	O	the	det	15	SENT_194	[p9l357t2756r401b2781],
12	presence	NN	O	presence	nn	15	SENT_194	[p9l413t2764r536b2788],
13	and	CC	O	and	_	0	SENT_194	[p9l548t2756r596b2781],
14	absence	NN	O	absence	nn	15	SENT_194	[p9l609t2756r721b2781],
15	ofcrizotinib	NN	O	ofcrizotinib	prep_in	9	SENT_194	[p9l732t2755r905b2785],
16	,	,	O	,	_	0	SENT_194	[p9l732t2755r905b2785],
17	respectively	RB	O	respectively	advmod	9	SENT_194	[p9l919t2756r1088b2789],
18	.	.	O	.	_	0	SENT_194	[p9l919t2756r1088b2789],

1	Panel	NN	O	panel	nn	2	SENT_195	[p9l1102t2756r1174b2781],
2	D	NN	O	d	nsubj	3	SENT_195	[p9l1189t2758r1208b2780],
3	shows	VBZ	O	show	dep	9	SENT_195	[p9l1220t2756r1306b2781],
4	the	DT	O	the	det	6	SENT_195	[p9l1317t2756r1360b2781],
5	crystal	NN	O	crystal	nn	6	SENT_195	[p9l1372t2756r1460b2789],
6	structure	NN	O	structure	dobj	3	SENT_195	[p9l1474t2760r1599b2781],
7	of	IN	O	of	_	0	SENT_195	[p9l1610t2755r1640b2781],
8	crizotinib	NN	O	crizotinib	prep_of	6	SENT_195	[p9l1647t2756r1776b2781],
9	bound	VBD	O	bind	_	0	SENT_195	[p9l1789t2755r1875b2781],
10	to	TO	O	to	_	0	SENT_195	[p9l1887t2760r1913b2781],
11	the	DT	O	the	det	15	SENT_195	[p9l1924t2755r1967b2781],
12	nonmutant	JJ	O	nonmutant	amod	15	SENT_195	[p9l121t2802r276b2823],
13	ROS1	NN	O	ros1	nn	15	SENT_195	[p9l289t2799r362b2823],
14	kinase	NN	O	kinase	nn	15	SENT_195	[p9l376t2797r462b2823],
15	domain	NN	O	domain	prep_to	9	SENT_195	[p9l473t2797r577b2823],
16	(	CD	NUMBER	(	tmod	9	SENT_195	[p9l592t2799r626b2830],
17	at	IN	O	at	_	0	SENT_195	[p9l592t2799r626b2830],
18	left	JJ	O	left	amod	19	SENT_195	[p9l638t2797r689b2830],
19	)	NN	O	)	prep_at	16	SENT_195	[p9l638t2797r689b2830],
20	and	CC	O	and	_	0	SENT_195	[p9l704t2797r752b2823],
21	a	DT	O	a	det	24	SENT_195	[p9l765t2806r778b2822],
22	model	NN	O	model	nn	24	SENT_195	[p9l791t2797r876b2823],
23	ofthe	NN	O	ofthe	nn	24	SENT_195	[p9l889t2797r968b2823],
24	G2032R	NN	O	g2032r	prep_at	16	SENT_195	[p9l979t2799r1087b2823],
25	mutant	JJ	O	mutant	amod	26	SENT_195	[p9l1099t2802r1199b2823],
26	(	NN	O	(	nsubj	9	SENT_195	[p9l1212t2799r1246b2830],
27	at	IN	O	at	_	0	SENT_195	[p9l1212t2799r1246b2830],
28	right	JJ	O	right	amod	29	SENT_195	[p9l1258t2797r1339b2831],
29	)	NN	O	)	prep_at	26	SENT_195	[p9l1258t2797r1339b2831],
30	,	,	O	,	_	0	SENT_195	[p9l1258t2797r1339b2831],
31	in	IN	O	in	_	0	SENT_195	[p9l1352t2800r1374b2822],
32	which	WDT	O	which	rel	34	SENT_195	[p9l1386t2797r1466b2823],
33	there	EX	O	there	expl	34	SENT_195	[p9l1477t2797r1549b2823],
34	is	VBZ	O	be	rcmod	26	SENT_195	[p9l1561t2800r1580b2823],
35	a	DT	O	a	det	38	SENT_195	[p9l1592t2806r1605b2822],
36	predicted	VBN	O	predict	amod	38	SENT_195	[p9l1619t2797r1747b2830],
37	steric	JJ	O	steric	amod	38	SENT_195	[p9l1761t2800r1836b2823],
38	clash	NN	O	clash	nsubj	34	SENT_195	[p9l1846t2797r1915b2823],
39	with	IN	O	with	_	0	SENT_195	[p9l1927t2797r1984b2823],
40	crizotinib	NN	O	crizotinib	prep_with	38	SENT_195	[p9l120t2839r256b2864],
41	.	.	O	.	_	0	SENT_195	[p9l120t2839r256b2864],

1	In	IN	O	in	_	0	SENT_196	[p9l271t2841r293b2864],
2	this	DT	O	this	det	4	SENT_196	[p9l305t2839r355b2864],
3	atom-coloring	NN	O	atom-coloring	nn	4	SENT_196	[p9l367t2839r564b2872],
4	scheme	NN	O	scheme	prep_in	9	SENT_196	[p9l575t2839r689b2869],
5	,	,	O	,	_	0	SENT_196	[p9l575t2839r689b2869],
6	ROS1	NN	O	ros1	nn	7	SENT_196	[p9l704t2841r777b2864],
7	carbon	NN	O	carbon	nsubj	9	SENT_196	[p9l790t2839r884b2864],
8	is	VBZ	O	be	cop	9	SENT_196	[p9l898t2841r917b2864],
9	green	JJ	O	green	_	0	SENT_196	[p9l929t2848r1014b2872],
10	,	,	O	,	_	0	SENT_196	[p9l929t2848r1014b2872],
11	crizotinib	JJ	O	crizotinib	amod	12	SENT_196	[p9l1026t2839r1155b2864],
12	carbon	NN	O	carbon	conj_and	9	SENT_196	[p9l1167t2839r1261b2864],
13	purple	JJ	O	purple	amod	12	SENT_196	[p9l1275t2839r1370b2872],
14	,	,	O	,	_	0	SENT_196	[p9l1275t2839r1370b2872],
15	oxygen	NN	O	oxygen	nn	16	SENT_196	[p9l1383t2848r1477b2872],
16	red	NN	O	red	conj_and	9	SENT_196	[p9l1491t2839r1541b2869],
17	,	,	O	,	_	0	SENT_196	[p9l1491t2839r1541b2869],
18	nitrogen	NN	O	nitrogen	nn	19	SENT_196	[p9l1555t2841r1668b2872],
19	blue	NN	O	blue	conj_and	9	SENT_196	[p9l1682t2839r1747b2869],
20	,	,	O	,	_	0	SENT_196	[p9l1682t2839r1747b2869],
21	chlorine	NN	O	chlorine	nn	22	SENT_196	[p9l1759t2839r1871b2864],
22	gold	NN	O	gold	conj_and	9	SENT_196	[p9l1882t2839r1949b2872],
23	,	,	O	,	_	0	SENT_196	[p9l1882t2839r1949b2872],
24	and	CC	O	and	_	0	SENT_196	[p9l1962t2839r2011b2864],
25	fluorine	NN	O	fluorine	conj_and	9	SENT_196	[p9l119t2880r228b2906],
26	brown	JJ	O	brown	amod	25	SENT_196	[p9l241t2881r333b2906],
27	.	.	O	.	_	0	SENT_196	[p9l241t2881r333b2906],

1	For	IN	O	for	_	0	SENT_197	[p9l348t2883r391b2906],
2	emphasis	NN	O	emphasis	prep_for	7	SENT_197	[p9l401t2881r542b2913],
3	,	,	O	,	_	0	SENT_197	[p9l401t2881r542b2913],
4	residue	NN	O	residue	nsubjpass	7	SENT_197	[p9l556t2881r655b2906],
5	2032	CD	DATE	2032	num	4	SENT_197	[p9l667t2882r731b2906],
6	is	VBZ	O	be	auxpass	7	SENT_197	[p9l744t2883r763b2906],
7	shown	VBN	O	show	_	0	SENT_197	[p9l776t2881r864b2906],
8	in	IN	O	in	_	0	SENT_197	[p9l877t2883r899b2905],
9	a	DT	O	a	det	11	SENT_197	[p9l912t2889r925b2906],
10	space-filling	JJ	O	space-filling	amod	11	SENT_197	[p9l938t2880r1106b2914],
11	representation	NN	O	representation	prep_in	7	SENT_197	[p9l1118t2883r1327b2913],
12	.	.	O	.	_	0	SENT_197	[p9l1118t2883r1327b2913],

1	The	DT	O	the	det	3	SENT_198	[p9l1339t2881r1390b2906],
2	red	JJ	O	red	amod	3	SENT_198	[p9l1403t2881r1444b2906],
3	asterisks	NNS	O	asterisk	nsubj	4	SENT_198	[p9l1457t2881r1577b2906],
4	indicate	VBP	O	indicate	_	0	SENT_198	[p9l1590t2881r1698b2906],
5	the	DT	O	the	det	8	SENT_198	[p9l1709t2881r1752b2906],
6	L2026	NN	O	l2026	nn	8	SENT_198	[p9l1765t2882r1846b2906],
7	gatekeeper	NN	O	gatekeeper	nn	8	SENT_198	[p9l1858t2881r2010b2914],
8	residue	NN	O	residue	dobj	4	SENT_198	[p9l121t2922r221b2948],
9	of	IN	O	of	_	0	SENT_198	[p9l232t2922r262b2948],
10	ROS1	NN	O	ros1	prep_of	8	SENT_198	[p9l271t2924r353b2948],
11	.	.	O	.	_	0	SENT_198	[p9l271t2924r353b2948],

1	ther	NN	O	ther	_	0	SENT_199	[p9l94t3043r161b3074],
2	nonmutated	JJ	O	nonmutated	amod	5	SENT_199	[p9l187t3043r390b3074],
3	or	CC	O	or	_	0	SENT_199	[p9l418t3053r452b3074],
4	G2032R	NN	O	g2032r	amod	5	SENT_199	[p9l478t3045r614b3076],
5	CD74-ROS1	NN	O	cd74-ros1	dep	1	SENT_199	[p9l637t3046r826b3074],
6	.	.	O	.	_	0	SENT_199	[p9l637t3046r826b3074],

1	The	DT	O	the	nsubjpass	6	SENT_200	[p9l854t3043r916b3074],
2	transfected	VBN	O	transfect	partmod	1	SENT_200	[p9l94t3092r280b3123],
3	cells	NNS	O	cell	dobj	2	SENT_200	[p9l297t3092r369b3123],
4	were	VBD	O	be	auxpass	6	SENT_200	[p9l384t3102r462b3123],
5	subsequently	RB	O	subsequently	advmod	6	SENT_200	[p9l479t3092r697b3132],
6	treated	VBN	O	treat	_	0	SENT_200	[p9l711t3092r827b3123],
7	with	IN	O	with	_	0	SENT_200	[p9l841t3092r916b3123],
8	increasing	VBG	O	increase	amod	9	SENT_200	[p9l93t3143r268b3181],
9	doses	NNS	O	dose	prep_with	6	SENT_200	[p9l288t3142r380b3173],
10	of	IN	O	of	_	0	SENT_200	[p9l402t3142r441b3173],
11	tyrosine	NN	O	tyrosine	nn	13	SENT_200	[p9l456t3143r590b3181],
12	kinase	NN	O	kinase	nn	13	SENT_200	[p9l611t3142r720b3173],
13	inhibitors	NNS	O	inhibitor	prep_of	9	SENT_200	[p9l741t3142r914b3173],
14	.	.	O	.	_	0	SENT_200	[p9l741t3142r914b3173],

1	Although	IN	O	although	mark	2	SENT_201	[p9l92t3191r250b3230],
2	crizotinib	NN	O	crizotinib	_	0	SENT_201	[p9l269t3191r432b3222],
3	and	CC	O	and	prep	2	SENT_201	[p9l451t3191r512b3222],
4	TAE684	NN	O	tae684	dep	3	SENT_201	[p9l529t3193r690b3222],
5	“	CD	NUMBER	“	num	4	SENT_201	[p9l529t3193r690b3222],
6	(	CD	NUMBER	(	num	7	SENT_201	[p9l710t3192r779b3230],
7	Fig	NN	O	fig	dep	4	SENT_201	[p9l710t3192r779b3230],
8	.	.	O	.	_	0	SENT_201	[p9l710t3192r779b3230],

1	3B	NN	O	3b	nn	2	SENT_202	[p9l800t3193r851b3226],
2	)	NN	O	)	nsubj	3	SENT_202	[p9l800t3193r851b3226],
3	inhibited	VBD	O	inhibit	_	0	SENT_202	[p9l871t3192r916b3221, p9l93t3240r207b3271],
4	the	DT	O	the	det	5	SENT_202	[p9l221t3240r272b3271],
5	phosphorylation	NN	O	phosphorylation	dobj	3	SENT_202	[p9l285t3240r554b3279],
6	of	IN	O	of	_	0	SENT_202	[p9l568t3240r607b3271],
7	nonmutant	JJ	O	nonmutant	amod	8	SENT_202	[p9l613t3247r798b3271],
8	CD74ROS1	NN	O	cd74ros1	prep_of	5	SENT_202	[p9l809t3242r918b3271, p9l93t3291r185b3322],
9	in	IN	O	in	_	0	SENT_202	[p9l207t3290r240b3320],
10	a	DT	O	a	det	12	SENT_202	[p9l261t3299r278b3320],
11	dose	NN	O	dose	nn	12	SENT_202	[p9l300t3289r571b3329],
12	—	NN	O	—	prep_in	3	SENT_202	[p9l300t3289r571b3329],
13	dependent	JJ	O	dependent	amod	12	SENT_202	[p9l300t3289r571b3329],
14	manner	NN	O	manner	tmod	13	SENT_202	[p9l591t3299r731b3327],
15	,	,	O	,	_	0	SENT_202	[p9l591t3299r731b3327],
16	with	IN	O	with	_	0	SENT_202	[p9l753t3289r830b3320],
17	IC50	NN	O	ic50	nn	19	SENT_202	[p9l851t3291r917b3331],
18	(	CD	NUMBER	(	num	19	SENT_202	[p9l95t3339r328b3374],
19	half	NN	O	half	prep_with	14	SENT_202	[p9l95t3339r328b3374],
20	—	CD	NUMBER	—	num	19	SENT_202	[p9l95t3339r328b3374],
21	maximal	JJ	O	maximal	amod	25	SENT_202	[p9l95t3339r328b3374],
22	inhibitory	JJ	O	inhibitory	amod	25	SENT_202	[p9l342t3339r506b3378],
23	concentration	NN	O	concentration	nn	25	SENT_202	[p9l519t3340r755b3374],
24	)	NN	O	)	nn	25	SENT_202	[p9l519t3340r755b3374],
25	values	NNS	O	value	tmod	3	SENT_202	[p9l770t3339r869b3370],
26	of	IN	O	of	_	0	SENT_202	[p9l885t3339r924b3370],
27	approximately	RB	O	approximately	quantmod	28	SENT_202	[p9l93t3388r332b3427],
28	30	CD	NUMBER	30	num	29	SENT_202	[p9l353t3390r391b3419],
29	nM	NN	O	nm	prep_of	25	SENT_202	[p9l414t3391r469b3418],
30	and	CC	O	and	_	0	SENT_202	[p9l491t3388r552b3419],
31	50	CD	NUMBER	50	num	32	SENT_202	[p9l575t3390r613b3419],
32	nM	NN	O	nm	prep_of	25	SENT_202	[p9l635t3391r700b3425],
33	,	,	O	,	_	0	SENT_202	[p9l635t3391r700b3425],
34	respectively	RB	O	respectively	advmod	25	SENT_202	[p9l724t3388r918b3427],
35	(	CD	NUMBER	(	num	36	SENT_202	[p9l95t3438r162b3477],
36	Fig	NN	O	fig	dep	25	SENT_202	[p9l95t3438r162b3477],
37	.	.	O	.	_	0	SENT_202	[p9l95t3438r162b3477],

1	S3	NN	O	s3	ccomp	10	SENT_203	[p9l176t3439r211b3468],
2	in	IN	O	in	_	0	SENT_203	[p9l223t3438r255b3468],
3	the	DT	O	the	det	6	SENT_203	[p9l267t3437r317b3468],
4	Supplementary	NNP	O	Supplementary	nn	6	SENT_203	[p9l329t3437r570b3477],
5	Appendix	NNP	O	Appendix	nn	6	SENT_203	[p9l578t3437r751b3477],
6	)	NNP	O	)	prep_in	1	SENT_203	[p9l578t3437r751b3477],
7	,	,	O	,	_	0	SENT_203	[p9l578t3437r751b3477],
8	they	PRP	O	they	nsubj	10	SENT_203	[p9l764t3437r833b3477],
9	were	VBD	O	be	cop	10	SENT_203	[p9l841t3447r917b3468],
10	ineffective	JJ	O	ineffective	_	0	SENT_203	[p9l956t3043r1125b3074],
11	against	IN	O	against	_	0	SENT_203	[p9l1138t3043r1258b3082],
12	the	DT	O	the	det	14	SENT_203	[p9l1270t3043r1321b3073],
13	G2032R	NN	O	g2032r	nn	14	SENT_203	[p9l1335t3045r1469b3075],
14	mutant	NN	O	mutant	prep_against	10	SENT_203	[p9l1478t3049r1605b3080],
15	,	,	O	,	_	0	SENT_203	[p9l1478t3049r1605b3080],
16	for	IN	O	for	_	0	SENT_203	[p9l1621t3043r1668b3074],
17	which	WDT	O	which	rel	24	SENT_203	[p9l1679t3043r1779b3074],
18	ICSO	NN	O	icso	nn	19	SENT_203	[p9l956t3094r1019b3134],
19	values	NNS	O	value	nsubj	24	SENT_203	[p9l1029t3092r1128b3123],
20	for	IN	O	for	_	0	SENT_203	[p9l1141t3092r1188b3123],
21	both	DT	O	both	det	22	SENT_203	[p9l1198t3092r1274b3123],
22	compounds	NNS	O	compound	prep_for	19	SENT_203	[p9l1286t3092r1477b3131],
23	were	VBD	O	be	cop	24	SENT_203	[p9l1488t3102r1565b3123],
24	greater	JJR	O	greater	rcmod	14	SENT_203	[p9l1576t3098r1692b3132],
25	than	IN	O	than	_	0	SENT_203	[p9l1703t3092r1779b3123],
26	1000	CD	DATE	1000	num	27	SENT_203	[p9l957t3144r1036b3173],
27	nM	NN	O	nm	prep_than	24	SENT_203	[p9l1047t3145r1112b3173],
28	.	.	O	.	_	0	SENT_203	[p9l1047t3145r1112b3173],

1	We	PRP	O	we	nsubj	4	SENT_204	[p9l1124t3145r1175b3172],
2	did	VBD	O	do	aux	4	SENT_204	[p9l1187t3142r1239b3173],
3	not	RB	O	not	neg	4	SENT_204	[p9l1250t3148r1306b3173],
4	observe	VB	O	observe	_	0	SENT_204	[p9l1315t3142r1441b3173],
5	activity	NN	O	activity	dobj	4	SENT_204	[p9l1451t3142r1572b3181],
6	of	IN	O	of	_	0	SENT_204	[p9l1581t3142r1620b3173],
7	the	DT	O	the	det	12	SENT_204	[p9l1624t3142r1676b3172],
8	selective	JJ	O	selective	amod	12	SENT_204	[p9l1687t3142r1779b3172, p9l956t3191r1014b3222],
9	ALI	NNP	O	ALI	nn	12	SENT_204	[p9l1034t3194r1109b3222],
10	(	NN	O	(	nn	12	SENT_204	[p9l1034t3194r1109b3222],
11	inhibitor	NN	O	inhibitor	nn	12	SENT_204	[p9l1129t3191r1277b3222],
12	CH54248O215	NN	O	ch54248o215	prep_of	5	SENT_204	[p9l1298t3193r1519b3222],
13	against	IN	O	against	_	0	SENT_204	[p9l1542t3191r1664b3230],
14	either	CC	O	either	preconj	16	SENT_204	[p9l1685t3191r1780b3221],
15	the	DT	O	the	dep	16	SENT_204	[p9l956t3240r1008b3270],
16	nonmutant	JJ	O	nonmutant	prep_against	12	SENT_204	[p9l1025t3246r1213b3271],
17	or	CC	O	or	_	0	SENT_204	[p9l1228t3250r1262b3271],
18	mutant	JJ	O	mutant	amod	19	SENT_204	[p9l1278t3246r1399b3271],
19	forms	NNS	O	form	prep_against	12	SENT_204	[p9l1414t3240r1512b3271],
20	of	IN	O	of	_	0	SENT_204	[p9l1530t3240r1569b3271],
21	CD74-ROS1	NN	O	cd74-ros1	nn	23	SENT_204	[p9l1578t3242r1779b3272],
22	(	CD	NUMBER	(	num	23	SENT_204	[p9l958t3289r1028b3329],
23	Fig	NN	O	fig	prep_of	5	SENT_204	[p9l958t3289r1028b3329],
24	.	.	O	.	_	0	SENT_204	[p9l958t3289r1028b3329],

1	S4	NN	O	s4	_	0	SENT_205	[p9l1044t3291r1083b3320],
2	in	IN	O	in	_	0	SENT_205	[p9l1095t3289r1128b3319],
3	the	DT	O	the	det	6	SENT_205	[p9l1141t3289r1193b3320],
4	Supplementary	NNP	O	Supplementary	nn	6	SENT_205	[p9l1207t3289r1458b3328],
5	Appendix	NNP	O	Appendix	nn	6	SENT_205	[p9l1468t3289r1649b3328],
6	)	NN	O	)	prep_in	1	SENT_205	[p9l1468t3289r1649b3328],
7	.	.	O	.	_	0	SENT_205	[p9l1468t3289r1649b3328],

1	In	FW	O	in	nn	2	SENT_206	[p9l1006t3342r1040b3369],
2	vitro	FW	O	vitro	amod	4	SENT_206	[p9l1051t3339r1126b3370],
3	enzymatic	JJ	O	enzymatic	amod	4	SENT_206	[p9l1140t3339r1308b3378],
4	assays	NNS	O	assay	nsubj	6	SENT_206	[p9l1321t3349r1422b3378],
5	also	RB	O	also	advmod	6	SENT_206	[p9l1435t3339r1500b3370],
6	showed	VBD	O	show	_	0	SENT_206	[p9l1514t3339r1638b3370],
7	that	IN	O	that	complm	11	SENT_206	[p9l1651t3339r1716b3369],
8	the	DT	O	the	det	10	SENT_206	[p9l1728t3339r1779b3369],
9	crizotinib	JJ	O	crizotinib	amod	10	SENT_206	[p9l956t3388r1120b3419],
10	concentration	NN	O	concentration	nsubj	11	SENT_206	[p9l1140t3388r1366b3419],
11	needed	VBN	O	need	ccomp	6	SENT_206	[p9l1385t3388r1501b3419],
12	to	TO	O	to	aux	13	SENT_206	[p9l1520t3394r1551b3419],
13	achieve	VB	O	achieve	xcomp	11	SENT_206	[p9l1570t3388r1689b3419],
14	50	CD	PERCENT	50	number	15	SENT_206	[p9l1709t3390r1780b3419],
15	%	NN	PERCENT	%	amod	17	SENT_206	[p9l1709t3390r1780b3419],
16	enzyme	NN	O	enzyme	nn	17	SENT_206	[p9l956t3447r1082b3476],
17	inhibition	NN	O	inhibition	dobj	13	SENT_206	[p9l1097t3437r1260b3468],
18	(	CD	NUMBER	(	num	19	SENT_206	[p9l1277t3440r1365b3478],
19	K	NN	O	k	dep	17	SENT_206	[p9l1277t3440r1365b3478],
20	,	,	O	,	_	0	SENT_206	[p9l1277t3440r1365b3478],
21	"	``	O	"	punct	17	SENT_206	[p9l1277t3440r1365b3478],
22	PP	NN	O	pp	nn	23	SENT_206	[p9l1277t3440r1365b3478],
23	)	NN	O	)	nsubjpass	25	SENT_206	[p9l1277t3440r1365b3478],
24	was	VBD	O	be	auxpass	25	SENT_206	[p9l1381t3447r1444b3468],
25	increased	VBN	O	increase	dep	17	SENT_206	[p9l1461t3437r1619b3468],
26	by	IN	O	by	_	0	SENT_206	[p9l1635t3437r1673b3476],
27	a	DT	O	a	det	28	SENT_206	[p9l1686t3447r1704b3468],
28	facNENGLJMED368	NN	O	facnengljmed368	agent	25	SENT_206	[p9l1719t3437r1779b3468, p9l622t3536r884b3564],
29	;	:	O	;	_	0	SENT_206	[p9l1719t3437r1779b3468, p9l622t3536r884b3564],
30	25	CD	NUMBER	25	dep	28	SENT_206	[p9l1719t3437r1779b3468, p9l622t3536r884b3564],

1	NEJM.ORG	NNP	O	NEJM.ORG	_	0	SENT_207	[p9l919t3542r1043b3564],
2	JUNE	NNP	DATE	JUNE	dep	1	SENT_207	[p9l1074t3542r1138b3564],
3	20	CD	DATE	20	num	2	SENT_207	[p9l1149t3542r1186b3562],
4	,	,	DATE	,	_	0	SENT_207	[p9l1149t3542r1186b3562],
5	2013	CD	DATE	2013	num	2	SENT_207	[p9l1197t3542r1253b3564],

1	The	DT	O	the	det	4	SENT_208	[p9l752t3599r803b3623],
2	New	NNP	O	New	nn	4	SENT_208	[p9l812t3600r874b3623],
3	England	NNP	O	England	nn	4	SENT_208	[p9l883t3599r994b3630],
4	Joumal	NNP	O	Joumal	nsubj	16	SENT_208	[p9l1003t3599r1100b3623],
5	of	IN	O	of	_	0	SENT_208	[p9l1110t3599r1139b3623],
6	Medicine	NNP	O	Medicine	nn	7	SENT_208	[p9l1145t3599r1270b3623],
7	tor	NN	O	tor	prep_of	4	SENT_208	[p10l12t284r136b346],
8	of	IN	O	of	_	0	SENT_208	[p10l196t266r296b346],
9	270	CD	NUMBER	270	prep_of	7	SENT_208	[p10l341t273r490b346],
10	for	IN	O	for	_	0	SENT_208	[p10l554t266r678b346],
11	the	DT	O	the	det	14	SENT_208	[p10l739t267r871b345],
12	G2032R	NN	O	g2032r	nn	14	SENT_208	[p10l935t273r1287b351],
13	mutant	JJ	O	mutant	amod	14	SENT_208	[p10l1340t284r1655b346],
14	kinase	NN	O	kinase	prep_for	9	SENT_208	[p10l1712t267r1992b346],
15	as	IN	O	as	advmod	16	SENT_208	[p10l2055t293r2140b345],
16	compared	VBN	O	compare	_	0	SENT_208	[p10l13t395r441b496],
17	with	IN	O	with	_	0	SENT_208	[p10l491t395r687b475],
18	nonmutant	JJ	O	nonmutant	amod	21	SENT_208	[p10l741t412r1227b475],
19	ROS1	NN	O	ros1	nn	21	SENT_208	[p10l1275t401r1510b479],
20	(	NN	O	(	nn	21	SENT_208	[p10l1570t402r1771b499],
21	Kfpp	NN	O	kfpp	prep_with	16	SENT_208	[p10l1570t402r1771b499],
22	570i29	CD	NUMBER	570i29	num	23	SENT_208	[p10l1828t401r2142b474],
23	nM	NN	O	nm	dobj	16	SENT_208	[p10l12t532r154b603],
24	vs.	CC	O	vs.	_	0	SENT_208	[p10l195t550r304b603],
25	K591	NN	O	k591	conj_vs.	23	SENT_208	[p10l352t532r526b628],
26	’	CD	NUMBER	’	number	27	SENT_208	[p10l352t532r526b628],
27	2.1	CD	NUMBER	2.1	num	28	SENT_208	[p10l570t530r880b603],
28	iO	NN	O	io	dep	25	SENT_208	[p10l570t530r880b603],
29	.1	CD	NUMBER	.1	num	30	SENT_208	[p10l570t530r880b603],
30	nM	NN	O	nm	dep	25	SENT_208	[p10l923t531r1092b615],
31	)	CD	NUMBER	)	number	32	SENT_208	[p10l923t531r1092b615],
32	(	CD	NUMBER	(	num	33	SENT_208	[p10l1144t525r1319b626],
33	Fig	NN	O	fig	dep	30	SENT_208	[p10l1144t525r1319b626],
34	.	.	O	.	_	0	SENT_208	[p10l1144t525r1319b626],

1	3C	NN	O	3c	_	0	SENT_209	[p10l1368t530r1529b615],
2	)	NN	O	)	dep	1	SENT_209	[p10l1368t530r1529b615],
3	.	.	O	.	_	0	SENT_209	[p10l1368t530r1529b615],

1	Furthermore	RB	O	furthermore	dep	6	SENT_210	[p10l1575t524r2137b620],
2	,	,	O	,	_	0	SENT_210	[p10l1575t524r2137b620],
3	the	DT	O	the	dep	6	SENT_210	[p10l12t653r143b731],
4	ATP	NN	ORGANIZATION	atp	nn	5	SENT_210	[p10l207t659r382b731],
5	concentration	NN	O	concentration	nsubj	6	SENT_210	[p10l447t654r1023b732],
6	needed	VBN	O	need	_	0	SENT_210	[p10l1087t653r1380b732],
7	to	TO	O	to	aux	8	SENT_210	[p10l1445t670r1524b732],
8	achieve	VB	O	achieve	xcomp	6	SENT_210	[p10l1589t653r1889b732],
9	halfmaximal	NN	O	halfmaximal	dobj	8	SENT_210	[p10l1953t652r2142b731, p10l12t781r384b859],

1	enzyme	NN	O	enzyme	nn	2	SENT_211	[p10l432t807r753b881],
2	velocity	NN	O	velocity	_	0	SENT_211	[p10l799t781r1113b881],
3	(	CD	NUMBER	(	num	5	SENT_211	[p10l1162t788r1416b885],
4	Kmapp	NN	O	kmapp	nn	5	SENT_211	[p10l1162t788r1416b885],
5	)	NN	O	)	nsubjpass	11	SENT_211	[p10l1162t788r1416b885],
6	for	IN	O	for	_	0	SENT_211	[p10l1470t780r1589b860],
7	the	DT	O	the	det	9	SENT_211	[p10l1635t781r1764b860],
8	G2032R	NN	O	g2032r	nn	9	SENT_211	[p10l1812t787r2153b865],
9	mutant	NN	O	mutant	prep_for	5	SENT_211	[p10l12t926r316b989],
10	was	VBD	O	be	auxpass	11	SENT_211	[p10l343t935r501b989],
11	reduced	VBN	O	reduce	rcmod	2	SENT_211	[p10l539t909r865b989],
12	by	IN	O	by	_	0	SENT_211	[p10l901t909r997b1009],
13	a	DT	O	a	det	14	SENT_211	[p10l1030t935r1074b987],
14	factor	NN	O	factor	agent	11	SENT_211	[p10l1111t908r1357b988],
15	of	IN	O	of	_	0	SENT_211	[p10l1393t908r1492b988],
16	3	CD	NUMBER	3	prep_of	14	SENT_211	[p10l1512t915r1556b988],
17	as	IN	O	as	_	0	SENT_211	[p10l1597t935r1682b987],
18	compared	VBN	O	compare	prepc_as	11	SENT_211	[p10l1723t909r2143b1009],
19	with	IN	O	with	pcomp	18	SENT_211	[p10l7t1038r200b1118],
20	that	DT	O	that	pobj	19	SENT_211	[p10l243t1038r413b1116],
21	for	IN	O	for	_	0	SENT_211	[p10l449t1037r571b1117],
22	nonmutant	JJ	O	nonmutant	amod	23	SENT_211	[p10l609t1055r1086b1118],
23	ROS1	NN	O	ros1	prep_for	20	SENT_211	[p10l1123t1044r1358b1122],
24	(	CD	NUMBER	(	dep	29	SENT_211	[p10l1407t1045r1643b1142],
25	I	PRP	O	I	dep	24	SENT_211	[p10l1407t1045r1643b1142],
26	<	JJR	O	<	amod	27	SENT_211	[p10l1407t1045r1643b1142],
27	maPP	NN	O	mapp	dep	29	SENT_211	[p10l1407t1045r1643b1142],
28	22	CD	NUMBER	22	num	29	SENT_211	[p10l1688t1044r1788b1116],
29	MM	NN	O	mm	dep	33	SENT_211	[p10l1833t1046r1986b1138],
30	vs.	IN	O	vs.	_	0	SENT_211	[p10l2027t1064r2137b1118],
31	I	PRP	O	I	prep_vs.	29	SENT_211	[p10l11t1175r221b1271],
32	<	JJR	O	<	amod	33	SENT_211	[p10l11t1175r221b1271],
33	maPP	NN	O	mapp	dep	34	SENT_211	[p10l11t1175r221b1271],
34	65	CD	NUMBER	65	dep	20	SENT_211	[p10l262t1173r357b1246],
35	;	:	O	;	_	0	SENT_211	[p10l401t1174r585b1267],
36	u.	CD	NUMBER	u.	num	37	SENT_211	[p10l401t1174r585b1267],
37	M	NN	O	m	dep	2	SENT_211	[p10l401t1174r585b1267],
38	)	CD	NUMBER	)	number	39	SENT_211	[p10l401t1174r585b1267],
39	(	CD	NUMBER	(	num	40	SENT_211	[p10l637t1168r817b1269],
40	Fig	NN	O	fig	dep	37	SENT_211	[p10l637t1168r817b1269],
41	.	.	O	.	_	0	SENT_211	[p10l637t1168r817b1269],

1	S5	NN	O	s5	_	0	SENT_212	[p10l867t1173r958b1246],
2	in	IN	O	in	_	0	SENT_212	[p10l1003t1168r1086b1245],
3	the	DT	O	the	det	7	SENT_212	[p10l1128t1167r1261b1245],
4	Supplementary	NNP	O	Supplementary	nn	7	SENT_212	[p10l1305t1167r1955b1268],
5	Appendix	NNP	O	Appendix	nn	7	SENT_212	[p10l1988t1175r2141b1268, p10l11t1296r331b1396],
6	)	CD	NUMBER	)	num	7	SENT_212	[p10l1988t1175r2141b1268, p10l11t1296r331b1396],
7	—	NN	O	—	nsubj	9	SENT_212	[p10l366t1341r474b1349],
8	perhaps	RB	O	perhaps	advmod	9	SENT_212	[p10l501t1296r843b1396],
9	contributing	VBG	O	contribute	prepc_in	1	SENT_212	[p10l878t1296r1422b1397],
10	to	TO	O	to	_	0	SENT_212	[p10l1452t1313r1533b1375],
11	the	DT	O	the	det	13	SENT_212	[p10l1568t1296r1701b1374],
12	increased	VBN	O	increase	amod	13	SENT_212	[p10l1733t1296r2144b1375],
13	activity	NN	O	activity	prep_to	9	SENT_212	[p10l11t1424r322b1523],
14	of	IN	O	of	_	0	SENT_212	[p10l364t1422r464b1502],
15	the	DT	O	the	det	17	SENT_212	[p10l491t1423r624b1501],
16	mutant	JJ	O	mutant	amod	17	SENT_212	[p10l669t1440r984b1503],
17	kinase	NN	O	kinase	prep_of	13	SENT_212	[p10l1024t1423r1327b1503],
18	.	.	O	.	_	0	SENT_212	[p10l1024t1423r1327b1503],

1	However	RB	O	however	_	0	SENT_213	[p10l1377t1431r1773b1519],
2	,	,	O	,	_	0	SENT_213	[p10l1377t1431r1773b1519],
3	in	IN	O	in	dep	1	SENT_213	[p10l1823t1424r1906b1501],
4	softagar	JJ	O	softagar	amod	5	SENT_213	[p10l1952t1422r2142b1502, p10l11t1578r200b1653],
5	assays	NNS	O	assay	pobj	3	SENT_213	[p10l232t1578r523b1652],
6	,	,	O	,	_	0	SENT_213	[p10l232t1578r523b1652],
7	the	DT	O	the	det	9	SENT_213	[p10l564t1552r697b1630],
8	transforming	VBG	O	transform	amod	9	SENT_213	[p10l732t1551r1322b1653],
9	capacities	NNS	O	capacity	appos	5	SENT_213	[p10l1356t1553r1783b1652],
10	of	IN	O	of	_	0	SENT_213	[p10l1823t1551r1924b1631],
11	nonmutant	JJ	O	nonmutant	amod	14	SENT_213	[p10l1943t1578r2141b1631, p10l12t1697r333b1759],
12	and	CC	O	and	_	0	SENT_213	[p10l389t1680r550b1759],
13	mutant	JJ	O	mutant	amod	14	SENT_213	[p10l613t1697r933b1759],
14	CD74	NN	O	cd74	prep_of	9	SENT_213	[p10l991t1686r1516b1763],
15	.	.	O	.	_	0	SENT_213	[p10l991t1686r1516b1763],

1	—	NN	O	—	_	0	SENT_214	[p10l991t1686r1516b1763],
2	.	.	O	.	_	0	SENT_214	[p10l991t1686r1516b1763],

1	ROS1	NN	O	ros1	nsubj	5	SENT_215	[p10l991t1686r1516b1763],
2	were	VBD	O	be	cop	5	SENT_215	[p10l1574t1706r1776b1759],
3	similar	JJ	O	similar	amod	5	SENT_215	[p10l1839t1680r2146b1758],
4	(	CD	NUMBER	(	tmod	3	SENT_215	[p10l17t1809r197b1909],
5	Fig	NN	O	fig	_	0	SENT_215	[p10l17t1809r197b1909],
6	.	.	O	.	_	0	SENT_215	[p10l17t1809r197b1909],

1	S6	NN	O	s6	_	0	SENT_216	[p10l245t1814r341b1887],
2	in	IN	O	in	_	0	SENT_216	[p10l381t1809r465b1886],
3	the	DT	O	the	det	6	SENT_216	[p10l505t1808r638b1886],
4	Supplementary	NNP	O	Supplementary	nn	6	SENT_216	[p10l680t1808r1329b1908],
5	Appendix	NNP	O	Appendix	nn	6	SENT_216	[p10l1361t1808r1828b1908],
6	)	NN	O	)	prep_in	1	SENT_216	[p10l1361t1808r1828b1908],
7	.	.	O	.	_	0	SENT_216	[p10l1361t1808r1828b1908],

1	To	TO	O	to	aux	2	SENT_217	[p10l138t1942r244b2015],
2	elucidate	VB	O	elucidate	csubj	9	SENT_217	[p10l289t1936r677b2015],
3	the	DT	O	the	det	5	SENT_217	[p10l720t1936r855b2014],
4	molecular	JJ	O	molecular	amod	5	SENT_217	[p10l898t1936r1341b2015],
5	basis	NN	O	basis	dobj	2	SENT_217	[p10l1381t1936r1597b2015],
6	of	IN	O	of	_	0	SENT_217	[p10l1643t1935r1744b2015],
7	G2032R	NN	O	g2032r	nn	8	SENT_217	[p10l1767t1942r2141b2020],
8	—	NN	O	—	prep_of	5	SENT_217	[p10l1767t1942r2141b2020],
9	mediated	VBD	O	mediate	ccomp	13	SENT_217	[p10l12t2064r419b2143],
10	resistance	NN	O	resistance	dobj	9	SENT_217	[p10l460t2065r924b2160],
11	,	,	O	,	_	0	SENT_217	[p10l460t2065r924b2160],
12	we	PRP	O	we	nsubj	13	SENT_217	[p10l967t2090r1086b2144],
13	determined	VBD	O	determine	_	0	SENT_217	[p10l1128t2064r1634b2143],
14	the	DT	O	the	det	16	SENT_217	[p10l1675t2064r1810b2142],
15	crystal	NN	O	crystal	nn	16	SENT_217	[p10l1852t2064r2143b2164],
16	structure	NN	O	structure	dobj	13	SENT_217	[p10l14t2209r387b2272],
17	of	IN	O	of	_	0	SENT_217	[p10l430t2191r528b2271],
18	the	DT	O	the	prep_of	16	SENT_217	[p10l552t2192r681b2270],
19	phosphorylated	VBN	O	phosphorylate	partmod	18	SENT_217	[p10l722t2192r1367b2292],
20	nonmutant	JJ	O	nonmutant	amod	23	SENT_217	[p10l1410t2209r1878b2272],
21	ROS1	NN	O	ros1	nn	23	SENT_217	[p10l1914t2198r2143b2276],
22	kinase	NN	O	kinase	nn	23	SENT_217	[p10l12t2321r283b2400],
23	domain	NN	O	domain	nsubj	24	SENT_217	[p10l321t2321r644b2400],
24	bound	VBD	O	bind	ccomp	19	SENT_217	[p10l681t2321r949b2400],
25	to	TO	O	to	_	0	SENT_217	[p10l986t2338r1066b2400],
26	crizotinib	JJ	O	crizotinib	amod	28	SENT_217	[p10l1104t2321r1512b2400],
27	(	NN	O	(	nn	28	SENT_217	[p10l1555t2322r1728b2422],
28	Fig	NN	O	fig	prep_to	24	SENT_217	[p10l1555t2322r1728b2422],
29	.	.	O	.	_	0	SENT_217	[p10l1555t2322r1728b2422],

1	3D	NN	O	3d	nsubj	3	SENT_218	[p10l1771t2327r1905b2417],
2	,	,	O	,	_	0	SENT_218	[p10l1771t2327r1905b2417],
3	left	VBD	O	leave	_	0	SENT_218	[p10l1946t2320r2138b2412],
4	)	CD	NUMBER	)	dobj	3	SENT_218	[p10l1946t2320r2138b2412],
5	.	.	O	.	_	0	SENT_218	[p10l1946t2320r2138b2412],

1	Like	IN	O	like	_	0	SENT_219	[p10l11t2449r191b2529],
2	ALK	NNP	O	ALK	pobj	1	SENT_219	[p10l228t2457r419b2530],
3	and	CC	O	and	_	0	SENT_219	[p10l455t2449r612b2528],
4	c	NN	O	c	conj_and	2	SENT_219	[p10l650t2455r926b2527],
5	.	.	O	.	_	0	SENT_219	[p10l650t2455r926b2527],

1	—	NN	O	—	_	0	SENT_220	[p10l650t2455r926b2527],
2	.	.	O	.	_	0	SENT_220	[p10l650t2455r926b2527],

1	MET	NN	O	met	nn	2	SENT_221	[p10l650t2455r926b2527],
2	(	NN	O	(	nsubj	4	SENT_221	[p10l965t2449r1157b2540],
3	also	RB	O	also	advmod	4	SENT_221	[p10l965t2449r1157b2540],
4	known	VBN	O	know	partmod	15	SENT_221	[p10l1196t2449r1491b2529],
5	as	IN	O	as	_	0	SENT_221	[p10l1528t2475r1613b2527],
6	the	DT	O	the	det	12	SENT_221	[p10l1653t2449r1784b2527],
7	hepatocyte	NN	O	hepatocyte	nn	12	SENT_221	[p10l1822t2449r2141b2549, p10l13t2595r178b2678],
8	growth	NN	O	growth	nn	12	SENT_221	[p10l232t2577r821b2679],
9	—	NN	O	—	nn	12	SENT_221	[p10l232t2577r821b2679],
10	factor	NN	O	factor	nn	12	SENT_221	[p10l232t2577r821b2679],
11	receptor	NN	O	receptor	nn	12	SENT_221	[p10l872t2585r1267b2678],
12	)	NN	O	)	prep_as	4	SENT_221	[p10l872t2585r1267b2678],
13	,	,	O	,	_	0	SENT_221	[p10l872t2585r1267b2678],
14	ROS1	NN	O	ros1	nsubj	15	SENT_221	[p10l1325t2584r1556b2661],
15	binds	VBZ	O	bind	_	0	SENT_221	[p10l1612t2578r1841b2657],
16	crizotinib	NN	O	crizotinib	nsubj	64	SENT_221	[p10l1898t2579r2141b2657, p10l12t2706r211b2785],
17	at	IN	O	at	_	0	SENT_221	[p10l245t2723r323b2784],
18	the	DT	O	the	det	22	SENT_221	[p10l353t2706r484b2784],
19	ATP	NN	O	atp	nn	22	SENT_221	[p10l515t2706r1061b2807],
20	—	NN	O	—	nn	22	SENT_221	[p10l515t2706r1061b2807],
21	binding	VBG	O	bind	amod	22	SENT_221	[p10l515t2706r1061b2807],
22	site	NN	O	site	prep_at	16	SENT_221	[p10l1096t2707r1239b2785],
23	in	IN	O	in	_	0	SENT_221	[p10l1275t2707r1358b2784],
24	the	DT	O	the	det	25	SENT_221	[p10l1394t2706r1528b2784],
25	cleft	NN	O	cleft	prep_in	46	SENT_221	[p10l1565t2705r1753b2785],
26	between	IN	O	between	_	0	SENT_221	[p10l1784t2706r2143b2785],
27	the	DT	O	the	det	28	SENT_221	[p10l12t2834r146b2912],
28	N	NN	O	n	prep_between	25	SENT_221	[p10l194t2834r676b2913],
29	—	JJ	O	—	amod	35	SENT_221	[p10l194t2834r676b2913],
30	terminal	JJ	O	terminal	dep	33	SENT_221	[p10l194t2834r676b2913],
31	and	CC	O	and	_	0	SENT_221	[p10l724t2834r883b2913],
32	C	NN	O	c	conj_and	33	SENT_221	[p10l932t2834r1403b2913],
33	—	JJ	O	—	amod	35	SENT_221	[p10l932t2834r1403b2913],
34	terminal	JJ	O	terminal	amod	35	SENT_221	[p10l932t2834r1403b2913],
35	domains	NNS	O	domain	dep	42	SENT_221	[p10l1452t2834r1826b2913],
36	of	IN	O	of	_	0	SENT_221	[p10l1878t2833r1978b2913],
37	the	DT	O	the	det	38	SENT_221	[p10l2009t2834r2143b2912],
38	l	NN	O	l	prep_of	35	SENT_221	[p10l12t2963r394b3042],
39	<	JJR	O	<	amod	38	SENT_221	[p10l12t2963r394b3042],
40	inase	CD	NUMBER	inase	num	41	SENT_221	[p10l12t2963r394b3042],
41	.2	NN	NUMBER	.2	dep	42	SENT_221	[p10l12t2963r394b3042],
42	°	CD	NUMBER	°	dep	25	SENT_221	[p10l12t2963r394b3042],
43	The	DT	O	the	det	45	SENT_221	[p10l442t2963r603b3041],
44	G2032	NN	MISC	g2032	nn	45	SENT_221	[p10l656t2969r928b3042],
45	residue	NN	O	residue	dep	42	SENT_221	[p10l982t2963r1287b3042],
46	sits	VBZ	O	sit	ccomp	15	SENT_221	[p10l1341t2964r1480b3041],
47	at	IN	O	at	_	0	SENT_221	[p10l1534t2980r1613b3041],
48	the	DT	O	the	det	50	SENT_221	[p10l1660t2963r1793b3042],
49	solvent	JJ	O	solvent	amod	50	SENT_221	[p10l1846t2963r2148b3042],
50	front	NN	O	front	prep_at	46	SENT_221	[p10l12t3090r229b3170],
51	in	IN	O	in	_	0	SENT_221	[p10l276t3092r360b3169],
52	the	DT	O	the	det	54	SENT_221	[p10l414t3091r546b3169],
53	distal	JJ	O	distal	amod	54	SENT_221	[p10l600t3091r835b3170],
54	end	NN	O	end	prep_in	50	SENT_221	[p10l884t3091r1033b3170],
55	of	IN	O	of	_	0	SENT_221	[p10l1082t3090r1181b3170],
56	the	DT	O	the	det	58	SENT_221	[p10l1211t3091r1340b3169],
57	kinase	NN	O	kinase	nn	58	SENT_221	[p10l1389t3091r1658b3170],
58	hinge	NN	O	hinge	prep_of	54	SENT_221	[p10l1707t3091r1941b3192],
59	and	CC	O	and	_	0	SENT_221	[p10l1989t3091r2143b3170],
60	creates	VBZ	O	create	conj_and	46	SENT_221	[p10l13t3236r295b3298],
61	a	DT	O	a	det	62	SENT_221	[p10l331t3245r375b3297],
62	turn	NN	O	turn	dobj	60	SENT_221	[p10l409t3236r608b3315],
63	,	,	O	,	_	0	SENT_221	[p10l409t3236r608b3315],
64	putting	VBG	O	put	conj_and	46	SENT_221	[p10l646t3220r958b3320],
65	the	DT	O	the	det	68	SENT_221	[p10l991t3219r1122b3297],
66	G2032	NN	MISC	g2032	nn	68	SENT_221	[p10l1159t3225r1428b3298],
67	alpha	NN	O	alpha	nn	68	SENT_221	[p10l1465t3219r1697b3319],
68	carbon	NN	O	carbon	dobj	64	SENT_221	[p10l1732t3219r2025b3298],
69	in	IN	O	in	_	0	SENT_221	[p10l2060t3220r2143b3297],
70	position	NN	O	position	prep_in	64	SENT_221	[p10l11t3348r357b3447],
71	to	TO	O	to	aux	72	SENT_221	[p10l391t3364r471b3426],
72	engage	VB	O	engage	xcomp	64	SENT_221	[p10l507t3373r802b3448],
73	in	IN	O	in	_	0	SENT_221	[p10l836t3348r919b3425],
74	a	DT	O	a	det	75	SENT_221	[p10l954t3373r998b3425],
75	van	NN	O	van	prep_in	72	SENT_221	[p10l1028t3373r1178b3426],
76	der	FW	O	der	nn	78	SENT_221	[p10l1214t3347r1350b3426],
77	Waals	FW	O	waals	nn	78	SENT_221	[p10l1378t3347r1636b3425],
78	interaction	NN	O	interaction	dobj	72	SENT_221	[p10l1673t3348r2143b3426],
79	with	IN	O	with	_	0	SENT_221	[p10l7t3475r204b3554],
80	the	DT	O	the	det	82	SENT_221	[p10l240t3475r373b3553],
81	pyrazole	NN	O	pyrazole	nn	82	SENT_221	[p10l407t3475r772b3575],
82	ring	NN	O	ring	prep_with	78	SENT_221	[p10l807t3476r987b3576],
83	of	IN	O	of	_	0	SENT_221	[p10l1020t3474r1120b3554],
84	crizotinib	NN	O	crizotinib	prep_of	82	SENT_221	[p10l1138t3475r1582b3554],
85	.	.	O	.	_	0	SENT_221	[p10l1138t3475r1582b3554],

1	An	DT	O	a	det	2	SENT_222	[p10l1619t3483r1744b3553],
2	arginine	NN	O	arginine	nsubjpass	8	SENT_222	[p10l1779t3476r2143b3576],
3	at	IN	O	at	_	0	SENT_222	[p10l11t3620r90b3681],
4	position	NN	O	position	prep_at	2	SENT_222	[p10l123t3604r477b3703],
5	2032	CD	DATE	2032	num	4	SENT_222	[p10l516t3609r716b3682],
6	has	VBZ	O	have	aux	8	SENT_222	[p10l756t3603r896b3681],
7	been	VBN	O	be	auxpass	8	SENT_222	[p10l933t3603r1129b3682],
8	modeled	VBN	O	model	_	0	SENT_222	[p10l1163t3603r1520b3682],
9	into	IN	O	into	_	0	SENT_222	[p10l1553t3604r1717b3682],
10	an	DT	O	a	det	11	SENT_222	[p10l1752t3629r1853b3681],
11	empty	JJ	O	empty	prep_into	8	SENT_222	[p10l1889t3620r2148b3703],

1	ROS1	NN	O	ros1	nn	6	SENT_223	[p11l11t27r239b104],
2	ATP	NN	O	atp	nn	6	SENT_223	[p11l271t21r863b100],
3	—	NN	O	—	nn	6	SENT_223	[p11l271t21r863b100],
4	inhibitor	NN	O	inhibitor	nn	6	SENT_223	[p11l271t21r863b100],
5	binding	NN	O	binding	nn	6	SENT_223	[p11l898t21r1237b122],
6	site	NN	O	site	_	0	SENT_223	[p11l1275t22r1418b100],
7	(	CD	NUMBER	(	num	8	SENT_223	[p11l1463t22r1643b122],
8	Fig	NN	O	fig	dep	6	SENT_223	[p11l1463t22r1643b122],
9	.	.	O	.	_	0	SENT_223	[p11l1463t22r1643b122],

1	3D	NN	O	3d	nn	2	SENT_224	[p11l1690t27r1832b112],
2	)	NN	O	)	nsubjpass	5	SENT_224	[p11l1690t27r1832b112],
3	and	CC	O	and	advmod	5	SENT_224	[p11l1877t21r2036b100],
4	is	VBZ	O	be	auxpass	5	SENT_224	[p11l2075t22r2140b99],
5	believed	VBN	O	believe	_	0	SENT_224	[p11l13t149r362b228],
6	to	TO	O	to	aux	8	SENT_224	[p11l417t166r498b228],
7	sterically	RB	O	sterically	advmod	8	SENT_224	[p11l556t149r945b249],
8	clash	VB	O	clash	xcomp	5	SENT_224	[p11l996t149r1214b227],
9	with	IN	O	with	_	0	SENT_224	[p11l1265t149r1460b229],
10	the	DT	O	the	det	12	SENT_224	[p11l1516t149r1649b227],
11	piperidine	NN	O	piperidine	nn	12	SENT_224	[p11l1702t149r2143b249],
12	ring	NN	O	ring	prep_with	8	SENT_224	[p11l12t279r191b379],
13	of	IN	O	of	_	0	SENT_224	[p11l248t277r348b357],
14	crizotinib	NN	O	crizotinib	prep_of	12	SENT_224	[p11l389t278r811b357],
15	while	IN	O	while	mark	17	SENT_224	[p11l867t278r1099b357],
16	still	RB	O	still	advmod	17	SENT_224	[p11l1158t278r1315b356],
17	allowing	VBG	O	allow	advcl	8	SENT_224	[p11l1372t278r1744b379],
18	for	IN	O	for	_	0	SENT_224	[p11l1797t277r1919b357],
19	ATP	NN	O	atp	nn	20	SENT_224	[p11l1969t284r2144b356],
20	binding	NN	O	binding	prep_for	17	SENT_224	[p11l13t406r344b507],
21	(	CD	NUMBER	(	num	22	SENT_224	[p11l377t407r553b507],
22	Fig	NN	O	fig	dep	20	SENT_224	[p11l377t407r553b507],
23	.	.	O	.	_	0	SENT_224	[p11l377t407r553b507],

1	S7	NN	O	s7	_	0	SENT_225	[p11l591t412r686b485],
2	in	IN	O	in	_	0	SENT_225	[p11l717t407r800b484],
3	the	DT	O	the	det	6	SENT_225	[p11l831t406r962b484],
4	Supplementary	NNP	O	Supplementary	nn	6	SENT_225	[p11l996t406r1645b506],
5	Appendix	NNP	O	Appendix	nn	6	SENT_225	[p11l1670t406r2138b506],
6	)	NN	O	)	prep_in	1	SENT_225	[p11l1670t406r2138b506],
7	.	.	O	.	_	0	SENT_225	[p11l1670t406r2138b506],

1	These	DT	O	these	det	2	SENT_226	[p11l8t534r261b612],
2	data	NNS	O	datum	nsubj	3	SENT_226	[p11l305t534r488b613],
3	provide	VBP	O	provide	_	0	SENT_226	[p11l528t534r848b634],
4	a	DT	O	a	det	8	SENT_226	[p11l890t560r935b612],
5	biochemical	JJ	O	biochemical	amod	8	SENT_226	[p11l977t534r1490b613],
6	and	CC	O	and	_	0	SENT_226	[p11l1530t534r1687b613],
7	structural	JJ	O	structural	amod	8	SENT_226	[p11l1728t534r2143b613],
8	basis	NN	O	basis	nsubj	14	SENT_226	[p11l13t662r221b741],
9	for	IN	O	for	_	0	SENT_226	[p11l255t661r376b741],
10	the	DT	O	the	det	11	SENT_226	[p11l406t662r537b740],
11	resistance	NN	O	resistance	prep_for	8	SENT_226	[p11l569t663r990b740],
12	to	TO	O	to	_	0	SENT_226	[p11l1024t679r1105b741],
13	crizotinib	NN	O	crizotinib	prep_to	11	SENT_226	[p11l1142t662r1564b741],
14	conferred	VBD	O	confer	ccomp	3	SENT_226	[p11l1600t661r2015b741],
15	by	IN	O	by	_	0	SENT_226	[p11l2050t662r2148b762],
16	the	DT	O	the	det	18	SENT_226	[p11l12t791r146b869],
17	G2032R	NN	O	g2032r	nn	18	SENT_226	[p11l186t797r538b874],
18	mutation	NN	O	mutation	prep_by	14	SENT_226	[p11l567t792r984b870],
19	.	.	O	.	_	0	SENT_226	[p11l567t792r984b870],

1	DISCUSSION	NN	O	discussion	_	0	SENT_227	[p11l737t1088r1418b1148],

1	In	IN	O	in	_	0	SENT_228	[p11l11t1366r100b1436],
2	this	DT	O	this	det	3	SENT_228	[p11l134t1358r294b1436],
3	study	NN	O	study	prep_in	6	SENT_228	[p11l331t1358r574b1458],
4	,	,	O	,	_	0	SENT_228	[p11l331t1358r574b1458],
5	we	PRP	O	we	nsubj	6	SENT_228	[p11l608t1384r726b1438],
6	report	VBP	O	report	_	0	SENT_228	[p11l760t1375r1028b1458],
7	an	DT	O	a	det	9	SENT_228	[p11l1055t1384r1158b1436],
8	acquired	VBN	O	acquire	amod	9	SENT_228	[p11l1191t1358r1562b1458],
9	mutation	NN	O	mutation	dobj	6	SENT_228	[p11l1595t1359r1989b1438],
10	for	IN	O	for	_	0	SENT_228	[p11l2022t1357r2146b1437],
11	crizotinib	JJ	O	crizotinib	amod	12	SENT_228	[p11l13t1487r435b1566],
12	resistance	NN	O	resistance	prep_for	6	SENT_228	[p11l469t1488r900b1565],
13	in	IN	O	in	_	0	SENT_228	[p11l933t1488r1016b1565],
14	a	DT	O	a	det	15	SENT_228	[p11l1049t1513r1094b1565],
15	cancer	NN	O	cancer	prep_in	12	SENT_228	[p11l1126t1513r1408b1565],
16	driven	VBN	O	drive	partmod	15	SENT_228	[p11l1439t1487r1706b1566],
17	by	IN	O	by	_	0	SENT_228	[p11l1740t1487r1837b1587],
18	an	DT	O	a	det	21	SENT_228	[p11l1866t1513r1969b1565],
19	oncogenic	JJ	O	oncogenic	amod	21	SENT_228	[p11l2004t1513r2142b1566, p11l13t1617r343b1717],
20	ROS1	NN	O	ros1	nn	21	SENT_228	[p11l376t1623r582b1696],
21	fusion	NN	O	fusion	agent	16	SENT_228	[p11l622t1615r916b1695],
22	.	.	O	.	_	0	SENT_228	[p11l622t1615r916b1695],

1	We	PRP	O	we	nsubj	3	SENT_229	[p11l955t1624r1089b1695],
2	also	RB	O	also	advmod	3	SENT_229	[p11l1125t1616r1297b1695],
3	present	VBP	DATE	present	_	0	SENT_229	[p11l1334t1633r1655b1716],
4	the	DT	O	the	det	6	SENT_229	[p11l1687t1616r1820b1694],
5	crystal	NN	O	crystal	nn	6	SENT_229	[p11l1859t1616r2143b1716],
6	structure	NN	O	structure	nsubj	9	SENT_229	[p11l14t1761r404b1823],
7	of	IN	O	of	_	0	SENT_229	[p11l437t1743r537b1823],
8	crizotinib	NN	O	crizotinib	prep_of	6	SENT_229	[p11l552t1744r974b1823],
9	bound	VBD	O	bind	ccomp	3	SENT_229	[p11l1008t1744r1283b1823],
10	to	TO	O	to	_	0	SENT_229	[p11l1315t1761r1397b1823],
11	the	DT	O	the	det	14	SENT_229	[p11l1431t1744r1565b1822],
12	ROS1	NN	O	ros1	nn	14	SENT_229	[p11l1596t1750r1831b1828],
13	kinase	NN	O	kinase	nn	14	SENT_229	[p11l1863t1744r2143b1823],
14	domain	NN	O	domain	prep_to	9	SENT_229	[p11l13t1872r367b1951],
15	.	.	O	.	_	0	SENT_229	[p11l13t1872r367b1951],

1	Unlike	IN	O	unlike	_	0	SENT_230	[p11l406t1872r691b1951],
2	the	DT	O	the	det	5	SENT_230	[p11l726t1872r858b1950],
3	classic	JJ	O	classic	amod	5	SENT_230	[p11l893t1872r1172b1950],
4	gatekeeper	NN	O	gatekeeper	nn	5	SENT_230	[p11l1205t1872r1674b1973],
5	mutations	NNS	O	mutation	pobj	1	SENT_230	[p11l1705t1873r2140b1951],
6	for	IN	O	for	_	0	SENT_230	[p11l12t1999r136b2079],
7	drug	NN	O	drug	nn	8	SENT_230	[p11l179t2000r383b2101],
8	resistance	NN	O	resistance	prep_for	5	SENT_230	[p11l425t2001r855b2079],
9	that	WDT	O	that	nsubjpass	12	SENT_230	[p11l901t2000r1073b2078],
10	have	VBP	O	have	aux	12	SENT_230	[p11l1113t2000r1304b2079],
11	been	VBN	O	be	auxpass	12	SENT_230	[p11l1350t2000r1552b2079],
12	identified	VBN	O	identify	rcmod	5	SENT_230	[p11l1596t1999r2015b2079],
13	in	IN	O	in	_	0	SENT_230	[p11l2060t2001r2143b2078],
14	ABL	NNP	O	ABL	nn	16	SENT_230	[p11l6t2133r269b2224],
15	,21	CD	NUMBER	,21	num	16	SENT_230	[p11l6t2133r269b2224],
16	EGFR	NN	ORGANIZATION	egfr	prep_in	12	SENT_230	[p11l297t2134r609b2224],
17	,	,	O	,	_	0	SENT_230	[p11l297t2134r609b2224],
18	”	NN	O	”	conj_and	16	SENT_230	[p11l297t2134r609b2224],
19	and	CC	O	and	_	0	SENT_230	[p11l639t2128r797b2207],
20	ALK	NN	O	alk	conj_and	16	SENT_230	[p11l820t2133r1090b2224],
21	,	,	O	,	_	0	SENT_230	[p11l820t2133r1090b2224],
22	“	IN	O	“	_	0	SENT_230	[p11l820t2133r1090b2224],
23	the	DT	O	the	det	26	SENT_230	[p11l1120t2128r1253b2207],
24	G2032R	NN	O	g2032r	nn	26	SENT_230	[p11l1283t2134r1635b2211],
25	ROS1	NN	O	ros1	nn	26	SENT_230	[p11l1653t2134r1858b2208],
26	mutation	NN	O	mutation	prep_“	28	SENT_230	[p11l1891t2145r2141b2207, p11l12t2258r182b2336],
27	is	VBZ	O	be	cop	28	SENT_230	[p11l222t2258r288b2335],
28	located	JJ	O	located	dep	1	SENT_230	[p11l330t2257r639b2336],
29	in	IN	O	in	_	0	SENT_230	[p11l679t2258r762b2335],
30	the	DT	O	the	det	32	SENT_230	[p11l803t2257r936b2335],
31	solvent	JJ	O	solvent	amod	32	SENT_230	[p11l978t2257r1280b2336],
32	front	NN	O	front	prep_in	28	SENT_230	[p11l1315t2256r1532b2336],
33	of	IN	O	of	_	0	SENT_230	[p11l1568t2256r1668b2336],
34	the	DT	O	the	det	36	SENT_230	[p11l1690t2257r1823b2335],
35	kinase	NN	O	kinase	nn	36	SENT_230	[p11l1863t2257r2143b2336],
36	domain	NN	O	domain	prep_of	32	SENT_230	[p11l13t2385r349b2464],
37	and	CC	O	and	_	0	SENT_230	[p11l403t2385r564b2464],
38	is	VBZ	O	be	cop	39	SENT_230	[p11l617t2386r684b2463],
39	analogous	JJ	O	analogous	conj_and	28	SENT_230	[p11l740t2385r1192b2486],
40	to	TO	O	to	_	0	SENT_230	[p11l1249t2402r1332b2464],
41	the	DT	O	the	det	44	SENT_230	[p11l1388t2385r1523b2464],
42	G1202R	NN	O	g1202r	nn	44	SENT_230	[p11l1578t2391r1937b2468],
43	ALK	NN	O	alk	nn	44	SENT_230	[p11l1974t2391r2152b2463],
44	mutation	NN	O	mutation	prep_to	39	SENT_230	[p11l12t2514r409b2592],
45	identified	VBN	O	identify	partmod	44	SENT_230	[p11l461t2512r880b2592],
46	in	IN	O	in	_	0	SENT_230	[p11l933t2514r1016b2591],
47	crizotinib	JJ	O	crizotinib	amod	48	SENT_230	[p11l1070t2513r1906b2592],
48	—	NN	O	—	prep_in	45	SENT_230	[p11l1070t2513r1906b2592],
49	resistant	JJ	O	resistant	amod	50	SENT_230	[p11l1070t2513r1906b2592],
50	ALKrearranged	NN	O	alkrearranged	dobj	28	SENT_230	[p11l1947t2519r2142b2591, p11l12t2641r486b2742],

1	lung	NN	O	lung	nn	2	SENT_231	[p11l519t2641r713b2742],
2	cancers15	NN	O	cancers15	_	0	SENT_231	[p11l745t2646r1140b2719],
3	(	CD	NUMBER	(	num	4	SENT_231	[p11l1182t2642r1362b2742],
4	Fig	NN	O	fig	dep	2	SENT_231	[p11l1182t2642r1362b2742],
5	.	.	O	.	_	0	SENT_231	[p11l1182t2642r1362b2742],

1	S8	NN	O	s8	_	0	SENT_232	[p11l1404t2647r1501b2720],
2	in	IN	O	in	_	0	SENT_232	[p11l1536t2642r1620b2719],
3	the	DT	O	the	det	6	SENT_232	[p11l1655t2641r1788b2719],
4	Supplementary	NNP	O	Supplementary	nn	6	SENT_232	[p11l1825t2641r2141b2741, p11l12t2786r374b2869],
5	Appendix	NNP	O	Appendix	nn	6	SENT_232	[p11l419t2769r887b2869],
6	)	NN	O	)	prep_in	1	SENT_232	[p11l419t2769r887b2869],
7	.	.	O	.	_	0	SENT_232	[p11l419t2769r887b2869],

1	Whereas	IN	O	whereas	mark	10	SENT_233	[p11l942t2769r1317b2847],
2	the	DT	O	the	det	6	SENT_233	[p11l1373t2769r1506b2847],
3	L1196M	NN	O	l1196m	nn	6	SENT_233	[p11l1558t2775r1903b2848],
4	ALK	NN	O	alk	nn	6	SENT_233	[p11l1955t2777r2147b2850],
5	gatekeeper	NN	O	gatekeeper	nn	6	SENT_233	[p11l12t2898r481b2999],
6	mutant	NN	O	mutant	nsubj	10	SENT_233	[p11l508t2915r823b2977],
7	may	MD	O	may	aux	10	SENT_233	[p11l848t2924r1028b2998],
8	still	RB	O	still	advmod	10	SENT_233	[p11l1055t2898r1217b2976],
9	be	VB	O	be	cop	10	SENT_233	[p11l1247t2898r1344b2977],
10	sensitive	JJ	O	sensitive	advcl	22	SENT_233	[p11l1376t2899r1740b2977],
11	to	TO	O	to	_	0	SENT_233	[p11l1771t2915r1853b2977],
12	newer	JJR	O	newer	amod	14	SENT_233	[p11l1885t2924r2145b2977],
13	ALK	NN	O	alk	nn	14	SENT_233	[p11l8t3034r201b3107],
14	inhibitors	NNS	O	inhibitor	prep_to	10	SENT_233	[p11l238t3026r688b3122],
15	,	,	O	,	_	0	SENT_233	[p11l238t3026r688b3122],
16	such	JJ	O	such	_	0	SENT_233	[p11l736t3026r932b3105],
17	as	IN	O	as	_	0	SENT_233	[p11l973t3052r1059b3104],
18	CH54248O2	NN	O	ch54248o2	prep_such_as	14	SENT_233	[p11l1103t3031r1704b3122],
19	,18	CD	NUMBER	,18	num	18	SENT_233	[p11l1103t3031r1704b3122],
20	We	PRP	O	we	nsubj	22	SENT_233	[p11l1743t3052r1861b3106],
21	previously	RB	DATE	previously	advmod	22	SENT_233	[p11l1902t3027r2147b3126, p11l12t3155r237b3256],
22	found	VBD	O	find	_	0	SENT_233	[p11l269t3154r524b3235],
23	that	IN	O	that	complm	26	SENT_233	[p11l561t3155r734b3234],
24	G1202R	NN	O	g1202r	nn	25	SENT_233	[p11l767t3161r1122b3239],
25	ALK	NN	O	alk	nsubj	26	SENT_233	[p11l1145t3163r1338b3236],
26	confers	VBZ	O	confer	ccomp	22	SENT_233	[p11l1373t3154r1688b3235],
27	high	JJ	O	high	amod	30	SENT_233	[p11l1728t3155r2149b3257],
28	—	NN	O	—	nn	30	SENT_233	[p11l1728t3155r2149b3257],
29	level	NN	O	level	nn	30	SENT_233	[p11l1728t3155r2149b3257],
30	resistance	NN	O	resistance	dobj	26	SENT_233	[p11l12t3285r443b3362],
31	to	TO	O	to	_	0	SENT_233	[p11l477t3301r559b3363],
32	crizotinib	NN	O	crizotinib	prep_to	30	SENT_233	[p11l594t3284r1016b3363],
33	and	CC	O	and	_	0	SENT_233	[p11l1049t3284r1208b3363],
34	to	TO	O	to	_	0	SENT_233	[p11l1241t3301r1324b3363],
35	all	PDT	O	all	predet	37	SENT_233	[p11l1357t3284r1463b3362],
36	the	DT	O	the	det	37	SENT_233	[p11l1495t3284r1629b3362],
37	neXt	NN	O	next	prep_to	30	SENT_233	[p11l1662t3301r2147b3385],
38	—	NN	O	—	nn	43	SENT_233	[p11l1662t3301r2147b3385],
39	gener	NN	O	gener	nn	43	SENT_233	[p11l1662t3301r2147b3385],
40	—	NN	O	—	nn	43	SENT_233	[p11l1662t3301r2147b3385],
41	ation	NN	O	ation	nn	43	SENT_233	[p11l11t3413r230b3491],
42	ALK	NN	O	alk	nn	43	SENT_233	[p11l281t3419r473b3492],
43	inhibitors	NNS	O	inhibitor	dep	30	SENT_233	[p11l524t3412r948b3491],
44	that	WDT	O	that	nsubjpass	46	SENT_233	[p11l1005t3412r1178b3490],
45	were	VBD	O	be	auxpass	46	SENT_233	[p11l1223t3438r1426b3491],
46	examined	VBN	O	examine	rcmod	30	SENT_233	[p11l1481t3412r2003b3491],
47	.	.	O	.	_	0	SENT_233	[p11l1481t3412r2003b3491],

1	“	NN	O	“	npadvmod	11	SENT_234	[p11l1481t3412r2003b3491],
2	In	IN	O	in	_	0	SENT_234	[p11l2058t3420r2148b3489],
3	light	NN	O	light	prep_in	11	SENT_234	[p11l11t3540r214b3642],
4	of	IN	O	of	_	0	SENT_234	[p11l253t3539r354b3620],
5	these	DT	O	these	det	6	SENT_234	[p11l380t3540r605b3619],
6	observations	NNS	O	observation	prep_of	3	SENT_234	[p11l650t3540r1221b3637],
7	,	,	O	,	_	0	SENT_234	[p11l650t3540r1221b3637],
8	it	PRP	O	it	nsubj	11	SENT_234	[p11l1270t3541r1329b3619],
9	may	MD	O	may	aux	11	SENT_234	[p11l1368t3566r1548b3641],
10	be	VB	O	be	cop	11	SENT_234	[p11l1588t3540r1686b3620],
11	necessary	JJ	O	necessary	_	0	SENT_234	[p11l1730t3566r2153b3641],
12	to	TO	O	to	aux	13	SENT_234	[p11l12t3685r94b3747],
13	identify	VB	O	identify	xcomp	11	SENT_234	[p11l125t3667r460b3768],
14	novel	JJ	O	novel	amod	15	SENT_234	[p11l486t3668r712b3747],
15	compounds	NNS	O	compound	dobj	13	SENT_234	[p11l742t3668r1247b3768],
16	that	WDT	O	that	nsubj	18	SENT_234	[p11l1280t3668r1453b3746],
17	specifically	RB	O	specifically	advmod	18	SENT_234	[p11l1480t3667r1971b3768],
18	target	VBP	O	target	rcmod	15	SENT_234	[p11l1997t3685r2147b3746, p12l12t38r146b122],

1	the	DT	O	the	det	3	SENT_235	[p12l173t21r306b100],
2	G1202R	NN	O	g1202r	nn	3	SENT_235	[p12l338t27r693b104],
3	ALK	NN	O	alk	nsubj	10	SENT_235	[p12l711t29r903b102],
4	or	CC	O	or	_	0	SENT_235	[p12l933t47r1022b100],
5	G2032R	NN	O	g2032r	nn	7	SENT_235	[p12l1051t27r1403b104],
6	ROS1	NN	O	ros1	nn	7	SENT_235	[p12l1423t27r1659b104],
7	mutant	NN	O	mutant	nsubj	10	SENT_235	[p12l1691t38r2027b117],
8	,	,	O	,	_	0	SENT_235	[p12l1691t38r2027b117],
9	to	TO	O	to	aux	10	SENT_235	[p12l2065t38r2147b100],
10	overcome	VB	O	overcome	_	0	SENT_235	[p12l12t174r416b228],
11	the	DT	O	the	det	12	SENT_235	[p12l445t148r577b226],
12	development	NN	O	development	dobj	10	SENT_235	[p12l607t148r1148b248],
13	of	IN	O	of	_	0	SENT_235	[p12l1173t147r1272b227],
14	crizotinib	JJ	O	crizotinib	amod	15	SENT_235	[p12l1283t148r1696b227],
15	resistance	NN	O	resistance	prep_of	12	SENT_235	[p12l1727t149r2148b226],
16	in	IN	O	in	_	0	SENT_235	[p12l11t279r95b356],
17	these	DT	O	these	det	18	SENT_235	[p12l130t278r355b356],
18	cancers	NNS	O	cancer	prep_in	10	SENT_235	[p12l391t304r738b357],
19	.	.	O	.	_	0	SENT_235	[p12l391t304r738b357],

1	At	IN	O	at	_	0	SENT_236	[p12l138t414r238b485],
2	the	DT	O	the	det	3	SENT_236	[p12l274t406r407b485],
3	time	NN	O	time	prep_at	19	SENT_236	[p12l448t407r643b485],
4	of	IN	O	of	_	0	SENT_236	[p12l684t405r785b486],
5	disease	NN	O	disease	nn	6	SENT_236	[p12l808t406r1120b486],
6	progression	NN	O	progression	prep_of	3	SENT_236	[p12l1159t407r1696b508],
7	,	,	O	,	_	0	SENT_236	[p12l1159t407r1696b508],
8	when	WRB	O	when	advmod	12	SENT_236	[p12l1738t406r1973b486],
9	the	DT	O	the	det	10	SENT_236	[p12l2014t406r2148b485],
10	patient	NN	O	patient	nsubj	12	SENT_236	[p12l11t536r308b635],
11	was	VBD	O	be	aux	12	SENT_236	[p12l333t561r494b614],
12	taking	VBG	O	take	advcl	19	SENT_236	[p12l531t535r808b636],
13	crizotinib	NN	O	crizotinib	dobj	12	SENT_236	[p12l840t535r1274b631],
14	,	,	O	,	_	0	SENT_236	[p12l840t535r1274b631],
15	a	DT	O	a	det	17	SENT_236	[p12l1314t561r1359b613],
16	repeat	NN	O	repeat	nn	17	SENT_236	[p12l1391t552r1655b635],
17	biopsy	NN	O	biopsy	nsubjpass	19	SENT_236	[p12l1685t535r1960b635],
18	was	VBD	O	be	auxpass	19	SENT_236	[p12l1985t561r2146b614],
19	performed	VBN	O	perform	_	0	SENT_236	[p12l11t662r452b764],
20	to	TO	O	to	aux	21	SENT_236	[p12l495t680r575b743],
21	identify	VB	O	identify	xcomp	19	SENT_236	[p12l618t662r938b764],
22	the	DT	O	the	det	23	SENT_236	[p12l976t663r1105b742],
23	mechanism	NN	O	mechanism	dobj	21	SENT_236	[p12l1147t663r1635b742],
24	of	IN	O	of	_	0	SENT_236	[p12l1678t662r1776b743],
25	drug	NN	O	drug	nn	26	SENT_236	[p12l1800t663r1999b765],
26	resistance	NN	O	resistance	prep_of	23	SENT_236	[p12l2038t689r2147b742, p12l13t792r372b870],
27	.	.	O	.	_	0	SENT_236	[p12l2038t689r2147b742, p12l13t792r372b870],

1	The	DT	O	the	det	2	SENT_237	[p12l404t791r564b869],
2	biopsy	NN	O	biopsy	nsubjpass	4	SENT_237	[p12l595t791r869b891],
3	was	VBD	O	be	auxpass	4	SENT_237	[p12l890t817r1051b871],
4	performed	VBN	O	perform	_	0	SENT_237	[p12l1082t790r1533b891],
5	in	IN	O	in	_	0	SENT_237	[p12l1562t792r1644b869],
6	accordance	NN	O	accordance	prep_in	4	SENT_237	[p12l1674t791r2148b870],
7	with	IN	O	with	_	0	SENT_237	[p12l7t920r204b999],
8	a	DT	O	a	det	10	SENT_237	[p12l238t946r282b998],
9	clinical	JJ	O	clinical	amod	10	SENT_237	[p12l316t920r631b998],
10	protocol	NN	O	protocol	prep_with	4	SENT_237	[p12l664t920r1027b1020],
11	that	WDT	O	that	nsubjpass	13	SENT_237	[p12l1061t920r1235b998],
12	was	VBD	O	be	auxpass	13	SENT_237	[p12l1260t946r1423b1000],
13	approved	VBN	O	approve	rcmod	10	SENT_237	[p12l1459t920r1852b1020],
14	by	IN	O	by	_	0	SENT_237	[p12l1887t920r1984b1020],
15	the	DT	O	the	det	18	SENT_237	[p12l2014t920r2148b998],
16	institutional	JJ	O	institutional	amod	18	SENT_237	[p12l11t1049r548b1128],
17	review	NN	O	review	nn	18	SENT_237	[p12l585t1050r867b1129],
18	board	NN	O	board	agent	13	SENT_237	[p12l900t1049r1150b1128],
19	at	IN	O	at	_	0	SENT_237	[p12l1186t1066r1265b1127],
20	our	PRP$	O	we	poss	21	SENT_237	[p12l1298t1075r1444b1128],
21	institution	NN	O	institution	prep_at	18	SENT_237	[p12l1478t1050r1934b1128],
22	speciﬁcally	RB	O	speciﬁcally	advmod	13	SENT_237	[p12l1972t1075r2147b1149, p12l12t1176r348b1277],
23	for	IN	O	for	_	0	SENT_237	[p12l387t1176r509b1256],
24	patients	NNS	O	patient	prep_for	13	SENT_237	[p12l548t1178r885b1277],
25	in	IN	O	in	_	0	SENT_237	[p12l930t1178r1012b1255],
26	whom	WP	O	whom	rel	29	SENT_237	[p12l1051t1177r1321b1257],
27	resistance	NN	O	resistance	nsubj	29	SENT_237	[p12l1364t1178r1786b1255],
28	has	VBZ	O	have	aux	29	SENT_237	[p12l1830t1177r1972b1255],
29	developed	VBN	O	develop	rcmod	24	SENT_237	[p12l2019t1177r2147b1256, p12l7t1306r332b1406],
30	to	TO	O	to	_	0	SENT_237	[p12l375t1323r458b1385],
31	targeted	VBN	O	target	amod	32	SENT_237	[p12l505t1306r862b1407],
32	therapies	NNS	O	therapy	prep_to	29	SENT_237	[p12l908t1306r1300b1406],
33	such	JJ	O	such	_	0	SENT_237	[p12l1349t1306r1544b1385],
34	as	IN	O	as	_	0	SENT_237	[p12l1589t1332r1675b1384],
35	crizotinib	NN	O	crizotinib	prep_such_as	32	SENT_237	[p12l1724t1306r2147b1385],
36	and	CC	O	and	_	0	SENT_237	[p12l11t1434r168b1513],
37	erlotinib	NN	O	erlotinib	conj_and	35	SENT_237	[p12l200t1434r582b1513],
38	.	.	O	.	_	0	SENT_237	[p12l200t1434r582b1513],

1	Repeat	NN	O	repeat	nn	2	SENT_238	[p12l618t1440r911b1534],
2	biopsies	NNS	O	biopsy	nsubj	4	SENT_238	[p12l939t1434r1278b1534],
3	have	VBP	O	have	aux	4	SENT_238	[p12l1312t1434r1500b1513],
4	emerged	VBN	O	emerge	_	0	SENT_238	[p12l1532t1434r1896b1535],
5	as	IN	O	as	_	0	SENT_238	[p12l1927t1460r2012b1512],
6	an	DT	O	a	det	8	SENT_238	[p12l2045t1460r2148b1512],
7	invaluable	JJ	O	invaluable	amod	8	SENT_238	[p12l11t1562r449b1642],
8	tool	NN	O	tool	prep_as	4	SENT_238	[p12l487t1562r654b1642],
9	for	IN	O	for	_	0	SENT_238	[p12l691t1561r815b1642],
10	discovering	VBG	O	discover	prepc_for	4	SENT_238	[p12l850t1562r1349b1664],
11	clinically	RB	O	clinically	advmod	12	SENT_238	[p12l1384t1562r1778b1663],
12	relevant	JJ	O	relevant	amod	14	SENT_238	[p12l1810t1562r2153b1642],
13	resistance	NN	O	resistance	nn	14	SENT_238	[p12l12t1692r433b1770],
14	mechanisms	NNS	O	mechanism	dobj	10	SENT_238	[p12l471t1691r1032b1787],
15	,	,	O	,	_	0	SENT_238	[p12l471t1691r1032b1787],
16	including	VBG	O	include	_	0	SENT_238	[p12l1074t1691r1479b1792],
17	secondary	JJ	O	secondary	amod	20	SENT_238	[p12l1515t1691r1947b1791],
18	mu	NN	O	mu	nn	20	SENT_238	[p12l1980t1717r2147b1770],
19	—	NN	O	—	nn	20	SENT_238	[p12l1980t1717r2147b1770],
20	tations	NNS	O	tation	conj_and	20	SENT_238	[p12l12t1820r302b1899],
21	within	IN	O	within	_	0	SENT_238	[p12l329t1819r616b1899],
22	the	DT	O	the	det	23	SENT_238	[p12l648t1819r781b1898],
23	target	NN	O	target	prep_within	20	SENT_238	[p12l814t1836r1092b1921],
24	,	,	O	,	_	0	SENT_238	[p12l814t1836r1092b1921],
25	activation	NN	O	activation	appos	23	SENT_238	[p12l1129t1820r1548b1899],
26	of	IN	O	of	_	0	SENT_238	[p12l1581t1818r1682b1899],
27	alternative	JJ	O	alternative	amod	29	SENT_238	[p12l1695t1819r2148b1899],
28	signaling	NN	O	signaling	nn	29	SENT_238	[p12l13t1948r419b2050],
29	pathways	NNS	O	pathway	prep_of	25	SENT_238	[p12l470t1948r896b2049],
30	,	,	O	,	_	0	SENT_238	[p12l470t1948r896b2049],
31	and	CC	O	and	_	0	SENT_238	[p12l957t1948r1116b2028],
32	in	IN	O	in	_	0	SENT_238	[p12l1170t1949r1255b2026],
33	the	DT	O	the	det	34	SENT_238	[p12l1310t1948r1444b2027],
34	case	NN	O	case	prep_in	20	SENT_238	[p12l1500t1974r1681b2027],
35	of	IN	O	of	_	0	SENT_238	[p12l1737t1947r1838b2028],
36	EGFRmutant	NN	O	egfrmutant	nn	38	SENT_238	[p12l1874t1954r2147b2033, p12l12t2094r328b2157],
37	lung	NN	O	lung	nn	38	SENT_238	[p12l356t2077r551b2179],
38	cancer	NN	O	cancer	prep_of	34	SENT_238	[p12l584t2103r885b2174],
39	,	,	O	,	_	0	SENT_238	[p12l584t2103r885b2174],
40	small	JJ	O	small	amod	43	SENT_238	[p12l927t2077r1348b2156],
41	—	NN	O	—	nn	43	SENT_238	[p12l927t2077r1348b2156],
42	cell	NN	O	cell	nn	43	SENT_238	[p12l927t2077r1348b2156],
43	transformation	NN	O	transformation	appos	38	SENT_238	[p12l1383t2076r2147b2157],
44	.	.	O	.	_	0	SENT_238	[p12l1383t2076r2147b2157],

1	”	RB	O	”	advmod	2	SENT_239	[p12l1383t2076r2147b2157],
2	Elucidating	VBG	O	elucidate	csubj	6	SENT_239	[p12l11t2206r482b2307],
3	these	DT	O	these	det	4	SENT_239	[p12l512t2206r728b2285],
4	mechanisms	NNS	O	mechanism	dobj	2	SENT_239	[p12l760t2206r1287b2285],
5	has	VBZ	O	have	aux	6	SENT_239	[p12l1321t2206r1462b2284],
6	helped	VBN	O	help	_	0	SENT_239	[p12l1496t2206r1772b2306],
7	to	TO	O	to	aux	8	SENT_239	[p12l1804t2223r1883b2285],
8	guide	VB	O	guide	xcomp	6	SENT_239	[p12l1917t2206r2148b2307],
9	the	DT	O	the	det	10	SENT_239	[p12l12t2334r144b2413],
10	development	NN	O	development	dobj	8	SENT_239	[p12l189t2334r730b2435],
11	of	IN	O	of	_	0	SENT_239	[p12l770t2333r869b2414],
12	new	JJ	O	new	amod	14	SENT_239	[p12l895t2360r1072b2414],
13	treatment	NN	O	treatment	nn	14	SENT_239	[p12l1112t2351r1530b2413],
14	strategies	NNS	O	strategy	prep_of	10	SENT_239	[p12l1570t2335r1972b2436],
15	designed	VBN	O	design	partmod	14	SENT_239	[p12l2019t2334r2147b2414, p12l13t2465r289b2566],
16	to	TO	O	to	aux	17	SENT_239	[p12l327t2482r408b2544],
17	overcome	VB	O	overcome	xcomp	15	SENT_239	[p12l450t2491r860b2544],
18	resistance	NN	O	resistance	dobj	17	SENT_239	[p12l900t2466r1355b2544],
19	.	.	O	.	_	0	SENT_239	[p12l900t2466r1355b2544],

1	The	DT	O	the	det	2	SENT_240	[p12l138t2592r300b2670],
2	autopsy	NN	O	autopsy	nsubj	7	SENT_240	[p12l346t2609r680b2692],
3	performed	VBN	O	perform	partmod	2	SENT_240	[p12l721t2591r1180b2692],
4	in	IN	O	in	_	0	SENT_240	[p12l1226t2593r1310b2670],
5	this	DT	O	this	det	6	SENT_240	[p12l1357t2592r1517b2670],
6	case	NN	O	case	prep_in	3	SENT_240	[p12l1567t2618r1748b2670],
7	revealed	VBD	O	reveal	_	0	SENT_240	[p12l1795t2592r2148b2672],
8	the	DT	O	the	det	9	SENT_240	[p12l12t2721r144b2800],
9	presence	NN	O	presence	dobj	7	SENT_240	[p12l177t2747r546b2822],
10	of	IN	O	of	_	0	SENT_240	[p12l581t2720r681b2801],
11	the	DT	O	the	det	12	SENT_240	[p12l696t2721r828b2800],
12	CD74	NN	O	cd74	prep_of	9	SENT_240	[p12l861t2728r1319b2802],
13	.	.	O	.	_	0	SENT_240	[p12l861t2728r1319b2802],

1	—	NN	O	—	_	0	SENT_241	[p12l861t2728r1319b2802],
2	.	.	O	.	_	0	SENT_241	[p12l861t2728r1319b2802],

1	ROS1	NN	O	ros1	nn	3	SENT_242	[p12l861t2728r1319b2802],
2	gene	NN	O	gene	nn	3	SENT_242	[p12l1355t2747r1552b2823],
3	translocation	NN	O	translocation	_	0	SENT_242	[p12l1587t2721r2148b2801],
4	at	IN	O	at	_	0	SENT_242	[p12l12t2867r90b2929],
5	all	DT	O	all	det	6	SENT_242	[p12l119t2850r224b2929],
6	sites	NNS	O	site	prep_at	3	SENT_242	[p12l259t2851r445b2929],
7	of	IN	O	of	_	0	SENT_242	[p12l482t2849r582b2930],
8	disease	NN	O	disease	prep_of	3	SENT_242	[p12l599t2850r934b2930],
9	.	.	O	.	_	0	SENT_242	[p12l599t2850r934b2930],

1	Despite	IN	O	despite	_	0	SENT_243	[p12l972t2851r1295b2951],
2	the	DT	O	the	det	4	SENT_243	[p12l1330t2850r1463b2929],
3	genetic	JJ	O	genetic	amod	4	SENT_243	[p12l1496t2851r1807b2952],
4	heterogeneity	NN	O	heterogeneity	prep_despite	21	SENT_243	[p12l1840t2850r2147b2930, p12l12t2980r325b3081],
5	that	WDT	O	that	nsubjpass	8	SENT_243	[p12l358t2979r532b3058],
6	has	VBZ	O	have	aux	8	SENT_243	[p12l564t2979r708b3058],
7	been	VBN	O	be	auxpass	8	SENT_243	[p12l749t2979r951b3059],
8	identified	VBN	O	identify	rcmod	4	SENT_243	[p12l988t2978r1408b3059],
9	at	IN	O	at	_	0	SENT_243	[p12l1444t2996r1524b3058],
10	various	JJ	O	various	amod	12	SENT_243	[p12l1552t2980r1863b3059],
11	metastatic	JJ	O	metastatic	amod	12	SENT_243	[p12l1902t2996r2147b3058, p12l13t3109r238b3187],
12	sites	NNS	O	site	prep_at	8	SENT_243	[p12l270t3109r452b3187],
13	in	IN	O	in	_	0	SENT_243	[p12l485t3109r568b3186],
14	an	DT	O	a	det	16	SENT_243	[p12l599t3134r702b3187],
15	individual	JJ	O	individual	amod	16	SENT_243	[p12l733t3108r1157b3188],
16	patient	NN	O	patient	prep_in	12	SENT_243	[p12l1187t3109r1582b3209],
17	,	,	O	,	_	0	SENT_243	[p12l1187t3109r1582b3209],
18	“	CD	NUMBER	“	nsubj	21	SENT_243	[p12l1187t3109r1582b3209],
19	our	PRP$	O	we	poss	20	SENT_243	[p12l1614t3134r1759b3188],
20	findings	NNS	O	finding	dep	18	SENT_243	[p12l1787t3107r2146b3210],
21	support	VBP	O	support	_	0	SENT_243	[p12l13t3254r348b3337],
22	the	DT	O	the	det	23	SENT_243	[p12l386t3237r520b3315],
23	notion	NN	O	notion	dobj	21	SENT_243	[p12l563t3238r846b3316],
24	that	IN	O	that	complm	29	SENT_243	[p12l889t3237r1063b3315],
25	some	DT	O	some	det	27	SENT_243	[p12l1102t3263r1327b3316],
26	oncogenic	JJ	O	oncogenic	amod	27	SENT_243	[p12l1371t3238r1813b3338],
27	drivers	NNS	O	driver	nsubj	29	SENT_243	[p12l1856t3237r2146b3316],
28	are	VBP	O	be	cop	29	SENT_243	[p12l11t3390r139b3442],
29	present	JJ	DATE	present	ccomp	21	SENT_243	[p12l172t3381r486b3464],
30	in	IN	O	in	_	0	SENT_243	[p12l514t3365r597b3442],
31	founder	NN	O	founder	prep_in	29	SENT_243	[p12l631t3363r965b3444],
32	clones25	CD	NUMBER	clones25	num	31	SENT_243	[p12l996t3364r1331b3443],
33	and	CC	O	and	_	0	SENT_243	[p12l1367t3364r1524b3443],
34	therefore	RB	O	therefore	advmod	37	SENT_243	[p12l1558t3363r1940b3443],
35	may	MD	O	may	aux	37	SENT_243	[p12l1975t3390r2153b3464],
36	be	VB	O	be	cop	37	SENT_243	[p12l12t3492r107b3571],
37	present	JJ	DATE	present	ccomp	21	SENT_243	[p12l140t3509r449b3592],
38	at	IN	O	at	_	0	SENT_243	[p12l477t3509r554b3570],
39	all	DT	O	all	det	40	SENT_243	[p12l582t3492r682b3570],
40	sites	NNS	O	site	prep_at	37	SENT_243	[p12l717t3493r895b3570],
41	of	IN	O	of	_	0	SENT_243	[p12l932t3491r1030b3571],
42	metastasis	NN	O	metastasis	prep_of	40	SENT_243	[p12l1045t3493r1504b3571],
43	.	.	O	.	_	0	SENT_243	[p12l1045t3493r1504b3571],

1	It	PRP	O	it	nsubj	4	SENT_244	[p12l1542t3500r1605b3570],
2	is	VBZ	O	be	cop	4	SENT_244	[p12l1633t3493r1697b3570],
3	also	RB	O	also	advmod	4	SENT_244	[p12l1732t3492r1899b3571],
4	noteworthy	JJ	O	noteworthy	_	0	SENT_244	[p12l1934t3509r2147b3571, p12l7t3620r305b3720],
5	that	IN	O	that	complm	18	SENT_244	[p12l357t3620r531b3698],
6	the	DT	O	the	det	8	SENT_244	[p12l587t3620r721b3698],
7	same	JJ	O	same	amod	8	SENT_244	[p12l784t3646r1006b3698],
8	mechanism	NN	O	mechanism	nsubjpass	18	SENT_244	[p12l1067t3620r1571b3698],
9	of	IN	O	of	_	0	SENT_244	[p12l1633t3619r1734b3699],
10	acquired	VBN	O	acquire	amod	11	SENT_244	[p12l1776t3620r2148b3720],
11	resistance	NN	O	resistance	prep_of	8	SENT_244	[p13l12t22r443b99],
12	—	IN	O	—	_	0	SENT_244	[p13l476t66r584b74],
13	the	DT	O	the	det	16	SENT_244	[p13l617t21r751b99],
14	G2032R	NN	O	g2032r	nn	16	SENT_244	[p13l787t27r1141b105],
15	mutation	NN	O	mutation	nn	16	SENT_244	[p13l1166t22r1561b100],
16	—	NN	O	—	prep_—	11	SENT_244	[p13l1595t66r1703b74],
17	was	VBD	O	be	auxpass	18	SENT_244	[p13l1731t47r1894b100],
18	identified	VBN	O	identify	ccomp	4	SENT_244	[p13l1932t21r2147b100, p13l12t148r245b228],

1	at	IN	O	at	_	0	SENT_245	[p13l286t166r365b227],
2	all	PDT	O	all	predet	4	SENT_245	[p13l400t149r506b227],
3	the	DT	O	the	det	4	SENT_245	[p13l548t149r681b228],
4	sites	NNS	O	site	pobj	1	SENT_245	[p13l725t150r911b227],
5	of	IN	O	of	_	0	SENT_245	[p13l955t148r1056b228],
6	disease	NN	O	disease	prep_of	4	SENT_245	[p13l1079t149r1391b228],
7	that	WDT	O	that	nsubjpass	9	SENT_245	[p13l1434t149r1608b227],
8	were	VBD	O	be	auxpass	9	SENT_245	[p13l1639t175r1843b228],
9	examined	VBN	O	examine	rcmod	4	SENT_245	[p13l1885t175r2147b228, p13l11t277r220b373],
10	,	,	O	,	_	0	SENT_245	[p13l1885t175r2147b228, p13l11t277r220b373],

1	and	CC	O	and	cc	8	SENT_246	[p13l269t277r428b356],
2	no	DT	O	no	det	6	SENT_246	[p13l471t303r577b356],
3	other	JJ	O	other	amod	6	SENT_246	[p13l623t277r852b356],
4	ROS1	NN	O	ros1	nn	6	SENT_246	[p13l890t283r1096b357],
5	kinase	NN	O	kinase	nn	6	SENT_246	[p13l1142t277r1422b356],
6	mutations	NNS	O	mutation	nsubjpass	8	SENT_246	[p13l1466t278r1904b356],
7	were	VBD	O	be	auxpass	8	SENT_246	[p13l1945t303r2148b356],
8	identified	VBN	O	identify	_	0	SENT_246	[p13l11t405r431b486],
9	by	IN	O	by	_	0	SENT_246	[p13l478t406r576b507],
10	deep	JJ	O	deep	amod	11	SENT_246	[p13l618t406r817b507],
11	sequencing	NN	O	sequencing	agent	8	SENT_246	[p13l866t407r1374b508],
12	.	.	O	.	_	0	SENT_246	[p13l866t407r1374b508],

1	Thus	RB	O	thus	advmod	4	SENT_247	[p13l1423t406r1660b503],
2	,	,	O	,	_	0	SENT_247	[p13l1423t406r1660b503],
3	it	PRP	O	it	nsubj	4	SENT_247	[p13l1711t407r1771b485],
4	appears	VBZ	O	appear	_	0	SENT_247	[p13l1811t432r2145b507],
5	that	IN	O	that	complm	8	SENT_247	[p13l12t535r186b613],
6	this	DT	O	this	det	7	SENT_247	[p13l216t535r377b613],
7	mutation	NN	O	mutation	nsubj	8	SENT_247	[p13l414t536r808b614],
8	occurred	VBD	O	occur	ccomp	4	SENT_247	[p13l844t535r1225b614],
9	early	RB	O	early	advmod	8	SENT_247	[p13l1261t535r1468b635],
10	in	IN	O	in	_	0	SENT_247	[p13l1497t536r1581b613],
11	the	DT	O	the	det	12	SENT_247	[p13l1617t535r1751b613],
12	development	NN	O	development	prep_in	8	SENT_247	[p13l1787t535r2147b635, p13l12t681r231b743],
13	of	IN	O	of	_	0	SENT_247	[p13l265t663r364b744],
14	resistance	NN	O	resistance	prep_of	12	SENT_247	[p13l384t665r805b743],
15	and	CC	O	and	_	0	SENT_247	[p13l843t664r999b744],
16	suggests	VBZ	O	suggest	ccomp	4	SENT_247	[p13l1039t681r1400b766],
17	that	IN	O	that	complm	29	SENT_247	[p13l1442t664r1612b743],
18	a	DT	O	a	det	20	SENT_247	[p13l1644t691r1689b743],
19	potent	JJ	O	potent	amod	20	SENT_247	[p13l1724t681r2000b765],
20	inhibitor	NN	O	inhibitor	nsubj	29	SENT_247	[p13l2033t665r2147b742, p13l12t792r293b871],
21	of	IN	O	of	_	0	SENT_247	[p13l326t791r425b871],
22	this	DT	O	this	det	24	SENT_247	[p13l443t792r597b870],
23	mutant	JJ	O	mutant	amod	24	SENT_247	[p13l634t809r939b872],
24	kinase	NN	O	kinase	prep_of	20	SENT_247	[p13l970t792r1239b872],
25	may	MD	O	may	aux	29	SENT_247	[p13l1275t818r1452b892],
26	have	VB	O	have	aux	29	SENT_247	[p13l1483t792r1668b871],
27	been	VBN	O	be	cop	29	SENT_247	[p13l1704t792r1900b871],
28	clinically	RB	O	clinically	advmod	29	SENT_247	[p13l1936t792r2147b870, p13l12t920r203b1020],
29	effective	JJ	O	effective	ccomp	16	SENT_247	[p13l235t919r593b1000],
30	after	IN	O	after	_	0	SENT_247	[p13l632t919r835b999],
31	the	DT	O	the	det	32	SENT_247	[p13l873t920r1006b998],
32	failure	NN	O	failure	prep_after	29	SENT_247	[p13l1047t919r1325b1000],
33	of	IN	O	of	_	0	SENT_247	[p13l1366t919r1466b999],
34	crizotinib	NN	O	crizotinib	prep_of	32	SENT_247	[p13l1488t920r1934b999],
35	.	.	O	.	_	0	SENT_247	[p13l1488t920r1934b999],

1	Supported	VBN	O	support	_	0	SENT_248	[p13l99t1069r438b1145],
2	by	IN	O	by	_	0	SENT_248	[p13l469t1069r543b1145],
3	Pfizer	NNP	ORGANIZATION	Pfizer	prep_by	1	SENT_248	[p13l569t1068r782b1141],
4	,	,	O	,	_	0	SENT_248	[p13l569t1068r782b1141],
5	by	IN	O	by	_	0	SENT_248	[p13l817t1069r891b1145],
6	grants	NNS	O	grant	prep_by	3	SENT_248	[p13l918t1082r1128b1145],
7	from	IN	O	from	_	0	SENT_248	[p13l1160t1068r1321b1128],
8	the	DT	O	the	det	13	SENT_248	[p13l1351t1069r1453b1128],
9	National	NNP	ORGANIZATION	National	nn	13	SENT_248	[p13l1482t1069r1769b1129],
10	Cancer	NNP	ORGANIZATION	Cancer	nn	13	SENT_248	[p13l1799t1073r2029b1128],
11	Institute	NNP	ORGANIZATION	Institute	nn	13	SENT_248	[p13l2055t1074r2148b1128, p13l12t1154r220b1213],
12	(	NN	O	(	nn	13	SENT_248	[p13l294t1158r941b1225],
13	5RO1CA164273-O2	NN	O	5ro1ca164273-o2	prep_from	6	SENT_248	[p13l294t1158r941b1225],
14	,	,	O	,	_	0	SENT_248	[p13l294t1158r941b1225],
15	to	TO	O	to	_	0	SENT_248	[p13l1017t1166r1078b1213],
16	Drs.	NNP	O	Drs.	nn	17	SENT_248	[p13l1149t1159r1283b1213],
17	Shaw	NNP	PERSON	Shaw	prep_to	3	SENT_248	[p13l1359t1154r1534b1214],
18	and	CC	O	and	_	0	SENT_248	[p13l1601t1154r1722b1213],
19	Engelman	NNP	PERSON	Engelman	conj_and	17	SENT_248	[p13l1791t1154r2145b1229],
20	;	:	O	;	_	0	SENT_248	[p13l1791t1154r2145b1229],
21	RO1CA137008	NN	O	ro1ca137008	nn	25	SENT_248	[p13l10t1253r472b1311],
22	and	CC	O	and	_	0	SENT_248	[p13l496t1249r617b1308],
23	Lung	NN	O	lung	conj_and	21	SENT_248	[p13l639t1254r808b1324],
24	SPORE	NN	O	spore	nn	25	SENT_248	[p13l830t1253r1055b1311],
25	P5OCAO90578	NN	O	p5ocao90578	prep_to	3	SENT_248	[p13l1078t1253r1555b1320],
26	,	,	O	,	_	0	SENT_248	[p13l1078t1253r1555b1320],
27	to	TO	O	to	_	0	SENT_248	[p13l1583t1261r1645b1308],
28	Dr.	NNP	O	Dr.	nn	29	SENT_248	[p13l1667t1254r1765b1308],
29	Engelman	NNP	PERSON	Engelman	prep_to	25	SENT_248	[p13l1791t1249r2145b1324],
30	;	:	O	;	_	0	SENT_248	[p13l1791t1249r2145b1324],
31	and	CC	O	and	_	0	SENT_248	[p13l11t1334r132b1393],
32	a1R21CA161590-01	NN	O	a1r21ca161590-01	conj_and	17	SENT_248	[p13l181t1338r848b1406],
33	,	,	O	,	_	0	SENT_248	[p13l181t1338r848b1406],
34	to	TO	O	to	_	0	SENT_248	[p13l902t1346r964b1393],
35	Dr.	NNP	O	Dr.	nn	37	SENT_248	[p13l1014t1339r1112b1393],
36	Iafrate	NNP	PERSON	Iafrate	nn	37	SENT_248	[p13l1164t1333r1421b1406],
37	)	NN	O	)	prep_to	3	SENT_248	[p13l1164t1333r1421b1406],
38	,	,	O	,	_	0	SENT_248	[p13l1164t1333r1421b1406],
39	by	IN	O	by	_	0	SENT_248	[p13l1475t1334r1550b1410],
40	a	DT	O	a	det	45	SENT_248	[p13l1595t1354r1629b1393],
41	V	NN	O	v	nn	45	SENT_248	[p13l1674t1339r1721b1393],
42	Foundation	NNP	ORGANIZATION	Foundation	nn	45	SENT_248	[p13l1767t1334r2148b1394],
43	Translational	JJ	ORGANIZATION	translational	amod	45	SENT_248	[p13l8t1421r454b1480],
44	Research	NN	ORGANIZATION	research	nn	45	SENT_248	[p13l482t1421r783b1483],
45	Grant	NNP	ORGANIZATION	Grant	prep_by	3	SENT_248	[p13l813t1425r1006b1480],
46	(	CD	NUMBER	(	num	45	SENT_248	[p13l1036t1426r1118b1489],
47	to	TO	O	to	_	0	SENT_248	[p13l1036t1426r1118b1489],
48	Drs.	NNP	O	Drs.	nn	49	SENT_248	[p13l1148t1426r1282b1480],
49	Shaw	NNP	PERSON	Shaw	prep_to	1	SENT_248	[p13l1318t1421r1491b1480],
50	and	CC	O	and	_	0	SENT_248	[p13l1518t1421r1639b1480],
51	Engelman	NNP	PERSON	Engelman	nn	52	SENT_248	[p13l1668t1421r2043b1496],
52	)	NNP	O	)	prep_to	1	SENT_248	[p13l1668t1421r2043b1496],
53	,	,	O	,	_	0	SENT_248	[p13l1668t1421r2043b1496],
54	by	IN	O	by	_	0	SENT_248	[p13l2078t1421r2152b1496],
55	Be	VB	O	be	cop	57	SENT_248	[p13l10t1513r89b1567],
56	a	DT	O	a	det	57	SENT_248	[p13l126t1528r159b1567],
57	Piece	NN	O	piece	prepc_by	1	SENT_248	[p13l195t1509r362b1567],
58	of	IN	O	of	_	0	SENT_248	[p13l400t1507r477b1567],
59	the	DT	O	the	det	60	SENT_248	[p13l500t1508r602b1567],
60	Solution	NN	O	solution	prep_of	57	SENT_248	[p13l641t1508r933b1580],
61	,	,	O	,	_	0	SENT_248	[p13l641t1508r933b1580],
62	and	CC	O	and	_	0	SENT_248	[p13l974t1508r1095b1567],
63	by	IN	O	by	_	0	SENT_248	[p13l1132t1508r1207b1584],
64	the	DT	O	the	det	68	SENT_248	[p13l1240t1508r1342b1567],
65	Evan	NNP	ORGANIZATION	Evan	nn	68	SENT_248	[p13l1379t1513r1535b1568],
66	Spirito	NNP	ORGANIZATION	Spirito	nn	68	SENT_248	[p13l1574t1509r1791b1584],
67	Memorial	NNP	ORGANIZATION	Memorial	nn	68	SENT_248	[p13l1827t1508r2149b1567],
68	Foundation	NNP	ORGANIZATION	Foundation	conj_and	57	SENT_248	[p13l10t1595r410b1655],
69	.	.	O	.	_	0	SENT_248	[p13l10t1595r410b1655],

1	Disclosure	NN	O	disclosure	nsubj	2	SENT_249	[p13l96t1682r446b1742],
2	forms	VBZ	O	form	_	0	SENT_249	[p13l479t1681r673b1741],
3	provided	VBN	O	provide	csubj	8	SENT_249	[p13l706t1682r995b1758],
4	by	IN	O	by	_	0	SENT_249	[p13l1029t1682r1103b1758],
5	the	DT	O	the	det	6	SENT_249	[p13l1133t1682r1235b1741],
6	authors	NNS	O	author	prep_by	3	SENT_249	[p13l1267t1682r1516b1742],
7	are	VBP	O	be	cop	8	SENT_249	[p13l1550t1702r1649b1741],
8	available	JJ	O	available	ccomp	2	SENT_249	[p13l1682t1682r1969b1742],
9	with	IN	O	with	_	0	SENT_249	[p13l1999t1682r2149b1742],
10	the	DT	O	the	det	12	SENT_249	[p13l11t1770r114b1829],
11	full	JJ	O	full	amod	12	SENT_249	[p13l139t1769r254b1830],
12	text	NN	O	text	prep_with	8	SENT_249	[p13l279t1783r403b1829],
13	of	IN	O	of	_	0	SENT_249	[p13l425t1769r502b1829],
14	this	DT	O	this	det	15	SENT_249	[p13l513t1770r636b1829],
15	article	NN	O	article	prep_of	12	SENT_249	[p13l663t1770r870b1829],
16	at	IN	O	at	_	0	SENT_249	[p13l895t1783r956b1829],
17	NEJM.org	NN	O	nejm.org	prep_at	15	SENT_249	[p13l976t1775r1317b1846],
18	.	.	O	.	_	0	SENT_249	[p13l976t1775r1317b1846],

1	NENGLJ	NN	O	nenglj	nn	2	SENT_250	[p13l964t1931r1071b1953],
2	MED368	NN	O	med368	_	0	SENT_250	[p13l1085t1925r1226b1953],
3	;	:	O	;	_	0	SENT_250	[p13l1085t1925r1226b1953],
4	25	CD	NUMBER	25	num	7	SENT_250	[p13l1085t1925r1226b1953],
5	NEjM	NNP	O	NEjM	nn	7	SENT_250	[p13l1262t1931r1386b1953],
6	,	,	O	,	_	0	SENT_250	[p13l1262t1931r1386b1953],
7	ORG	NNP	O	ORG	dep	2	SENT_250	[p13l1262t1931r1386b1953],
8	JUNE20	NN	O	june20	dep	7	SENT_250	[p13l1417t1931r1595b1953],
9	,2013	CD	NUMBER	,2013	num	8	SENT_250	[p13l1417t1931r1595b1953],
10	The	DT	O	the	det	13	SENT_250	[p13l936t1964r987b1988],
11	New	NNP	O	New	nn	13	SENT_250	[p13l996t1965r1058b1988],
12	England	NNP	O	England	nn	13	SENT_250	[p13l1067t1964r1178b1995],
13	Journal	NNP	O	Journal	dep	7	SENT_250	[p13l1187t1964r1284b1988],
14	of	IN	O	of	_	0	SENT_250	[p13l1294t1964r1323b1988],
15	Medicine	NNP	O	Medicine	prep_of	13	SENT_250	[p13l1330t1964r1455b1988],

1	REFERENCES	NNS	O	reference	_	0	SENT_251	[p13l14t2399r334b2429],

1	1	LS	NUMBER	1	_	0	SENT_252	[p13l13t2466r49b2504],
2	.	.	O	.	_	0	SENT_252	[p13l13t2466r49b2504],

1	Druker	NN	PERSON	druker	nn	3	SENT_253	[p13l105t2460r278b2504],
2	B	NN	O	b	nn	3	SENT_253	[p13l299t2464r360b2513],
3	]	NN	O	]	_	0	SENT_253	[p13l299t2464r360b2513],
4	,	,	O	,	_	0	SENT_253	[p13l299t2464r360b2513],
5	Talpaz	NNP	O	Talpaz	nn	6	SENT_253	[p13l385t2460r547b2516],
6	M	NNP	O	M	appos	3	SENT_253	[p13l569t2464r630b2513],
7	,	,	O	,	_	0	SENT_253	[p13l569t2464r630b2513],
8	Resta	NNP	ORGANIZATION	Resta	nn	9	SENT_253	[p13l656t2464r790b2507],
9	DJ	NNP	ORGANIZATION	DJ	appos	3	SENT_253	[p13l812t2464r879b2513],
10	,	,	O	,	_	0	SENT_253	[p13l812t2464r879b2513],
11	et	FW	O	et	nn	12	SENT_253	[p13l907t2469r950b2504],
12	al.	FW	O	al.	appos	3	SENT_253	[p13l971t2461r1026b2504],
13	.	.	O	.	_	0	SENT_253	[p13l971t2461r1026b2504],

1	Efficacy	NN	O	efficacy	_	0	SENT_254	[p13l11t2530r207b2586],
2	and	CC	O	and	_	0	SENT_254	[p13l225t2530r314b2574],
3	safety	NN	O	safety	conj_and	1	SENT_254	[p13l335t2530r478b2586],
4	of	IN	O	of	_	0	SENT_254	[p13l497t2530r552b2574],
5	a	DT	O	a	det	7	SENT_254	[p13l563t2545r587b2574],
6	specific	JJ	O	specific	amod	7	SENT_254	[p13l608t2530r795b2586],
7	inhibitor	NN	O	inhibitor	prep_of	1	SENT_254	[p13l815t2531r1031b2574],
8	of	IN	O	of	_	0	SENT_254	[p13l12t2600r67b2644],
9	the	DT	O	the	det	12	SENT_254	[p13l74t2601r148b2644],
10	BCR-ABL	NN	MISC	bcr-abl	nn	12	SENT_254	[p13l164t2604r384b2647],
11	tyrosine	NN	O	tyrosine	nn	12	SENT_254	[p13l399t2601r595b2656],
12	kinase	NN	O	kinase	prep_of	7	SENT_254	[p13l611t2601r768b2644],
13	in	IN	O	in	_	0	SENT_254	[p13l784t2601r831b2643],
14	chronic	JJ	O	chronic	amod	16	SENT_254	[p13l847t2601r1030b2644],
15	myeloid	JJ	O	myeloid	amod	16	SENT_254	[p13l11t2670r200b2726],
16	leukemia	NN	O	leukemia	prep_in	1	SENT_254	[p13l215t2671r450b2714],
17	.	.	O	.	_	0	SENT_254	[p13l215t2671r450b2714],

1	N	NN	O	n	nn	3	SENT_255	[p13l467t2674r508b2714],
2	Engl	NNP	O	Engl	nn	3	SENT_255	[p13l522t2671r661b2726],
3	]	NNP	O	]	nsubj	4	SENT_255	[p13l522t2671r661b2726],
4	Med	VBD	O	med	_	0	SENT_255	[p13l673t2670r777b2714],
5	2001	CD	DATE	2001	dobj	4	SENT_255	[p13l792t2674r1027b2723],
6	;	:	O	;	_	0	SENT_255	[p13l792t2674r1027b2723],
7	344	CD	NUMBER	344	num	9	SENT_255	[p13l792t2674r1027b2723],
8	:	:	O	:	_	0	SENT_255	[p13l792t2674r1027b2723],
9	1031-7	CD	NUMBER	1031-7	dep	5	SENT_255	[p13l13t2744r171b2784],
10	.	.	O	.	_	0	SENT_255	[p13l13t2744r171b2784],

1	2	LS	NUMBER	2	_	0	SENT_256	[p13l10t2816r50b2854],
2	.	.	O	.	_	0	SENT_256	[p13l10t2816r50b2854],

1	Lynch	NNP	PERSON	Lynch	nn	3	SENT_257	[p13l105t2810r248b2866],
2	T	NN	O	t	nn	3	SENT_257	[p13l272t2814r335b2863],
3	]	NN	O	]	_	0	SENT_257	[p13l272t2814r335b2863],
4	,	,	O	,	_	0	SENT_257	[p13l272t2814r335b2863],
5	Bell	NNP	ORGANIZATION	Bell	nn	6	SENT_257	[p13l363t2811r455b2854],
6	DW	NNP	ORGANIZATION	DW	appos	3	SENT_257	[p13l480t2814r577b2863],
7	,	,	O	,	_	0	SENT_257	[p13l480t2814r577b2863],
8	Sordella	NNP	PERSON	Sordella	nn	9	SENT_257	[p13l607t2811r804b2854],
9	R	NNP	PERSON	R	appos	3	SENT_257	[p13l828t2814r876b2863],
10	,	,	O	,	_	0	SENT_257	[p13l828t2814r876b2863],
11	et	FW	O	et	nn	12	SENT_257	[p13l905t2819r949b2854],
12	al.	FW	O	al.	appos	3	SENT_257	[p13l971t2811r1026b2854],
13	.	.	O	.	_	0	SENT_257	[p13l971t2811r1026b2854],

1	Activating	VBG	O	activate	amod	2	SENT_258	[p13l9t2881r259b2936],
2	mutations	NNS	O	mutation	_	0	SENT_258	[p13l297t2881r542b2924],
3	in	IN	O	in	_	0	SENT_258	[p13l583t2881r630b2923],
4	the	DT	O	the	det	7	SENT_258	[p13l671t2881r745b2924],
5	epidermal	JJ	O	epidermal	amod	7	SENT_258	[p13l786t2880r1029b2936],
6	growth	NN	O	growth	nn	7	SENT_258	[p13l11t2951r188b3006],
7	factor	NN	O	factor	prep_in	2	SENT_258	[p13l232t2950r373b2994],
8	receptor	NN	O	receptor	nn	10	SENT_258	[p13l416t2959r617b3006],
9	underlying	VBG	O	underlie	amod	10	SENT_258	[p13l659t2950r923b3006],
10	responsiveness	NN	O	responsiveness	dep	2	SENT_258	[p13l965t2965r1028b2994, p13l12t3021r325b3076],
11	of	IN	O	of	_	0	SENT_258	[p13l348t3020r404b3064],
12	non	JJ	O	non	amod	16	SENT_258	[p13l415t3020r778b3064],
13	—	JJ	O	—	amod	16	SENT_258	[p13l415t3020r778b3064],
14	small-cell	NN	O	small-cell	nn	16	SENT_258	[p13l415t3020r778b3064],
15	lung	NN	O	lung	nn	16	SENT_258	[p13l798t3021r907b3076],
16	cancer	NN	O	cancer	prep_of	10	SENT_258	[p13l927t3035r1028b3064, p13l12t3105r83b3134],
17	to	TO	O	to	_	0	SENT_258	[p13l107t3099r152b3134],
18	gefitinib	NN	O	gefitinib	prep_to	10	SENT_258	[p13l178t3090r401b3146],
19	.	.	O	.	_	0	SENT_258	[p13l178t3090r401b3146],

1	N	NN	O	n	nn	3	SENT_259	[p13l428t3094r470b3134],
2	Engl	NNP	O	Engl	nn	3	SENT_259	[p13l493t3090r602b3146],
3	J	NNP	O	J	nsubj	4	SENT_259	[p13l621t3094r642b3141],
4	Med	VBD	O	med	_	0	SENT_259	[p13l664t3090r769b3134],
5	2004	CD	DATE	2004	dobj	4	SENT_259	[p13l793t3094r1027b3143],
6	;	:	O	;	_	0	SENT_259	[p13l793t3094r1027b3143],
7	350	CD	NUMBER	350	num	9	SENT_259	[p13l793t3094r1027b3143],
8	:	:	O	:	_	0	SENT_259	[p13l793t3094r1027b3143],
9	2129-39	CD	NUMBER	2129-39	dep	5	SENT_259	[p13l11t3164r214b3204],
10	.	.	O	.	_	0	SENT_259	[p13l11t3164r214b3204],

1	3	LS	NUMBER	3	_	0	SENT_260	[p13l11t3236r48b3274],
2	.	.	O	.	_	0	SENT_260	[p13l11t3236r48b3274],

1	Paez	NNP	PERSON	Paez	nn	2	SENT_261	[p13l105t3234r214b3274],
2	JG	NNP	O	JG	_	0	SENT_261	[p13l227t3234r301b3283],
3	,	,	O	,	_	0	SENT_261	[p13l227t3234r301b3283],
4	Jéinne	NNP	ORGANIZATION	Jéinne	nn	5	SENT_261	[p13l318t3234r456b3281],
5	PA	NN	ORGANIZATION	pa	appos	2	SENT_261	[p13l474t3234r550b3283],
6	,	,	O	,	_	0	SENT_261	[p13l474t3234r550b3283],
7	Lee	NNP	PERSON	Lee	nn	8	SENT_261	[p13l571t3234r652b3274],
8	JC	NNP	PERSON	JC	appos	2	SENT_261	[p13l665t3234r734b3283],
9	,	,	O	,	_	0	SENT_261	[p13l665t3234r734b3283],
10	et	FW	O	et	nn	11	SENT_261	[p13l757t3239r800b3274],
11	al.	FW	O	al.	appos	2	SENT_261	[p13l816t3231r871b3274],
12	.	.	O	.	_	0	SENT_261	[p13l816t3231r871b3274],

1	EGFR	NN	ORGANIZATION	egfr	nn	2	SENT_262	[p13l892t3234r1035b3277],
2	mutations	NNS	O	mutation	_	0	SENT_262	[p13l11t3301r251b3344],
3	in	IN	O	in	_	0	SENT_262	[p13l270t3301r317b3343],
4	lung	NN	O	lung	nn	5	SENT_262	[p13l334t3301r441b3356],
5	cancer	NN	O	cancer	prep_in	2	SENT_262	[p13l458t3314r625b3344],
6	:	:	O	:	_	0	SENT_262	[p13l458t3314r625b3344],
7	correlation	NN	O	correlation	dep	2	SENT_262	[p13l646t3300r906b3344],
8	with	IN	O	with	_	0	SENT_262	[p13l922t3300r1029b3344],
9	clinical	JJ	O	clinical	amod	10	SENT_262	[p13l12t3370r189b3414],
10	response	NN	O	response	prep_with	7	SENT_262	[p13l206t3384r421b3426],
11	to	TO	O	to	_	0	SENT_262	[p13l439t3379r485b3414],
12	geﬁtinib	NN	O	geﬁtinib	nn	13	SENT_262	[p13l503t3370r713b3426],
13	therapy	NN	O	therapy	prep_to	10	SENT_262	[p13l732t3371r922b3426],
14	.	.	O	.	_	0	SENT_262	[p13l732t3371r922b3426],

1	Science	NNP	O	Science	_	0	SENT_263	[p13l944t3371r1028b3414, p13l12t3454r118b3484],
2	2004	CD	DATE	2004	num	1	SENT_263	[p13l137t3444r604b3493],
3	;	:	O	;	_	0	SENT_263	[p13l137t3444r604b3493],
4	304:1497	CD	NUMBER	304:1497	number	5	SENT_263	[p13l137t3444r604b3493],
5	-500	CD	NUMBER	-500	dep	1	SENT_263	[p13l137t3444r604b3493],
6	.	.	O	.	_	0	SENT_263	[p13l137t3444r604b3493],

1	4	LS	NUMBER	4	_	0	SENT_264	[p13l10t3516r49b3554],
2	.	.	O	.	_	0	SENT_264	[p13l10t3516r49b3554],

1	Herbst	NNP	ORGANIZATION	Herbst	nn	2	SENT_265	[p13l106t3511r270b3554],
2	RS	NN	ORGANIZATION	r	_	0	SENT_265	[p13l283t3514r361b3563],
3	,	,	O	,	_	0	SENT_265	[p13l283t3514r361b3563],
4	Heymach	NNP	O	Heymach	nn	5	SENT_265	[p13l382t3511r609b3566],
5	JV	NNP	O	JV	appos	2	SENT_265	[p13l621t3514r685b3563],
6	,	,	O	,	_	0	SENT_265	[p13l621t3514r685b3563],
7	Lippman	NNP	PERSON	Lippman	nn	8	SENT_265	[p13l705t3511r921b3566],
8	SM	NNP	O	SM	appos	5	SENT_265	[p13l940t3514r1026b3554],
9	.	.	O	.	_	0	SENT_265	[p13l940t3514r1026b3554],

1	Lung	NN	O	lung	_	0	SENT_266	[p13l11t3584r134b3636],
2	cancer	NN	O	cancer	dep	1	SENT_266	[p13l148t3594r317b3624],
3	.	.	O	.	_	0	SENT_266	[p13l148t3594r317b3624],

1	N	NN	O	n	nn	3	SENT_267	[p13l335t3584r376b3624],
2	Engl	NNP	O	Engl	nn	3	SENT_267	[p13l391t3580r530b3636],
3	]	NNP	O	]	nsubj	4	SENT_267	[p13l391t3580r530b3636],
4	Med	VBD	O	med	_	0	SENT_267	[p13l543t3581r647b3624],
5	2008	CD	DATE	2008	dobj	4	SENT_267	[p13l663t3584r1028b3633, p13l12t3654r80b3694],
6	;	:	O	;	_	0	SENT_267	[p13l663t3584r1028b3633, p13l12t3654r80b3694],
7	359:136780	CD	NUMBER	359:136780	dep	5	SENT_267	[p13l663t3584r1028b3633, p13l12t3654r80b3694],
8	.	.	O	.	_	0	SENT_267	[p13l663t3584r1028b3633, p13l12t3654r80b3694],

1	5	CD	NUMBER	5	_	0	SENT_268	[p13l12t3726r48b3764],
2	.	.	O	.	_	0	SENT_268	[p13l12t3726r48b3764],

1	Soda	NNP	O	Soda	nn	2	SENT_269	[p13l107t3720r223b3764],
2	M	NNP	O	M	_	0	SENT_269	[p13l246t3724r306b3773],
3	,	,	O	,	_	0	SENT_269	[p13l246t3724r306b3773],
4	Choi	NNP	PERSON	Choi	nn	5	SENT_269	[p13l335t3721r446b3764],
5	YL	NNP	PERSON	YL	appos	2	SENT_269	[p13l469t3724r544b3773],
6	,	,	O	,	_	0	SENT_269	[p13l469t3724r544b3773],
7	Enomoto	NNP	PERSON	Enomoto	nn	8	SENT_269	[p13l572t3724r792b3764],
8	M	NNP	O	M	appos	2	SENT_269	[p13l816t3724r877b3773],
9	,	,	O	,	_	0	SENT_269	[p13l816t3724r877b3773],
10	et	FW	O	et	nn	11	SENT_269	[p13l905t3729r949b3764],
11	al.	FW	O	al.	appos	2	SENT_269	[p13l971t3721r1026b3764],
12	.	.	O	.	_	0	SENT_269	[p13l971t3721r1026b3764],

1	BRIEF	JJ	O	brief	amod	2	SENT_270	[p13l1385t2221r1569b2256],
2	REPORT	NN	O	report	_	0	SENT_270	[p13l1597t2220r1844b2256],

1	10	CD	NUMBER	10	_	0	SENT_271	[p13l1106t2465r1167b2504],
2	.	.	O	.	_	0	SENT_271	[p13l1106t2465r1167b2504],

1	Camidge	NNP	O	Camidge	nn	2	SENT_272	[p13l1199t2460r1413b2516],
2	DR	NN	O	dr	_	0	SENT_272	[p13l1429t2464r1517b2513],
3	,	,	O	,	_	0	SENT_272	[p13l1429t2464r1517b2513],
4	Bang	NNP	O	Bang	nn	5	SENT_272	[p13l1535t2464r1660b2516],
5	Y-J	NNP	O	Y-J	appos	2	SENT_272	[p13l1672t2464r1746b2513],
6	,	,	O	,	_	0	SENT_272	[p13l1672t2464r1746b2513],
7	Kwak	NNP	PERSON	Kwak	nn	8	SENT_272	[p13l1765t2461r1900b2505],
8	EL	NNP	O	EL	appos	2	SENT_272	[p13l1913t2464r1988b2513],
9	,	,	O	,	_	0	SENT_272	[p13l1913t2464r1988b2513],
10	et	FW	O	et	nn	11	SENT_272	[p13l2007t2469r2051b2504],
11	al.	FW	O	al.	appos	2	SENT_272	[p13l2064t2461r2119b2504],
12	.	.	O	.	_	0	SENT_272	[p13l2064t2461r2119b2504],

1	Activity	NN	O	activity	_	0	SENT_273	[p13l1102t2531r1288b2586],
2	and	CC	O	and	_	0	SENT_273	[p13l1319t2530r1407b2574],
3	safety	NN	O	safety	conj_and	1	SENT_273	[p13l1442t2530r1584b2586],
4	of	IN	O	of	_	0	SENT_273	[p13l1616t2530r1672b2574],
5	crizotinib	NN	O	crizotinib	prep_of	1	SENT_273	[p13l1696t2531r1934b2574],
6	in	IN	O	in	_	0	SENT_273	[p13l1968t2531r2014b2573],
7	patients	NNS	O	patient	prep_in	5	SENT_273	[p13l2047t2545r2121b2586, p13l1104t2601r1237b2644],
8	With	IN	O	with	_	0	SENT_273	[p13l1276t2601r1386b2644],
9	ALK-positive	JJ	O	alk-positive	amod	14	SENT_273	[p13l1423t2601r1731b2656],
10	non	JJ	O	non	amod	14	SENT_273	[p13l1771t2600r2122b2644],
11	—	NN	O	—	nn	14	SENT_273	[p13l1771t2600r2122b2644],
12	small-cell	NN	O	small-cell	nn	14	SENT_273	[p13l1771t2600r2122b2644],
13	lung	NN	O	lung	nn	14	SENT_273	[p13l1103t2671r1212b2726],
14	cancer	NN	O	cancer	prep_with	7	SENT_273	[p13l1227t2685r1398b2714],
15	:	:	O	:	_	0	SENT_273	[p13l1227t2685r1398b2714],
16	updated	VBN	O	update	amod	17	SENT_273	[p13l1417t2670r1612b2726],
17	results	NNS	O	result	dep	1	SENT_273	[p13l1629t2671r1789b2714],
18	from	IN	O	from	_	0	SENT_273	[p13l1807t2670r1925b2714],
19	a	DT	O	a	det	22	SENT_273	[p13l1942t2685r1966b2714],
20	phase	NN	O	phase	nn	22	SENT_273	[p13l1982t2671r2122b2726],
21	1	CD	NUMBER	1	num	22	SENT_273	[p13l1106t2744r1130b2783],
22	study	NN	O	study	prep_from	17	SENT_273	[p13l1150t2740r1288b2796],
23	.	.	O	.	_	0	SENT_273	[p13l1150t2740r1288b2796],

1	Lancet	NNP	O	Lancet	nn	2	SENT_274	[p13l1309t2744r1471b2784],
2	Oncol	NNP	O	Oncol	_	0	SENT_274	[p13l1487t2741r1630b2784],
3	2012	CD	DATE	2012	num	2	SENT_274	[p13l1648t2744r2024b2793],
4	;	:	O	;	_	0	SENT_274	[p13l1648t2744r2024b2793],
5	13:1011	CD	NUMBER	13:1011	number	6	SENT_274	[p13l1648t2744r2024b2793],
6	-9	CD	NUMBER	-9	dep	2	SENT_274	[p13l1648t2744r2024b2793],
7	.	.	O	.	_	0	SENT_274	[p13l1648t2744r2024b2793],

1	11	CD	NUMBER	11	_	0	SENT_275	[p13l1106t2816r1168b2854],
2	.	.	O	.	_	0	SENT_275	[p13l1106t2816r1168b2854],

1	Bergethon	NNP	O	Bergethon	nn	2	SENT_276	[p13l1198t2811r1450b2866],
2	K	NNP	O	K	_	0	SENT_276	[p13l1467t2814r1516b2863],
3	,	,	O	,	_	0	SENT_276	[p13l1467t2814r1516b2863],
4	Shaw	NNP	ORGANIZATION	Shaw	nn	5	SENT_276	[p13l1537t2811r1665b2854],
5	AT	NNP	O	AT	appos	2	SENT_276	[p13l1678t2814r1756b2863],
6	,	,	O	,	_	0	SENT_276	[p13l1678t2814r1756b2863],
7	Ou	NNP	LOCATION	Ou	nn	8	SENT_276	[p13l1777t2814r1847b2854],
8	S-HI	NNP	O	S-HI	appos	2	SENT_276	[p13l1866t2814r1985b2863],
9	,	,	O	,	_	0	SENT_276	[p13l1866t2814r1985b2863],
10	et	FW	O	et	nn	11	SENT_276	[p13l2006t2819r2050b2854],
11	al.	FW	O	al.	appos	2	SENT_276	[p13l2064t2811r2119b2854],
12	.	.	O	.	_	0	SENT_276	[p13l2064t2811r2119b2854],

1	ROS1	NN	O	ros1	nn	2	SENT_277	[p13l1103t2884r1232b2927],
2	rearrangements	NNS	O	rearrangement	nsubj	3	SENT_277	[p13l1249t2889r1625b2936],
3	define	VBP	O	define	_	0	SENT_277	[p13l1643t2880r1792b2924],
4	a	DT	O	a	det	7	SENT_277	[p13l1808t2895r1833b2924],
5	unique	JJ	O	unique	amod	7	SENT_277	[p13l1848t2881r2011b2936],
6	molecular	JJ	O	molecular	amod	7	SENT_277	[p13l2027t2894r2121b2924, p13l1103t2951r1266b2994],
7	class	NN	O	class	dobj	3	SENT_277	[p13l1285t2950r1398b2994],
8	of	IN	O	of	_	0	SENT_277	[p13l1420t2950r1476b2994],
9	lung	NN	O	lung	nn	10	SENT_277	[p13l1486t2951r1593b3006],
10	cancers	NNS	O	cancer	prep_of	7	SENT_277	[p13l1612t2964r1804b2994],
11	.	.	O	.	_	0	SENT_277	[p13l1612t2964r1804b2994],

1	J	NNP	O	J	nn	3	SENT_278	[p13l1822t2954r1843b3001],
2	Clin	NNP	O	Clin	nn	3	SENT_278	[p13l1863t2950r1960b2994],
3	Oncol	NNP	O	Oncol	_	0	SENT_278	[p13l1982t2950r2122b2994],
4	2012	CD	DATE	2012	num	3	SENT_278	[p13l1104t3024r1483b3073],
5	;	:	O	;	_	0	SENT_278	[p13l1104t3024r1483b3073],
6	30:863	CD	NUMBER	30:863	number	7	SENT_278	[p13l1104t3024r1483b3073],
7	-70	CD	NUMBER	-70	dep	3	SENT_278	[p13l1104t3024r1483b3073],
8	.	.	O	.	_	0	SENT_278	[p13l1104t3024r1483b3073],

1	12	CD	NUMBER	12	_	0	SENT_279	[p13l1106t3096r1169b3134],
2	.	.	O	.	_	0	SENT_279	[p13l1106t3096r1169b3134],

1	Davies	NNP	PERSON	Davies	nn	2	SENT_280	[p13l1198t3091r1355b3134],
2	KD	NN	O	kd	_	0	SENT_280	[p13l1373t3094r1462b3143],
3	,	,	O	,	_	0	SENT_280	[p13l1373t3094r1462b3143],
4	Le	NNP	O	Le	nn	5	SENT_280	[p13l1481t3094r1536b3134],
5	AT	NNP	O	AT	appos	2	SENT_280	[p13l1551t3094r1629b3143],
6	,	,	O	,	_	0	SENT_280	[p13l1551t3094r1629b3143],
7	Theodoro	NNP	O	Theodoro	nn	8	SENT_280	[p13l1647t3090r1882b3134],
8	MF	NN	O	mf	appos	2	SENT_280	[p13l1898t3094r1986b3143],
9	,	,	O	,	_	0	SENT_280	[p13l1898t3094r1986b3143],
10	et	FW	O	et	nn	11	SENT_280	[p13l2006t3099r2050b3134],
11	al.	FW	O	al.	appos	2	SENT_280	[p13l2064t3091r2119b3134],
12	.	.	O	.	_	0	SENT_280	[p13l2064t3091r2119b3134],

1	Identifying	VBG	O	identify	_	0	SENT_281	[p13l1103t3160r1374b3216],
2	and	CC	O	and	_	0	SENT_281	[p13l1398t3160r1486b3204],
3	targeting	VBG	O	target	conj_and	1	SENT_281	[p13l1512t3161r1737b3216],
4	ROS1	NN	O	ros1	nn	6	SENT_281	[p13l1760t3164r1891b3207],
5	gene	NN	O	gene	nn	6	SENT_281	[p13l1917t3175r2029b3216],
6	fusions	NNS	O	fusion	dobj	1	SENT_281	[p13l2054t3160r2121b3204, p13l1105t3231r1227b3274],
7	in	IN	O	in	_	0	SENT_281	[p13l1251t3231r1298b3273],
8	non-small	JJ	O	non-small	amod	11	SENT_281	[p13l1322t3230r1568b3274],
9	cell	NN	O	cell	nn	11	SENT_281	[p13l1591t3231r1673b3274],
10	lung	NN	O	lung	nn	11	SENT_281	[p13l1696t3231r1805b3286],
11	cancer	NN	O	cancer	prep_in	1	SENT_281	[p13l1827t3244r1996b3274],
12	.	.	O	.	_	0	SENT_281	[p13l1827t3244r1996b3274],

1	Clin	NNP	O	Clin	nn	3	SENT_282	[p13l2022t3231r2122b3274],
2	Cancer	NNP	O	Cancer	nn	3	SENT_282	[p13l1104t3304r1272b3344],
3	Res	NNP	O	Res	_	0	SENT_282	[p13l1288t3304r1373b3347],
4	2012	CD	DATE	2012	num	3	SENT_282	[p13l1393t3304r1772b3353],
5	;	:	O	;	_	0	SENT_282	[p13l1393t3304r1772b3353],
6	18:4570	CD	NUMBER	18:4570	number	7	SENT_282	[p13l1393t3304r1772b3353],
7	-9	CD	NUMBER	-9	dep	3	SENT_282	[p13l1393t3304r1772b3353],
8	.	.	O	.	_	0	SENT_282	[p13l1393t3304r1772b3353],

1	13	CD	NUMBER	13	_	0	SENT_283	[p13l1106t3376r1168b3414],
2	.	.	O	.	_	0	SENT_283	[p13l1106t3376r1168b3414],

1	Shaw	NNP	ORGANIZATION	Shaw	nn	2	SENT_284	[p13l1200t3370r1328b3414],
2	AT	NNP	O	AT	_	0	SENT_284	[p13l1343t3374r1422b3423],
3	,	,	O	,	_	0	SENT_284	[p13l1343t3374r1422b3423],
4	Camidge	NNP	O	Camidge	nn	5	SENT_284	[p13l1445t3370r1659b3426],
5	DR	NN	O	dr	appos	2	SENT_284	[p13l1679t3374r1767b3423],
6	,	,	O	,	_	0	SENT_284	[p13l1679t3374r1767b3423],
7	Engelman	NNP	PERSON	Engelman	nn	8	SENT_284	[p13l1789t3371r2035b3426],
8	JA	NNP	O	JA	appos	2	SENT_284	[p13l2050t3374r2119b3423],
9	,	,	O	,	_	0	SENT_284	[p13l2050t3374r2119b3423],
10	et	FW	O	et	nn	11	SENT_284	[p13l1104t3449r1147b3484],
11	al.	FW	O	al.	appos	2	SENT_284	[p13l1168t3441r1222b3484],
12	.	.	O	.	_	0	SENT_284	[p13l1168t3441r1222b3484],

1	Clinical	JJ	O	clinical	amod	2	SENT_285	[p13l1250t3440r1434b3484],
2	activity	NN	O	activity	_	0	SENT_285	[p13l1458t3441r1629b3496],
3	of	IN	O	of	_	0	SENT_285	[p13l1651t3440r1707b3484],
4	crizotinib	NN	O	crizotinib	prep_of	2	SENT_285	[p13l1722t3441r1954b3484],
5	in	IN	O	in	_	0	SENT_285	[p13l1979t3441r2025b3483],
6	advanced	JJ	O	advanced	amod	12	SENT_285	[p13l2049t3440r2121b3484, p13l1101t3510r1266b3554],
7	non-small	JJ	O	non-small	amod	12	SENT_285	[p13l1279t3511r1521b3554],
8	cell	NN	O	cell	nn	12	SENT_285	[p13l1535t3511r1615b3554],
9	lung	NN	O	lung	nn	12	SENT_285	[p13l1629t3510r1736b3566],
10	cancer	NN	O	cancer	nn	12	SENT_285	[p13l1748t3524r1904b3554],
11	(	CD	NUMBER	(	num	12	SENT_285	[p13l1918t3514r2119b3561],
12	NSCLC	NN	O	nsclc	prep_in	4	SENT_285	[p13l1918t3514r2119b3561],
13	)	CD	NUMBER	)	dep	2	SENT_285	[p13l1918t3514r2119b3561],
14	harboring	VBG	O	harbor	partmod	2	SENT_285	[p13l1104t3581r1348b3636],
15	ROS1	NN	O	ros1	nn	17	SENT_285	[p13l1398t3584r1529b3627],
16	gene	NN	O	gene	nn	17	SENT_285	[p13l1581t3595r1693b3636],
17	rearrangement	NN	O	rearrangement	dobj	14	SENT_285	[p13l1745t3589r2119b3636],
18	.	.	O	.	_	0	SENT_285	[p13l1745t3589r2119b3636],

1	Presented	VBN	O	present	_	0	SENT_286	[p13l1103t3650r1339b3694],
2	at	IN	O	at	_	0	SENT_286	[p13l1367t3659r1412b3694],
3	the	DT	O	the	det	4	SENT_286	[p13l1438t3651r1512b3694],
4	Annual	JJ	SET	annual	prep_at	1	SENT_286	[p13l1539t3650r1717b3694],
5	Meeting	VBG	O	meet	partmod	4	SENT_286	[p13l1744t3651r1945b3706],
6	of	IN	O	of	_	0	SENT_286	[p13l1972t3650r2028b3694],
7	the	DT	O	the	det	9	SENT_286	[p13l2047t3650r2122b3694],
8	American	NNP	ORGANIZATION	American	nn	9	SENT_286	[p13l1102t3721r1338b3764],
9	Society	NNP	ORGANIZATION	Society	prep_of	5	SENT_286	[p13l1373t3721r1545b3776],
10	of	IN	ORGANIZATION	of	_	0	SENT_286	[p13l1577t3720r1633b3764],
11	Clinical	JJ	ORGANIZATION	clinical	amod	12	SENT_286	[p13l1656t3721r1844b3764],
12	Oncology	NN	ORGANIZATION	oncology	prep_of	9	SENT_286	[p13l1877t3720r2119b3776],
13	,	,	O	,	_	0	SENT_286	[p13l1877t3720r2119b3776],

1	Identification	NN	O	identification	_	0	SENT_287	[p14l11t14r344b58],
2	of	IN	O	of	_	0	SENT_287	[p14l364t14r420b58],
3	the	DT	O	the	det	7	SENT_287	[p14l429t14r504b58],
4	transforming	VBG	O	transform	amod	7	SENT_287	[p14l524t14r851b70],
5	EML4ALK	NN	O	eml4alk	nn	7	SENT_287	[p14l868t18r1028b58, p14l9t88r116b129],
6	fusion	NN	O	fusion	nn	7	SENT_287	[p14l144t84r296b128],
7	gene	NN	O	gene	prep_of	1	SENT_287	[p14l325t99r437b140],
8	in	IN	O	in	_	0	SENT_287	[p14l467t85r513b127],
9	non	JJ	O	non	amod	13	SENT_287	[p14l543t84r893b128],
10	—	JJ	O	—	amod	13	SENT_287	[p14l543t84r893b128],
11	small-cell	NN	O	small-cell	nn	13	SENT_287	[p14l543t84r893b128],
12	lung	NN	O	lung	nn	13	SENT_287	[p14l922t85r1031b140],
13	cancer	NN	O	cancer	prep_in	1	SENT_287	[p14l12t169r180b198],
14	.	.	O	.	_	0	SENT_287	[p14l12t169r180b198],

1	Nature	NNP	O	Nature	_	0	SENT_288	[p14l201t158r367b198],
2	2007	CD	DATE	2007	num	1	SENT_288	[p14l386t158r766b207],
3	;	:	O	;	_	0	SENT_288	[p14l386t158r766b207],
4	448:561	CD	NUMBER	448:561	number	5	SENT_288	[p14l386t158r766b207],
5	-6	CD	NUMBER	-6	dep	1	SENT_288	[p14l386t158r766b207],
6	.	.	O	.	_	0	SENT_288	[p14l386t158r766b207],

1	6	CD	NUMBER	6	_	0	SENT_289	[p14l11t230r50b268],
2	.	.	O	.	_	0	SENT_289	[p14l11t230r50b268],

1	Rikova	NN	PERSON	rikova	nn	2	SENT_290	[p14l105t225r271b271],
2	K	NN	PERSON	k	_	0	SENT_290	[p14l288t228r337b277],
3	,	,	O	,	_	0	SENT_290	[p14l288t228r337b277],
4	Guo	NNP	O	Guo	nn	5	SENT_290	[p14l358t228r458b268],
5	A	NNP	O	A	appos	2	SENT_290	[p14l475t228r524b277],
6	,	,	O	,	_	0	SENT_290	[p14l475t228r524b277],
7	Zeng	NNP	O	Zeng	nn	8	SENT_290	[p14l545t228r666b280],
8	Q	NNP	O	Q	appos	2	SENT_290	[p14l682t228r736b278],
9	,	,	O	,	_	0	SENT_290	[p14l682t228r736b278],
10	et	FW	O	et	nn	11	SENT_290	[p14l758t233r801b268],
11	al.	FW	O	al.	appos	2	SENT_290	[p14l817t224r872b268],
12	.	.	O	.	_	0	SENT_290	[p14l817t224r872b268],

1	Global	JJ	O	global	amod	2	SENT_291	[p14l893t225r1028b268, p14l11t295r53b338],
2	survey	NN	O	survey	nsubj	6	SENT_291	[p14l89t309r243b350],
3	of	IN	O	of	_	0	SENT_291	[p14l277t294r333b338],
4	phosphotyrosine	NN	O	phosphotyrosine	nn	5	SENT_291	[p14l357t294r766b350],
5	signaling	NN	O	signaling	prep_of	2	SENT_291	[p14l803t295r1031b350],
6	identifies	VBZ	O	identify	_	0	SENT_291	[p14l11t364r239b408],
7	oncogenic	JJ	O	oncogenic	amod	8	SENT_291	[p14l261t365r509b420],
8	kinases	NNS	O	kinase	dobj	6	SENT_291	[p14l529t364r710b408],
9	in	IN	O	in	_	0	SENT_291	[p14l732t365r779b407],
10	lung	NN	O	lung	nn	11	SENT_291	[p14l799t365r908b420],
11	cancer	NN	O	cancer	prep_in	8	SENT_291	[p14l927t378r1028b408, p14l12t449r94b478],
12	.	.	O	.	_	0	SENT_291	[p14l927t378r1028b408, p14l12t449r94b478],

1	Cell	NN	O	cell	_	0	SENT_292	[p14l116t435r209b478],
2	2007	CD	DATE	2007	num	1	SENT_292	[p14l228t438r691b487],
3	;	:	O	;	_	0	SENT_292	[p14l228t438r691b487],
4	131:1190	CD	NUMBER	131:1190	number	5	SENT_292	[p14l228t438r691b487],
5	-203	CD	NUMBER	-203	dep	1	SENT_292	[p14l228t438r691b487],
6	.	.	O	.	_	0	SENT_292	[p14l228t438r691b487],

1	7	CD	NUMBER	7	_	0	SENT_293	[p14l12t510r45b548],
2	.	.	O	.	_	0	SENT_293	[p14l12t510r45b548],

1	Demetri	NNP	PERSON	Demetri	nn	2	SENT_294	[p14l105t505r304b548],
2	GD	NN	O	gd	_	0	SENT_294	[p14l320t508r410b557],
3	,	,	O	,	_	0	SENT_294	[p14l320t508r410b557],
4	Reichardt	NNP	PERSON	Reichardt	nn	5	SENT_294	[p14l429t505r665b551],
5	P	NN	PERSON	p	appos	2	SENT_294	[p14l678t508r715b557],
6	,	,	O	,	_	0	SENT_294	[p14l678t508r715b557],
7	Kang	NNP	PERSON	Kang	nn	8	SENT_294	[p14l733t508r862b560],
8	Y-K	NNP	PERSON	Y-K	appos	2	SENT_294	[p14l874t508r969b557],
9	,	,	O	,	_	0	SENT_294	[p14l874t508r969b557],
10	et	FW	O	et	nn	11	SENT_294	[p14l989t513r1032b548],
11	al.	FW	O	al.	appos	2	SENT_294	[p14l11t575r66b618],
12	.	.	O	.	_	0	SENT_294	[p14l11t575r66b618],

1	Efficacy	NN	O	efficacy	_	0	SENT_295	[p14l92t574r288b630],
2	and	CC	O	and	_	0	SENT_295	[p14l309t574r398b618],
3	safety	NN	O	safety	conj_and	1	SENT_295	[p14l422t574r565b630],
4	of	IN	O	of	_	0	SENT_295	[p14l586t574r643b618],
5	regorafenib	NN	O	regorafenib	prep_of	1	SENT_295	[p14l656t574r937b630],
6	for	IN	O	for	_	0	SENT_295	[p14l962t574r1031b618],
7	advanced	JJ	O	advanced	amod	10	SENT_295	[p14l11t644r226b688],
8	gastrointestinal	JJ	O	gastrointestinal	amod	10	SENT_295	[p14l244t644r612b700],
9	stromal	JJ	O	stromal	amod	10	SENT_295	[p14l632t645r812b688],
10	tumours	NNS	O	tumour	prep_for	5	SENT_295	[p14l830t653r1028b688],
11	after	IN	O	after	_	0	SENT_295	[p14l11t715r125b759],
12	failure	NN	O	failure	prep_after	10	SENT_295	[p14l161t715r317b759],
13	of	IN	O	of	_	0	SENT_295	[p14l355t715r411b759],
14	imatinib	NN	O	imatinib	prep_of	12	SENT_295	[p14l438t716r646b759],
15	and	CC	O	and	_	0	SENT_295	[p14l683t715r772b759],
16	sunitinib	NN	O	sunitinib	prep_after	10	SENT_295	[p14l810t715r1028b759],
17	(	CD	NUMBER	(	num	16	SENT_295	[p14l14t789r196b836],
18	GRID	NN	O	grid	dep	16	SENT_295	[p14l14t789r196b836],
19	)	CD	NUMBER	)	num	18	SENT_295	[p14l14t789r196b836],
20	:	:	O	:	_	0	SENT_295	[p14l14t789r196b836],
21	an	DT	O	a	det	30	SENT_295	[p14l245t800r303b829],
22	international	JJ	O	international	amod	28	SENT_295	[p14l351t785r682b838],
23	,	,	O	,	_	0	SENT_295	[p14l351t785r682b838],
24	multicentre	JJ	O	multicentre	amod	28	SENT_295	[p14l733t786r1026b838],
25	,	,	O	,	_	0	SENT_295	[p14l733t786r1026b838],
26	randomised	JJ	O	randomised	amod	28	SENT_295	[p14l11t855r314b908],
27	,	,	O	,	_	0	SENT_295	[p14l11t855r314b908],
28	placebo-controlled	JJ	O	placebo-controlled	amod	30	SENT_295	[p14l340t855r812b911],
29	,	,	O	,	_	0	SENT_295	[p14l340t855r812b911],
30	phase	NN	O	phase	dep	1	SENT_295	[p14l838t855r978b911],
31	3	CD	NUMBER	3	num	32	SENT_295	[p14l1003t859r1027b899],
32	trial	NN	O	trial	dep	30	SENT_295	[p14l11t926r125b969],
33	.	.	O	.	_	0	SENT_295	[p14l11t926r125b969],

1	Lancet	NNP	O	Lancet	_	0	SENT_296	[p14l147t929r308b969],
2	2013	CD	DATE	2013	num	1	SENT_296	[p14l325t929r764b978],
3	;	:	O	;	_	0	SENT_296	[p14l325t929r764b978],
4	381:295	CD	NUMBER	381:295	number	5	SENT_296	[p14l325t929r764b978],
5	-302	CD	NUMBER	-302	dep	1	SENT_296	[p14l325t929r764b978],
6	.	.	O	.	_	0	SENT_296	[p14l325t929r764b978],

1	8	CD	NUMBER	8	_	0	SENT_297	[p14l11t1000r50b1039],
2	.	.	O	.	_	0	SENT_297	[p14l11t1000r50b1039],

1	Cortes	NNP	O	Cortes	nn	2	SENT_298	[p14l106t999r262b1039],
2	JE	NNP	O	JE	_	0	SENT_298	[p14l282t999r348b1048],
3	,	,	O	,	_	0	SENT_298	[p14l282t999r348b1048],
4	Kantarjian	NNP	O	Kantarjian	nn	5	SENT_298	[p14l375t996r633b1051],
5	H	NNP	O	H	appos	2	SENT_298	[p14l657t999r711b1048],
6	,	,	O	,	_	0	SENT_298	[p14l657t999r711b1048],
7	Shah	NNP	PERSON	Shah	nn	8	SENT_298	[p14l739t995r857b1039],
8	NP	NNP	O	NP	appos	2	SENT_298	[p14l880t999r961b1048],
9	,	,	O	,	_	0	SENT_298	[p14l880t999r961b1048],
10	et	FW	O	et	nn	11	SENT_298	[p14l989t1004r1032b1039],
11	al.	FW	O	al.	appos	2	SENT_298	[p14l11t1066r66b1109],
12	.	.	O	.	_	0	SENT_298	[p14l11t1066r66b1109],

1	Ponatinib	NNP	O	Ponatinib	_	0	SENT_299	[p14l103t1066r338b1109],
2	in	IN	O	in	_	0	SENT_299	[p14l373t1066r420b1108],
3	refractory	JJ	O	refractory	amod	8	SENT_299	[p14l455t1065r695b1121],
4	Philadelphia	NN	LOCATION	philadelphium	nn	8	SENT_299	[p14l727t1065r1030b1121],
5	chromosome	NN	O	chromosome	nn	8	SENT_299	[p14l12t1135r549b1191],
6	—	CD	NUMBER	—	num	8	SENT_299	[p14l12t1135r549b1191],
7	positive	JJ	O	positive	amod	8	SENT_299	[p14l12t1135r549b1191],
8	leukemias	NNS	O	leukemia	prep_in	1	SENT_299	[p14l572t1135r832b1179],
9	.	.	O	.	_	0	SENT_299	[p14l572t1135r832b1179],

1	N	NN	O	n	nn	3	SENT_300	[p14l857t1139r899b1179],
2	Engl	NNP	O	Engl	nn	3	SENT_300	[p14l921t1135r1029b1191],
3	J	NNP	O	J	nsubj	4	SENT_300	[p14l6t1209r26b1256],
4	Med	VBD	O	med	_	0	SENT_300	[p14l43t1205r147b1249],
5	2012	CD	DATE	2012	dobj	4	SENT_300	[p14l166t1209r605b1258],
6	;	:	O	;	_	0	SENT_300	[p14l166t1209r605b1258],
7	367:2075	CD	NUMBER	367:2075	num	8	SENT_300	[p14l166t1209r605b1258],
8	-88	CD	NUMBER	-88	dep	5	SENT_300	[p14l166t1209r605b1258],
9	.	.	O	.	_	0	SENT_300	[p14l166t1209r605b1258],

1	9	CD	NUMBER	9	_	0	SENT_301	[p14l11t1280r48b1319],
2	.	.	O	.	_	0	SENT_301	[p14l11t1280r48b1319],

1	Kwak	NNP	PERSON	Kwak	nn	2	SENT_302	[p14l106t1276r241b1320],
2	EL	NNP	O	EL	_	0	SENT_302	[p14l254t1279r328b1328],
3	,	,	O	,	_	0	SENT_302	[p14l254t1279r328b1328],
4	Bang	NNP	O	Bang	nn	5	SENT_302	[p14l347t1279r471b1331],
5	Y-J	NNP	O	Y-J	appos	2	SENT_302	[p14l484t1279r557b1328],
6	,	,	O	,	_	0	SENT_302	[p14l484t1279r557b1328],
7	Camidge	NNP	O	Camidge	nn	8	SENT_302	[p14l577t1275r791b1331],
8	DR	NN	O	dr	appos	2	SENT_302	[p14l807t1279r895b1328],
9	,	,	O	,	_	0	SENT_302	[p14l807t1279r895b1328],
10	et	FW	O	et	nn	11	SENT_302	[p14l915t1284r958b1319],
11	al.	FW	O	al.	appos	2	SENT_302	[p14l971t1276r1026b1319],
12	.	.	O	.	_	0	SENT_302	[p14l971t1276r1026b1319],

1	Anaplastic	JJ	O	anaplastic	amod	4	SENT_303	[p14l9t1346r262b1401],
2	lymphoma	NN	O	lymphoma	nn	4	SENT_303	[p14l280t1345r535b1401],
3	kinase	NN	O	kinase	nn	4	SENT_303	[p14l553t1346r707b1389],
4	inhibition	NN	O	inhibition	_	0	SENT_303	[p14l727t1346r964b1389],
5	in	IN	O	in	_	0	SENT_303	[p14l983t1346r1029b1388],
6	non	JJ	O	non	amod	10	SENT_303	[p14l11t1415r366b1459],
7	—	JJ	O	—	amod	10	SENT_303	[p14l11t1415r366b1459],
8	small-cell	NN	O	small-cell	nn	10	SENT_303	[p14l11t1415r366b1459],
9	lung	NN	O	lung	nn	10	SENT_303	[p14l387t1416r494b1471],
10	cancer	NN	O	cancer	prep_in	4	SENT_303	[p14l514t1429r679b1459],
11	.	.	O	.	_	0	SENT_303	[p14l514t1429r679b1459],

1	N	NN	O	n	nn	3	SENT_304	[p14l702t1419r744b1459],
2	Engl	NNP	O	Engl	nn	3	SENT_304	[p14l764t1416r871b1471],
3	J	NNP	O	J	nsubj	4	SENT_304	[p14l887t1419r908b1466],
4	Med	VBD	O	med	_	0	SENT_304	[p14l926t1415r1029b1459],
5	2010	CD	DATE	2010	dobj	4	SENT_304	[p14l11t1489r470b1538],
6	;	:	O	;	_	0	SENT_304	[p14l11t1489r470b1538],
7	363:1693	CD	NUMBER	363:1693	num	8	SENT_304	[p14l11t1489r470b1538],
8	-703	CD	NUMBER	-703	dep	5	SENT_304	[p14l11t1489r470b1538],
9	.	.	O	.	_	0	SENT_304	[p14l11t1489r470b1538],

1	Chicago	NNP	LOCATION	Chicago	_	0	SENT_305	[p14l1104t15r1312b70],
2	,	,	O	,	_	0	SENT_305	[p14l1104t15r1312b70],
3	June	NNP	DATE	June	appos	1	SENT_305	[p14l1329t18r1438b65],
4	1-5	CD	DATE	1-5	num	3	SENT_305	[p14l1459t18r1552b67],
5	,	,	DATE	,	_	0	SENT_305	[p14l1459t18r1552b67],
6	2012	CD	DATE	2012	num	3	SENT_305	[p14l1574t18r1703b58],
7	.	.	O	.	_	0	SENT_305	[p14l1574t18r1703b58],

1	abstract	JJ	O	abstract	_	0	SENT_306	[p14l1724t15r1931b58],
2	.	.	O	.	_	0	SENT_306	[p14l1724t15r1931b58],

1	14	CD	NUMBER	14	_	0	SENT_307	[p14l1106t90r1168b128],
2	.	.	O	.	_	0	SENT_307	[p14l1106t90r1168b128],

1	Choi	NNP	PERSON	Choi	nn	2	SENT_308	[p14l1199t85r1310b128],
2	YL	NNP	PERSON	YL	_	0	SENT_308	[p14l1331t88r1406b137],
3	,	,	O	,	_	0	SENT_308	[p14l1331t88r1406b137],
4	Soda	NNP	O	Soda	nn	5	SENT_308	[p14l1435t84r1550b128],
5	M	NNP	O	M	appos	2	SENT_308	[p14l1572t88r1632b137],
6	,	,	O	,	_	0	SENT_308	[p14l1572t88r1632b137],
7	Yamashita	NNP	PERSON	Yamashita	nn	8	SENT_308	[p14l1657t84r1911b128],
8	Y	NN	PERSON	y	appos	2	SENT_308	[p14l1932t88r1973b137],
9	,	,	O	,	_	0	SENT_308	[p14l1932t88r1973b137],
10	et	FW	O	et	nn	11	SENT_308	[p14l2000t93r2043b128],
11	al.	FW	O	al.	appos	2	SENT_308	[p14l2064t85r2119b128],
12	.	.	O	.	_	0	SENT_308	[p14l2064t85r2119b128],

1	EML4-ALK	NN	O	eml4-alk	nn	2	SENT_309	[p14l1103t158r1370b199],
2	mutations	NNS	O	mutation	_	0	SENT_309	[p14l1389t155r1634b198],
3	in	IN	O	in	_	0	SENT_309	[p14l1655t155r1702b197],
4	lung	NN	O	lung	nn	5	SENT_309	[p14l1722t155r1831b210],
5	cancer	NN	O	cancer	prep_in	2	SENT_309	[p14l1850t169r2008b198],
6	that	WDT	O	that	nsubj	7	SENT_309	[p14l2027t154r2125b198],
7	confer	VBP	O	confer	rcmod	5	SENT_309	[p14l1104t224r1255b268],
8	resistance	NN	O	resistance	dobj	7	SENT_309	[p14l1269t225r1505b268],
9	to	TO	O	to	_	0	SENT_309	[p14l1520t233r1565b268],
10	ALK	NN	O	alk	nn	11	SENT_309	[p14l1579t228r1684b269],
11	inhibitors	NNS	O	inhibitor	prep_to	7	SENT_309	[p14l1697t225r1943b268],
12	.	.	O	.	_	0	SENT_309	[p14l1697t225r1943b268],

1	N	NN	O	n	nn	3	SENT_310	[p14l1960t228r2001b268],
2	Engl	NNP	O	Engl	nn	3	SENT_310	[p14l2014t225r2122b280],
3	J	NNP	O	J	nsubj	4	SENT_310	[p14l1098t298r1119b345],
4	Med	VBD	O	med	_	0	SENT_310	[p14l1135t295r1240b338],
5	2010	CD	DATE	2010	dobj	4	SENT_310	[p14l1259t298r1666b347],
6	;	:	O	;	_	0	SENT_310	[p14l1259t298r1666b347],
7	363:1734	CD	NUMBER	363:1734	num	8	SENT_310	[p14l1259t298r1666b347],
8	-9	CD	NUMBER	-9	dep	5	SENT_310	[p14l1259t298r1666b347],
9	.	.	O	.	_	0	SENT_310	[p14l1259t298r1666b347],

1	15	CD	NUMBER	15	_	0	SENT_311	[p14l1106t370r1167b408],
2	.	.	O	.	_	0	SENT_311	[p14l1106t370r1167b408],

1	Katayama	NNP	PERSON	Katayama	nn	2	SENT_312	[p14l1198t368r1438b420],
2	R	NNP	PERSON	R	_	0	SENT_312	[p14l1463t368r1512b417],
3	,	,	O	,	_	0	SENT_312	[p14l1463t368r1512b417],
4	Shaw	NNP	ORGANIZATION	Shaw	nn	5	SENT_312	[p14l1543t364r1671b408],
5	AT	NNP	O	AT	appos	2	SENT_312	[p14l1693t368r1771b417],
6	,	,	O	,	_	0	SENT_312	[p14l1693t368r1771b417],
7	Khan	NNP	PERSON	Khan	nn	8	SENT_312	[p14l1801t364r1932b409],
8	TM	NNP	O	TM	appos	2	SENT_312	[p14l1957t368r2051b417],
9	,	,	O	,	_	0	SENT_312	[p14l1957t368r2051b417],
10	et	FW	O	et	nn	11	SENT_312	[p14l2081t373r2125b408],
11	al.	FW	O	al.	appos	2	SENT_312	[p14l1103t435r1158b478],
12	.	.	O	.	_	0	SENT_312	[p14l1103t435r1158b478],

1	Mechanisms	NNS	O	mechanism	_	0	SENT_313	[p14l1179t435r1486b478],
2	of	IN	O	of	_	0	SENT_313	[p14l1507t434r1562b478],
3	acquired	VBN	O	acquire	amod	5	SENT_313	[p14l1571t434r1780b490],
4	crizotinib	JJ	O	crizotinib	amod	5	SENT_313	[p14l1800t435r2037b478],
5	resistance	NN	O	resistance	prep_of	1	SENT_313	[p14l2058t449r2121b478, p14l1105t505r1298b548],
6	in	IN	O	in	_	0	SENT_313	[p14l1319t505r1366b547],
7	ALK-rearranged	JJ	O	alk-rearranged	amod	9	SENT_313	[p14l1385t504r1774b560],
8	lung	NN	O	lung	nn	9	SENT_313	[p14l1795t505r1903b560],
9	cancers	NNS	O	cancer	prep_in	5	SENT_313	[p14l1923t519r2118b548],
10	.	.	O	.	_	0	SENT_313	[p14l1923t519r2118b548],

1	Sci	NNP	O	Sci	nn	3	SENT_314	[p14l1105t575r1172b618],
2	Transl	NNP	O	Transl	nn	3	SENT_314	[p14l1189t575r1343b618],
3	Med	NNP	O	Med	_	0	SENT_314	[p14l1360t574r1464b618],
4	2012	CD	DATE	2012	num	3	SENT_314	[p14l1483t578r1861b627],
5	;	:	O	;	_	0	SENT_314	[p14l1483t578r1861b627],
6	4:120	CD	NUMBER	4:120	num	7	SENT_314	[p14l1483t578r1861b627],
7	ra17	NN	O	ra17	dep	3	SENT_314	[p14l1483t578r1861b627],
8	.	.	O	.	_	0	SENT_314	[p14l1483t578r1861b627],

1	16	CD	NUMBER	16	_	0	SENT_315	[p14l1106t650r1168b688],
2	.	.	O	.	_	0	SENT_315	[p14l1106t650r1168b688],

1	Doebele	NNP	O	Doebele	nn	2	SENT_316	[p14l1198t645r1393b688],
2	RC	NNP	O	RC	_	0	SENT_316	[p14l1412t648r1495b697],
3	,	,	O	,	_	0	SENT_316	[p14l1412t648r1495b697],
4	Pilling	NNP	ORGANIZATION	Pilling	nn	5	SENT_316	[p14l1517t645r1679b700],
5	AB	NNP	ORGANIZATION	AB	appos	2	SENT_316	[p14l1695t648r1779b697],
6	,	,	O	,	_	0	SENT_316	[p14l1695t648r1779b697],
7	Aisner	NNP	PERSON	Aisner	nn	8	SENT_316	[p14l1800t645r1958b688],
8	DL	NNP	O	DL	appos	2	SENT_316	[p14l1976t648r2057b697],
9	,	,	O	,	_	0	SENT_316	[p14l1976t648r2057b697],
10	et	FW	O	et	nn	11	SENT_316	[p14l2081t653r2124b688],
11	al.	FW	O	al.	appos	2	SENT_316	[p14l1103t716r1158b759],
12	.	.	O	.	_	0	SENT_316	[p14l1103t716r1158b759],

1	Mechanisms	NNS	O	mechanism	_	0	SENT_317	[p14l1175t716r1483b759],
2	of	IN	O	of	_	0	SENT_317	[p14l1500t715r1556b759],
3	resistance	NN	O	resistance	prep_of	1	SENT_317	[p14l1562t716r1804b759],
4	to	TO	O	to	_	0	SENT_317	[p14l1821t724r1866b759],
5	crizotinib	NN	O	crizotinib	prep_to	1	SENT_317	[p14l1883t716r2121b759],
6	in	IN	O	in	_	0	SENT_317	[p14l1103t786r1149b828],
7	patients	NNS	O	patient	prep_in	1	SENT_317	[p14l1165t786r1353b841],
8	with	IN	O	with	_	0	SENT_317	[p14l1368t786r1476b829],
9	ALK	NN	O	alk	nn	10	SENT_317	[p14l1490t789r1596b830],
10	gene	NN	O	gene	prep_with	1	SENT_317	[p14l1610t799r1720b841],
11	rearranged	VBN	O	rearrange	partmod	1	SENT_317	[p14l1736t785r1997b841],
12	nonsmall	JJ	O	nonsmall	amod	15	SENT_317	[p14l2013t799r2121b829, p14l1105t856r1236b899],
13	cell	NN	O	cell	nn	15	SENT_317	[p14l1265t856r1348b899],
14	lung	NN	O	lung	nn	15	SENT_317	[p14l1376t856r1484b911],
15	cancer	NN	O	cancer	dobj	11	SENT_317	[p14l1512t870r1681b899],
16	.	.	O	.	_	0	SENT_317	[p14l1512t870r1681b899],

1	Clin	NNP	O	Clin	nn	3	SENT_318	[p14l1713t856r1812b899],
2	Cancer	NNP	O	Cancer	nn	3	SENT_318	[p14l1841t859r2010b899],
3	Res	NNP	O	Res	_	0	SENT_318	[p14l2036t859r2120b902],
4	2012	CD	DATE	2012	num	3	SENT_318	[p14l1104t929r1508b978],
5	;	:	O	;	_	0	SENT_318	[p14l1104t929r1508b978],
6	18:1472	CD	NUMBER	18:1472	number	7	SENT_318	[p14l1104t929r1508b978],
7	—	CD	NUMBER	—	dep	3	SENT_318	[p14l1104t929r1508b978],
8	82	CD	NUMBER	82	dep	7	SENT_318	[p14l1104t929r1508b978],
9	.	.	O	.	_	0	SENT_318	[p14l1104t929r1508b978],

1	17	CD	NUMBER	17	_	0	SENT_319	[p14l1106t1001r1163b1039],
2	.	.	O	.	_	0	SENT_319	[p14l1106t1001r1163b1039],

1	Katayama	NNP	PERSON	Katayama	nn	2	SENT_320	[p14l1198t999r1438b1051],
2	R	NNP	PERSON	R	_	0	SENT_320	[p14l1453t999r1502b1048],
3	,	,	O	,	_	0	SENT_320	[p14l1453t999r1502b1048],
4	Khan	NNP	PERSON	Khan	nn	5	SENT_320	[p14l1521t996r1652b1040],
5	TM	NNP	O	TM	appos	2	SENT_320	[p14l1667t999r1761b1048],
6	,	,	O	,	_	0	SENT_320	[p14l1667t999r1761b1048],
7	Benes	NNP	PERSON	Benes	nn	8	SENT_320	[p14l1780t999r1921b1039],
8	C	NNP	O	C	appos	2	SENT_320	[p14l1939t999r1986b1048],
9	,	,	O	,	_	0	SENT_320	[p14l1939t999r1986b1048],
10	et	FW	O	et	nn	11	SENT_320	[p14l2006t1004r2050b1039],
11	al.	FW	O	al.	appos	2	SENT_320	[p14l2064t996r2119b1039],
12	.	.	O	.	_	0	SENT_320	[p14l2064t996r2119b1039],

1	Therapeutic	JJ	O	therapeutic	amod	2	SENT_321	[p14l1102t1065r1391b1121],
2	strategies	NNS	O	strategy	nsubj	4	SENT_321	[p14l1412t1066r1643b1121],
3	to	TO	O	to	aux	4	SENT_321	[p14l1665t1074r1710b1109],
4	overcome	VB	O	overcome	_	0	SENT_321	[p14l1731t1079r1961b1109],
5	crizotinib	JJ	O	crizotinib	amod	6	SENT_321	[p14l1981t1066r2121b1109, p14l1104t1136r1218b1179],
6	resistance	NN	O	resistance	dobj	4	SENT_321	[p14l1254t1136r1497b1179],
7	in	IN	O	in	_	0	SENT_321	[p14l1532t1136r1579b1178],
8	non-small	JJ	O	non-small	amod	11	SENT_321	[p14l1615t1136r1861b1179],
9	cell	NN	O	cell	nn	11	SENT_321	[p14l1897t1135r1979b1179],
10	lung	NN	O	lung	nn	11	SENT_321	[p14l2014t1135r2123b1191],
11	cancers	NNS	O	cancer	prep_in	4	SENT_321	[p14l1104t1219r1285b1249],
12	harboring	VBG	O	harbor	partmod	11	SENT_321	[p14l1320t1206r1565b1261],
13	the	DT	O	the	det	16	SENT_321	[p14l1597t1206r1671b1249],
14	fusion	NN	O	fusion	nn	16	SENT_321	[p14l1705t1205r1857b1249],
15	oncogene	NN	O	oncogene	nn	16	SENT_321	[p14l1891t1219r2122b1261],
16	EML4-ALK	NN	O	eml4-alk	dobj	12	SENT_321	[p14l1103t1279r1382b1320],
17	.	.	O	.	_	0	SENT_321	[p14l1103t1279r1382b1320],

1	Proc	NNP	ORGANIZATION	Proc	nn	7	SENT_322	[p14l1420t1279r1527b1319],
2	Natl	NNP	ORGANIZATION	Natl	nn	7	SENT_322	[p14l1561t1275r1663b1319],
3	Acad	NNP	ORGANIZATION	Acad	nn	7	SENT_322	[p14l1697t1275r1816b1319],
4	Sci	NNP	ORGANIZATION	Sci	nn	7	SENT_322	[p14l1853t1276r1919b1319],
5	U	NNP	ORGANIZATION	U	nn	7	SENT_322	[p14l1954t1279r1992b1319],
6	S	NNP	ORGANIZATION	S	nn	7	SENT_322	[p14l2028t1279r2052b1319],
7	A	NNP	O	A	_	0	SENT_322	[p14l2086t1279r2123b1318],
8	2011	CD	DATE	2011	num	7	SENT_322	[p14l1104t1349r1540b1398],
9	;	:	O	;	_	0	SENT_322	[p14l1104t1349r1540b1398],
10	108:7535	CD	NUMBER	108:7535	number	11	SENT_322	[p14l1104t1349r1540b1398],
11	-40	CD	NUMBER	-40	dep	7	SENT_322	[p14l1104t1349r1540b1398],
12	.	.	O	.	_	0	SENT_322	[p14l1104t1349r1540b1398],

1	18	CD	NUMBER	18	_	0	SENT_323	[p14l1106t1420r1169b1459],
2	.	.	O	.	_	0	SENT_323	[p14l1106t1420r1169b1459],

1	Sakamoto	NNP	PERSON	Sakamoto	nn	2	SENT_324	[p14l1200t1416r1440b1459],
2	H	NNP	PERSON	H	_	0	SENT_324	[p14l1465t1419r1519b1468],
3	,	,	O	,	_	0	SENT_324	[p14l1465t1419r1519b1468],
4	Tsukaguchi	NNP	ORGANIZATION	Tsukaguchi	nn	5	SENT_324	[p14l1544t1415r1826b1471],
5	T	NN	ORGANIZATION	t	appos	2	SENT_324	[p14l1849t1419r1892b1468],
6	,	,	O	,	_	0	SENT_324	[p14l1849t1419r1892b1468],
7	Hiroshima	NNP	LOCATION	Hiroshima	nn	8	SENT_324	[p14l1918t1416r2121b1459, p14l1104t1500r1178b1529],
8	S	NNP	O	S	appos	2	SENT_324	[p14l1204t1489r1241b1538],
9	,	,	O	,	_	0	SENT_324	[p14l1204t1489r1241b1538],
10	et	FW	O	et	nn	11	SENT_324	[p14l1270t1494r1314b1529],
11	al.	FW	O	al.	appos	2	SENT_324	[p14l1336t1486r1391b1529],
12	.	.	O	.	_	0	SENT_324	[p14l1336t1486r1391b1529],

1	CH5424802	NN	O	ch5424802	_	0	SENT_325	[p14l1419t1489r1713b1538],
2	,	,	O	,	_	0	SENT_325	[p14l1419t1489r1713b1538],
3	a	DT	O	a	det	5	SENT_325	[p14l1741t1500r1766b1529],
4	selective	JJ	O	selective	amod	5	SENT_325	[p14l1791t1486r1993b1529],
5	ALK	NN	O	alk	appos	1	SENT_325	[p14l2017t1490r2124b1530],

1	inhibitor	NN	O	inhibitor	_	0	SENT_326	[p14l92t1969r524b2057],
2	capable	JJ	O	capable	amod	1	SENT_326	[p14l556t1969r916b2081],
3	of	IN	O	of	_	0	SENT_326	[p14l950t1969r1063b2056],
4	blocking	VBG	O	block	prepc_of	2	SENT_326	[p14l1076t1971r1502b2081],
5	the	DT	O	the	det	8	SENT_326	[p14l1532t1969r1681b2056],
6	resistant	JJ	O	resistant	amod	8	SENT_326	[p14l1715t1971r2138b2056],
7	gatekeeper	NN	O	gatekeeper	nn	8	SENT_326	[p14l92t2111r621b2223],
8	mutant	NN	O	mutant	dobj	4	SENT_326	[p14l668t2130r1045b2199],
9	.	.	O	.	_	0	SENT_326	[p14l668t2130r1045b2199],

1	Cancer	NN	O	cancer	nn	2	SENT_327	[p14l1102t2118r1439b2198],
2	Cell	NN	O	cell	_	0	SENT_327	[p14l1487t2111r1675b2199],
3	2011	CD	DATE	2011	num	5	SENT_327	[p14l1725t2118r2128b2217],
4	;	:	O	;	_	0	SENT_327	[p14l1725t2118r2128b2217],
5	19	CD	NUMBER	19	dep	2	SENT_327	[p14l1725t2118r2128b2217],
6	:	:	O	:	_	0	SENT_327	[p14l1725t2118r2128b2217],

1	19	CD	NUMBER	19	_	0	SENT_328	[p14l97t2408r219b2485],
2	.	.	O	.	_	0	SENT_328	[p14l97t2408r219b2485],

1	Becker	NNP	PERSON	Becker	_	0	SENT_329	[p14l282t2399r1044b2485],
2	.	.	O	.	_	0	SENT_329	[p14l282t2399r1044b2485],

1	—	NN	O	—	_	0	SENT_330	[p14l282t2399r1044b2485],
2	.	.	O	.	_	0	SENT_330	[p14l282t2399r1044b2485],

1	Herman	NNP	PERSON	Herman	nn	2	SENT_331	[p14l282t2399r1044b2485],
2	S	NNP	PERSON	S	_	0	SENT_331	[p14l1133t2404r1209b2504],
3	,	,	O	,	_	0	SENT_331	[p14l1133t2404r1209b2504],
4	Arie	NNP	PERSON	Arie	nn	7	SENT_331	[p14l1298t2399r1500b2485],
5	G	NNP	PERSON	G	nn	7	SENT_331	[p14l1588t2404r1692b2504],
6	,	,	O	,	_	0	SENT_331	[p14l1588t2404r1692b2504],
7	Medve	NNP	O	Medve	appos	2	SENT_331	[p14l1782t2397r2130b2485],
8	—	CD	NUMBER	—	num	7	SENT_331	[p14l1782t2397r2130b2485],

1	dovsky	NN	O	dovsky	nn	2	SENT_332	[p14l93t2539r429b2651],
2	H	NN	O	h	_	0	SENT_332	[p14l468t2548r575b2645],
3	,	,	O	,	_	0	SENT_332	[p14l468t2548r575b2645],
4	Kerem	NNP	PERSON	Kerem	nn	5	SENT_332	[p14l624t2548r939b2628],
5	A	NNP	O	A	appos	2	SENT_332	[p14l979t2548r1078b2645],
6	,	,	O	,	_	0	SENT_332	[p14l979t2548r1078b2645],
7	Shachar	NNP	PERSON	Shachar	appos	5	SENT_332	[p14l1131t2539r1518b2626],
8	1	CD	NUMBER	1	num	7	SENT_332	[p14l1557t2548r1617b2626],
9	.	.	O	.	_	0	SENT_332	[p14l1557t2548r1617b2626],

1	CD74	NN	O	cd74	nsubj	4	SENT_333	[p14l1668t2546r1921b2626],
2	is	VBZ	O	be	cop	4	SENT_333	[p14l1964t2541r2039b2626],
3	a	DT	O	a	det	4	SENT_333	[p14l2084t2569r2134b2626],
4	member	NN	O	member	_	0	SENT_333	[p14l92t2681r495b2768],
5	of	IN	O	of	_	0	SENT_333	[p14l537t2681r649b2768],
6	the	DT	O	the	det	10	SENT_333	[p14l674t2683r824b2768],
7	regulated	VBN	O	regulate	amod	10	SENT_333	[p14l870t2681r1329b2793],
8	intramembrane	NN	O	intramembrane	nn	10	SENT_333	[p14l1374t2681r2132b2768],
9	proteolysis	NN	O	proteolysis	nn	10	SENT_333	[p14l91t2823r1143b2935],
10	—	NN	O	—	prep_of	4	SENT_333	[p14l91t2823r1143b2935],
11	processed	VBN	O	process	partmod	10	SENT_333	[p14l91t2823r1143b2935],
12	protein	NN	O	protein	nn	13	SENT_333	[p14l1182t2825r1534b2935],
13	family	NN	O	family	dobj	11	SENT_333	[p14l1576t2823r1902b2935],
14	.	.	O	.	_	0	SENT_333	[p14l1576t2823r1902b2935],

1	Mol	NNP	O	Mol	_	0	SENT_334	[p14l1945t2823r2132b2910],

1	Biol	NNP	O	Biol	nn	2	SENT_335	[p14l91t2968r278b3054],
2	Cell	NNP	O	Cell	_	0	SENT_335	[p14l316t2966r503b3054],
3	2005	CD	DATE	2005	num	2	SENT_335	[p14l541t2973r1295b3073],
4	;	:	O	;	_	0	SENT_335	[p14l541t2973r1295b3073],
5	16:5061	CD	NUMBER	16:5061	number	6	SENT_335	[p14l541t2973r1295b3073],
6	—	CD	NUMBER	—	dep	2	SENT_335	[p14l541t2973r1295b3073],
7	9	CD	NUMBER	9	dep	6	SENT_335	[p14l541t2973r1295b3073],
8	.	.	O	.	_	0	SENT_335	[p14l541t2973r1295b3073],

1	20	CD	NUMBER	20	_	0	SENT_336	[p14l91t3118r225b3196],
2	.	.	O	.	_	0	SENT_336	[p14l91t3118r225b3196],

1	Cui	NN	PERSON	cuus	nn	2	SENT_337	[p14l284t3111r446b3196],
2	J	NN	PERSON	j	_	0	SENT_337	[p14l492t3118r594b3215],
3	]	CD	NUMBER	]	dep	2	SENT_337	[p14l492t3118r594b3215],
4	,	,	O	,	_	0	SENT_337	[p14l492t3118r594b3215],
5	Tran	NNP	PERSON	Tran	appos	3	SENT_337	[p14l655t3107r1175b3196],
6	.	.	O	.	_	0	SENT_337	[p14l655t3107r1175b3196],

1	—	NN	O	—	_	0	SENT_338	[p14l655t3107r1175b3196],
2	.	.	O	.	_	0	SENT_338	[p14l655t3107r1175b3196],

1	Dubé	NNP	O	Dubé	nn	2	SENT_339	[p14l655t3107r1175b3196],
2	M	NNP	O	M	_	0	SENT_339	[p14l1230t3118r1352b3215],
3	,	,	O	,	_	0	SENT_339	[p14l1230t3118r1352b3215],
4	Shen	NNP	PERSON	Shen	nn	5	SENT_339	[p14l1418t3109r1648b3196],
5	H	NNP	PERSON	H	appos	2	SENT_339	[p14l1705t3118r1812b3215],
6	,	,	O	,	_	0	SENT_339	[p14l1705t3118r1812b3215],
7	et	FW	O	et	nn	8	SENT_339	[p14l1877t3128r1965b3196],
8	al.	FW	O	al.	appos	5	SENT_339	[p14l2016t3110r2126b3196],
9	.	.	O	.	_	0	SENT_339	[p14l2016t3110r2126b3196],

1	Structure	NN	O	structure	nsubj	2	SENT_340	[p14l95t3257r543b3338],
2	based	VBN	O	base	_	0	SENT_340	[p14l583t3250r859b3337],
3	drug	NN	O	drug	nn	4	SENT_340	[p14l900t3250r1129b3362],
4	design	NN	O	design	dobj	2	SENT_340	[p14l1165t3250r1483b3362],
5	of	IN	O	of	_	0	SENT_340	[p14l1523t3250r1635b3337],
6	crizotinib	NN	O	crizotinib	nn	8	SENT_340	[p14l1654t3252r2130b3337],
7	(	CD	NUMBER	(	num	8	SENT_340	[p14l97t3399r815b3498],
8	PF	NN	O	pf	prep_of	4	SENT_340	[p14l97t3399r815b3498],
9	—	CD	NUMBER	—	number	10	SENT_340	[p14l97t3399r815b3498],
10	02341066	CD	NUMBER	02341066	num	11	SENT_340	[p14l97t3399r815b3498],
11	)	NN	O	)	dep	8	SENT_340	[p14l97t3399r815b3498],
12	,	,	O	,	_	0	SENT_340	[p14l97t3399r815b3498],
13	a	DT	O	a	det	18	SENT_340	[p14l853t3422r903b3479],
14	potent	JJ	O	potent	amod	18	SENT_340	[p14l933t3411r1249b3504],
15	and	CC	O	and	_	0	SENT_340	[p14l1275t3392r1453b3479],
16	selective	JJ	O	selective	conj_and	14	SENT_340	[p14l1487t3394r1891b3480],
17	dual	JJ	O	dual	amod	18	SENT_340	[p14l1926t3392r2134b3480],
18	inhibitor	NN	O	inhibitor	appos	8	SENT_340	[p14l92t3534r524b3621],
19	of	IN	O	of	_	0	SENT_340	[p14l560t3534r672b3621],
20	mesenchymal-epithelial	JJ	O	mesenchymal-epithelial	amod	24	SENT_340	[p14l691t3534r1858b3646],
21	transition	NN	O	transition	nn	24	SENT_340	[p14l1896t3553r2130b3621, p14l94t3678r364b3763],
22	factor	NN	O	factor	nn	24	SENT_340	[p14l404t3676r688b3763],
23	(	CD	NUMBER	(	num	24	SENT_340	[p14l731t3683r1106b3777],
24	c	NN	O	c	prep_of	18	SENT_340	[p14l731t3683r1106b3777],
25	.	.	O	.	_	0	SENT_340	[p14l731t3683r1106b3777],

1	—	NN	O	—	_	0	SENT_341	[p14l731t3683r1106b3777],
2	.	.	O	.	_	0	SENT_341	[p14l731t3683r1106b3777],

1	MET	NN	O	met	nn	3	SENT_342	[p14l731t3683r1106b3777],
2	)	NN	O	)	nn	3	SENT_342	[p14l731t3683r1106b3777],
3	kinase	NN	O	kinase	_	0	SENT_342	[p14l1152t3676r1466b3765],
4	and	CC	O	and	_	0	SENT_342	[p14l1506t3676r1683b3763],
5	anaplas	NN	O	anapla	nn	6	SENT_342	[p14l1723t3676r2130b3788],
6	—	NN	O	—	conj_and	3	SENT_342	[p14l1723t3676r2130b3788],

1	tic	JJ	O	tic	amod	3	SENT_343	[p15l93t24r210b109],
2	lymphoma	NN	O	lymphoma	nn	3	SENT_343	[p15l252t24r771b134],
3	l	NN	O	l	dep	4	SENT_343	[p15l813t22r1127b111],
4	<	JJR	O	<	_	0	SENT_343	[p15l813t22r1127b111],
5	inase	CD	NUMBER	inase	num	7	SENT_343	[p15l813t22r1127b111],
6	(	NN	O	(	nn	7	SENT_343	[p15l1178t30r1479b123],
7	ALK	NN	O	alk	dep	4	SENT_343	[p15l1178t30r1479b123],
8	)	CD	NUMBER	)	dep	7	SENT_343	[p15l1178t30r1479b123],
9	.	.	O	.	_	0	SENT_343	[p15l1178t30r1479b123],

1	I	PRP	O	I	nsubj	2	SENT_344	[p15l1519t31r1561b123],
2	Med	VBD	O	med	_	0	SENT_344	[p15l1599t22r1809b109],
3	Chem	NNP	O	Chem	dobj	2	SENT_344	[p15l1852t22r2132b109],
4	2011	CD	DATE	2011	num	3	SENT_344	[p15l93t173r916b272],
5	;	:	O	;	_	0	SENT_344	[p15l93t173r916b272],
6	54:6342	CD	NUMBER	54:6342	number	7	SENT_344	[p15l93t173r916b272],
7	—	CD	NUMBER	—	dep	3	SENT_344	[p15l93t173r916b272],
8	63	CD	NUMBER	63	dep	7	SENT_344	[p15l93t173r916b272],
9	.	.	O	.	_	0	SENT_344	[p15l93t173r916b272],

1	21	CD	NUMBER	21	_	0	SENT_345	[p15l91t319r223b396],
2	.	.	O	.	_	0	SENT_345	[p15l91t319r223b396],

1	Gorre	NNP	ORGANIZATION	Gorre	nn	2	SENT_346	[p15l282t315r564b396],
2	ME	NNP	O	ME	_	0	SENT_346	[p15l594t317r781b415],
3	,	,	O	,	_	0	SENT_346	[p15l594t317r781b415],
4	Mohammed	NNP	PERSON	Mohammed	nn	5	SENT_346	[p15l819t308r1409b396],
5	M	NNP	PERSON	M	appos	2	SENT_346	[p15l1439t317r1561b415],
6	,	,	O	,	_	0	SENT_346	[p15l1439t317r1561b415],
7	Ellwood	NNP	PERSON	Ellwood	nn	8	SENT_346	[p15l1599t308r1995b396],
8	K	NNP	PERSON	K	appos	2	SENT_346	[p15l2029t317r2125b415],
9	,	,	O	,	_	0	SENT_346	[p15l2029t317r2125b415],
10	et	FW	O	et	nn	11	SENT_346	[p15l93t470r180b539],
11	al.	FW	O	al.	appos	2	SENT_346	[p15l208t453r318b539],
12	.	.	O	.	_	0	SENT_346	[p15l208t453r318b539],

1	Clinical	JJ	O	clinical	amod	2	SENT_347	[p15l358t451r735b539],
2	resistance	NN	O	resistance	nsubj	8	SENT_347	[p15l768t453r1253b539],
3	to	TO	O	to	_	0	SENT_347	[p15l1289t470r1380b539],
4	ST	JJ	O	st	amod	7	SENT_347	[p15l1418t458r1539b539],
5	I-571	NN	MISC	i-571	nn	7	SENT_347	[p15l1542t458r1784b539],
6	cancer	NN	O	cancer	nn	7	SENT_347	[p15l1818t480r2136b539],
7	therapy	NN	O	therapy	prep_to	2	SENT_347	[p15l93t593r457b705],
8	caused	VBN	O	cause	_	0	SENT_347	[p15l514t593r840b681],
9	by	IN	O	by	_	0	SENT_347	[p15l902t595r1011b705],
10	BCR	NN	O	bcr	prep_by	8	SENT_347	[p15l1064t600r1506b686],
11	.	.	O	.	_	0	SENT_347	[p15l1064t600r1506b686],

1	—	NN	O	—	_	0	SENT_348	[p15l1064t600r1506b686],
2	.	.	O	.	_	0	SENT_348	[p15l1064t600r1506b686],

1	ABL	NN	ORGANIZATION	abl	nn	2	SENT_349	[p15l1064t600r1506b686],
2	gene	NN	O	gene	_	0	SENT_349	[p15l1565t622r1788b705],
3	mutation	NN	O	mutation	dep	2	SENT_349	[p15l1850t612r2130b681, p15l93t737r284b822],
4	or	CC	O	or	_	0	SENT_349	[p15l343t763r442b822],
5	ampliﬁcation	NN	O	ampliﬁcation	dep	2	SENT_349	[p15l497t735r1184b847],
6	.	.	O	.	_	0	SENT_349	[p15l497t735r1184b847],

1	Science	NNP	O	Science	_	0	SENT_350	[p15l1252t737r1605b822],
2	2001	CD	DATE	2001	num	1	SENT_350	[p15l1664t742r2128b841],
3	;	:	O	;	_	0	SENT_350	[p15l1664t742r2128b841],
4	293	CD	NUMBER	293	num	6	SENT_350	[p15l1664t742r2128b841],
5	:	:	O	:	_	0	SENT_350	[p15l1664t742r2128b841],
6	876-80	CD	NUMBER	876-80	dep	1	SENT_350	[p15l93t886r444b966],
7	.	.	O	.	_	0	SENT_350	[p15l93t886r444b966],

1	22	CD	NUMBER	22	_	0	SENT_351	[p15l91t1031r227b1107],
2	.	.	O	.	_	0	SENT_351	[p15l91t1031r227b1107],

1	Kobayashi	NNP	LOCATION	Kobayashi	nn	2	SENT_352	[p15l282t1020r781b1132],
2	S	NNP	LOCATION	S	_	0	SENT_352	[p15l830t1027r907b1126],
3	,	,	O	,	_	0	SENT_352	[p15l830t1027r907b1126],
4	Boggon	NNP	PERSON	Boggon	nn	6	SENT_352	[p15l960t1028r1336b1132],
5	T	NN	O	t	nn	6	SENT_352	[p15l1380t1027r1508b1126],
6	]	NN	O	]	appos	2	SENT_352	[p15l1380t1027r1508b1126],
7	,	,	O	,	_	0	SENT_352	[p15l1380t1027r1508b1126],
8	Dayaram	NN	ORGANIZATION	dayaram	nn	9	SENT_352	[p15l1561t1028r1995b1132],
9	T	NN	ORGANIZATION	t	appos	2	SENT_352	[p15l2040t1027r2126b1126],
10	,	,	O	,	_	0	SENT_352	[p15l2040t1027r2126b1126],
11	et	FW	O	et	nn	12	SENT_352	[p15l93t1182r181b1250],
12	al.	FW	O	al.	appos	2	SENT_352	[p15l244t1163r353b1250],
13	.	.	O	.	_	0	SENT_352	[p15l244t1163r353b1250],

1	EGFR	NN	ORGANIZATION	egfr	nn	2	SENT_353	[p15l426t1171r665b1252],
2	mutation	NN	O	mutation	_	0	SENT_353	[p15l727t1165r1171b1250],
3	and	CC	O	and	_	0	SENT_353	[p15l1239t1163r1416b1250],
4	resistance	NN	O	resistance	conj_and	2	SENT_353	[p15l1485t1165r1970b1250],
5	of	IN	O	of	_	0	SENT_353	[p15l2041t1163r2153b1250],
6	non	JJ	O	non	amod	10	SENT_353	[p15l92t1304r819b1391],
7	—	JJ	O	—	amod	10	SENT_353	[p15l92t1304r819b1391],
8	small-cell	NN	O	small-cell	nn	10	SENT_353	[p15l92t1304r819b1391],
9	lung	NN	O	lung	nn	10	SENT_353	[p15l878t1306r1095b1416],
10	cancer	NN	O	cancer	prep_of	2	SENT_353	[p15l1152t1333r1470b1391],
11	to	TO	O	to	_	0	SENT_353	[p15l1527t1323r1618b1391],
12	gefitinib	NN	O	gefitinib	prep_to	2	SENT_353	[p15l1679t1304r2126b1416],
13	.	.	O	.	_	0	SENT_353	[p15l1679t1304r2126b1416],

1	N	NN	O	n	nn	3	SENT_354	[p15l90t1455r174b1534],
2	Engl	NNP	O	Engl	nn	3	SENT_354	[p15l208t1447r495b1558],
3	]	NNP	O	]	nsubj	4	SENT_354	[p15l208t1447r495b1558],
4	Med	VBD	O	med	_	0	SENT_354	[p15l527t1446r737b1533],
5	2005	CD	DATE	2005	dobj	4	SENT_354	[p15l775t1453r1594b1552],
6	;	:	O	;	_	0	SENT_354	[p15l775t1453r1594b1552],
7	352:786	CD	NUMBER	352:786	number	8	SENT_354	[p15l775t1453r1594b1552],
8	—	CD	NUMBER	—	dep	5	SENT_354	[p15l775t1453r1594b1552],
9	92	CD	NUMBER	92	dep	8	SENT_354	[p15l775t1453r1594b1552],
10	.	.	O	.	_	0	SENT_354	[p15l775t1453r1594b1552],

1	23	CD	NUMBER	23	_	0	SENT_355	[p15l91t1599r223b1675],
2	.	.	O	.	_	0	SENT_355	[p15l91t1599r223b1675],

1	Sequist	NNP	O	Sequist	nn	2	SENT_356	[p15l286t1590r638b1700],
2	LV	NNP	O	LV	_	0	SENT_356	[p15l678t1597r811b1694],
3	,	,	O	,	_	0	SENT_356	[p15l678t1597r811b1694],
4	Waltman	NNP	PERSON	Waltman	nn	5	SENT_356	[p15l862t1588r1308b1675],
5	BA	NN	O	ba	appos	2	SENT_356	[p15l1354t1596r1518b1694],
6	,	,	O	,	_	0	SENT_356	[p15l1354t1596r1518b1694],
7	Dias	NNP	O	Dias	appos	5	SENT_356	[p15l1570t1590r2130b1675],
8	.	.	O	.	_	0	SENT_356	[p15l1570t1590r2130b1675],

1	—	NN	O	—	_	0	SENT_357	[p15l1570t1590r2130b1675],
2	.	.	O	.	_	0	SENT_357	[p15l1570t1590r2130b1675],

1	Santa	NNP	LOCATION	Santa	nn	3	SENT_358	[p15l1570t1590r2130b1675],
2	gata	NNP	O	gata	nn	3	SENT_358	[p15l92t1749r297b1842],
3	D	NNP	O	D	_	0	SENT_358	[p15l343t1738r442b1836],
4	,	,	O	,	_	0	SENT_358	[p15l343t1738r442b1836],
5	et	FW	O	et	nn	6	SENT_358	[p15l497t1749r583b1817],
6	al.	FW	O	al.	appos	3	SENT_358	[p15l626t1730r735b1817],
7	.	.	O	.	_	0	SENT_358	[p15l626t1730r735b1817],

1	Genotypic	JJ	MISC	genotypic	amod	4	SENT_359	[p15l790t1732r1287b1842],
2	and	CC	O	and	_	0	SENT_359	[p15l1334t1730r1512b1817],
3	histological	JJ	O	histological	conj_and	1	SENT_359	[p15l1559t1730r2132b1842],
4	evolution	NN	O	evolution	_	0	SENT_359	[p15l93t1874r539b1960],
5	of	IN	O	of	_	0	SENT_359	[p15l581t1872r693b1959],
6	lung	NN	O	lung	nn	7	SENT_359	[p15l710t1872r929b1984],
7	cancers	NNS	O	cancer	prep_of	4	SENT_359	[p15l965t1901r1327b1959],
8	acquiring	VBG	O	acquire	partmod	4	SENT_359	[p15l1370t1874r1837b1984],
9	resistance	NN	O	resistance	dobj	8	SENT_359	[p15l1873t1874r2130b1959, p15l93t2033r351b2101],
10	to	TO	O	to	_	0	SENT_359	[p15l394t2033r486b2101],
11	EGFR	NN	ORGANIZATION	egfr	nn	12	SENT_359	[p15l528t2021r815b2107],
12	inhibitors	NNS	O	inhibitor	prep_to	8	SENT_359	[p15l845t2014r1352b2101],
13	.	.	O	.	_	0	SENT_359	[p15l845t2014r1352b2101],

1	Sci	NNP	O	Sci	nn	3	SENT_360	[p15l1403t2016r1538b2101],
2	Transl	NNP	O	Transl	nn	3	SENT_360	[p15l1576t2014r1884b2101],
3	Med	NNP	O	Med	_	0	SENT_360	[p15l1923t2014r2132b2101],

1	2011	CD	DATE	2011	_	0	SENT_361	[p15l93t2165r796b2264],
2	;	:	O	;	_	0	SENT_361	[p15l93t2165r796b2264],
3	3:75	CD	NUMBER	3:75	num	4	SENT_361	[p15l93t2165r796b2264],
4	ra26	NN	O	ra26	dep	1	SENT_361	[p15l93t2165r796b2264],
5	.	.	O	.	_	0	SENT_361	[p15l93t2165r796b2264],

1	24	CD	NUMBER	24	_	0	SENT_362	[p15l91t2310r223b2386],
2	.	.	O	.	_	0	SENT_362	[p15l91t2310r223b2386],

1	Gerlinger	NN	O	gerlinger	nn	2	SENT_363	[p15l284t2301r750b2411],
2	M	NN	O	m	_	0	SENT_363	[p15l775t2308r897b2405],
3	,	,	O	,	_	0	SENT_363	[p15l775t2308r897b2405],
4	Rowan	NNP	PERSON	Rowan	nn	6	SENT_363	[p15l933t2307r1268b2392],
5	A	NNP	O	A	nn	6	SENT_363	[p15l1296t2308r1426b2405],
6	]	NN	O	]	appos	2	SENT_363	[p15l1296t2308r1426b2405],
7	,	,	O	,	_	0	SENT_363	[p15l1296t2308r1426b2405],
8	Horswell	NNP	PERSON	Horswell	nn	9	SENT_363	[p15l1464t2299r1902b2387],
9	S	NNP	O	S	appos	2	SENT_363	[p15l1936t2306r2012b2405],
10	,	,	O	,	_	0	SENT_363	[p15l1936t2306r2012b2405],
11	et	FW	O	et	nn	12	SENT_363	[p15l2050t2318r2138b2386],
12	al.	FW	O	al.	appos	2	SENT_363	[p15l92t2441r199b2528],
13	.	.	O	.	_	0	SENT_363	[p15l92t2441r199b2528],

1	Intratumor	JJ	O	intratumor	amod	2	SENT_364	[p15l238t2450r771b2529],
2	heterogeneity	NN	O	heterogeneity	_	0	SENT_364	[p15l802t2441r1452b2553],
3	and	CC	O	and	_	0	SENT_364	[p15l1481t2441r1656b2528],
4	branched	VBD	O	branch	amod	5	SENT_364	[p15l1690t2441r2132b2529],
5	evolution	NN	O	evolution	conj_and	2	SENT_364	[p15l93t2583r530b2671],
6	revealed	VBN	O	reveal	partmod	2	SENT_364	[p15l562t2583r950b2671],
7	by	IN	O	by	_	0	SENT_364	[p15l982t2585r1091b2695],
8	multiregion	JJ	O	multiregion	amod	9	SENT_364	[p15l1117t2585r1683b2695],
9	sequencing	NN	O	sequencing	agent	6	SENT_364	[p15l1717t2612r2130b2695, p15l92t2727r267b2837],
10	.	.	O	.	_	0	SENT_364	[p15l1717t2612r2130b2695, p15l92t2727r267b2837],

1	N	NN	O	n	nn	3	SENT_365	[p15l324t2734r406b2813],
2	Engl	NNP	O	Engl	nn	3	SENT_365	[p15l455t2725r674b2837],
3	J	NNP	O	J	nsubj	4	SENT_365	[p15l714t2734r756b2826],
4	Med	VBD	O	med	_	0	SENT_365	[p15l802t2725r1011b2812],
5	2012	CD	DATE	2012	dobj	4	SENT_365	[p15l1064t2732r1892b2831],
6	;	:	O	;	_	0	SENT_365	[p15l1064t2732r1892b2831],
7	366:883	CD	NUMBER	366:883	number	8	SENT_365	[p15l1064t2732r1892b2831],
8	—	CD	NUMBER	—	dep	5	SENT_365	[p15l1064t2732r1892b2831],
9	92	CD	NUMBER	92	dep	8	SENT_365	[p15l1064t2732r1892b2831],
10	.	.	O	.	_	0	SENT_365	[p15l1064t2732r1892b2831],

1	[	NN	O	[	nn	2	SENT_366	[p15l1961t2733r2130b2826, p15l92t2886r412b2973],
2	Erratum	NN	O	erratum	nsubj	7	SENT_366	[p15l1961t2733r2130b2826, p15l92t2886r412b2973],
3	,	,	O	,	_	0	SENT_366	[p15l1961t2733r2130b2826, p15l92t2886r412b2973],
4	N	NN	O	n	appos	2	SENT_366	[p15l453t2876r537b2955],
5	Engl	NNP	O	Engl	nn	6	SENT_366	[p15l571t2867r790b2979],
6	J	NNP	O	J	dep	4	SENT_366	[p15l817t2876r859b2968],
7	Med	VBD	O	med	_	0	SENT_366	[p15l891t2867r1101b2954],
8	2012	CD	DATE	2012	dobj	7	SENT_366	[p15l1138t2874r1826b2973],
9	;	:	O	;	_	0	SENT_366	[p15l1138t2874r1826b2973],
10	367:976	CD	NUMBER	367:976	dep	8	SENT_366	[p15l1138t2874r1826b2973],
11	.	.	O	.	_	0	SENT_366	[p15l1138t2874r1826b2973],
12	]	SYM	O	]	dep	8	SENT_366	[p15l1138t2874r1826b2973],

1	25	CD	NUMBER	25	_	0	SENT_367	[p15l91t3020r221b3096],
2	.	.	O	.	_	0	SENT_367	[p15l91t3020r221b3096],

1	Govindan	NNP	PERSON	Govindan	nn	2	SENT_368	[p15l284t3009r760b3097],
2	R	NNP	PERSON	R	_	0	SENT_368	[p15l794t3017r891b3115],
3	,	,	O	,	_	0	SENT_368	[p15l794t3017r891b3115],
4	Ding	NNP	PERSON	Ding	nn	5	SENT_368	[p15l929t3011r1169b3121],
5	L	NNP	PERSON	L	appos	2	SENT_368	[p15l1198t3018r1283b3115],
6	,	,	O	,	_	0	SENT_368	[p15l1198t3018r1283b3115],
7	Griffith	NNP	PERSON	Griffith	nn	8	SENT_368	[p15l1325t3009r1706b3096],
8	M	NNP	O	M	appos	2	SENT_368	[p15l1738t3018r1858b3115],
9	,	,	O	,	_	0	SENT_368	[p15l1738t3018r1858b3115],
10	et	FW	O	et	nn	11	SENT_368	[p15l1900t3028r1987b3096],
11	al.	FW	O	al.	appos	2	SENT_368	[p15l2016t3009r2126b3096],
12	.	.	O	.	_	0	SENT_368	[p15l2016t3009r2126b3096],

1	Genomic	JJ	MISC	genomic	amod	2	SENT_369	[p15l93t3153r526b3238],
2	landscape	NN	O	landscape	_	0	SENT_369	[p15l562t3151r1036b3263],
3	of	IN	O	of	_	0	SENT_369	[p15l1075t3151r1186b3238],
4	non	JJ	O	non	amod	9	SENT_369	[p15l1203t3151r1687b3238],
5	—	JJ	O	—	amod	9	SENT_369	[p15l1203t3151r1687b3238],
6	small	JJ	O	small	amod	9	SENT_369	[p15l1203t3151r1687b3238],
7	cell	NN	O	cell	nn	9	SENT_369	[p15l1725t3151r1886b3238],
8	lung	NN	O	lung	nn	9	SENT_369	[p15l1921t3153r2136b3263],
9	cancer	NN	O	cancer	prep_of	2	SENT_369	[p15l93t3322r404b3381],
10	in	IN	O	in	_	0	SENT_369	[p15l432t3296r526b3379],
11	smokers	NNS	O	smoker	nn	15	SENT_369	[p15l560t3294r954b3383],
12	and	CC	O	and	cc	11	SENT_369	[p15l988t3294r1163b3381],
13	never	RB	O	never	advmod	11	SENT_369	[p15l1195t3296r1911b3383],
14	—	JJ	O	—	amod	15	SENT_369	[p15l1195t3296r1911b3383],
15	smokers	NNS	O	smoker	prep_in	2	SENT_369	[p15l1195t3296r1911b3383],
16	.	.	O	.	_	0	SENT_369	[p15l1195t3296r1911b3383],

1	Cell	NN	O	cell	_	0	SENT_370	[p15l1949t3294r2132b3381],

1	2012	CD	DATE	2012	_	0	SENT_371	[p15l92t3444r971b3543],
2	;	:	O	;	_	0	SENT_371	[p15l92t3444r971b3543],
3	150:1121	CD	NUMBER	150:1121	number	4	SENT_371	[p15l92t3444r971b3543],
4	—	CD	NUMBER	—	dep	1	SENT_371	[p15l92t3444r971b3543],
5	34	CD	NUMBER	34	dep	4	SENT_371	[p15l92t3444r971b3543],
6	.	.	O	.	_	0	SENT_371	[p15l92t3444r971b3543],

1	Copyright	NN	O	copyright	_	0	SENT_372	[p15l95t3564r450b3659],
2	©	CD	NUMBER	©	num	6	SENT_372	[p15l485t3572r564b3651],
3	2013	CD	DATE	2013	num	6	SENT_372	[p15l603t3569r787b3636],
4	Massachusetts	NNP	ORGANIZATION	Massachusetts	nn	6	SENT_372	[p15l824t3564r1357b3636],
5	Medical	NNP	ORGANIZATION	Medical	nn	6	SENT_372	[p15l1391t3564r1685b3636],
6	Society	NNP	ORGANIZATION	Society	dep	1	SENT_372	[p15l1715t3568r1989b3657],
7	.	.	O	.	_	0	SENT_372	[p15l1715t3568r1989b3657],

1	MY	NNP	O	MY	nn	2	SENT_373	[p16l879t250r911b266],
2	NEJM	NNP	O	NEJM	_	0	SENT_373	[p16l923t250r979b271],
3	IN	IN	O	in	_	0	SENT_373	[p16l993t250r1015b266],
4	THE	DT	O	the	det	6	SENT_373	[p16l1027t250r1071b266],
5	JOURNAL	NN	O	journal	nn	6	SENT_373	[p16l1078t250r1184b271],
6	ONLINE	NN	O	online	prep_in	2	SENT_373	[p16l1195t250r1282b266],

1	Individual	JJ	O	individual	amod	2	SENT_374	[p16l648t285r774b308],
2	subscribers	NNS	O	subscriber	nsubj	4	SENT_374	[p16l783t285r926b308],
3	can	MD	O	can	aux	4	SENT_374	[p16l936t292r978b308],
4	store	VB	O	store	_	0	SENT_374	[p16l987t290r1049b308],
5	articles	NNS	O	article	dobj	4	SENT_374	[p16l1057t285r1146b308],
6	and	CC	O	and	_	0	SENT_374	[p16l1155t285r1202b308],
7	searches	NNS	O	search	conj_and	5	SENT_374	[p16l1211t285r1317b308],
8	using	VBG	O	use	xcomp	4	SENT_374	[p16l1326t285r1396b315],
9	a	DT	O	a	det	10	SENT_374	[p16l1404t293r1416b308],
10	feature	NN	O	feature	dobj	8	SENT_374	[p16l1425t285r1511b308],
11	on	IN	O	on	_	0	SENT_374	[p16l732t330r763b346],
12	the	DT	O	the	det	13	SENT_374	[p16l772t322r810b346],
13	journal	NN	O	journal	poss	18	SENT_374	[p16l819t322r925b352],
14	’s	POS	O	’s	_	0	SENT_374	[p16l819t322r925b352],
15	website	NN	O	website	nn	18	SENT_374	[p16l933t323r1029b346],
16	(	CD	NUMBER	(	num	18	SENT_374	[p16l1039t324r1181b352],
17	NEJM.org	NN	O	nejm.org	nn	18	SENT_374	[p16l1039t324r1181b352],
18	)	NN	O	)	prep_on	8	SENT_374	[p16l1039t324r1181b352],
19	called	VBN	O	call	partmod	18	SENT_374	[p16l1192t323r1264b346],
20	“	CD	NUMBER	“	dobj	19	SENT_374	[p16l1274t324r1325b352],
21	My	PRP$	O	my	poss	22	SENT_374	[p16l1274t324r1325b352],
22	NEJM	NNP	O	NEJM	dep	20	SENT_374	[p16l1332t324r1426b349],
23	.	.	O	.	_	0	SENT_374	[p16l1332t324r1426b349],

1	”	NN	O	”	_	0	SENT_375	[p16l1332t324r1426b349],

1	Each	DT	O	each	det	2	SENT_376	[p16l658t360r718b383],
2	article	NN	O	article	nsubj	5	SENT_376	[p16l727t360r804b383],
3	and	CC	O	and	_	0	SENT_376	[p16l812t360r859b383],
4	search	NN	O	search	nsubj	5	SENT_376	[p16l868t360r948b383],
5	result	VBP	O	result	_	0	SENT_376	[p16l956t360r1028b383],
6	links	NNS	O	link	dobj	5	SENT_376	[p16l1035t360r1096b383],
7	to	TO	O	to	_	0	SENT_376	[p16l1105t365r1129b383],
8	this	DT	O	this	det	9	SENT_376	[p16l1138t360r1183b383],
9	feature	NN	O	feature	prep_to	5	SENT_376	[p16l1192t360r1286b383],
10	.	.	O	.	_	0	SENT_376	[p16l1192t360r1286b383],

1	Users	NNS	O	user	nsubj	3	SENT_377	[p16l1296t362r1366b383],
2	can	MD	O	can	aux	3	SENT_377	[p16l1375t368r1418b383],
3	create	VB	O	create	_	0	SENT_377	[p16l1427t365r1500b383],
4	personal	JJ	O	personal	amod	5	SENT_377	[p16l611t398r721b427],
5	folders	NNS	O	folder	dobj	3	SENT_377	[p16l729t397r816b421],
6	and	CC	O	and	_	0	SENT_377	[p16l825t398r871b421],
7	move	VB	O	move	conj_and	3	SENT_377	[p16l879t405r946b421],
8	articles	NNS	O	article	dobj	7	SENT_377	[p16l954t398r1044b421],
9	into	IN	O	into	_	0	SENT_377	[p16l1053t398r1102b421],
10	them	PRP	O	they	prep_into	7	SENT_377	[p16l1111t398r1175b421],
11	for	IN	O	for	_	0	SENT_377	[p16l1184t397r1220b421],
12	convenient	JJ	O	convenient	amod	13	SENT_377	[p16l1228t398r1366b421],
13	retrieval	NN	O	retrieval	prep_for	10	SENT_377	[p16l1374t398r1475b421],
14	later	RB	O	later	advmod	7	SENT_377	[p16l1483t398r1545b421],
15	.	.	O	.	_	0	SENT_377	[p16l1483t398r1545b421],

1	N	NN	O	n	nn	3	SENT_378	[p16l268t710r306b753],
2	ENGLJ	NN	O	englj	nn	3	SENT_378	[p16l349t710r569b771],
3	MED	NN	O	med	_	0	SENT_378	[p16l612t710r759b752],
4	368	CD	NUMBER	368	dep	3	SENT_378	[p16l788t693r1013b770],
5	;	:	O	;	_	0	SENT_378	[p16l788t693r1013b770],
6	25	CD	NUMBER	25	num	8	SENT_378	[p16l788t693r1013b770],
7	NEJM.ORG	NN	O	nejm.org	nn	8	SENT_378	[p16l1113t710r1465b771],
8	JUNE	NN	DATE	june	dep	4	SENT_378	[p16l1554t710r1735b771],
9	20	CD	DATE	20	dep	8	SENT_378	[p16l1766t710r1872b764],
10	,	,	DATE	,	_	0	SENT_378	[p16l1766t710r1872b764],
11	2013	CD	DATE	2013	appos	9	SENT_378	[p16l1904t710r2061b770],

1	The	DT	O	the	det	4	SENT_379	[p16l638t804r782b870],
2	New	NNP	O	New	nn	4	SENT_379	[p16l809t806r984b870],
3	England	NNP	O	England	nn	4	SENT_379	[p16l1011t804r1326b890],
4	Journal	NNP	O	Journal	_	0	SENT_379	[p16l1351t804r1627b870],
5	of	IN	O	of	_	0	SENT_379	[p16l1655t803r1737b870],
6	Medicine	NNP	O	Medicine	prep_of	4	SENT_379	[p16l1756t803r2112b870],

